approved_symbol,hgnc_id,evidence_count,source_count_percentile,pLI,oe_lof,lof_z,mis_z,omim_summary,gencc_summary,clingen_summary,clinvar,clinical_groups_p,onset_groups_p,syndromic_groups_p,mgi_phenotype,interaction_score,stringdb_interaction_sum_score,stringdb_interaction_normalized_score,stringdb_interaction_string,expression_score,gtex_kidney_medulla,gtex_kidney_cortex,descartes_kidney_tpm,cur_id
ACE,2707,5,4.257174056734751,0,0.8746,0.97837,-0.69323,"{Stroke, hemorrhagic}[OMIM:614519]-NA | Renal tubular dysgenesis[OMIM:267430]-Autosomal recessive inheritance | {Microvascular complications of diabetes 3}[OMIM:612624]-NA","Limited, Supportive (renal tubular dysgenesis of genetic origin[MONDO:0009970]-Autosomal recessive) | Limited (intracerebral hemorrhage[MONDO:0013792]-Unknown) | Strong (renal tubular dysgenesis[MONDO:0017609]-Autosomal recessive)",NULL,P:24; LP:15; VUS:221,OMIM:267430 (complement: 0.143 | cakut: 0.016 | glomerulopathy: 0.007 | cyst_cilio: 0.003),NULL,OMIM:267430 (syndromic: 0.014 | skeletal: 0.05 | neurologic: 0.029),hm (true); ht (true),0.5,3097,0.5723270440251572,"9606.ENSP00000252486:325, 9606.ENSP00000305302:442, 9606.ENSP00000215832:379, 9606.ENSP00000355627:700, 9606.ENSP00000368727:311, 9606.ENSP00000231509:216, 9606.ENSP00000216181:508, 9606.ENSP00000325822:216",0,2.02982,3.8524,2.0540630055529,cur_001
ACTG2,145,4,3.007962351574665,NULL,NULL,NULL,NULL,Megacystis-microcolon-intestinal hypoperistalsis syndrome 5[OMIM:619431]-Autosomal dominant inheritance | Visceral myopathy 1[OMIM:155310]-Autosomal dominant inheritance,Supportive (megacystis-microcolon-intestinal hypoperistalsis syndrome[MONDO:0007960]-Autosomal dominant) | Supportive (familial visceral myopathy[MONDO:0016829]-Autosomal dominant) | Strong (visceral myopathy 1[MONDO:0020754]-Autosomal dominant),NULL,P:22; LP:17; VUS:28,OMIM:155310 (cakut: 0.137 | cyst_cilio: 0.021 | cancer: 0.02 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002); OMIM:619431 (cakut: 0.097 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:619431 (antenatal_or_congenital: 0.899),OMIM:155310 (syndromic: 0.005 | neurologic: 0.011),hm (false); ht (false),0.5,2582,0.5073375262054507,"9606.ENSP00000262518:194, 9606.ENSP00000357283:209, 9606.ENSP00000311505:153, 9606.ENSP00000252699:206, 9606.ENSP00000216181:910, 9606.ENSP00000379616:910",0,2.30606,0.9816030000000001,0.838759965043748,cur_002
ACTN4,166,5,4.057388332144462,1,0.02077,6.2964,4.1552,"Glomerulosclerosis, focal segmental, 1[OMIM:603278]-Autosomal dominant inheritance","Moderate (focal segmental glomerulosclerosis 1[MONDO:0011303]-Autosomal dominant) | Strong, Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:5; LP:5; VUS:89,OMIM:603278 (glomerulopathy: 0.235 | cyst_cilio: 0.165 | cakut: 0.069 | cancer: 0.05 | tubulopathy: 0.049 | nephrocalcinosis: 0.042 | complement: 0.036),NULL,NULL,hm (true); ht (false),1,11037,0.9308176100628931,"9606.ENSP00000269305:163, 9606.ENSP00000231509:309, 9606.ENSP00000265970:190, 9606.ENSP00000358866:187, 9606.ENSP00000288235:321, 9606.ENSP00000386896:650, 9606.ENSP00000352264:437, 9606.ENSP00000386857:206, 9606.ENSP00000362924:292, 9606.ENSP00000356587:739, 9606.ENSP00000482968:380, 9606.ENSP00000356319:292, 9606.ENSP00000376410:336, 9606.ENSP00000379204:206, 9606.ENSP00000367316:650, 9606.ENSP00000265748:473, 9606.ENSP00000216181:447, 9606.ENSP00000362424:292, 9606.ENSP00000200181:650, 9606.ENSP00000340913:454, 9606.ENSP00000377789:728, 9606.ENSP00000287820:292, 9606.ENSP00000356405:292, 9606.ENSP00000368190:914, 9606.ENSP00000346839:346, 9606.ENSP00000228606:292, 9606.ENSP00000352138:499",0.5,157.86700000000002,140.608,426.248179504114,cur_003
ADAMTS13,1366,5,3.273615423619376,NULL,NULL,NULL,NULL,"Thrombotic thrombocytopenic purpura, hereditary[OMIM:274150]-Autosomal recessive inheritance","Definitive, Strong, Strong, Supportive (congenital thrombotic thrombocytopenic purpura[MONDO:0010122]-Autosomal recessive)",Definitive (congenital thrombotic thrombocytopenic purpura[MONDO:0010122]-AR),P:41; LP:22; VUS:227,OMIM:274150 (complement: 0.143 | glomerulopathy: 0.042 | tubulopathy: 0.028 | nephrocalcinosis: 0.021),NULL,OMIM:274150 (syndromic: 0.005 | neurologic: 0.01),hm (false); ht (false),0.5,793,0.1928721174004193,"9606.ENSP00000386896:244, 9606.ENSP00000367316:225, 9606.ENSP00000437256:161, 9606.ENSP00000280481:163",0.5,4.84555,3.2947699999999998,13.3578951909432,cur_004
ADAMTS9,13202,2,1.797236241211451,1e-6,0.29427,7.1321,0.95461,NULL,Limited (ciliopathy[MONDO:0005308]-Autosomal recessive) | Supportive (nephronophthisis 1[MONDO:0009728]-Autosomal recessive),Limited (ciliopathy[MONDO:0005308]-AR),P:0; LP:1; VUS:120,NULL,NULL,NULL,hm (false); ht (false),0,171,0.031446540880503145,9606.ENSP00000256646:171,0.5,11.9264,10.9867,204.377287163022,cur_005
ADCY10,21285,4,2.0714247394040384,0,0.84637,1.2854,0.45524,"{Hypercalciuria, absorptive, susceptibility to}[OMIM:143870]-Autosomal dominant inheritance","Strong, Limited (hypercalciuria, absorptive, 2[MONDO:0007748]-Autosomal dominant) | Supportive (idiopathic inherited hypercalciuria[MONDO:0016352]-Autosomal dominant)",NULL,P:15; LP:3; VUS:139,OMIM:143870 (tubulopathy: 0.028 | nephrocalcinosis: 0.021),NULL,NULL,hm (false); ht (false),0,300,0.07127882599580712,9606.ENSP00000078429:300,0,0.028280700000000002,0.0295587,4.05616707548396,cur_006
AFF3,6473,2,1.0390919821927485,NULL,NULL,NULL,NULL,KINSSHIP syndrome[OMIM:619297]-Autosomal dominant inheritance,NULL,NULL,P:7; LP:4; VUS:56,OMIM:619297 (cakut: 0.117 | cancer: 0.1 | cyst_cilio: 0.047 | glomerulopathy: 0.011 | tubulopathy: 0.007),NULL,OMIM:619297 (syndromic: 0.163 | growth: 0.421 | skeletal: 0.174 | neurologic: 0.176),hm (false); ht (false),0,540,0.13626834381551362,9606.ENSP00000356405:540,1,0.765606,0.734201,1323.30740570324,cur_007
AGT,333,5,4.152697193639472,0,0.89384,0.36045,-0.19921,"Renal tubular dysgenesis[OMIM:267430]-Autosomal recessive inheritance | {Hypertension, essential, susceptibility to}[OMIM:145500]-Multifactorial inheritance",Supportive (renal tubular dysgenesis of genetic origin[MONDO:0009970]-Autosomal recessive) | Strong (renal tubular dysgenesis[MONDO:0017609]-Autosomal recessive),NULL,P:6; LP:5; VUS:76,OMIM:267430 (complement: 0.143 | cakut: 0.016 | glomerulopathy: 0.007 | cyst_cilio: 0.003),NULL,OMIM:267430 (syndromic: 0.014 | skeletal: 0.05 | neurologic: 0.029),hm (true); ht (true),0.5,4966,0.740041928721174,"9606.ENSP00000272190:961, 9606.ENSP00000269305:229, 9606.ENSP00000350815:614, 9606.ENSP00000315011:693, 9606.ENSP00000290866:700, 9606.ENSP00000346839:292, 9606.ENSP00000347244:229, 9606.ENSP00000260649:910, 9606.ENSP00000339191:175, 9606.ENSP00000237014:163",0,17.4583,28.7566,1.15796494559246,cur_008
AGTR1,336,5,4.086652680860323,NULL,NULL,NULL,NULL,"{Hypertension, essential}[OMIM:145500]-Multifactorial inheritance | Renal tubular dysgenesis[OMIM:267430]-Autosomal recessive inheritance","No Known Disease Relationship (essential hypertension, genetic[MONDO:0007781]-Unknown) | Moderate, Supportive (renal tubular dysgenesis of genetic origin[MONDO:0009970]-Autosomal recessive)",NULL,P:5; LP:4; VUS:67,OMIM:267430 (complement: 0.143 | cakut: 0.016 | glomerulopathy: 0.007 | cyst_cilio: 0.003),NULL,OMIM:267430 (syndromic: 0.014 | skeletal: 0.05 | neurologic: 0.029),hm (true); ht (false),0,NULL,NULL,NULL,0.5,5.070209999999999,5.55385,36.7676972052136,cur_009
AGXT,341,5,3.8985108168976494,0,0.65744,1.4648,-0.26789,"Hyperoxaluria, primary, type 1[OMIM:259900]-Autosomal recessive inheritance","Definitive, Definitive, Definitive, Strong, Supportive (primary hyperoxaluria type 1[MONDO:0009823]-Autosomal recessive) | Definitive (alanine glyoxylate aminotransferase deficiency[MONDO:0100278]-Autosomal recessive)",Definitive (alanine glyoxylate aminotransferase deficiency[MONDO:0100278]-AR),P:174; LP:99; VUS:87,OMIM:259900 (nephrocalcinosis: 0.333 | tubulopathy: 0.294 | complement: 0.214 | glomerulopathy: 0.144 | cyst_cilio: 0.081 | cakut: 0.065 | cancer: 0.03),OMIM:259900 (neonatal_or_pediatric: 0.402),OMIM:259900 (syndromic: 0.003 | skeletal: 0.004 | neurologic: 0.004),hm (true); ht (false),0,NULL,NULL,NULL,0,0.722362,3.03036,0.0160510134189565,cur_010
AHI1,21575,5,4.07431328977996,NULL,NULL,NULL,NULL,Joubert syndrome 3[OMIM:608629]-Autosomal recessive inheritance,"Definitive, Definitive, Definitive (Joubert syndrome 3[MONDO:0012078]-Autosomal recessive) | Definitive (Joubert syndrome 17[MONDO:0013824]-Autosomal recessive) | Supportive (Joubert syndrome with ocular defect[MONDO:0016364]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Supportive (retinitis pigmentosa[MONDO:0019200]-Autosomal dominant) | Limited (retinitis pigmentosa[MONDO:0019200]-Autosomal recessive)",Definitive (Joubert syndrome 3[MONDO:0012078]-AR),P:118; LP:52; VUS:504,OMIM:608629 (cyst_cilio: 0.223 | glomerulopathy: 0.135 | tubulopathy: 0.042 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,OMIM:608629 (syndromic: 0.065 | neurologic: 0.097),hm (false); ht (false),0,NULL,NULL,NULL,0.5,6.20866,3.4861800000000005,195.665363692671,cur_011
AIRE,360,3,1.963494598722141,0,0.77454,1.0879,-0.002056,"Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia[OMIM:240300]-Autosomal dominant inheritance | Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia[OMIM:240300]-Autosomal recessive inheritance","Strong, Moderate (autoimmune polyendocrine syndrome type 1[MONDO:0009411]-Autosomal dominant) | Definitive, Definitive, Strong, Strong, Supportive (autoimmune polyendocrine syndrome type 1[MONDO:0009411]-Autosomal recessive) | Supportive (familial isolated hypoparathyroidism due to impaired PTH secretion[MONDO:0016000]-Autosomal dominant)",NULL,P:98; LP:97; VUS:288,OMIM:240300 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),OMIM:240300 (neonatal_or_pediatric: 0.262),OMIM:240300 (syndromic: 0.001 | skeletal: 0.004),hm (false); ht (false),0.5,1203,0.2809224318658281,"9606.ENSP00000262367:578, 9606.ENSP00000310668:362, 9606.ENSP00000406229:263",0,0.6048100000000001,0.287119,0.407478467861531,cur_012
ALG1,18294,2,1.5022322151139376,0,1.0878,-0.40528,-2.0466,"Congenital disorder of glycosylation, type Ik[OMIM:608540]-Autosomal recessive inheritance","Definitive, Definitive, Strong, Strong, Supportive (ALG1-congenital disorder of glycosylation[MONDO:0012052]-Autosomal recessive)",NULL,P:37; LP:39; VUS:235,NULL,OMIM:608540 (antenatal_or_congenital: 0.028),OMIM:608540 (syndromic: 0.085 | growth: 0.102 | skeletal: 0.093 | neurologic: 0.139),hm (false); ht (false),0,292,0.0649895178197065,9606.ENSP00000322323:292,0.5,6.993469999999999,4.62066,12.7782683316908,cur_013
ALG5,20266,3,1.5695005782401632,0.46347,0.21546,3.5022,1.0063,Polycystic kidney disease 7[OMIM:620056]-Autosomal dominant inheritance,Limited (polycystic kidney disease 7[MONDO:0031062]-Autosomal dominant),NULL,P:4; LP:0; VUS:7,OMIM:620056 (glomerulopathy: 0.211 | cyst_cilio: 0.21 | tubulopathy: 0.147 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.077 | cancer: 0.03),OMIM:620056 (adult: 0.218),NULL,hm (false); ht (false),0,486,0.11949685534591195,"9606.ENSP00000237596:323, 9606.ENSP00000357283:163",0.5,19.6716,14.2856,42.7701358084967,cur_014
ALG8,23161,5,3.42825505963297,0,0.55991,2.3123,0.60409,"Congenital disorder of glycosylation, type Ih[OMIM:608104]-Autosomal recessive inheritance | Polycystic liver disease 3 with or without kidney cysts[OMIM:617874]-Autosomal dominant inheritance","Definitive, Strong, Moderate, Supportive (ALG8-congenital disorder of glycosylation[MONDO:0011969]-Autosomal recessive) | Strong, Limited, Limited (polycystic liver disease 3 with or without kidney cysts[MONDO:0054743]-Autosomal dominant)",Limited (polycystic liver disease 3 with or without kidney cysts[MONDO:0054743]-AD),P:19; LP:15; VUS:90,OMIM:617874 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:608104 (antenatal_or_congenital: 0.899 | neonatal_or_pediatric: 0.402),OMIM:608104 (syndromic: 0.025 | growth: 0.273 | skeletal: 0.023),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,11.1428,6.21068,46.3951746512086,cur_015
ALG9,15672,5,3.887246333297385,NULL,NULL,NULL,NULL,"Gillessen-Kaesbach-Nishimura syndrome[OMIM:263210]-Autosomal recessive inheritance | Congenital disorder of glycosylation, type Il[OMIM:608776]-Autosomal recessive inheritance","Moderate, Supportive (autosomal dominant polycystic kidney disease[MONDO:0004691]-Autosomal dominant) | Moderate (Gillessen-Kaesbach-Nishimura syndrome[MONDO:0009890]-Autosomal recessive) | Strong, Strong, Limited, Supportive (ALG9-congenital disorder of glycosylation[MONDO:0012117]-Autosomal recessive) | Definitive (ALG9-associated autosomal dominant polycystic kidney disease[MONDO:0700000]-Autosomal dominant)",Definitive (ALG9-associated autosomal dominant polycystic kidney disease[MONDO:0700000]-AD),P:10; LP:5; VUS:153,OMIM:263210 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01); OMIM:608776 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:263210 (antenatal_or_congenital: 0.821),OMIM:263210 (syndromic: 0.05 | skeletal: 0.133 | neurologic: 0.029); OMIM:608776 (syndromic: 0.14 | growth: 0.171 | skeletal: 0.112 | neurologic: 0.199),hm (NA); ht (NA),0,191,0.03773584905660377,9606.ENSP00000304941:191,0.5,5.42495,3.78734,29.7142028971484,cur_016
ALMS1,428,5,3.741651647473285,NULL,NULL,NULL,NULL,Alstrom syndrome[OMIM:203800]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Strong, Strong, Supportive (Alstrom syndrome[MONDO:0008763]-Autosomal recessive)",Definitive (Alstrom syndrome[MONDO:0008763]-AR),P:503; LP:283; VUS:2813,OMIM:203800 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.1 | cyst_cilio: 0.084 | complement: 0.071 | cakut: 0.04 | cancer: 0.02),NULL,OMIM:203800 (syndromic: 0.057 | growth: 0.258 | skeletal: 0.051 | neurologic: 0.057),hm (true); ht (false),0.5,1658,0.36268343815513626,"9606.ENSP00000355250:165, 9606.ENSP00000257861:407, 9606.ENSP00000252699:380, 9606.ENSP00000356319:292, 9606.ENSP00000264499:414",0.5,2.60744,2.35606,112.379069360761,cur_017
ALPL,438,5,2.9040718712206517,3.64e-4,0.40858,2.7113,1.2672,"Odontohypophosphatasia[OMIM:146300]-Autosomal dominant inheritance | Odontohypophosphatasia[OMIM:146300]-Autosomal recessive inheritance | Hypophosphatasia, infantile[OMIM:241500]-Autosomal recessive inheritance | Hypophosphatasia, childhood[OMIM:241510]-Autosomal recessive inheritance | Hypophosphatasia, adult[OMIM:146300]-Autosomal dominant inheritance | Hypophosphatasia, adult[OMIM:146300]-Autosomal recessive inheritance","Definitive, Strong, Supportive (adult hypophosphatasia[MONDO:0007798]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (infantile hypophosphatasia[MONDO:0009427]-Autosomal recessive) | Definitive, Supportive (childhood hypophosphatasia[MONDO:0009428]-Autosomal dominant) | Definitive, Definitive (childhood hypophosphatasia[MONDO:0009428]-Autosomal recessive) | Supportive (perinatal lethal hypophosphatasia[MONDO:0016605]-Autosomal recessive) | Supportive (odontohypophosphatasia[MONDO:0016607]-Autosomal dominant) | Definitive (hypophosphatasia[MONDO:0018570]-Autosomal recessive)",Definitive (obsolete adult hypophosphatasia[MONDO:0007798]-AD) | Definitive (obsolete infantile hypophosphatasia[MONDO:0009427]-AR) | Definitive (obsolete childhood hypophosphatasia[MONDO:0009428]-AD) | Definitive (obsolete childhood hypophosphatasia[MONDO:0009428]-AR),P:142; LP:172; VUS:184,OMIM:241500 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),NULL,OMIM:146300 (syndromic: 0.004 | skeletal: 0.011); OMIM:241500 (syndromic: 0.039 | growth: 0.184 | skeletal: 0.023 | neurologic: 0.045); OMIM:241510 (syndromic: 0.043 | growth: 0.25 | skeletal: 0.027 | neurologic: 0.043),hm (false); ht (false),0,NULL,NULL,NULL,0,12.3686,26.1397,6.98265366073266,cur_018
AMMECR1,467,2,0.7169685706555018,0.82117,0.099529,2.6449,1.0801,"Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis[OMIM:300990]-X-linked recessive inheritance","Supportive (Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome[MONDO:0010263]-X-linked) | Strong, Moderate (midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis[MONDO:0010516]-X-linked)",NULL,P:4; LP:4; VUS:19,OMIM:300990 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | cakut: 0.06 | cyst_cilio: 0.021 | glomerulopathy: 0.02 | cancer: 0.01),OMIM:300990 (neonatal_or_pediatric: 0.402),OMIM:300990 (syndromic: 0.091 | growth: 0.25 | skeletal: 0.062 | neurologic: 0.06),hm (false); ht (false),0,NULL,NULL,NULL,0.5,3.2065200000000003,1.8325799999999999,44.7326682221312,cur_019
AMN,14604,5,3.09294934922121,2.65e-4,0.46738,2.1658,0.60643,Imerslund-Grasbeck syndrome 2[OMIM:618882]-Autosomal recessive inheritance,Supportive (Imerslund-Grasbeck syndrome[MONDO:0009853]-Autosomal recessive),NULL,P:12; LP:21; VUS:85,OMIM:618882 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),NULL,NULL,hm (false); ht (false),0.5,1498,0.3417190775681342,"9606.ENSP00000236850:499, 9606.ENSP00000367064:999",0,22.12,57.1196,8.90538941049255,cur_020
ANKFY1,20763,2,1.0969140300565716,NULL,NULL,NULL,NULL,NULL,Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant),NULL,P:0; LP:0; VUS:40,NULL,NULL,NULL,hm (false); ht (false),0.5,1123,0.2662473794549266,"9606.ENSP00000265351:161, 9606.ENSP00000231509:165, 9606.ENSP00000264414:647, 9606.ENSP00000242591:150",0.5,10.7907,8.41605,91.6291228638279,cur_021
ANKS6,26724,5,4.165417475241564,7e-6,0.44408,2.8925,-0.075603,Nephronophthisis 16[OMIM:615382]-Autosomal recessive inheritance,Supportive (nephronophthisis 1[MONDO:0009728]-Autosomal recessive) | Supportive (nephronophthisis 2[MONDO:0011190]-Autosomal recessive) | Definitive (nephronophthisis 16[MONDO:0014158]-Autosomal recessive),Definitive (nephronophthisis 16[MONDO:0014158]-AR),P:16; LP:6; VUS:125,OMIM:615382 (cyst_cilio: 0.378 | glomerulopathy: 0.217 | tubulopathy: 0.147 | nephrocalcinosis: 0.132 | cakut: 0.109 | complement: 0.107 | cancer: 0.06),OMIM:615382 (neonatal_or_pediatric: 0.865 | antenatal_or_congenital: 0.821),NULL,hm (true); ht (false),0.5,3336,0.6058700209643606,"9606.ENSP00000262457:790, 9606.ENSP00000338766:897, 9606.ENSP00000242591:150, 9606.ENSP00000268766:968, 9606.ENSP00000362993:531",0.5,8.419960000000001,5.4473199999999995,40.6736413023064,cur_022
ANLN,14082,5,3.333253034796112,0.14261,0.23938,5.3903,0.89692,Focal segmental glomerulosclerosis 8[OMIM:616032]-Autosomal dominant inheritance,Limited (focal segmental glomerulosclerosis 8[MONDO:0014462]-Autosomal dominant) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant),NULL,P:2; LP:0; VUS:163,OMIM:616032 (glomerulopathy: 0.333 | cyst_cilio: 0.134 | cakut: 0.056 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:616032 (adult: 0.48 | neonatal_or_pediatric: 0.2),NULL,hm (false); ht (false),1,13006,0.9706498951781971,"9606.ENSP00000470972:292, 9606.ENSP00000463784:292, 9606.ENSP00000414321:292, 9606.ENSP00000359345:292, 9606.ENSP00000377789:420, 9606.ENSP00000357283:359, 9606.ENSP00000376410:506, 9606.ENSP00000362680:292, 9606.ENSP00000249442:292, 9606.ENSP00000360141:292, 9606.ENSP00000327943:292, 9606.ENSP00000358866:394, 9606.ENSP00000356319:292, 9606.ENSP00000367721:292, 9606.ENSP00000379616:292, 9606.ENSP00000323421:292, 9606.ENSP00000216181:420, 9606.ENSP00000355922:292, 9606.ENSP00000452762:292, 9606.ENSP00000360532:349, 9606.ENSP00000258439:292, 9606.ENSP00000360540:292, 9606.ENSP00000252699:473, 9606.ENSP00000288235:511, 9606.ENSP00000362924:292, 9606.ENSP00000348849:292, 9606.ENSP00000287647:292, 9606.ENSP00000337088:225, 9606.ENSP00000344314:292, 9606.ENSP00000310668:292, 9606.ENSP00000265970:163, 9606.ENSP00000352264:731, 9606.ENSP00000349658:292, 9606.ENSP00000339191:292, 9606.ENSP00000262518:292, 9606.ENSP00000246957:292, 9606.ENSP00000078429:292, 9606.ENSP00000231509:189, 9606.ENSP00000363435:382, 9606.ENSP00000481646:292",0.5,0.247265,0.184094,22.3061017855685,cur_023
ANOS1,6211,4,2.75862369870357,0.99793,0.095842,4.6876,0.885,Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)[OMIM:308700]-X-linked recessive inheritance,"Definitive, Strong (hypogonadotropic hypogonadism 1 with or without anosmia[MONDO:0010635]-X-linked) | Supportive (Kallmann syndrome[MONDO:0018800]-Autosomal dominant)",Definitive (hypogonadotropic hypogonadism 1 with or without anosmia[MONDO:0010635]-XL),P:46; LP:15; VUS:50,OMIM:308700 (cakut: 0.048 | cancer: 0.02 | tubulopathy: 0.007 | cyst_cilio: 0.005),OMIM:308700 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402),OMIM:308700 (syndromic: 0.018 | growth: 0.001 | neurologic: 0.02),hm (false); ht (false),0.5,2245,0.44863731656184486,"9606.ENSP00000339824:292, 9606.ENSP00000393312:980, 9606.ENSP00000217270:276, 9606.ENSP00000346839:292, 9606.ENSP00000410294:405",0,0.164434,0.191995,NULL,cur_024
AP2S1,565,4,2.377830296997559,0.78518,0.10592,2.5458,2.8609,"Hypocalciuric hypercalcemia, type III[OMIM:600740]-Autosomal dominant inheritance","Limited (autism spectrum disorder[MONDO:0005258]-Autosomal dominant) | Strong, Strong, Strong (familial hypocalciuric hypercalcemia 3[MONDO:0010926]-Autosomal dominant)",NULL,P:3; LP:0; VUS:21,OMIM:600740 (tubulopathy: 0.238 | nephrocalcinosis: 0.236 | glomerulopathy: 0.093 | cyst_cilio: 0.081 | complement: 0.071 | cakut: 0.056 | cancer: 0.03),NULL,OMIM:600740 (syndromic: 0.003 | skeletal: 0.003 | neurologic: 0.006),hm (false); ht (false),0,NULL,NULL,NULL,0.5,78.0276,58.5632,38.6568037897832,cur_025
APOA1,600,5,3.2129498453100007,5.49e-4,0.68041,0.87943,0.50968,"Hypoalphalipoproteinemia, primary, 2[OMIM:618463]-Autosomal recessive inheritance | Amyloidosis, 3 or more types[OMIM:105200]-Autosomal dominant inheritance | Hypoalphalipoproteinemia, primary, 2, intermediate[OMIM:619836]-Autosomal dominant inheritance","Definitive, Strong (familial visceral amyloidosis[MONDO:0007099]-Autosomal dominant) | Supportive (AApoAI amyloidosis[MONDO:0019731]-Autosomal dominant) | Supportive (apolipoprotein A-I deficiency[MONDO:0100189]-Autosomal dominant)",NULL,P:25; LP:5; VUS:96,OMIM:105200 (complement: 0.179 | glomerulopathy: 0.173 | cancer: 0.05 | nephrocalcinosis: 0.042 | tubulopathy: 0.035 | cakut: 0.024 | cyst_cilio: 0.018),OMIM:618463 (adult: 0.372),OMIM:105200 (syndromic: 0.002 | neurologic: 0.004); OMIM:618463 (syndromic: 0 | skeletal: 0.001),hm (false); ht (false),1,12997,0.9685534591194969,"9606.ENSP00000381448:269, 9606.ENSP00000231509:292, 9606.ENSP00000287600:161, 9606.ENSP00000414398:334, 9606.ENSP00000377836:499, 9606.ENSP00000362924:224, 9606.ENSP00000264005:990, 9606.ENSP00000245907:883, 9606.ENSP00000322323:499, 9606.ENSP00000396688:414, 9606.ENSP00000237014:892, 9606.ENSP00000264896:349, 9606.ENSP00000252486:996, 9606.ENSP00000312987:413, 9606.ENSP00000356969:997, 9606.ENSP00000317674:997, 9606.ENSP00000416561:361, 9606.ENSP00000299155:499, 9606.ENSP00000466775:974, 9606.ENSP00000346839:723, 9606.ENSP00000261267:266, 9606.ENSP00000367064:965",0.5,0.690074,0.574734,11.2430088159141,cur_026
APOA2,601,2,1.2745528353691342,0.0448,0.65054,0.56781,0.31347,"{Hypercholesterolemia, familial, modifier of}[OMIM:143890]-Autosomal dominant inheritance | {Hypercholesterolemia, familial, modifier of}[OMIM:143890]-Autosomal recessive inheritance",Supportive (apolipoprotein A-II amyloidosis[MONDO:0016533]-Autosomal dominant),NULL,P:2; LP:0; VUS:8,NULL,NULL,OMIM:143890 (syndromic: 0 | skeletal: 0.001),hm (false); ht (false),0.5,6063,0.7861635220125787,"9606.ENSP00000416561:454, 9606.ENSP00000236850:997, 9606.ENSP00000317674:795, 9606.ENSP00000377836:499, 9606.ENSP00000252486:997, 9606.ENSP00000466775:951, 9606.ENSP00000322323:499, 9606.ENSP00000264005:871",0,0.445279,0.30801100000000003,0.362676970091312,cur_027
APOC2,609,2,1.4676080939994776,NULL,NULL,NULL,NULL,"Hyperlipoproteinemia, type Ib[OMIM:207750]-Autosomal recessive inheritance","Strong, Strong, Supportive (familial apolipoprotein C-II deficiency[MONDO:0008810]-Autosomal recessive) | Strong (familial apolipoprotein C-II deficiency[MONDO:0008810]-Semidominant)",NULL,P:13; LP:1; VUS:30,NULL,NULL,NULL,hm (false); ht (false),0.5,4928,0.7379454926624738,"9606.ENSP00000252486:997, 9606.ENSP00000236850:974, 9606.ENSP00000264005:787, 9606.ENSP00000377836:499, 9606.ENSP00000356969:951, 9606.ENSP00000317674:720",0,1.48279,3.1734400000000003,0.00315538231026339,cur_028
APOE,613,5,3.200962972038616,0.001868,0.52375,1.4937,0.74028,"Alzheimer disease 2[OMIM:104310]-Autosomal dominant inheritance | Sea-blue histiocyte disease[OMIM:269600]-Autosomal recessive inheritance | {?Alzheimer disease, protection against, due to APOE3-Christchurch}[OMIM:607822]-Autosomal dominant inheritance | {Coronary artery disease, severe, susceptibility to}[OMIM:617347]-NA | Lipoprotein glomerulopathy[OMIM:611771]-NA | {?Macular degeneration, age-related}[OMIM:603075]-Autosomal dominant inheritance | Hyperlipoproteinemia, type III[OMIM:617347]-NA","Definitive (Alzheimer disease 2[MONDO:0007089]-Autosomal dominant) | Supportive (sea-blue histiocyte syndrome[MONDO:0010017]-Autosomal dominant) | Strong, Supportive (lipoprotein glomerulopathy[MONDO:0012725]-Autosomal dominant) | Strong (hyperlipoproteinemia type 3[MONDO:0018473]-Autosomal dominant) | Strong, Moderate (hyperlipoproteinemia type 3[MONDO:0018473]-Autosomal recessive)",NULL,P:15; LP:7; VUS:55,OMIM:611771 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.098 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:104310 (adult: 0.108); OMIM:269600 (adult: 0.218); OMIM:603075 (adult: 0.108); OMIM:607822 (adult: 0.218),OMIM:104310 (syndromic: 0.004 | neurologic: 0.009); OMIM:607822 (syndromic: 0.053 | neurologic: 0.111),hm (true); ht (false),1,11526,0.9454926624737946,"9606.ENSP00000313967:416, 9606.ENSP00000264005:837, 9606.ENSP00000322323:499, 9606.ENSP00000237014:766, 9606.ENSP00000269305:202, 9606.ENSP00000377836:499, 9606.ENSP00000362924:400, 9606.ENSP00000451828:165, 9606.ENSP00000294304:623, 9606.ENSP00000287878:382, 9606.ENSP00000466775:997, 9606.ENSP00000290866:325, 9606.ENSP00000346839:152, 9606.ENSP00000339191:635, 9606.ENSP00000356399:891, 9606.ENSP00000180166:222, 9606.ENSP00000317674:931, 9606.ENSP00000356969:997, 9606.ENSP00000236850:996, 9606.ENSP00000416561:371, 9606.ENSP00000264664:220",0.5,150.055,629.226,41.7436218508662,cur_029
APOL1,618,5,3.67839779125034,NULL,NULL,NULL,NULL,"{Glomerulosclerosis, focal segmental, 4, susceptibility to}[OMIM:612551]-Autosomal dominant inheritance","Definitive (focal segmental glomerulosclerosis 4, susceptibility to[MONDO:0012931]-Autosomal recessive)","Definitive (focal segmental glomerulosclerosis 4, susceptibility to[MONDO:0012931]-AR)",P:0; LP:0; VUS:50,OMIM:612551 (glomerulopathy: 0.224 | cyst_cilio: 0.134 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),NULL,NULL,hm (false); ht (false),0.5,5250,0.7589098532494759,"9606.ENSP00000252486:931, 9606.ENSP00000264896:299, 9606.ENSP00000264005:720, 9606.ENSP00000466775:720, 9606.ENSP00000322323:630, 9606.ENSP00000236850:997, 9606.ENSP00000227507:158, 9606.ENSP00000356969:795",0,43.1851,27.1554,5.37529435232963,cur_030
APRT,626,5,3.860914958766819,0,1.7501,-2.0349,-0.23784,Adenine phosphoribosyltransferase deficiency[OMIM:614723]-Autosomal recessive inheritance,"Definitive, Strong, Supportive (adenine phosphoribosyltransferase deficiency[MONDO:0013869]-Autosomal recessive)",NULL,P:56; LP:12; VUS:30,OMIM:614723 (tubulopathy: 0.28 | nephrocalcinosis: 0.278 | complement: 0.214 | glomerulopathy: 0.137 | cyst_cilio: 0.084 | cakut: 0.069 | cancer: 0.03),OMIM:614723 (neonatal_or_pediatric: 0.463),NULL,hm (true); ht (true),0.5,1257,0.2976939203354298,"9606.ENSP00000445175:179, 9606.ENSP00000298556:919, 9606.ENSP00000357283:159",0.5,101.9,79.9664,35.0364238275732,cur_031
AQP2,634,5,4.0137305870008415,2e-6,0.91172,0.25702,1.0598,"Diabetes insipidus, nephrogenic, 2[OMIM:125800]-Autosomal dominant inheritance | Diabetes insipidus, nephrogenic, 2[OMIM:125800]-Autosomal recessive inheritance",Supportive (nephrogenic diabetes insipidus[MONDO:0016383]-Autosomal dominant),NULL,P:38; LP:18; VUS:81,OMIM:125800 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:125800 (neonatal_or_pediatric: 0.134),OMIM:125800 (syndromic: 0.064 | growth: 0.421 | neurologic: 0.086),hm (true); ht (true),0.5,697,0.1761006289308176,"9606.ENSP00000265171:167, 9606.ENSP00000327943:229, 9606.ENSP00000484824:301",0.5,367.805,182.646,6.87206405646483,cur_032
ARHGAP24,25361,3,2.5194379068298898,0,0.57859,2.3526,0.15336,NULL,Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant),NULL,P:0; LP:0; VUS:63,NULL,NULL,NULL,hm (NA); ht (NA),0.5,965,0.22641509433962265,9606.ENSP00000358866:965,0.5,19.7838,12.7166,234.694405523053,cur_033
ARHGDIA,678,4,3.490645786442282,0.03642,0.38028,1.8625,1.2041,"Nephrotic syndrome, type 8[OMIM:615244]-Autosomal recessive inheritance","Moderate (nephrotic syndrome, type 8[MONDO:0014099]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:3; LP:0; VUS:14,OMIM:615244 (glomerulopathy: 0.297 | cyst_cilio: 0.139 | nephrocalcinosis: 0.062 | cakut: 0.06 | cancer: 0.05 | tubulopathy: 0.042 | complement: 0.036),OMIM:615244 (neonatal_or_pediatric: 0.134),OMIM:615244 (syndromic: 0.039 | neurologic: 0.081),hm (true); ht (false),0,NULL,NULL,NULL,0.5,134.30700000000002,126.83,78.4815845855732,cur_034
ARL13B,25419,4,3.379340120476713,0,0.69124,1.4189,-0.059241,Joubert syndrome 8[OMIM:612291]-Autosomal recessive inheritance,"Definitive, Strong, Moderate (Joubert syndrome 8[MONDO:0012855]-Autosomal recessive) | Definitive, Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive)",Definitive (Joubert syndrome[MONDO:0018772]-AR),P:17; LP:11; VUS:149,NULL,OMIM:612291 (neonatal_or_pediatric: 0.134),OMIM:612291 (syndromic: 0.066 | growth: 0.043 | skeletal: 0.001 | neurologic: 0.133),hm (false); ht (false),0.5,4782,0.7295597484276729,"9606.ENSP00000360777:900, 9606.ENSP00000393541:472, 9606.ENSP00000404122:594, 9606.ENSP00000242591:590, 9606.ENSP00000287600:887, 9606.ENSP00000256078:233, 9606.ENSP00000362121:639, 9606.ENSP00000260746:467",0.5,4.0288900000000005,2.61616,71.6591140559088,cur_035
ARL6,13210,5,4.481688340014491,0.01013,0.43627,1.7684,0.55514,"Retinitis pigmentosa 55[OMIM:613575]-Autosomal recessive inheritance | {Bardet-Biedl syndrome 1, modifier of}[OMIM:209900]-Autosomal recessive inheritance | {Bardet-Biedl syndrome 1, modifier of}[OMIM:209900]-Digenic inheritance | Bardet-Biedl syndrome 3[OMIM:600151]-Autosomal recessive inheritance","Definitive, Strong, Strong (Bardet-Biedl syndrome 3[MONDO:0010832]-Autosomal recessive) | Definitive (retinitis pigmentosa 55[MONDO:0013312]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Supportive (retinitis pigmentosa[MONDO:0019200]-Autosomal dominant)",NULL,P:22; LP:6; VUS:78,OMIM:209900 (cyst_cilio: 0.018 | cancer: 0.01 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:600151 (cakut: 0.089 | cyst_cilio: 0.037 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:209900 (antenatal_or_congenital: 0.821); OMIM:600151 (antenatal_or_congenital: 0.821),OMIM:209900 (syndromic: 0.093 | growth: 0.054 | skeletal: 0.052 | neurologic: 0.133); OMIM:600151 (syndromic: 0.051 | growth: 0.043 | skeletal: 0.017 | neurologic: 0.091),hm (false); ht (false),0,NULL,NULL,NULL,0.5,3.85411,2.74419,19.5805400474747,cur_036
ARMC9,20730,2,1.7684813486654547,NULL,NULL,NULL,NULL,Joubert syndrome 30[OMIM:617622]-Autosomal recessive inheritance,"Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Definitive, Definitive, Strong (Joubert syndrome 30[MONDO:0033308]-Autosomal recessive)",Definitive (Joubert syndrome 30[MONDO:0033308]-AR),P:21; LP:21; VUS:333,NULL,OMIM:617622 (antenatal_or_congenital: 0.821),OMIM:617622 (syndromic: 0.092 | skeletal: 0.009 | neurologic: 0.19),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,0.0592379,0.0412333,185.507042697717,cur_037
ATP1A1,799,2,1.687314191193802,NULL,NULL,NULL,NULL,"Hypomagnesemia, seizures, and impaired intellectual development 2[OMIM:618314]-Autosomal dominant inheritance | Charcot-Marie-Tooth disease, axonal, type 2DD[OMIM:618036]-Autosomal dominant inheritance","Limited (hypomagnesemia, seizures, and intellectual disability 2[MONDO:0020788]-Autosomal dominant) | Moderate, Moderate, Supportive (charcot-marie-tooth disease, axonal, type 2DD[MONDO:0054833]-Autosomal dominant)","Moderate (charcot-marie-tooth disease, axonal, type 2DD[MONDO:0054833]-AD)",P:11; LP:7; VUS:155,OMIM:618314 (nephrocalcinosis: 0.25 | tubulopathy: 0.238 | cyst_cilio: 0.026 | glomerulopathy: 0.022 | cancer: 0.01 | cakut: 0.008),OMIM:618036 (adult: 0.218 | neonatal_or_pediatric: 0.2); OMIM:618314 (neonatal_or_pediatric: 0.537),OMIM:618036 (syndromic: 0.01 | neurologic: 0.02); OMIM:618314 (syndromic: 0.054 | neurologic: 0.113),hm (false); ht (false),0.5,4692,0.7211740041928721,"9606.ENSP00000215832:292, 9606.ENSP00000451828:206, 9606.ENSP00000231509:292, 9606.ENSP00000262418:292, 9606.ENSP00000256078:212, 9606.ENSP00000322323:292, 9606.ENSP00000292079:954, 9606.ENSP00000339191:333, 9606.ENSP00000356319:292, 9606.ENSP00000362680:371, 9606.ENSP00000237596:286, 9606.ENSP00000340913:292, 9606.ENSP00000311505:292, 9606.ENSP00000262304:286",0.5,498.37,344.699,108.071809653078,cur_038
ATP6V0A4,866,5,3.859222288540487,0,0.76337,1.5266,0.85465,"Distal renal tubular acidosis 3, with or without sensorineural hearing loss[OMIM:602722]-Autosomal recessive inheritance","Strong, Strong (renal tubular acidosis, distal, 3, with or without sensorineural hearing loss[MONDO:0011268]-Autosomal recessive) | Supportive (autosomal recessive distal renal tubular acidosis[MONDO:0018440]-Autosomal recessive)",NULL,P:35; LP:13; VUS:126,OMIM:602722 (nephrocalcinosis: 0.208 | tubulopathy: 0.154 | glomerulopathy: 0.018 | cakut: 0.012 | cancer: 0.01 | cyst_cilio: 0.003),OMIM:602722 (neonatal_or_pediatric: 0.799),OMIM:602722 (syndromic: 0.014 | growth: 0.262 | skeletal: 0.002),hm (true); ht (true),0.5,1163,0.27253668763102723,"9606.ENSP00000417052:243, 9606.ENSP00000234396:920",0.5,111.04299999999999,94.4026,21.9937179818772,cur_039
ATP6V1B1,853,5,3.8905012505423406,0,0.63915,1.7745,0.23189,Distal renal tubular acidosis 2 with progressive sensorineural hearing loss[OMIM:267300]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Strong, Strong (renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss[MONDO:0009968]-Autosomal recessive) | Supportive (autosomal recessive distal renal tubular acidosis[MONDO:0018440]-Autosomal recessive)","Definitive (renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss[MONDO:0009968]-AR)",P:53; LP:29; VUS:121,OMIM:267300 (nephrocalcinosis: 0.146 | tubulopathy: 0.14 | cakut: 0.02 | glomerulopathy: 0.016 | cancer: 0.01 | cyst_cilio: 0.005),NULL,NULL,hm (true); ht (false),0.5,2209,0.44025157232704404,"9606.ENSP00000358423:499, 9606.ENSP00000262613:404, 9606.ENSP00000327650:223, 9606.ENSP00000308122:920, 9606.ENSP00000264896:163",0,54.1749,88.8299,2.96589477193137,cur_040
ATXN10,10549,2,1.3347396721785518,3.45e-4,0.41091,2.6929,-0.32533,Spinocerebellar ataxia 10[OMIM:603516]-Autosomal dominant inheritance,Supportive (spinocerebellar ataxia type 10[MONDO:0011330]-Autosomal dominant),NULL,P:1; LP:0; VUS:15,NULL,OMIM:603516 (adult: 0.575),OMIM:603516 (syndromic: 0.065 | neurologic: 0.135),hm (false); ht (false),0.5,1988,0.40670859538784065,"9606.ENSP00000313875:343, 9606.ENSP00000346839:229, 9606.ENSP00000368632:195, 9606.ENSP00000448012:396, 9606.ENSP00000311505:662, 9606.ENSP00000227507:163",0.5,0,0,246.672424262455,cur_041
AVP,894,4,2.511123175124746,0.074413000000000007,0.48081,0.98124,1.0546,"Diabetes insipidus, neurohypophyseal[OMIM:125700]-Autosomal dominant inheritance","Strong, Supportive (neurohypophyseal diabetes insipidus[MONDO:0007450]-Autosomal dominant)",NULL,P:22; LP:3; VUS:16,NULL,NULL,OMIM:125700 (syndromic: 0.012 | skeletal: 0.009 | neurologic: 0.002),hm (true); ht (true),0.5,2820,0.5366876310272537,"9606.ENSP00000370719:499, 9606.ENSP00000260649:298, 9606.ENSP00000347244:499, 9606.ENSP00000256474:296, 9606.ENSP00000330393:329, 9606.ENSP00000360141:499, 9606.ENSP00000264634:400",0,0.22469299999999998,0.621099,0.148889818660506,cur_042
AVPR2,897,5,3.6602183114061426,NULL,NULL,NULL,NULL,"Diabetes insipidus, nephrogenic, 1[OMIM:304800]-X-linked recessive inheritance | Nephrogenic syndrome of inappropriate antidiuresis[OMIM:300539]-X-linked recessive inheritance","Moderate, Supportive (nephrogenic syndrome of inappropriate antidiuresis[MONDO:0010356]-X-linked) | Definitive (diabetes insipidus, nephrogenic, X-linked[MONDO:0010581]-X-linked) | Supportive (nephrogenic diabetes insipidus[MONDO:0016383]-Autosomal dominant)",NULL,P:49; LP:24; VUS:44,OMIM:304800 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:300539 (neonatal_or_pediatric: 0.402); OMIM:304800 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.134),OMIM:300539 (syndromic: 0.003 | neurologic: 0.006); OMIM:304800 (syndromic: 0.064 | growth: 0.421 | neurologic: 0.086),hm (false); ht (true),0,NULL,NULL,NULL,0,10.8434,3.30685,0.321731891572694,cur_043
B2M,914,5,2.848585067458381,NULL,NULL,NULL,NULL,"?Amyloidosis, familial visceral[OMIM:105200]-Autosomal dominant inheritance | Immunodeficiency 43[OMIM:241600]-Autosomal recessive inheritance",Supportive (MHC class I deficiency[MONDO:0011476]-Autosomal recessive) | Supportive (variant ABeta2M amyloidosis[MONDO:0017810]-Autosomal dominant),NULL,P:1; LP:6; VUS:20,OMIM:105200 (complement: 0.179 | glomerulopathy: 0.173 | cancer: 0.05 | nephrocalcinosis: 0.042 | tubulopathy: 0.035 | cakut: 0.024 | cyst_cilio: 0.018),OMIM:241600 (neonatal_or_pediatric: 0.2 | adult: 0.049),OMIM:105200 (syndromic: 0.002 | neurologic: 0.004); OMIM:241600 (syndromic: 0.001 | skeletal: 0.003),hm (false); ht (false),0,NULL,NULL,NULL,0.5,806.415,735.012,174.650679363396,cur_044
B9D1,24123,3,2.7344691521819597,0.002803,0.48209,1.6931,0.10157,?Meckel syndrome 9[OMIM:614209]-Autosomal recessive inheritance | Joubert syndrome 27[OMIM:617120]-Autosomal recessive inheritance,"Definitive (ciliopathy[MONDO:0005308]-Autosomal recessive) | Strong, Moderate (Meckel syndrome, type 9[MONDO:0013630]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",Definitive (ciliopathy[MONDO:0005308]-AR),P:6; LP:5; VUS:88,OMIM:614209 (cakut: 0.016 | cancer: 0.01 | cyst_cilio: 0.008 | glomerulopathy: 0.002); OMIM:617120 (cyst_cilio: 0.003),OMIM:614209 (antenatal_or_congenital: 0.005); OMIM:617120 (neonatal_or_pediatric: 0.402),OMIM:614209 (syndromic: 0.001 | skeletal: 0.003 | neurologic: 0.001); OMIM:617120 (syndromic: 0.065 | skeletal: 0.019 | neurologic: 0.118),hm (true); ht (false),1,11104,0.9329140461215933,"9606.ENSP00000367398:547, 9606.ENSP00000386264:263, 9606.ENSP00000380779:995, 9606.ENSP00000403465:990, 9606.ENSP00000389998:985, 9606.ENSP00000376827:985, 9606.ENSP00000304941:988, 9606.ENSP00000314116:826, 9606.ENSP00000448012:951, 9606.ENSP00000258173:984, 9606.ENSP00000483364:972, 9606.ENSP00000313169:621, 9606.ENSP00000243578:997",0.5,11.4138,7.74555,22.3635440132608,cur_045
B9D2,28636,4,3.483981398902847,5.3e-5,0.85657,0.37995,-0.13015,?Meckel syndrome 10[OMIM:614175]-Autosomal recessive inheritance | Joubert syndrome 34[OMIM:614175]-Autosomal recessive inheritance,"Moderate (ciliopathy[MONDO:0005308]-Autosomal recessive) | Strong (Meckel syndrome, type 10[MONDO:0013609]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",Moderate (ciliopathy[MONDO:0005308]-AR),P:4; LP:7; VUS:22,OMIM:614175 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:614175 (antenatal_or_congenital: 0.077),OMIM:614175 (syndromic: 0.05 | skeletal: 0.043 | neurologic: 0.054),hm (false); ht (false),1,10928,0.9266247379454927,"9606.ENSP00000314116:816, 9606.ENSP00000386264:208, 9606.ENSP00000367398:400, 9606.ENSP00000403465:987, 9606.ENSP00000258173:966, 9606.ENSP00000448012:885, 9606.ENSP00000436596:155, 9606.ENSP00000376827:930, 9606.ENSP00000304941:974, 9606.ENSP00000389998:976, 9606.ENSP00000380779:986, 9606.ENSP00000483364:936, 9606.ENSP00000261499:997, 9606.ENSP00000262457:292, 9606.ENSP00000313169:420",0,7.789960000000001,6.41392,6.77567180415752,cur_046
BAP1,950,2,1.4201674439492031,0.99443,0.12103,4.6825,2.6442,"Kury-Isidor syndrome[OMIM:619762]-Autosomal dominant inheritance | Tumor predisposition syndrome 1[OMIM:614327]-Autosomal dominant inheritance | {Uveal melanoma, susceptibility to, 2}[OMIM:606661]-Autosomal dominant inheritance","Strong (renal cell carcinoma[MONDO:0005086]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong, Strong, Supportive (BAP1-related tumor predisposition syndrome[MONDO:0013692]-Autosomal dominant) | Strong (NA[NA]-Autosomal dominant)",Definitive (BAP1-related tumor predisposition syndrome[MONDO:0013692]-AD),P:209; LP:68; VUS:1082,OMIM:614327 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:619762 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:606661 (adult: 0.218); OMIM:614327 (adult: 0.683); OMIM:619762 (antenatal_or_congenital: 0.821),OMIM:614327 (syndromic: 0 | neurologic: 0.001); OMIM:619762 (syndromic: 0.149 | growth: 0.091 | skeletal: 0.101 | neurologic: 0.183),hm (false); ht (false),0.5,3978,0.6624737945492662,"9606.ENSP00000338766:165, 9606.ENSP00000297185:457, 9606.ENSP00000361021:457, 9606.ENSP00000360141:292, 9606.ENSP00000367203:292, 9606.ENSP00000363435:563, 9606.ENSP00000451828:292, 9606.ENSP00000481646:292, 9606.ENSP00000406229:292, 9606.ENSP00000324856:292, 9606.ENSP00000269305:292, 9606.ENSP00000357048:292",0.5,43.0225,35.8925,61.8758547489492,cur_047
BBIP1,28093,4,2.647918102596514,NULL,NULL,NULL,NULL,?Bardet-Biedl syndrome 18[OMIM:615995]-Autosomal recessive inheritance,"Strong, Limited (Bardet-Biedl syndrome 18[MONDO:0014446]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:2; LP:0; VUS:45,OMIM:615995 (glomerulopathy: 0.211 | cyst_cilio: 0.194 | tubulopathy: 0.147 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.077 | cancer: 0.02),NULL,OMIM:615995 (syndromic: 0.025 | growth: 0.043 | skeletal: 0.013 | neurologic: 0.04),hm (false); ht (false),1,7648,0.8427672955974843,"9606.ENSP00000245157:998, 9606.ENSP00000268057:998, 9606.ENSP00000311505:191, 9606.ENSP00000264499:998, 9606.ENSP00000295240:998, 9606.ENSP00000242067:996, 9606.ENSP00000482306:972, 9606.ENSP00000296135:499, 9606.ENSP00000317469:998",0.5,8.17503,4.55986,27.8527347344957,cur_048
BBS1,966,5,4.476991283288024,0,0.69212,1.6446,0.15597,Bardet-Biedl syndrome 1[OMIM:209900]-Autosomal recessive inheritance | Bardet-Biedl syndrome 1[OMIM:209900]-Digenic inheritance,"Definitive, Definitive, Definitive, Strong (Bardet-Biedl syndrome 1[MONDO:0008854]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:98; LP:85; VUS:284,OMIM:209900 (cyst_cilio: 0.018 | cancer: 0.01 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:209900 (antenatal_or_congenital: 0.821),OMIM:209900 (syndromic: 0.093 | growth: 0.054 | skeletal: 0.052 | neurologic: 0.133),hm (true); ht (false),1,13431,0.9769392033542977,"9606.ENSP00000433157:998, 9606.ENSP00000362121:232, 9606.ENSP00000359319:229, 9606.ENSP00000330393:747, 9606.ENSP00000264499:999, 9606.ENSP00000257861:222, 9606.ENSP00000466134:169, 9606.ENSP00000268057:999, 9606.ENSP00000438273:292, 9606.ENSP00000448012:201, 9606.ENSP00000245157:999, 9606.ENSP00000262366:614, 9606.ENSP00000482306:999, 9606.ENSP00000413017:535, 9606.ENSP00000295240:999, 9606.ENSP00000338766:442, 9606.ENSP00000296135:824, 9606.ENSP00000238628:215, 9606.ENSP00000311505:292, 9606.ENSP00000334379:292, 9606.ENSP00000242067:999, 9606.ENSP00000382717:525, 9606.ENSP00000393541:230, 9606.ENSP00000262304:378",0.5,21.3039,17.9973,38.1888624670295,cur_049
BBS10,26291,5,3.9827822153696704,NULL,NULL,NULL,NULL,Bardet-Biedl syndrome 10[OMIM:615987]-Autosomal recessive inheritance,"Definitive, Definitive, Strong (Bardet-Biedl syndrome 10[MONDO:0014438]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:118; LP:81; VUS:303,OMIM:615987 (cyst_cilio: 0.16 | tubulopathy: 0.112 | nephrocalcinosis: 0.111 | glomerulopathy: 0.089 | cakut: 0.085 | complement: 0.071 | cancer: 0.05),NULL,OMIM:615987 (syndromic: 0.05 | growth: 0.043 | skeletal: 0.003 | neurologic: 0.098),hm (true); ht (false),0,NULL,NULL,NULL,0.5,NULL,NULL,10.7051978711143,cur_050
BBS12,26648,5,3.9058591384465937,NULL,NULL,NULL,NULL,Bardet-Biedl syndrome 12[OMIM:615989]-Autosomal recessive inheritance,"Definitive, Definitive, Definitive, Strong (Bardet-Biedl syndrome 12[MONDO:0014440]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:91; LP:39; VUS:252,OMIM:615989 (cakut: 0.097 | cyst_cilio: 0.026 | cancer: 0.02 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:615989 (antenatal_or_congenital: 0.821),OMIM:615989 (syndromic: 0.007 | growth: 0.043 | skeletal: 0.01 | neurologic: 0.003),hm (true); ht (false),0.5,3423,0.6142557651991615,"9606.ENSP00000317469:292, 9606.ENSP00000246062:901, 9606.ENSP00000245157:292, 9606.ENSP00000268057:540, 9606.ENSP00000264499:793, 9606.ENSP00000242067:292, 9606.ENSP00000360777:313",0,3.3426199999999997,3.8029699999999997,2.01094553755102,cur_051
BBS2,967,5,4.005025032793211,0,0.78954,1.222,0.87045,Retinitis pigmentosa 74[OMIM:616562]-Autosomal recessive inheritance | Bardet-Biedl syndrome 2[OMIM:615981]-Autosomal recessive inheritance,"Definitive, Definitive, Definitive, Strong (Bardet-Biedl syndrome 2[MONDO:0014432]-Autosomal recessive) | Definitive (retinitis pigmentosa 74[MONDO:0014692]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Supportive (retinitis pigmentosa[MONDO:0019200]-Autosomal dominant)",NULL,P:86; LP:97; VUS:303,OMIM:616562 (cancer: 0.02 | cakut: 0.008 | cyst_cilio: 0.008 | tubulopathy: 0.007),OMIM:616562 (adult: 0.683 | neonatal_or_pediatric: 0.262),OMIM:615981 (syndromic: 0.048 | growth: 0.043 | skeletal: 0.007 | neurologic: 0.091); OMIM:616562 (syndromic: 0.003 | growth: 0.043 | skeletal: 0.003),hm (true); ht (false),1,10869,0.9224318658280922,"9606.ENSP00000246062:457, 9606.ENSP00000438273:292, 9606.ENSP00000311505:292, 9606.ENSP00000268057:999, 9606.ENSP00000448012:292, 9606.ENSP00000242067:999, 9606.ENSP00000334379:292, 9606.ENSP00000317469:999, 9606.ENSP00000312397:161, 9606.ENSP00000482306:997, 9606.ENSP00000262366:292, 9606.ENSP00000433157:998, 9606.ENSP00000413017:292, 9606.ENSP00000295240:999, 9606.ENSP00000359319:229, 9606.ENSP00000338766:451, 9606.ENSP00000264499:999, 9606.ENSP00000296135:829",0.5,21.2998,19.8465,25.5066634969975,cur_052
BBS4,969,5,3.94617424502676,0,0.85849,0.73538,-0.95574,Bardet-Biedl syndrome 4[OMIM:615982]-Autosomal recessive inheritance,"Definitive, Strong (Bardet-Biedl syndrome 4[MONDO:0014433]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:49; LP:30; VUS:230,OMIM:615982 (cyst_cilio: 0.11 | cakut: 0.048 | cancer: 0.04 | glomerulopathy: 0.009 | tubulopathy: 0.007),OMIM:615982 (antenatal_or_congenital: 0.821),OMIM:615982 (syndromic: 0.029 | growth: 0.043 | skeletal: 0.022 | neurologic: 0.04),hm (true); ht (false),1,11769,0.9538784067085954,"9606.ENSP00000311505:292, 9606.ENSP00000242067:999, 9606.ENSP00000295240:999, 9606.ENSP00000338766:436, 9606.ENSP00000413017:569, 9606.ENSP00000482306:999, 9606.ENSP00000438273:540, 9606.ENSP00000448012:478, 9606.ENSP00000362121:198, 9606.ENSP00000344314:163, 9606.ENSP00000334379:303, 9606.ENSP00000242591:303, 9606.ENSP00000296135:839, 9606.ENSP00000356405:244, 9606.ENSP00000245157:999, 9606.ENSP00000317469:999, 9606.ENSP00000377934:183, 9606.ENSP00000264499:999, 9606.ENSP00000359319:229, 9606.ENSP00000433157:998",0.5,16.7082,10.5321,46.6024583459942,cur_053
BBS5,970,3,2.6441871213345656,5e-6,0.54951,1.9508,0.85025,Bardet-Biedl syndrome 5[OMIM:615983]-Autosomal recessive inheritance,"Definitive, Strong, Strong, Strong (Bardet-Biedl syndrome 5[MONDO:0014434]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:30; LP:18; VUS:112,NULL,NULL,OMIM:615983 (syndromic: 0.01 | growth: 0.043 | skeletal: 0.022 | neurologic: 0.003),hm (true); ht (false),1,9261,0.8784067085953878,"9606.ENSP00000448012:292, 9606.ENSP00000242067:999, 9606.ENSP00000334379:292, 9606.ENSP00000311505:292, 9606.ENSP00000268057:999, 9606.ENSP00000245157:999, 9606.ENSP00000317469:999, 9606.ENSP00000482306:996, 9606.ENSP00000433157:998, 9606.ENSP00000413017:552, 9606.ENSP00000264499:999, 9606.ENSP00000296135:844",0.5,8.1408,5.93253,26.4933924939343,cur_054
BBS7,18758,3,2.6441871213345656,0,0.50564,2.8811,1.2326,Bardet-Biedl syndrome 7[OMIM:615984]-Autosomal recessive inheritance,"Definitive, Strong, Strong (Bardet-Biedl syndrome 7[MONDO:0014435]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:45; LP:17; VUS:251,NULL,NULL,OMIM:615984 (syndromic: 0.038 | growth: 0.043 | skeletal: 0.028 | neurologic: 0.04),hm (true); ht (false),1,12168,0.9643605870020965,"9606.ENSP00000360777:239, 9606.ENSP00000231509:165, 9606.ENSP00000278935:199, 9606.ENSP00000246062:457, 9606.ENSP00000269305:163, 9606.ENSP00000317469:999, 9606.ENSP00000482968:414, 9606.ENSP00000245157:999, 9606.ENSP00000438273:793, 9606.ENSP00000311505:292, 9606.ENSP00000268057:999, 9606.ENSP00000448012:201, 9606.ENSP00000334379:292, 9606.ENSP00000242067:999, 9606.ENSP00000413017:560, 9606.ENSP00000433157:998, 9606.ENSP00000482306:987, 9606.ENSP00000296135:821, 9606.ENSP00000468002:202, 9606.ENSP00000295240:999, 9606.ENSP00000414321:161, 9606.ENSP00000359319:229",0.5,5.8869,3.99001,27.5221633255361,cur_055
BBS9,30000,5,3.929723827973934,0,0.63475,2.5133,0.40365,Bardet-Biedl syndrome 9[OMIM:615986]-Autosomal recessive inheritance,"Definitive, Strong (Bardet-Biedl syndrome 9[MONDO:0014437]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:53; LP:15; VUS:339,OMIM:615986 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:615986 (antenatal_or_congenital: 0.821),OMIM:615986 (syndromic: 0.066 | growth: 0.051 | skeletal: 0.033 | neurologic: 0.113),hm (NA); ht (NA),1,8975,0.8721174004192872,"9606.ENSP00000245157:999, 9606.ENSP00000317469:999, 9606.ENSP00000438273:292, 9606.ENSP00000311505:292, 9606.ENSP00000268057:999, 9606.ENSP00000448012:201, 9606.ENSP00000334379:292, 9606.ENSP00000433157:996, 9606.ENSP00000482306:998, 9606.ENSP00000264499:999, 9606.ENSP00000296135:909, 9606.ENSP00000295240:999",0.5,5.13374,3.32082,128.693919386346,cur_056
BCS1L,1020,4,1.8859016250488072,NULL,NULL,NULL,NULL,"GRACILE syndrome[OMIM:603358]-Autosomal recessive inheritance | Mitochondrial complex III deficiency, nuclear type 1[OMIM:124000]-Autosomal recessive inheritance | Bjornstad syndrome[OMIM:262000]-Autosomal recessive inheritance","Strong (mitochondrial complex III deficiency nuclear type 1[MONDO:0007415]-Autosomal recessive) | Strong, Limited (Leigh syndrome[MONDO:0009723]-Autosomal recessive) | Definitive, Strong, Moderate, Supportive (Bjornstad syndrome[MONDO:0009872]-Autosomal recessive) | Definitive, Supportive (GRACILE syndrome[MONDO:0011308]-Autosomal recessive) | Supportive (mitochondrial complex III deficiency[MONDO:0015448]-Autosomal recessive) | Supportive (renal tubulopathy-encephalopathy-liver failure syndrome[MONDO:0016811]-Autosomal recessive)",Limited (Leigh syndrome[MONDO:0009723]-AR) | Definitive (Bjornstad syndrome[MONDO:0009872]-AR),P:53; LP:57; VUS:83,OMIM:124000 (cyst_cilio: 0.013 | glomerulopathy: 0.002),OMIM:124000 (antenatal_or_congenital: 0.821); OMIM:262000 (neonatal_or_pediatric: 0.402),OMIM:124000 (syndromic: 0.112 | growth: 0.171 | neurologic: 0.216); OMIM:262000 (syndromic: 0.019 | neurologic: 0.04); OMIM:603358 (syndromic: 0.005 | growth: 0.102),hm (true); ht (false),0.5,816,0.1949685534591195,"9606.ENSP00000356587:276, 9606.ENSP00000261643:540",0.5,26.686,22.6438,12.6952191367628,cur_057
BICC1,19351,4,3.1686452776982774,0.83685,0.19994,5.2432,1.2467,"{Renal dysplasia, cystic, susceptibility to}[OMIM:601331]-Autosomal dominant inheritance","Limited (renal dysplasia, cystic, susceptibility to[MONDO:0011037]-Autosomal dominant)",NULL,P:2; LP:1; VUS:80,OMIM:601331 (cakut: 0.173 | cyst_cilio: 0.126 | nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.091 | complement: 0.071 | cancer: 0.02),OMIM:601331 (antenatal_or_congenital: 0.038),NULL,hm (true); ht (true),0.5,1222,0.28721174004192873,"9606.ENSP00000393312:307, 9606.ENSP00000297837:531, 9606.ENSP00000268766:384",0.5,28.781999999999996,14.5486,223.809505784888,cur_058
BMP4,1071,5,3.3178744296998577,0.9564,0.070331,3.2484,1.0071,"Orofacial cleft 11[OMIM:600625]-NA | Microphthalmia, syndromic 6[OMIM:607932]-Autosomal dominant inheritance","Definitive, Strong, Moderate, Moderate (microphthalmia with brain and digit anomalies[MONDO:0011936]-Autosomal dominant) | Moderate (Stickler syndrome[MONDO:0019354]-Autosomal recessive) | Supportive (renal agenesis, unilateral[MONDO:0019636]-Autosomal dominant)",NULL,P:6; LP:4; VUS:93,OMIM:607932 (cakut: 0.089 | cyst_cilio: 0.037 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),NULL,OMIM:600625 (syndromic: 0.006); OMIM:607932 (syndromic: 0.113 | growth: 0.171 | skeletal: 0.132 | neurologic: 0.122),hm (false); ht (true),0.5,3185,0.5870020964360587,"9606.ENSP00000379204:960, 9606.ENSP00000322323:499, 9606.ENSP00000378650:439, 9606.ENSP00000264664:282, 9606.ENSP00000385675:275, 9606.ENSP00000359345:161, 9606.ENSP00000463784:161, 9606.ENSP00000379823:408",0.5,5.820790000000001,3.13778,36.6189947301117,cur_059
BMP7,1074,3,2.2170899616531545,0.12727,0.27097,2.902,1.7814,NULL,Limited (hypospadias[MONDO:0005345]-Autosomal dominant) | Moderate (multiple congenital anomalies/dysmorphic syndrome[MONDO:0019042]-Autosomal dominant),NULL,P:3; LP:0; VUS:23,NULL,NULL,NULL,hm (true); ht (false),0.5,2833,0.5387840670859538,"9606.ENSP00000297261:373, 9606.ENSP00000410294:345, 9606.ENSP00000346839:416, 9606.ENSP00000245451:960, 9606.ENSP00000252699:206, 9606.ENSP00000380432:295, 9606.ENSP00000349458:238",0.5,2.6655,4.39371,110.956026047332,cur_060
BNC2,30988,3,1.74732484602259,0.92762,0.17228,4.5265,0.36014,"Lower urinary tract obstruction, congenital[OMIM:618612]-Autosomal dominant inheritance","Supportive (posterior urethral valve[MONDO:0019640]-Autosomal recessive) | Moderate (lower urinary tract obstruction, congenital[MONDO:0032833]-Autosomal dominant)",NULL,P:2; LP:0; VUS:60,OMIM:618612 (cakut: 0.065 | cancer: 0.02 | cyst_cilio: 0.008 | glomerulopathy: 0.002),NULL,NULL,hm (false); ht (false),0,163,0.008385744234800839,9606.ENSP00000269305:163,0.5,1.1818600000000001,1.87841,269.301771179443,cur_061
BSND,16512,5,4.527750933817541,NULL,NULL,NULL,NULL,"Sensorineural deafness with mild renal dysfunction[OMIM:602522]-Autosomal recessive inheritance | Bartter syndrome, type 4a[OMIM:602522]-Autosomal recessive inheritance","Definitive, Definitive, Strong (Bartter disease type 4A[MONDO:0011242]-Autosomal recessive) | Supportive (Bartter syndrome type 4[MONDO:0019524]-Autosomal recessive) | Supportive (hearing loss, autosomal recessive[MONDO:0019588]-Autosomal recessive)",Definitive (Bartter disease type 4A[MONDO:0011242]-AR),P:23; LP:5; VUS:78,OMIM:602522 (tubulopathy: 0.259 | nephrocalcinosis: 0.236 | cyst_cilio: 0.123 | glomerulopathy: 0.095 | complement: 0.071 | cakut: 0.052 | cancer: 0.02),OMIM:602522 (antenatal_or_congenital: 0.821),OMIM:602522 (syndromic: 0.041 | growth: 0.171 | neurologic: 0.067),hm (true); ht (false),0,NULL,NULL,NULL,0,12.4703,8.48823,0.54864766396001,cur_062
C2CD3,24564,3,2.014823807996268,NULL,NULL,NULL,NULL,Orofaciodigital syndrome XIV[OMIM:615948]-Autosomal recessive inheritance,"Definitive, Strong, Supportive (orofaciodigital syndrome type 14[MONDO:0014413]-Autosomal recessive)",Definitive (orofaciodigital syndrome type 14[MONDO:0014413]-AR),P:26; LP:17; VUS:341,OMIM:615948 (cyst_cilio: 0.003),OMIM:615948 (antenatal_or_congenital: 0.821),OMIM:615948 (syndromic: 0.09 | skeletal: 0.099 | neurologic: 0.136),hm (false); ht (false),0.5,3054,0.5660377358490566,"9606.ENSP00000482306:303, 9606.ENSP00000344314:434, 9606.ENSP00000278935:237, 9606.ENSP00000245157:292, 9606.ENSP00000264499:292, 9606.ENSP00000317469:292, 9606.ENSP00000303058:317, 9606.ENSP00000268057:303, 9606.ENSP00000295240:292, 9606.ENSP00000242067:292",0.5,4.82522,3.3117199999999998,49.5121556108344,cur_063
C3,1318,5,4.076932223200416,0.90421,0.20804,7.0135,2.7489,"C3 deficiency[OMIM:613779]-Autosomal recessive inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to, 5}[OMIM:612925]-Autosomal dominant inheritance | {Macular degeneration, age-related, 9}[OMIM:611378]-NA","Definitive (atypical hemolytic-uremic syndrome with C3 anomaly[MONDO:0013043]-Autosomal dominant) | Definitive, Supportive (complement component 3 deficiency[MONDO:0013417]-Autosomal recessive)",Definitive (atypical hemolytic-uremic syndrome with C3 anomaly[MONDO:0013043]-AD),P:12; LP:19; VUS:348,OMIM:612925 (glomerulopathy: 0.2 | complement: 0.179 | cyst_cilio: 0.139 | tubulopathy: 0.084 | nephrocalcinosis: 0.056 | cakut: 0.052 | cancer: 0.02); OMIM:613779 (glomerulopathy: 0.202 | nephrocalcinosis: 0.111 | complement: 0.107 | tubulopathy: 0.105 | cyst_cilio: 0.068 | cancer: 0.05 | cakut: 0.048),OMIM:612925 (neonatal_or_pediatric: 0.865 | adult: 0.218); OMIM:613779 (neonatal_or_pediatric: 0.665),NULL,hm (true); ht (true),1,13507,0.9790356394129979,"9606.ENSP00000296280:676, 9606.ENSP00000364699:313, 9606.ENSP00000314299:984, 9606.ENSP00000322323:630, 9606.ENSP00000396688:988, 9606.ENSP00000237014:465, 9606.ENSP00000347942:398, 9606.ENSP00000231509:292, 9606.ENSP00000356386:976, 9606.ENSP00000313875:999, 9606.ENSP00000366307:737, 9606.ENSP00000256785:942, 9606.ENSP00000308938:410, 9606.ENSP00000261267:261, 9606.ENSP00000281043:161, 9606.ENSP00000356399:999, 9606.ENSP00000312987:292, 9606.ENSP00000356395:917, 9606.ENSP00000384092:185, 9606.ENSP00000236850:883, 9606.ENSP00000416561:999",0,6.45371,30.7397,3.44764248790378,cur_064
CPLANE1,25801,5,4.097382094588542,NULL,NULL,NULL,NULL,Orofaciodigital syndrome VI[OMIM:277170]-Autosomal recessive inheritance | Joubert syndrome 17[OMIM:614615]-Autosomal recessive inheritance,"Supportive (orofaciodigital syndrome type 6[MONDO:0010176]-Autosomal recessive) | Definitive (orofaciodigital syndrome type 6[MONDO:0010176]-Mitochondrial) | Definitive, Definitive, Definitive, Definitive (Joubert syndrome 17[MONDO:0013824]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive)",Definitive (Joubert syndrome 17[MONDO:0013824]-AR),P:146; LP:86; VUS:916,OMIM:277170 (cakut: 0.097 | cancer: 0.05 | cyst_cilio: 0.026 | glomerulopathy: 0.002); OMIM:614615 (cancer: 0.02 | cakut: 0.008 | cyst_cilio: 0.008 | tubulopathy: 0.007),OMIM:277170 (antenatal_or_congenital: 0.821); OMIM:614615 (neonatal_or_pediatric: 0.402),OMIM:277170 (syndromic: 0.117 | growth: 0.421 | skeletal: 0.07 | neurologic: 0.109); OMIM:614615 (syndromic: 0.036 | skeletal: 0.006 | neurologic: 0.072),hm (true); ht (false),0,NULL,NULL,NULL,0,NULL,NULL,NULL,cur_065
CFAP418,27232,3,1.885266958131408,2.4e-5,0.79253,0.61083,-0.072083,Retinitis pigmentosa 64[OMIM:614500]-Autosomal recessive inheritance | Cone-rod dystrophy 16[OMIM:614500]-Autosomal recessive inheritance | Bardet-Biedl syndrome 21[OMIM:617406]-Autosomal recessive inheritance,"Definitive, Moderate (cone-rod dystrophy 16[MONDO:0013786]-Autosomal recessive) | Limited (bardet-biedl syndrome 21[MONDO:0044308]-Autosomal recessive)",NULL,P:18; LP:5; VUS:118,OMIM:617406 (cancer: 0.07 | cakut: 0.028 | cyst_cilio: 0.01 | glomerulopathy: 0.007),NULL,OMIM:614500 (syndromic: 0.003 | skeletal: 0.004 | neurologic: 0.004); OMIM:617406 (syndromic: 0.016 | growth: 0.047 | skeletal: 0.005 | neurologic: 0.02),hm (true); ht (false),0,NULL,NULL,NULL,0,NULL,NULL,NULL,cur_066
CA2,1373,5,3.659963715787938,2e-6,0.81098,0.61508,0.35948,"Osteopetrosis, autosomal recessive 3, with renal tubular acidosis[OMIM:259730]-Autosomal recessive inheritance","Definitive, Strong, Supportive (autosomal recessive osteopetrosis 3[MONDO:0009818]-Autosomal recessive)",NULL,P:10; LP:5; VUS:61,OMIM:259730 (nephrocalcinosis: 0.035 | tubulopathy: 0.028 | cakut: 0.004),NULL,OMIM:259730 (syndromic: 0.036 | growth: 0.25 | skeletal: 0.006 | neurologic: 0.043),hm (true); ht (true),0.5,2781,0.5283018867924528,"9606.ENSP00000359345:342, 9606.ENSP00000262418:479, 9606.ENSP00000206542:390, 9606.ENSP00000393557:613, 9606.ENSP00000362680:347, 9606.ENSP00000268766:161, 9606.ENSP00000003084:449",0.5,134.868,138.411,12.2388203123969,cur_067
CACNA1D,1391,3,1.663471027214923,NULL,NULL,NULL,NULL,"Primary aldosteronism, seizures, and neurologic abnormalities[OMIM:615474]-Autosomal dominant inheritance | Sinoatrial node dysfunction and deafness[OMIM:614896]-Autosomal recessive inheritance","Strong, Moderate, Moderate, Supportive (sinoatrial node dysfunction and deafness[MONDO:0013960]-Autosomal recessive) | Definitive, Strong, Moderate (aldosterone-producing adenoma with seizures and neurological abnormalities[MONDO:0014200]-Autosomal dominant)",Moderate (sinoatrial node dysfunction and deafness[MONDO:0013960]-AR),P:7; LP:8; VUS:660,OMIM:615474 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),OMIM:614896 (antenatal_or_congenital: 0.821); OMIM:615474 (antenatal_or_congenital: 0.821),OMIM:615474 (syndromic: 0.058 | neurologic: 0.121),hm (false); ht (false),0.5,2040,0.4171907756813417,"9606.ENSP00000296266:183, 9606.ENSP00000363435:254, 9606.ENSP00000314444:253, 9606.ENSP00000334198:745, 9606.ENSP00000382717:214, 9606.ENSP00000406012:239, 9606.ENSP00000339191:152",0.5,0.988662,1.4056600000000001,128.896743819892,cur_068
CACNA1H,1395,2,1.3602625674859057,0,0.3753,5.3453,-2.3605,"{Epilepsy, childhood absence, susceptibility to, 6}[OMIM:611942]-NA | Hyperaldosteronism, familial, type IV[OMIM:617027]-Autosomal dominant inheritance | {Epilepsy, idiopathic generalized, susceptibility to, 6}[OMIM:611942]-NA","Disputed Evidence (epilepsy[MONDO:0005027]-Autosomal dominant) | Supportive (childhood absence epilepsy[MONDO:0010826]-Autosomal dominant) | Limited (epilepsy, childhood absence, susceptibility to, 6[MONDO:0012763]-Autosomal dominant)",Disputed (epilepsy[MONDO:0005027]-AD),P:1; LP:7; VUS:1055,NULL,OMIM:617027 (neonatal_or_pediatric: 0.865),NULL,hm (false); ht (false),0.5,2923,0.5513626834381551,"9606.ENSP00000396320:558, 9606.ENSP00000300061:540, 9606.ENSP00000288139:745, 9606.ENSP00000345751:540, 9606.ENSP00000353292:540",0.5,20.414,8.969339999999999,18.2720923663446,cur_069
CASR,1514,5,4.438585582584462,NULL,NULL,NULL,NULL,"Hypocalcemia, autosomal dominant, with Bartter syndrome[OMIM:601198]-Autosomal dominant inheritance | Hyperparathyroidism, neonatal[OMIM:239200]-Autosomal dominant inheritance | Hyperparathyroidism, neonatal[OMIM:239200]-Autosomal recessive inheritance | Hypocalcemia, autosomal dominant[OMIM:601198]-Autosomal dominant inheritance | Hypocalciuric hypercalcemia, type I[OMIM:145980]-Autosomal dominant inheritance | {?Epilepsy idiopathic generalized, susceptibility to, 8}[OMIM:612899]-Autosomal dominant inheritance","Disputed Evidence (epilepsy[MONDO:0005027]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (familial hypocalciuric hypercalcemia 1[MONDO:0007791]-Autosomal dominant) | Definitive, Supportive (neonatal severe primary hyperparathyroidism[MONDO:0009397]-Autosomal recessive) | Definitive, Definitive (autosomal dominant hypocalcemia 1[MONDO:0011013]-Autosomal dominant) | Supportive (autosomal dominant hypocalcemia[MONDO:0018543]-Autosomal dominant)",Disputed (epilepsy[MONDO:0005027]-AD) | Definitive (familial hypocalciuric hypercalcemia 1[MONDO:0007791]-AD) | Definitive (neonatal severe primary hyperparathyroidism[MONDO:0009397]-AR) | Definitive (autosomal dominant hypocalcemia 1[MONDO:0011013]-AD),P:139; LP:86; VUS:1246,OMIM:145980 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005); OMIM:239200 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004); OMIM:601198 (nephrocalcinosis: 0.326 | tubulopathy: 0.28 | glomerulopathy: 0.031 | cakut: 0.02 | cyst_cilio: 0.016 | cancer: 0.01),OMIM:601198 (neonatal_or_pediatric: 0.463 | adult: 0.372),OMIM:239200 (syndromic: 0.013 | growth: 0.171 | skeletal: 0.012 | neurologic: 0.001); OMIM:601198 (syndromic: 0.034 | growth: 0.25 | skeletal: 0.002 | neurologic: 0.043),hm (true); ht (true),0.5,3128,0.5786163522012578,"9606.ENSP00000256646:292, 9606.ENSP00000358866:784, 9606.ENSP00000365256:340, 9606.ENSP00000376432:327, 9606.ENSP00000339191:275, 9606.ENSP00000256474:292, 9606.ENSP00000402152:208, 9606.ENSP00000384092:218, 9606.ENSP00000385675:392",0.5,18.1293,2.9685900000000003,13.2831716241063,cur_070
CAV1,1527,2,1.7067501544539427,0.008274,0.57612,1.035,0.66885,"Lipodystrophy, congenital generalized, type 3[OMIM:612526]-Autosomal recessive inheritance | Pulmonary hypertension, primary, 3[OMIM:615343]-Autosomal dominant inheritance | Lipodystrophy, familial partial, type 7[OMIM:606721]-Autosomal dominant inheritance","Moderate (congenital generalized lipodystrophy type 3[MONDO:0012923]-Autosomal dominant) | Limited (congenital generalized lipodystrophy type 3[MONDO:0012923]-Autosomal recessive) | Limited (pulmonary hypertension, primary, 3[MONDO:0014135]-Autosomal dominant) | Definitive (pulmonary arterial hypertension[MONDO:0015924]-Autosomal dominant) | Supportive (heritable pulmonary arterial hypertension[MONDO:0017148]-Autosomal dominant) | Supportive (Berardinelli-Seip congenital lipodystrophy[MONDO:0018883]-Autosomal recessive)",Definitive (pulmonary arterial hypertension[MONDO:0015924]-AD),P:9; LP:1; VUS:30,OMIM:606721 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:606721 (antenatal_or_congenital: 0.821 | adult: 0.372 | neonatal_or_pediatric: 0.134); OMIM:612526 (neonatal_or_pediatric: 0.402); OMIM:615343 (adult: 0.683 | neonatal_or_pediatric: 0.463),OMIM:606721 (syndromic: 0.045 | growth: 0.217 | skeletal: 0.002 | neurologic: 0.049); OMIM:612526 (syndromic: 0.013 | growth: 0.25),hm (true); ht (false),1,15525,0.9853249475890985,"9606.ENSP00000264896:897, 9606.ENSP00000276297:672, 9606.ENSP00000317272:292, 9606.ENSP00000352264:400, 9606.ENSP00000445306:333, 9606.ENSP00000351015:292, 9606.ENSP00000368190:605, 9606.ENSP00000262613:234, 9606.ENSP00000380432:565, 9606.ENSP00000215832:292, 9606.ENSP00000363435:699, 9606.ENSP00000393312:330, 9606.ENSP00000231509:547, 9606.ENSP00000219476:286, 9606.ENSP00000420194:275, 9606.ENSP00000361021:838, 9606.ENSP00000287820:457, 9606.ENSP00000216117:487, 9606.ENSP00000288139:152, 9606.ENSP00000229135:197, 9606.ENSP00000255380:225, 9606.ENSP00000345751:365, 9606.ENSP00000362680:988, 9606.ENSP00000360141:165, 9606.ENSP00000358866:814, 9606.ENSP00000356319:292, 9606.ENSP00000385675:267, 9606.ENSP00000357283:163, 9606.ENSP00000355627:175, 9606.ENSP00000265748:292, 9606.ENSP00000252486:635, 9606.ENSP00000451828:606, 9606.ENSP00000350815:292, 9606.ENSP00000264414:292, 9606.ENSP00000358894:161, 9606.ENSP00000319756:292, 9606.ENSP00000200181:651",0,11.8758,4.81265,4.58900525670546,cur_071
CC2D2A,29253,5,4.5920100310458825,0,0.6274,3.3198,0.6467,COACH syndrome 2[OMIM:619111]-Autosomal recessive inheritance | Retinitis pigmentosa 93[OMIM:619845]-Autosomal recessive inheritance | Meckel syndrome 6[OMIM:612284]-Autosomal recessive inheritance | Joubert syndrome 9[OMIM:612285]-Autosomal recessive inheritance,"Definitive (ciliopathy[MONDO:0005308]-Autosomal recessive) | Supportive (COACH syndrome 1[MONDO:0008996]-Autosomal recessive) | Supportive (Joubert syndrome with oculorenal defect[MONDO:0009480]-Autosomal recessive) | Definitive, Strong (Joubert syndrome 9[MONDO:0012849]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",Definitive (ciliopathy[MONDO:0005308]-AR),P:116; LP:73; VUS:642,OMIM:612284 (cyst_cilio: 0.102 | cancer: 0.1 | cakut: 0.073 | glomerulopathy: 0.007 | tubulopathy: 0.007); OMIM:612285 (glomerulopathy: 0.129 | cyst_cilio: 0.126 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02); OMIM:619111 (cyst_cilio: 0.031 | cakut: 0.016 | glomerulopathy: 0.007),OMIM:612284 (antenatal_or_congenital: 0.077); OMIM:619111 (antenatal_or_congenital: 0.821); OMIM:619845 (antenatal_or_congenital: 0.821 | adult: 0.372),OMIM:612284 (syndromic: 0.012 | skeletal: 0.009 | neurologic: 0.008); OMIM:612285 (syndromic: 0.081 | skeletal: 0.038 | neurologic: 0.148); OMIM:619111 (syndromic: 0.053 | neurologic: 0.112),hm (true); ht (false),1,10227,0.9077568134171907,"9606.ENSP00000389998:887, 9606.ENSP00000376827:951, 9606.ENSP00000304941:985, 9606.ENSP00000380779:993, 9606.ENSP00000344314:292, 9606.ENSP00000483364:978, 9606.ENSP00000313169:288, 9606.ENSP00000261499:990, 9606.ENSP00000314116:826, 9606.ENSP00000367398:193, 9606.ENSP00000258173:966, 9606.ENSP00000243578:987, 9606.ENSP00000448012:891",0.5,5.549259999999999,4.72309,68.0695813201838,cur_072
CCDC28B,28163,2,1.9222114666244905,0,1.4648,-1.1803,1.0265,"{Bardet-Biedl syndrome 1, modifier of}[OMIM:209900]-Autosomal recessive inheritance | {Bardet-Biedl syndrome 1, modifier of}[OMIM:209900]-Digenic inheritance",No Known Disease Relationship (Bardet-Biedl syndrome 1[MONDO:0008854]-Autosomal recessive),NULL,P:0; LP:0; VUS:7,OMIM:209900 (cyst_cilio: 0.018 | cancer: 0.01 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:209900 (antenatal_or_congenital: 0.821),OMIM:209900 (syndromic: 0.093 | growth: 0.054 | skeletal: 0.052 | neurologic: 0.133),hm (NA); ht (NA),0.5,4318,0.6939203354297694,"9606.ENSP00000246062:292, 9606.ENSP00000349923:380, 9606.ENSP00000295240:552, 9606.ENSP00000206542:414, 9606.ENSP00000268057:569, 9606.ENSP00000482306:551, 9606.ENSP00000404122:173, 9606.ENSP00000317469:535, 9606.ENSP00000264499:560, 9606.ENSP00000245157:292",0,4.3430800000000005,3.53221,7.73125969462228,cur_073
CD151,1630,5,3.510819835533806,1.1e-5,0.64053,1.3162,0.59362,"[Blood group, Raph][OMIM:179620]-NA | Epidermolysis bullosa simplex 7, with nephropathy and deafness[OMIM:609057]-Autosomal recessive inheritance","Strong, Strong, Moderate, Supportive (nephrotic syndrome - deafness - pretibial epidermolysis bullosa syndrome[MONDO:0012190]-Autosomal recessive)",NULL,P:2; LP:1; VUS:39,OMIM:609057 (glomerulopathy: 0.146 | cyst_cilio: 0.129 | tubulopathy: 0.042 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,OMIM:609057 (syndromic: 0),hm (true); ht (false),0,NULL,NULL,NULL,0.5,135.472,101.09100000000001,60.9416386404785,cur_074
CD2AP,14258,5,3.781841761488749,0.22989,0.23683,4.3596,0.002148,"Glomerulosclerosis, focal segmental, 3[OMIM:607832]-NA","Strong (inherited focal segmental glomerulosclerosis[MONDO:0005363]-Autosomal dominant) | Limited (focal segmental glomerulosclerosis 3, susceptibility to[MONDO:0011917]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:6; LP:1; VUS:153,OMIM:607832 (glomerulopathy: 0.222 | complement: 0.214 | tubulopathy: 0.147 | nephrocalcinosis: 0.146 | cyst_cilio: 0.087 | cakut: 0.069 | cancer: 0.05),NULL,NULL,hm (true); ht (true),0.5,7346,0.8301886792452831,"9606.ENSP00000265748:731, 9606.ENSP00000362680:408, 9606.ENSP00000406229:444, 9606.ENSP00000356319:292, 9606.ENSP00000356587:990, 9606.ENSP00000451828:292, 9606.ENSP00000231509:197, 9606.ENSP00000269305:313, 9606.ENSP00000252699:437, 9606.ENSP00000352138:984, 9606.ENSP00000339191:400, 9606.ENSP00000368190:993, 9606.ENSP00000377789:865",0.5,21.9594,17.4649,171.757714848344,cur_075
CD46,6953,5,3.925468980428117,NULL,NULL,NULL,NULL,"{Hemolytic uremic syndrome, atypical, susceptibility to, 2}[OMIM:612922]-Autosomal dominant inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to, 2}[OMIM:612922]-Autosomal recessive inheritance",Strong (atypical hemolytic-uremic syndrome with MCP/CD46 anomaly[MONDO:0013040]-Autosomal dominant) | Definitive (atypical hemolytic-uremic syndrome with MCP/CD46 anomaly[MONDO:0013040]-Semidominant),NULL,P:19; LP:15; VUS:135,OMIM:612922 (complement: 0.143 | glomerulopathy: 0.071 | tubulopathy: 0.042 | nephrocalcinosis: 0.035 | cakut: 0.016 | cyst_cilio: 0.013),OMIM:612922 (neonatal_or_pediatric: 0.463),NULL,hm (false); ht (false),0.5,3394,0.6121593291404612,"9606.ENSP00000252934:343, 9606.ENSP00000396688:994, 9606.ENSP00000245907:999, 9606.ENSP00000362680:292, 9606.ENSP00000254958:766",0.5,73.6572,36.3367,89.4320642508626,cur_076
CDC5L,1743,2,1.760432337332176,1,0.040964,6.2097,2.782,NULL,NULL,NULL,P:0; LP:0; VUS:21,NULL,NULL,NULL,hm (NA); ht (NA),0.5,3256,0.5911949685534591,"9606.ENSP00000362424:342, 9606.ENSP00000377789:239, 9606.ENSP00000448012:161, 9606.ENSP00000356319:292, 9606.ENSP00000262210:185, 9606.ENSP00000256078:161, 9606.ENSP00000265748:349, 9606.ENSP00000261167:958, 9606.ENSP00000281043:161, 9606.ENSP00000437256:203, 9606.ENSP00000348984:205",0.5,10.2814,5.66202,63.9998650578661,cur_077
CDC73,16783,5,3.239633455078594,0.99995,0.072753,5.5176,3.7315,"Hyperparathyroidism, familial primary[OMIM:145000]-Autosomal dominant inheritance | Parathyroid adenoma with cystic changes[OMIM:145001]-Autosomal dominant inheritance | Parathyroid carcinoma[OMIM:608266]-NA | Hyperparathyroidism-jaw tumor syndrome[OMIM:145001]-Autosomal dominant inheritance","Definitive, Definitive, Definitive (hyperparathyroidism 2 with jaw tumors[MONDO:0007768]-Autosomal dominant) | Strong (parathyroid gland carcinoma[MONDO:0012004]-Autosomal dominant) | Supportive (familial isolated hyperparathyroidism[MONDO:0015027]-Autosomal dominant)",Definitive (hyperparathyroidism 2 with jaw tumors[MONDO:0007768]-AD),P:93; LP:20; VUS:570,OMIM:145001 (cancer: 0.15 | tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cyst_cilio: 0.068 | complement: 0.036 | cakut: 0.02 | glomerulopathy: 0.018),NULL,OMIM:145001 (syndromic: 0),hm (false); ht (false),0.5,5349,0.7610062893081762,"9606.ENSP00000252699:292, 9606.ENSP00000390436:533, 9606.ENSP00000481646:292, 9606.ENSP00000392028:161, 9606.ENSP00000216181:426, 9606.ENSP00000297185:292, 9606.ENSP00000308938:292, 9606.ENSP00000386834:540, 9606.ENSP00000268057:244, 9606.ENSP00000358866:292, 9606.ENSP00000367203:257, 9606.ENSP00000379258:499, 9606.ENSP00000376827:292, 9606.ENSP00000379619:157, 9606.ENSP00000482306:244, 9606.ENSP00000445175:292, 9606.ENSP00000338766:244",0.5,0.212745,0.197328,151.12049055186301,cur_078
CDKN1B,1785,3,1.6119178230271445,0.62376,0.13587,2.1724,-1.8481,"Multiple endocrine neoplasia, type IV[OMIM:610755]-Autosomal dominant inheritance","Definitive, Strong, Supportive (multiple endocrine neoplasia type 4[MONDO:0012552]-Autosomal dominant) | Limited (hereditary nonpolyposis colon cancer[MONDO:0018630]-Autosomal recessive)",Definitive (multiple endocrine neoplasia type 4[MONDO:0012552]-AD) | Limited (hereditary nonpolyposis colon cancer[MONDO:0018630]-AR),P:52; LP:9; VUS:473,OMIM:610755 (cancer: 0.01 | cyst_cilio: 0.005),NULL,OMIM:610755 (syndromic: 0 | neurologic: 0.001),hm (true); ht (true),0.5,5460,0.7693920335429769,"9606.ENSP00000269305:309, 9606.ENSP00000451828:657, 9606.ENSP00000362680:351, 9606.ENSP00000298552:292, 9606.ENSP00000413720:905, 9606.ENSP00000216911:616, 9606.ENSP00000262613:329, 9606.ENSP00000227507:999, 9606.ENSP00000256474:414, 9606.ENSP00000219476:588",0.5,22.5816,22.4812,38.4124596442714,cur_079
CENPF,1857,3,2.364755408437841,0,0.60797,4.141,-0.029674,Stromme syndrome[OMIM:243605]-Autosomal recessive inheritance,"Strong, Strong, Strong, Strong, Supportive, Supportive (Stromme syndrome[MONDO:0009477]-Autosomal recessive)",NULL,P:17; LP:18; VUS:236,OMIM:243605 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:243605 (antenatal_or_congenital: 0.821),OMIM:243605 (syndromic: 0.049 | skeletal: 0.077 | neurologic: 0.054),hm (false); ht (false),0.5,3878,0.6582809224318659,"9606.ENSP00000216911:328, 9606.ENSP00000229179:292, 9606.ENSP00000380911:540, 9606.ENSP00000265748:292, 9606.ENSP00000261396:694, 9606.ENSP00000281142:540, 9606.ENSP00000356319:362, 9606.ENSP00000278935:540, 9606.ENSP00000360540:290",0.5,0.152303,0.11574100000000001,198.045389829157,cur_080
CEP104,24866,3,1.9910616598613124,0,0.54175,3.0528,0.44421,"Joubert syndrome 25[OMIM:616781]-Autosomal recessive inheritance | Intellectual developmental disorder, autosomal recessive 77[OMIM:619988]-Autosomal recessive inheritance","Definitive (Joubert syndrome 17[MONDO:0013824]-Autosomal recessive) | Strong, Moderate (Joubert syndrome 25[MONDO:0014770]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive)",NULL,P:15; LP:12; VUS:120,NULL,OMIM:616781 (neonatal_or_pediatric: 0.402); OMIM:619988 (neonatal_or_pediatric: 0.402),OMIM:616781 (syndromic: 0.038 | neurologic: 0.079); OMIM:619988 (syndromic: 0.048 | skeletal: 0.009 | neurologic: 0.094),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,1.69277,1.12366,40.2464083007153,cur_081
CEP120,26690,4,2.252486297462421,0,0.59172,2.7822,-0.23317,Short-rib thoracic dysplasia 13 with or without polydactyly[OMIM:616300]-Autosomal recessive inheritance | Joubert syndrome 31[OMIM:617761]-Autosomal recessive inheritance,Supportive (Joubert syndrome with ocular defect[MONDO:0016364]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive),NULL,P:15; LP:12; VUS:165,OMIM:616300 (cakut: 0.133 | cyst_cilio: 0.129 | cancer: 0.03 | glomerulopathy: 0.011 | tubulopathy: 0.007),OMIM:616300 (antenatal_or_congenital: 0.821); OMIM:617761 (neonatal_or_pediatric: 0.134),OMIM:616300 (syndromic: 0.032 | growth: 0.017 | skeletal: 0.04 | neurologic: 0.012); OMIM:617761 (syndromic: 0.039 | neurologic: 0.081),hm (false); ht (false),0.5,1680,0.3668763102725367,"9606.ENSP00000346359:560, 9606.ENSP00000414884:224, 9606.ENSP00000334379:317, 9606.ENSP00000448012:414, 9606.ENSP00000249442:165",0.5,5.83893,4.01846,34.2344145651054,cur_082
CEP164,29182,5,4.1493475808408276,0,0.66885,2.7827,0.34541,Nephronophthisis 15[OMIM:614845]-Autosomal recessive inheritance,"Definitive (ciliopathy[MONDO:0005308]-Autosomal recessive) | Definitive, Strong (nephronophthisis 15[MONDO:0013917]-Autosomal recessive) | Strong, Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive)",Definitive (ciliopathy[MONDO:0005308]-AR),P:42; LP:41; VUS:567,OMIM:614845 (cyst_cilio: 0.097 | glomerulopathy: 0.007 | cakut: 0.004),NULL,OMIM:614845 (syndromic: 0.049 | growth: 0.043 | skeletal: 0.003 | neurologic: 0.096),hm (false); ht (false),0.5,4846,0.7358490566037735,"9606.ENSP00000269305:225, 9606.ENSP00000287600:153, 9606.ENSP00000367398:292, 9606.ENSP00000264499:199, 9606.ENSP00000380911:983, 9606.ENSP00000355922:540, 9606.ENSP00000355499:186, 9606.ENSP00000313169:292, 9606.ENSP00000334379:237, 9606.ENSP00000297185:165, 9606.ENSP00000281142:985, 9606.ENSP00000262457:292, 9606.ENSP00000338766:297",0.5,9.67145,6.54395,55.1626378952939,cur_083
CEP290,29021,5,4.884384028030665,0,0.83664,1.6878,0.47455,Leber congenital amaurosis 10[OMIM:611755]-NA | Joubert syndrome 5[OMIM:610188]-Autosomal recessive inheritance | Senior-Loken syndrome 6[OMIM:610189]-Autosomal recessive inheritance | ?Bardet-Biedl syndrome 14[OMIM:615991]-Autosomal recessive inheritance | Meckel syndrome 4[OMIM:611134]-Autosomal recessive inheritance,Supportive (Joubert syndrome with oculorenal defect[MONDO:0009480]-Autosomal recessive) | Definitive (Joubert syndrome 5[MONDO:0012432]-Autosomal recessive) | Moderate (Bardet-Biedl syndrome 14[MONDO:0014442]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive) | Supportive (Leber congenital amaurosis[MONDO:0018998]-Autosomal dominant) | Definitive (CEP290-related ciliopathy[MONDO:0100451]-Autosomal recessive),Definitive (CEP290-related ciliopathy[MONDO:0100451]-AR),P:448; LP:162; VUS:1012,OMIM:610188 (cyst_cilio: 0.239 | glomerulopathy: 0.14 | tubulopathy: 0.049 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.035 | cancer: 0.02); OMIM:610189 (glomerulopathy: 0.129 | cyst_cilio: 0.126 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02); OMIM:611134 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007); OMIM:615991 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:610189 (neonatal_or_pediatric: 0.262),OMIM:610188 (syndromic: 0.063 | skeletal: 0.001 | neurologic: 0.12); OMIM:610189 (syndromic: 0 | neurologic: 0); OMIM:611134 (syndromic: 0.038 | growth: 0.102 | skeletal: 0.061 | neurologic: 0.053); OMIM:611755 (syndromic: 0.02 | neurologic: 0.042); OMIM:615991 (syndromic: 0.047 | growth: 0.043 | skeletal: 0.003 | neurologic: 0.091),hm (true); ht (false),1,16584,0.989517819706499,"9606.ENSP00000258173:927, 9606.ENSP00000242067:201, 9606.ENSP00000311505:966, 9606.ENSP00000303058:414, 9606.ENSP00000403465:891, 9606.ENSP00000483364:745, 9606.ENSP00000313169:609, 9606.ENSP00000346359:292, 9606.ENSP00000376827:786, 9606.ENSP00000338766:433, 9606.ENSP00000295240:292, 9606.ENSP00000314116:749, 9606.ENSP00000261499:951, 9606.ENSP00000455426:541, 9606.ENSP00000482306:201, 9606.ENSP00000312397:171, 9606.ENSP00000389998:920, 9606.ENSP00000445175:292, 9606.ENSP00000304941:922, 9606.ENSP00000380779:946, 9606.ENSP00000268057:478, 9606.ENSP00000317469:201, 9606.ENSP00000367398:693, 9606.ENSP00000245157:292, 9606.ENSP00000310668:173, 9606.ENSP00000377934:292, 9606.ENSP00000252934:396, 9606.ENSP00000243578:885, 9606.ENSP00000360532:161, 9606.ENSP00000386264:271, 9606.ENSP00000264499:201, 9606.ENSP00000344314:292",0.5,4.551880000000001,3.45479,131.314002718767,cur_084
CEP41,12370,4,3.459206496619521,4e-6,0.56915,1.8333,0.34726,Joubert syndrome 15[OMIM:614464]-Autosomal recessive inheritance,"Definitive, Strong (Joubert syndrome 15[MONDO:0013763]-Autosomal recessive) | Supportive (Joubert syndrome with ocular defect[MONDO:0016364]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive)",NULL,P:10; LP:5; VUS:231,OMIM:614464 (cyst_cilio: 0.097 | glomerulopathy: 0.007 | cakut: 0.004),NULL,OMIM:614464 (syndromic: 0.054 | skeletal: 0.001 | neurologic: 0.112),hm (false); ht (false),0,NULL,NULL,NULL,0.5,2.1747400000000003,0.9457190000000001,31.6362047354219,cur_085
CEP55,1161,3,1.899946568869032,0,0.75643,1.2172,0.49692,"Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly[OMIM:236500]-Autosomal recessive inheritance","Strong, Moderate, Moderate (multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome[MONDO:0009359]-Autosomal recessive) | Moderate (complex neurodevelopmental disorder[MONDO:0100038]-Autosomal recessive)",NULL,P:8; LP:2; VUS:30,OMIM:236500 (cakut: 0.198 | cyst_cilio: 0.15 | cancer: 0.03 | glomerulopathy: 0.013 | tubulopathy: 0.007),NULL,OMIM:236500 (syndromic: 0.029 | skeletal: 0.05 | neurologic: 0.01),hm (true); ht (false),0.5,1776,0.3752620545073375,"9606.ENSP00000265748:292, 9606.ENSP00000216911:172, 9606.ENSP00000269305:163, 9606.ENSP00000355250:196, 9606.ENSP00000356319:338, 9606.ENSP00000355922:290, 9606.ENSP00000369497:325",0.5,0.14501,0.104682,12.2076819012697,cur_086
CEP83,17966,5,3.914650361353856,0,0.65172,2.1154,0.40633,Nephronophthisis 18[OMIM:615862]-Autosomal recessive inheritance,Supportive (nephronophthisis 2[MONDO:0011190]-Autosomal recessive) | Strong (nephronophthisis 18[MONDO:0014374]-Autosomal recessive),NULL,P:29; LP:3; VUS:212,OMIM:615862 (cyst_cilio: 0.268 | glomerulopathy: 0.175 | tubulopathy: 0.056 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,OMIM:615862 (syndromic: 0.022 | neurologic: 0.047),hm (NA); ht (NA),0.5,4116,0.6750524109014675,"9606.ENSP00000389998:380, 9606.ENSP00000281142:993, 9606.ENSP00000355922:540, 9606.ENSP00000362424:436, 9606.ENSP00000216181:163, 9606.ENSP00000483364:329, 9606.ENSP00000278935:983, 9606.ENSP00000356319:292",0,3.83077,2.37537,NULL,cur_087
CFB,1037,5,3.513162485825995,3.35e-4,0.33419,3.9933,1.4801,"?Complement factor B deficiency[OMIM:615561]-Autosomal recessive inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to, 4}[OMIM:612924]-Autosomal dominant inheritance | {Macular degeneration, age-related, 14, reduced risk of}[OMIM:615489]-Digenic inheritance","Strong, Moderate (atypical hemolytic-uremic syndrome with B factor anomaly[MONDO:0013042]-Autosomal dominant) | Moderate (complement factor b deficiency[MONDO:0014255]-Autosomal recessive)",Moderate (atypical hemolytic-uremic syndrome with B factor anomaly[MONDO:0013042]-AD),P:3; LP:0; VUS:168,OMIM:612924 (complement: 0.143 | glomerulopathy: 0.071 | tubulopathy: 0.042 | nephrocalcinosis: 0.035 | cakut: 0.016 | cyst_cilio: 0.013),OMIM:615561 (neonatal_or_pediatric: 0.262),OMIM:615561 (syndromic: 0 | neurologic: 0.001),hm (true); ht (false),0.5,4633,0.7190775681341719,"9606.ENSP00000245907:999, 9606.ENSP00000396688:681, 9606.ENSP00000314299:236, 9606.ENSP00000356399:601, 9606.ENSP00000252486:371, 9606.ENSP00000356969:454, 9606.ENSP00000356395:499, 9606.ENSP00000356386:431, 9606.ENSP00000236850:361",0,20.9592,34.4646,0.250431251718134,cur_088
CFH,4883,5,4.43452152928147,0.86061,0.20396,5.8893,0.99735,"{Macular degeneration, age-related, 4}[OMIM:610698]-Autosomal dominant inheritance | Basal laminar drusen[OMIM:126700]-Autosomal dominant inheritance | Complement factor H deficiency[OMIM:609814]-Autosomal dominant inheritance | Complement factor H deficiency[OMIM:609814]-Autosomal recessive inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to, 1}[OMIM:235400]-Autosomal dominant inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to, 1}[OMIM:235400]-Autosomal recessive inheritance","Supportive (Doyne honeycomb retinal dystrophy[MONDO:0007471]-Autosomal dominant) | Strong (basal laminar drusen[MONDO:0007472]-Autosomal dominant) | Moderate (hemolytic uremic syndrome, atypical, susceptibility to, 1[MONDO:0009335]-Autosomal dominant) | Moderate (complement factor H deficiency[MONDO:0012350]-Autosomal recessive) | Definitive (atypical hemolytic-uremic syndrome[MONDO:0016244]-Semidominant) | Supportive (dense deposit disease[MONDO:0019736]-Autosomal recessive)",Definitive (atypical hemolytic-uremic syndrome[MONDO:0016244]-SD),P:36; LP:23; VUS:285,OMIM:235400 (complement: 0.143 | glomerulopathy: 0.027 | cakut: 0.016 | nephrocalcinosis: 0.007 | tubulopathy: 0.007 | cyst_cilio: 0.003); OMIM:609814 (complement: 0.179 | glomerulopathy: 0.084 | tubulopathy: 0.077 | nephrocalcinosis: 0.069 | cyst_cilio: 0.026 | cakut: 0.02),OMIM:126700 (adult: 0.346); OMIM:609814 (neonatal_or_pediatric: 0.2); OMIM:610698 (adult: 0.218),OMIM:235400 (syndromic: 0.023 | neurologic: 0.047),hm (true); ht (false),0.5,6415,0.80083857442348,"9606.ENSP00000237014:347, 9606.ENSP00000252486:891, 9606.ENSP00000366307:540, 9606.ENSP00000296280:540, 9606.ENSP00000314299:886, 9606.ENSP00000274813:165, 9606.ENSP00000245907:999, 9606.ENSP00000396688:749, 9606.ENSP00000356386:277, 9606.ENSP00000416561:601, 9606.ENSP00000356395:420",0.5,9.45192,10.5349,18.1873464692574,cur_089
CFHR1,4888,5,3.7699782917684694,0,0.94972,0.16563,-0.32808,"{Macular degeneration, age-related, reduced risk of}[OMIM:603075]-Autosomal dominant inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to}[OMIM:235400]-Autosomal dominant inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to}[OMIM:235400]-Autosomal recessive inheritance","Limited (hemolytic uremic syndrome, atypical, susceptibility to, 1[MONDO:0009335]-Autosomal dominant) | Supportive (dense deposit disease[MONDO:0019736]-Autosomal recessive)",NULL,P:0; LP:2; VUS:22,OMIM:235400 (complement: 0.143 | glomerulopathy: 0.027 | cakut: 0.016 | nephrocalcinosis: 0.007 | tubulopathy: 0.007 | cyst_cilio: 0.003),OMIM:603075 (adult: 0.108),OMIM:235400 (syndromic: 0.023 | neurologic: 0.047),hm (NA); ht (NA),0.5,4503,0.710691823899371,"9606.ENSP00000313967:236, 9606.ENSP00000356395:499, 9606.ENSP00000396688:243, 9606.ENSP00000245907:984, 9606.ENSP00000362924:222, 9606.ENSP00000256785:698, 9606.ENSP00000356386:499, 9606.ENSP00000356399:886, 9606.ENSP00000416561:236",0,0.07533680000000001,1.22394,0.115173840948114,cur_090
CFHR2,4890,3,1.570826657520417,0,1.1899,-0.53493,-0.90186,NULL,NULL,NULL,P:0; LP:0; VUS:10,NULL,NULL,NULL,hm (NA); ht (NA),0,NULL,NULL,NULL,0,0.0396415,0,0.707818782691066,cur_091
CFHR3,16980,5,3.5310697020569304,0,1.0633,-0.22743,-9.41e-4,"{Macular degeneration, age-related, reduced risk of}[OMIM:603075]-Autosomal dominant inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to}[OMIM:235400]-Autosomal dominant inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to}[OMIM:235400]-Autosomal recessive inheritance",NULL,NULL,P:0; LP:0; VUS:20,OMIM:235400 (complement: 0.143 | glomerulopathy: 0.027 | cakut: 0.016 | nephrocalcinosis: 0.007 | tubulopathy: 0.007 | cyst_cilio: 0.003),OMIM:603075 (adult: 0.108),OMIM:235400 (syndromic: 0.023 | neurologic: 0.047),hm (NA); ht (NA),0.5,3693,0.6457023060796646,"9606.ENSP00000416561:499, 9606.ENSP00000356399:420, 9606.ENSP00000256785:696, 9606.ENSP00000356386:662, 9606.ENSP00000245907:917, 9606.ENSP00000314299:499",0,0.00775672,0.07387060000000001,0.0979669652639976,cur_092
CFHR4,16979,2,1.4918632824282143,NULL,NULL,NULL,NULL,NULL,NULL,NULL,P:0; LP:0; VUS:28,NULL,NULL,NULL,hm (NA); ht (NA),0.5,3591,0.6289308176100629,"9606.ENSP00000245907:976, 9606.ENSP00000396688:243, 9606.ENSP00000356395:662, 9606.ENSP00000314299:499, 9606.ENSP00000416561:431, 9606.ENSP00000356399:277, 9606.ENSP00000256785:503",0,0,0.037476499999999996,0.490162557518405,cur_093
CFHR5,24668,5,3.916857818911387,0,1.4363,-2.1601,-0.90324,Nephropathy due to CFHR5 deficiency[OMIM:614809]-Autosomal dominant inheritance,"Strong, Moderate (C3 glomerulonephritis[MONDO:0013892]-Autosomal dominant)",NULL,P:2; LP:0; VUS:93,OMIM:614809 (glomerulopathy: 0.273 | cyst_cilio: 0.197 | tubulopathy: 0.175 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.077 | cancer: 0.02),NULL,NULL,hm (NA); ht (NA),0.5,3031,0.5618448637316562,"9606.ENSP00000262418:192, 9606.ENSP00000356386:503, 9606.ENSP00000245907:942, 9606.ENSP00000356395:696, 9606.ENSP00000314299:698",0,0,0,0.0823967247466616,cur_094
CFI,5394,5,4.196232388959928,0,0.51346,2.6694,0.20108,"{Hemolytic uremic syndrome, atypical, susceptibility to, 3}[OMIM:612923]-Autosomal dominant inheritance | {Macular degeneration, age-related, 13, susceptibility to}[OMIM:615439]-Autosomal dominant inheritance | Complement factor I deficiency[OMIM:610984]-Autosomal recessive inheritance","Supportive (Doyne honeycomb retinal dystrophy[MONDO:0007471]-Autosomal dominant) | Strong, Supportive (complement factor I deficiency[MONDO:0012594]-Autosomal recessive) | Limited (atypical hemolytic-uremic syndrome with I factor anomaly[MONDO:0013041]-Autosomal dominant) | Limited (age related macular degeneration 13[MONDO:0014189]-Autosomal dominant) | Definitive (atypical hemolytic-uremic syndrome[MONDO:0016244]-Autosomal dominant)",Definitive (atypical hemolytic-uremic syndrome[MONDO:0016244]-AD),P:25; LP:16; VUS:170,OMIM:610984 (nephrocalcinosis: 0.118 | complement: 0.107 | tubulopathy: 0.105 | glomerulopathy: 0.1 | cyst_cilio: 0.071 | cakut: 0.044 | cancer: 0.02); OMIM:612923 (complement: 0.143 | glomerulopathy: 0.071 | tubulopathy: 0.042 | nephrocalcinosis: 0.035 | cakut: 0.016 | cyst_cilio: 0.013),OMIM:610984 (neonatal_or_pediatric: 0.865); OMIM:612923 (adult: 0.372 | neonatal_or_pediatric: 0.262),OMIM:610984 (syndromic: 0.001 | skeletal: 0.004 | neurologic: 0),hm (true); ht (false),0,NULL,NULL,NULL,0.5,51.2859,93.2334,18.5927806192075,cur_095
CHD1L,1916,2,2.1729688961653864,0,1.0357,-0.23873,-0.58031,NULL,Limited (congenital anomaly of kidney and urinary tract[MONDO:0019719]-Autosomal dominant),Limited (congenital anomaly of kidney and urinary tract[MONDO:0019719]-AD),P:1; LP:0; VUS:87,NULL,NULL,NULL,hm (false); ht (false),0,446,0.1090146750524109,"9606.ENSP00000484803:292, 9606.ENSP00000387982:154",0.5,23.3606,14.39,75.6600633520827,cur_096
CHD7,20626,4,2.9808288928810383,1,0.036285,10.483,3.2193,Hypogonadotropic hypogonadism 5 with or without anosmia[OMIM:612370]-Autosomal dominant inheritance | CHARGE syndrome[OMIM:214800]-Autosomal dominant inheritance,"Definitive, Definitive, Strong, Strong, Supportive (CHARGE syndrome[MONDO:0008965]-Autosomal dominant) | Supportive (Omenn syndrome[MONDO:0011338]-Autosomal recessive) | Supportive (hypogonadotropic hypogonadism[MONDO:0018555]-Autosomal dominant) | Supportive (Kallmann syndrome[MONDO:0018800]-Autosomal dominant)",Definitive (CHARGE syndrome[MONDO:0008965]-AD),P:505; LP:129; VUS:957,OMIM:214800 (cakut: 0.234 | cancer: 0.17 | cyst_cilio: 0.068 | glomerulopathy: 0.013 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:214800 (antenatal_or_congenital: 0.899),OMIM:214800 (syndromic: 0.116 | growth: 0.053 | skeletal: 0.132 | neurologic: 0.156); OMIM:612370 (syndromic: 0.006 | neurologic: 0.001),hm (false); ht (false),0.5,2752,0.5241090146750524,"9606.ENSP00000231509:165, 9606.ENSP00000356319:292, 9606.ENSP00000390436:292, 9606.ENSP00000245479:332, 9606.ENSP00000379258:292, 9606.ENSP00000254958:292, 9606.ENSP00000339824:276, 9606.ENSP00000356405:161, 9606.ENSP00000410294:282, 9606.ENSP00000281043:368",0.5,4.16132,2.25555,192.986064120823,cur_097
CHRM3,1952,4,2.8010157933375615,NULL,NULL,NULL,NULL,Prune belly syndrome[OMIM:100100]-Autosomal recessive inheritance,Supportive (prune belly syndrome[MONDO:0007032]-Autosomal dominant) | Strong (prune belly syndrome[MONDO:0007032]-Autosomal recessive),NULL,P:2; LP:0; VUS:20,OMIM:100100 (cakut: 0.097 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,OMIM:100100 (syndromic: 0.006 | skeletal: 0.021),hm (true); ht (false),0,528,0.13417190775681342,"9606.ENSP00000339824:303, 9606.ENSP00000339191:225",0.5,0.507317,0.589623,155.771301791215,cur_098
CHRNA3,1957,3,2.3474196590291663,0,0.72218,1.0923,0.73486,"{Lung cancer susceptibility 2}[OMIM:612052]-NA | Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT[OMIM:191800]-Autosomal recessive inheritance",NULL,NULL,P:4; LP:5; VUS:30,OMIM:191800 (cakut: 0.141 | cyst_cilio: 0.021 | cancer: 0.02 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,OMIM:191800 (syndromic: 0.009 | growth: 0.171 | neurologic: 0),hm (true); ht (false),0,458,0.11530398322851153,"9606.ENSP00000363435:231, 9606.ENSP00000258173:227",0,0.110417,0.0200801,1.83557652878192,cur_099
CLCN2,2020,2,1.1676960058135193,0,0.55436,2.8281,0.65376,"Leukoencephalopathy with ataxia[OMIM:615651]-Autosomal recessive inheritance | Hyperaldosteronism, familial, type II[OMIM:605635]-Autosomal dominant inheritance | {Epilepsy, juvenile myoclonic, susceptibility to, 8}[OMIM:607628]-Autosomal dominant inheritance | {Epilepsy, juvenile absence, susceptibility to, 2}[OMIM:607628]-Autosomal dominant inheritance | {Epilepsy, idiopathic generalized, susceptibility to, 11}[OMIM:607628]-Autosomal dominant inheritance","Refuted Evidence (epilepsy[MONDO:0005027]-Autosomal dominant) | Moderate, Supportive (familial hyperaldosteronism type II[MONDO:0011576]-Autosomal dominant) | Strong (epilepsy, idiopathic generalized, susceptibility to, 11[MONDO:0011875]-Autosomal dominant) | Definitive, Strong, Strong, Moderate, Supportive (leukoencephalopathy with mild cerebellar ataxia and white matter edema[MONDO:0014292]-Autosomal recessive)",Refuted (epilepsy[MONDO:0005027]-AD),P:19; LP:10; VUS:158,NULL,OMIM:605635 (neonatal_or_pediatric: 0.2); OMIM:615651 (neonatal_or_pediatric: 0.463 | adult: 0.238),OMIM:607628 (syndromic: 0.002 | neurologic: 0.005); OMIM:615651 (syndromic: 0.006 | neurologic: 0.012),hm (false); ht (true),0,165,0.018867924528301886,9606.ENSP00000261267:165,0,4.4764800000000005,2.9847200000000003,8.24149506052316,cur_100
CLCN5,2023,5,4.760501269283648,NULL,NULL,NULL,NULL,"Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis[OMIM:308990]-X-linked recessive inheritance | Hypophosphatemic rickets[OMIM:300554]-X-linked recessive inheritance | Dent disease 1[OMIM:300009]-X-linked recessive inheritance | Nephrolithiasis, type I[OMIM:310468]-X-linked recessive inheritance","Definitive, Supportive (Dent disease type 1[MONDO:0010225]-X-linked)",NULL,P:50; LP:24; VUS:155,OMIM:300009 (nephrocalcinosis: 0.472 | tubulopathy: 0.434 | glomerulopathy: 0.302 | cyst_cilio: 0.215 | cakut: 0.113 | complement: 0.107 | cancer: 0.03); OMIM:300554 (nephrocalcinosis: 0.451 | tubulopathy: 0.406 | glomerulopathy: 0.144 | complement: 0.107 | cyst_cilio: 0.089 | cakut: 0.077 | cancer: 0.03); OMIM:308990 (nephrocalcinosis: 0.354 | tubulopathy: 0.322 | glomerulopathy: 0.259 | cyst_cilio: 0.108 | complement: 0.071 | cakut: 0.06 | cancer: 0.06); OMIM:310468 (nephrocalcinosis: 0.493 | tubulopathy: 0.455 | glomerulopathy: 0.217 | cyst_cilio: 0.136 | complement: 0.107 | cakut: 0.077 | cancer: 0.03),NULL,OMIM:300009 (syndromic: 0.019 | growth: 0.25 | skeletal: 0.02); OMIM:300554 (syndromic: 0.019 | growth: 0.25 | skeletal: 0.021); OMIM:308990 (syndromic: 0.013 | growth: 0.25),hm (false); ht (true),0.5,876,0.20754716981132076,"9606.ENSP00000376432:375, 9606.ENSP00000402152:161, 9606.ENSP00000420194:340",0.5,21.4322,11.5337,86.9083052593191,cur_101
CLCNKA,2026,4,2.199674797940723,0,0.81818,1.0031,-0.33433,"Bartter syndrome, type 4b, digenic[OMIM:613090]-Digenic inheritance",Limited (Bartter disease type 4B[MONDO:0000909]-Autosomal recessive) | Moderate (Bartter disease type 4B[MONDO:0000909]-Unknown) | Supportive (Bartter syndrome type 4[MONDO:0019524]-Autosomal recessive),NULL,P:3; LP:2; VUS:50,OMIM:613090 (tubulopathy: 0.238 | nephrocalcinosis: 0.215 | cyst_cilio: 0.1 | glomerulopathy: 0.089 | complement: 0.071 | cakut: 0.048 | cancer: 0.02),OMIM:613090 (antenatal_or_congenital: 0.821),OMIM:613090 (syndromic: 0.041 | growth: 0.171 | neurologic: 0.066),hm (true); ht (false),0,NULL,NULL,NULL,0.5,293.026,40.9531,0.388568394440251,cur_102
CLCNKB,2027,5,4.268066461452806,0,0.93478000000000006,0.36979,-0.56265,"Bartter syndrome, type 3[OMIM:607364]-Autosomal recessive inheritance | Bartter syndrome, type 4b, digenic[OMIM:613090]-Digenic inheritance",Strong (Bartter disease type 4B[MONDO:0000909]-Autosomal recessive) | Supportive (Gitelman syndrome[MONDO:0009904]-Autosomal recessive) | Supportive (Bartter disease type 3[MONDO:0011822]-Autosomal recessive) | Strong (Bartter syndrome[MONDO:0015231]-Autosomal recessive) | Supportive (Bartter syndrome type 4[MONDO:0019524]-Autosomal recessive),NULL,P:37; LP:14; VUS:100,OMIM:607364 (nephrocalcinosis: 0.257 | tubulopathy: 0.238 | cyst_cilio: 0.026 | glomerulopathy: 0.022 | cancer: 0.01 | cakut: 0.008); OMIM:613090 (tubulopathy: 0.238 | nephrocalcinosis: 0.215 | cyst_cilio: 0.1 | glomerulopathy: 0.089 | complement: 0.071 | cakut: 0.048 | cancer: 0.02),OMIM:607364 (neonatal_or_pediatric: 0.865 | antenatal_or_congenital: 0.821); OMIM:613090 (antenatal_or_congenital: 0.821),OMIM:613090 (syndromic: 0.041 | growth: 0.171 | neurologic: 0.066),hm (true); ht (false),0,NULL,NULL,NULL,0.5,165.37900000000002,137.293,1.52351276481871,cur_103
CLDN10,2033,3,2.1873141911938023,8.39e-4,0.62095,1.0918,0.53617,HELIX syndrome[OMIM:617671]-Autosomal recessive inheritance,"Strong, Strong, Moderate, Supportive (HELIX syndrome[MONDO:0060564]-Autosomal recessive)",NULL,P:4; LP:1; VUS:13,OMIM:617671 (tubulopathy: 0.35 | nephrocalcinosis: 0.312 | glomerulopathy: 0.098 | cyst_cilio: 0.097 | complement: 0.071 | cakut: 0.06 | cancer: 0.03),OMIM:617671 (antenatal_or_congenital: 0.821),OMIM:617671 (syndromic: 0.001 | neurologic: 0.001),hm (false); ht (false),0.5,1472,0.33752620545073375,"9606.ENSP00000264734:650, 9606.ENSP00000296387:650, 9606.ENSP00000379619:172",0.5,1.39926,0.341468,27.9544718808449,cur_104
CLDN16,2037,5,3.944023029967734,0.025466,0.36012,2.2094,-0.076836,"Hypomagnesemia 3, renal[OMIM:248250]-Autosomal recessive inheritance","Strong, Supportive (renal hypomagnesemia 3[MONDO:0009550]-Autosomal recessive)",NULL,P:26; LP:13; VUS:123,OMIM:248250 (nephrocalcinosis: 0.479 | tubulopathy: 0.476 | complement: 0.179 | glomerulopathy: 0.098 | cyst_cilio: 0.055 | cakut: 0.04 | cancer: 0.01),OMIM:248250 (neonatal_or_pediatric: 0.2),OMIM:248250 (syndromic: 0.029 | growth: 0.171 | neurologic: 0.042),hm (true); ht (false),0.5,1640,0.36058700209643607,"9606.ENSP00000299339:650, 9606.ENSP00000296387:990",0,13.3205,4.19071,5.63228196353216,cur_105
CLDN19,2040,5,3.845919216623397,0.004968,0.51487,1.4009,0.77894,"Hypomagnesemia 5, renal, with ocular involvement[OMIM:248190]-Autosomal recessive inheritance","Definitive, Strong, Strong, Strong, Supportive (renal hypomagnesemia 5 with ocular involvement[MONDO:0009548]-Autosomal recessive) | Definitive (renal hypomagnesemia 5 with ocular involvement[MONDO:0009548]-Mitochondrial)",NULL,P:10; LP:6; VUS:83,OMIM:248190 (nephrocalcinosis: 0.361 | tubulopathy: 0.301 | glomerulopathy: 0.177 | cyst_cilio: 0.147 | cakut: 0.073 | complement: 0.036 | cancer: 0.03),OMIM:248190 (neonatal_or_pediatric: 0.865),OMIM:248190 (syndromic: 0.001 | skeletal: 0.002),hm (false); ht (false),0.5,2013,0.41509433962264153,"9606.ENSP00000299339:650, 9606.ENSP00000264734:990, 9606.ENSP00000417052:190, 9606.ENSP00000264896:183",0.5,31.2242,2.58889,15.1185685887748,cur_106
CNNM2,103,4,3.0016103766380193,0.99521,0.10328,4.4783,4.4105,"Hypomagnesemia 6, renal[OMIM:613882]-Autosomal dominant inheritance | Hypomagnesemia, seizures, and impaired intellectual development 1[OMIM:616418]-Autosomal dominant inheritance | Hypomagnesemia, seizures, and impaired intellectual development 1[OMIM:616418]-Autosomal recessive inheritance","Supportive (familial primary hypomagnesemia with normocalciuria and normocalcemia[MONDO:0018101]-Autosomal dominant) | Strong (hypomagnesemia, seizures, and intellectual disability 1[MONDO:0020787]-Autosomal dominant) | Strong (hypomagnesemia, seizures, and intellectual disability 1[MONDO:0020787]-Autosomal recessive)",NULL,P:19; LP:8; VUS:133,OMIM:613882 (tubulopathy: 0.007),OMIM:613882 (neonatal_or_pediatric: 0.463); OMIM:616418 (neonatal_or_pediatric: 0.665 | adult: 0.049),OMIM:613882 (syndromic: 0.001 | neurologic: 0.002); OMIM:616418 (syndromic: 0.092 | growth: 0 | skeletal: 0.049 | neurologic: 0.192),hm (false); ht (false),0,161,0.0041928721174004195,9606.ENSP00000339191:161,0.5,1.97279,2.41365,95.7699299933942,cur_107
COL4A1,2202,5,3.8916626332365976,1,0.065014,8.3233,3.0194,"?Retinal arteries, tortuosity of[OMIM:180000]-Autosomal dominant inheritance | {Hemorrhage, intracerebral, susceptibility to}[OMIM:614519]-NA | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps[OMIM:611773]-Autosomal dominant inheritance | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant[OMIM:618564]-Autosomal dominant inheritance | Brain small vessel disease with or without ocular anomalies[OMIM:175780]-Autosomal dominant inheritance","Supportive (muscular dystrophy-dystroglycanopathy, type A[MONDO:0000171]-Autosomal recessive) | Definitive, Strong, Strong, Moderate, Supportive (brain small vessel disease 1 with or without ocular anomalies[MONDO:0008289]-Autosomal dominant) | Supportive (retinal arterial tortuosity[MONDO:0008373]-Autosomal dominant) | Strong, Moderate, Supportive (autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome[MONDO:0012726]-Autosomal dominant) | Supportive (pontine autosomal dominant microangiopathy with leukoencephalopathy[MONDO:0018786]-Autosomal dominant) | Supportive (familial porencephaly[MONDO:0020496]-Autosomal dominant)",NULL,P:103; LP:143; VUS:544,OMIM:611773 (complement: 0.214 | cyst_cilio: 0.171 | tubulopathy: 0.147 | nephrocalcinosis: 0.139 | glomerulopathy: 0.133 | cakut: 0.101 | cancer: 0.05),OMIM:175780 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.665); OMIM:180000 (adult: 0.218); OMIM:618564 (adult: 0.575),OMIM:175780 (syndromic: 0.069 | neurologic: 0.144); OMIM:180000 (syndromic: 0.002 | neurologic: 0.004); OMIM:611773 (syndromic: 0.02 | neurologic: 0.042); OMIM:618564 (syndromic: 0.005 | neurologic: 0.01),hm (true); ht (true),0.5,3620,0.6310272536687631,"9606.ENSP00000379866:540, 9606.ENSP00000367316:415, 9606.ENSP00000378340:563, 9606.ENSP00000361021:269, 9606.ENSP00000256474:457, 9606.ENSP00000379823:647, 9606.ENSP00000331902:540, 9606.ENSP00000346839:189",0.5,51.687,31.8545,302.872769344561,cur_108
COL4A3,2204,5,4.773090524694064,0,0.3983,5.4462,1.9946,"Alport syndrome 3A, autosomal dominant[OMIM:104200]-Autosomal dominant inheritance | Hematuria, benign familial, 2[OMIM:620320]-NA | Alport syndrome 3B, autosomal recessive[OMIM:620536]-NA","Definitive, Strong, Supportive (autosomal dominant Alport syndrome[MONDO:0007086]-Autosomal dominant) | Strong (hematuria, benign familial[MONDO:0007709]-Autosomal dominant) | Definitive, Definitive, Strong, Strong, Supportive (autosomal recessive Alport syndrome[MONDO:0008762]-Autosomal recessive) | Strong (Alport syndrome[MONDO:0018965]-Autosomal recessive) | Definitive (Alport syndrome[MONDO:0018965]-Semidominant)",Definitive (Alport syndrome[MONDO:0018965]-SD),P:203; LP:309; VUS:397,OMIM:104200 (glomerulopathy: 0.432 | tubulopathy: 0.336 | nephrocalcinosis: 0.333 | complement: 0.25 | cyst_cilio: 0.207 | cakut: 0.105 | cancer: 0.06); OMIM:620320 (glomerulopathy: 0.031 | tubulopathy: 0.028 | nephrocalcinosis: 0.021),OMIM:620320 (adult: 0.218 | neonatal_or_pediatric: 0.2),NULL,hm (true); ht (true),0.5,3759,0.649895178197065,"9606.ENSP00000379866:942, 9606.ENSP00000378340:563, 9606.ENSP00000364979:647, 9606.ENSP00000256474:309, 9606.ENSP00000331902:890, 9606.ENSP00000245451:408",0.5,22.5385,27.3913,24.3678541307418,cur_109
COL4A4,2206,5,4.803998946627259,0,0.47332,4.4866,1.0151,"Hematuria, familial benign, 1[OMIM:141200]-Autosomal dominant inheritance | Alport syndrome 2, autosomal recessive[OMIM:203780]-Autosomal recessive inheritance","Supportive (autosomal dominant Alport syndrome[MONDO:0007086]-Autosomal dominant) | Strong, Moderate (hematuria, benign familial[MONDO:0007709]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong, Supportive (autosomal recessive Alport syndrome[MONDO:0008762]-Autosomal recessive) | Strong (Alport syndrome[MONDO:0018965]-Autosomal recessive) | Definitive (Alport syndrome[MONDO:0018965]-Semidominant)",Definitive (Alport syndrome[MONDO:0018965]-SD),P:207; LP:296; VUS:509,OMIM:141200 (complement: 0.143 | glomerulopathy: 0.049 | tubulopathy: 0.035 | nephrocalcinosis: 0.028 | cakut: 0.016 | cyst_cilio: 0.01); OMIM:203780 (glomerulopathy: 0.386 | complement: 0.25 | cyst_cilio: 0.207 | tubulopathy: 0.182 | nephrocalcinosis: 0.16 | cakut: 0.105 | cancer: 0.05),NULL,NULL,hm (true); ht (false),0.5,2882,0.5471698113207547,"9606.ENSP00000364979:540, 9606.ENSP00000378340:540, 9606.ENSP00000379823:942, 9606.ENSP00000331902:860",0.5,13.6017,15.0293,27.034106474903,cur_110
COL4A5,2207,5,4.29649035390268,1,0.09686,6.5869,2.4995,"Alport syndrome 1, X-linked[OMIM:301050]-X-linked dominant inheritance","Definitive, Strong, Strong, Supportive (X-linked Alport syndrome[MONDO:0010520]-X-linked) | Definitive, Strong (Alport syndrome[MONDO:0018965]-X-linked)",Definitive (Alport syndrome[MONDO:0018965]-XL),P:484; LP:466; VUS:275,OMIM:301050 (glomerulopathy: 0.37 | cyst_cilio: 0.197 | tubulopathy: 0.175 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.089 | cancer: 0.05),NULL,NULL,hm (false); ht (true),0.5,3489,0.6205450733752621,"9606.ENSP00000379823:890, 9606.ENSP00000379866:860, 9606.ENSP00000378340:876, 9606.ENSP00000364979:540, 9606.ENSP00000386896:323",0.5,14.0055,7.027589999999999,144.127674077727,cur_111
COL4A6,2208,2,1.6645455339912547,NULL,NULL,NULL,NULL,"?Deafness, X-linked 6[OMIM:300914]-X-linked recessive inheritance","Limited, Limited, Limited (hearing loss, X-linked 6[MONDO:0010484]-X-linked) | Limited (premature ovarian failure 1[MONDO:0010706]-X-linked) | Supportive (X-linked nonsyndromic hearing loss[MONDO:0019586]-X-linked)","Limited (hearing loss, X-linked 6[MONDO:0010484]-XL)",P:1; LP:1; VUS:125,NULL,OMIM:300914 (antenatal_or_congenital: 0.821),NULL,hm (false); ht (false),0.5,2542,0.4989517819706499,"9606.ENSP00000379866:540, 9606.ENSP00000364979:563, 9606.ENSP00000331902:876, 9606.ENSP00000379823:563",0.5,3.68595,1.70566,25.5808380407467,cur_112
COQ2,25223,5,4.050019596195967,NULL,NULL,NULL,NULL,"{Multiple system atrophy, susceptibility to}[OMIM:146500]-Autosomal dominant inheritance | {Multiple system atrophy, susceptibility to}[OMIM:146500]-Autosomal recessive inheritance | Coenzyme Q10 deficiency, primary, 1[OMIM:607426]-Autosomal recessive inheritance","Moderate (multiple system atrophy[MONDO:0007803]-Autosomal recessive) | Definitive, Strong (coenzyme Q10 deficiency, primary, 1[MONDO:0011829]-Autosomal recessive) | Supportive (Leigh syndrome with nephrotic syndrome[MONDO:0016816]-Autosomal recessive) | Definitive (mitochondrial disease[MONDO:0044970]-Autosomal recessive)",Definitive (mitochondrial disease[MONDO:0044970]-AR),P:10; LP:16; VUS:139,OMIM:607426 (glomerulopathy: 0.22 | complement: 0.036 | cancer: 0.03 | cakut: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:146500 (adult: 0.218); OMIM:607426 (neonatal_or_pediatric: 0.402),OMIM:146500 (syndromic: 0.035 | neurologic: 0.072); OMIM:607426 (syndromic: 0.109 | neurologic: 0.228),hm (false); ht (false),0.5,892,0.20964360587002095,"9606.ENSP00000297185:562, 9606.ENSP00000359680:330",0,5.11908,3.79713,9.72047286396979,cur_113
COQ6,20233,5,4.012502881386138,0,0.93759,0.28644,0.61796,"Coenzyme Q10 deficiency, primary, 6[OMIM:614650]-Autosomal recessive inheritance","Strong, Moderate, Supportive (familial steroid-resistant nephrotic syndrome with sensorineural deafness[MONDO:0013836]-Autosomal recessive) | Limited (schwannomatosis 1[MONDO:0024517]-Autosomal dominant)",NULL,P:18; LP:7; VUS:98,OMIM:614650 (glomerulopathy: 0.271 | tubulopathy: 0.182 | nephrocalcinosis: 0.153 | cyst_cilio: 0.142 | cancer: 0.06 | cakut: 0.048 | complement: 0.036),OMIM:614650 (neonatal_or_pediatric: 0.865),OMIM:614650 (syndromic: 0.02 | neurologic: 0.041),hm (false); ht (false),0.5,2469,0.48218029350104824,"9606.ENSP00000315118:783, 9606.ENSP00000452762:210, 9606.ENSP00000297185:195, 9606.ENSP00000322316:921, 9606.ENSP00000246957:197, 9606.ENSP00000346173:163",0.5,11.709000000000001,10.4177,10.0900796218067,cur_114
COQ7,2244,3,1.31434684780906,4e-6,0.86052,0.41799,-0.46251,"Coenzyme Q10 deficiency, primary, 8[OMIM:616733]-Autosomal recessive inheritance | Neuronopathy, distal hereditary motor, autosomal recessive 9[OMIM:620402]-Autosomal recessive inheritance","Strong, Limited (primary coenzyme Q10 deficiency 8[MONDO:0014754]-Autosomal recessive)",NULL,P:7; LP:3; VUS:85,OMIM:616733 (cakut: 0.052 | cyst_cilio: 0.018 | glomerulopathy: 0.002),OMIM:616733 (antenatal_or_congenital: 0.821),OMIM:616733 (syndromic: 0.047 | growth: 0.181 | skeletal: 0.013 | neurologic: 0.071),hm (false); ht (false),0.5,1558,0.3480083857442348,"9606.ENSP00000297185:226, 9606.ENSP00000452762:185, 9606.ENSP00000333946:921, 9606.ENSP00000315118:226",0.5,8.8326,6.96479,26.2061511464212,cur_115
COQ8B,19041,5,3.900516036673978,0,0.78224,1.0942,0.8896,"Nephrotic syndrome, type 9[OMIM:615573]-Autosomal recessive inheritance","Definitive, Strong (nephrotic syndrome, type 9[MONDO:0014257]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:14; LP:6; VUS:68,OMIM:615573 (glomerulopathy: 0.275 | cyst_cilio: 0.142 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:615573 (neonatal_or_pediatric: 0.865 | adult: 0.372),NULL,hm (false); ht (false),0.5,1236,0.2914046121593291,"9606.ENSP00000322316:226, 9606.ENSP00000297185:227, 9606.ENSP00000333946:783",0,22.7986,13.7314,NULL,cur_116
COX10,2260,2,1.0969140300565716,0.08405,0.29042,2.7283,-0.18011,"Mitochondrial complex IV deficiency, nuclear type 3[OMIM:619046]-Autosomal recessive inheritance","Supportive (cytochrome-c oxidase deficiency disease[MONDO:0009068]-Autosomal recessive) | Definitive, Moderate (Leigh syndrome[MONDO:0009723]-Autosomal recessive) | Strong (mitochondrial complex 4 deficiency, nuclear type 3[MONDO:0033635]-Autosomal recessive)",Moderate (Leigh syndrome[MONDO:0009723]-AR),P:5; LP:8; VUS:101,NULL,OMIM:619046 (neonatal_or_pediatric: 0.537),OMIM:619046 (syndromic: 0.023 | growth: 0.171 | neurologic: 0.029),hm (false); ht (false),0,540,0.13626834381551362,9606.ENSP00000413908:540,0.5,NULL,NULL,29.16078095596,cur_117
CPT2,2330,5,3.0826066934547365,0,0.78115,0.94605,0.39664,"{Encephalopathy, acute, infection-induced, 4, susceptibility to}[OMIM:614212]-Autosomal dominant inheritance | {Encephalopathy, acute, infection-induced, 4, susceptibility to}[OMIM:614212]-Autosomal recessive inheritance | CPT II deficiency, infantile[OMIM:600649]-Autosomal recessive inheritance | CPT II deficiency, lethal neonatal[OMIM:608836]-Autosomal recessive inheritance | CPT II deficiency, myopathic, stress-induced[OMIM:255110]-Autosomal dominant inheritance | CPT II deficiency, myopathic, stress-induced[OMIM:255110]-Autosomal recessive inheritance","Strong, Supportive (carnitine palmitoyl transferase II deficiency, myopathic form[MONDO:0009704]-Autosomal recessive) | Strong, Supportive (carnitine palmitoyl transferase II deficiency, severe infantile form[MONDO:0010914]-Autosomal recessive) | Strong, Supportive (carnitine palmitoyl transferase II deficiency, neonatal form[MONDO:0012136]-Autosomal recessive) | Definitive, Definitive (carnitine palmitoyltransferase II deficiency[MONDO:0015515]-Autosomal recessive)",Definitive (carnitine palmitoyltransferase II deficiency[MONDO:0015515]-AR),P:98; LP:80; VUS:332,OMIM:255110 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02); OMIM:608836 (cakut: 0.194 | cyst_cilio: 0.189 | nephrocalcinosis: 0.118 | tubulopathy: 0.105 | glomerulopathy: 0.095 | complement: 0.071 | cancer: 0.06),OMIM:255110 (adult: 0.372 | neonatal_or_pediatric: 0.262); OMIM:600649 (neonatal_or_pediatric: 0.402); OMIM:608836 (antenatal_or_congenital: 0.077),OMIM:600649 (syndromic: 0.021 | neurologic: 0.044); OMIM:608836 (syndromic: 0.069 | skeletal: 0.067 | neurologic: 0.095); OMIM:614212 (syndromic: 0.022 | neurologic: 0.046),hm (NA); ht (NA),0.5,672,0.1719077568134172,"9606.ENSP00000360141:288, 9606.ENSP00000312987:384",0.5,12.5473,10.6097,18.094329741701,cur_118
CRB2,18688,5,4.4566582303538045,0,0.65134,2.1559,1.1068,Focal segmental glomerulosclerosis 9[OMIM:616220]-Autosomal recessive inheritance | Ventriculomegaly with cystic kidney disease[OMIM:219730]-Autosomal recessive inheritance,"Strong (inherited focal segmental glomerulosclerosis[MONDO:0005363]-Autosomal recessive) | Definitive, Strong, Supportive (ventriculomegaly-cystic kidney disease[MONDO:0009063]-Autosomal recessive) | Definitive (focal segmental glomerulosclerosis 9[MONDO:0014539]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",Definitive (focal segmental glomerulosclerosis 9[MONDO:0014539]-AR),P:16; LP:11; VUS:225,OMIM:219730 (cyst_cilio: 0.118 | nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.095 | complement: 0.071 | cakut: 0.06 | cancer: 0.02); OMIM:616220 (glomerulopathy: 0.131 | cancer: 0.03 | cakut: 0.012 | cyst_cilio: 0.01 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:219730 (antenatal_or_congenital: 0.077); OMIM:616220 (neonatal_or_pediatric: 0.865),OMIM:219730 (syndromic: 0.03 | skeletal: 0.004 | neurologic: 0.06),hm (false); ht (false),0,156,0,9606.ENSP00000287239:156,0.5,0.47772600000000004,5.4453,12.4988773046868,cur_119
CSPP1,26193,4,2.8370361758079197,NULL,NULL,NULL,NULL,Joubert syndrome 21[OMIM:615636]-Autosomal recessive inheritance,"Definitive, Definitive (Joubert syndrome 21[MONDO:0014288]-Autosomal recessive) | Supportive (Joubert syndrome with Jeune asphyxiating thoracic dystrophy[MONDO:0018342]-Autosomal recessive) | Strong, Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",Definitive (Joubert syndrome 21[MONDO:0014288]-AR),P:72; LP:19; VUS:547,OMIM:615636 (cyst_cilio: 0.123 | cakut: 0.06 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:615636 (antenatal_or_congenital: 0.821),OMIM:615636 (syndromic: 0.087 | skeletal: 0.01 | neurologic: 0.178),hm (NA); ht (NA),0.5,1174,0.2746331236897275,"9606.ENSP00000261584:179, 9606.ENSP00000344314:449, 9606.ENSP00000360532:185, 9606.ENSP00000355250:196, 9606.ENSP00000231509:165",0.5,5.11383,4.1205099999999995,115.131129017643,cur_120
CST3,2475,2,1.165192316370061,NULL,NULL,NULL,NULL,"{Macular degeneration, age-related, 11}[OMIM:611953]-NA | Cerebral amyloid angiopathy[OMIM:105150]-Autosomal dominant inheritance",Strong (cerebral amyloid angiopathy[MONDO:0005620]-Autosomal dominant) | Supportive (ACys amyloidosis[MONDO:0007098]-Autosomal dominant),NULL,P:1; LP:0; VUS:12,NULL,NULL,OMIM:105150 (syndromic: 0.003 | neurologic: 0.007),hm (false); ht (false),0.5,2062,0.42138364779874216,"9606.ENSP00000396688:294, 9606.ENSP00000322323:630, 9606.ENSP00000312652:288, 9606.ENSP00000237014:382, 9606.ENSP00000236850:269, 9606.ENSP00000293288:199",0.5,106.772,96.1691,131.481822299452,cur_121
CTNS,2518,5,4.445114784770018,NULL,NULL,NULL,NULL,"Cystinosis, nephropathic[OMIM:219800]-Autosomal recessive inheritance | Cystinosis, ocular nonnephropathic[OMIM:219750]-Autosomal recessive inheritance | Cystinosis, late-onset juvenile or adolescent nephropathic[OMIM:219900]-Autosomal recessive inheritance | Cystinosis, atypical nephropathic[OMIM:219800]-Autosomal recessive inheritance","Strong, Supportive (ocular cystinosis[MONDO:0009064]-Autosomal recessive) | Strong, Supportive (juvenile nephropathic cystinosis[MONDO:0009066]-Autosomal recessive) | Definitive (cystinosis[MONDO:0016239]-Autosomal recessive) | Supportive (nephropathic infantile cystinosis[MONDO:0018467]-Autosomal recessive) | Definitive, Definitive, Strong (nephropathic cystinosis[MONDO:0100151]-Autosomal recessive)",NULL,P:84; LP:66; VUS:206,OMIM:219800 (tubulopathy: 0.469 | nephrocalcinosis: 0.382 | glomerulopathy: 0.302 | complement: 0.25 | cyst_cilio: 0.234 | cakut: 0.113 | cancer: 0.03); OMIM:219900 (glomerulopathy: 0.129 | cyst_cilio: 0.126 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),OMIM:219750 (adult: 0.372 | neonatal_or_pediatric: 0.2); OMIM:219800 (neonatal_or_pediatric: 0.402); OMIM:219900 (neonatal_or_pediatric: 0.2),OMIM:219750 (syndromic: 0.002 | neurologic: 0.004); OMIM:219800 (syndromic: 0.087 | growth: 0.382 | skeletal: 0.038 | neurologic: 0.119); OMIM:219900 (syndromic: 0.003 | growth: 0.008 | skeletal: 0.002 | neurologic: 0.004),hm (true); ht (false),0,286,0.06289308176100629,9606.ENSP00000369497:286,0.5,14.4698,13.0173,11.3591551120107,cur_122
CTU2,28005,3,1.527951442484126,0,1.1088,-0.53286,-3.9471,"Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome[OMIM:618142]-Autosomal recessive inheritance","Strong, Strong, Limited (microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome[MONDO:0020647]-Autosomal recessive)",NULL,P:4; LP:1; VUS:97,OMIM:618142 (cakut: 0.06 | cancer: 0.02 | tubulopathy: 0.007 | cyst_cilio: 0.005),OMIM:618142 (antenatal_or_congenital: 0.821),OMIM:618142 (syndromic: 0.086 | growth: 0.102 | skeletal: 0.107 | neurologic: 0.089),hm (NA); ht (NA),0,NULL,NULL,NULL,0,8.028410000000001,5.40117,6.57416044725205,cur_123
CUBN,2548,5,4.443624112274169,0,0.54692,5.62,-1.1655,"[Proteinuria, chronic benign][OMIM:618884]-Autosomal recessive inheritance | Imerslund-Grasbeck syndrome 1[OMIM:261100]-Autosomal recessive inheritance","Supportive (Imerslund-Grasbeck syndrome[MONDO:0009853]-Autosomal recessive) | Definitive, Definitive (Imerslund-Grasbeck syndrome type 1[MONDO:0100156]-Autosomal recessive)",NULL,P:48; LP:61; VUS:679,OMIM:261100 (glomerulopathy: 0.029 | tubulopathy: 0.028 | nephrocalcinosis: 0.021); OMIM:618884 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:261100 (neonatal_or_pediatric: 0.262),OMIM:261100 (syndromic: 0.003 | neurologic: 0.007),hm (false); ht (false),0.5,1964,0.4025157232704403,"9606.ENSP00000236850:965, 9606.ENSP00000299155:999",0.5,5.09794,17.0667,110.11193662402,cur_124
CUL3,2553,4,3.1590554843389653,0.9996,0.099704,5.2842,4.7538,"Neurodevelopmental disorder with or without autism or seizures[OMIM:619239]-Autosomal dominant inheritance | Pseudohypoaldosteronism, type IIE[OMIM:614496]-Autosomal dominant inheritance","Definitive, Strong, Supportive (pseudohypoaldosteronism type 2E[MONDO:0013782]-Autosomal dominant) | Definitive (complex neurodevelopmental disorder[MONDO:0100038]-Autosomal dominant)",Definitive (pseudohypoaldosteronism type 2E[MONDO:0013782]-AD) | Definitive (complex neurodevelopmental disorder[MONDO:0100038]-AD),P:41; LP:23; VUS:144,NULL,OMIM:619239 (neonatal_or_pediatric: 0.402),OMIM:619239 (syndromic: 0.088 | growth: 0.171 | skeletal: 0.051 | neurologic: 0.159),hm (false); ht (false),1,8073,0.8448637316561844,"9606.ENSP00000256078:333, 9606.ENSP00000384367:317, 9606.ENSP00000390436:630, 9606.ENSP00000272190:381, 9606.ENSP00000245479:292, 9606.ENSP00000356319:292, 9606.ENSP00000459943:647, 9606.ENSP00000246914:457, 9606.ENSP00000408292:292, 9606.ENSP00000216911:326, 9606.ENSP00000341292:199, 9606.ENSP00000339191:292, 9606.ENSP00000261584:292, 9606.ENSP00000379258:499, 9606.ENSP00000276297:292, 9606.ENSP00000380321:292, 9606.ENSP00000314444:292, 9606.ENSP00000312397:999, 9606.ENSP00000246868:398, 9606.ENSP00000281043:161, 9606.ENSP00000287647:390",0.5,11.8429,7.497739999999999,228.882105744421,cur_125
CYP11B1,2591,3,2.2934751975951686,1e-6,0.60071,1.7213,-1.5619,"Aldosteronism, glucocorticoid-remediable[OMIM:103900]-Autosomal dominant inheritance | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency[OMIM:202010]-Autosomal recessive inheritance","Strong (glucocorticoid-remediable aldosteronism[MONDO:0007080]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency[MONDO:0008729]-Autosomal recessive)",NULL,P:76; LP:75; VUS:136,NULL,OMIM:103900 (neonatal_or_pediatric: 0.463 | adult: 0.218); OMIM:202010 (neonatal_or_pediatric: 0.134),OMIM:202010 (syndromic: 0.014 | growth: 0.25 | skeletal: 0.002),hm (true); ht (false),0.5,1192,0.27672955974842767,"9606.ENSP00000356319:292, 9606.ENSP00000325822:900",0,0.158683,0.22845,0.0237475506182604,cur_126
CYP11B2,2592,3,2.13068817076804,0,1.1349,-0.59842,-0.84873,"Hypoaldosteronism, congenital, due to CMO I deficiency[OMIM:203400]-Autosomal recessive inheritance | Hypoaldosteronism, congenital, due to CMO II deficiency[OMIM:610600]-Autosomal recessive inheritance",Moderate (corticosterone methyloxidase type 1 deficiency[MONDO:0008751]-Autosomal recessive) | Supportive (familial hypoaldosteronism[MONDO:0018541]-Autosomal recessive),NULL,P:49; LP:19; VUS:83,NULL,OMIM:203400 (neonatal_or_pediatric: 0.134); OMIM:610600 (neonatal_or_pediatric: 0.134),OMIM:203400 (syndromic: 0.014 | growth: 0.262); OMIM:610600 (syndromic: 0.014 | growth: 0.262 | neurologic: 0),hm (true); ht (false),0.5,1745,0.3710691823899371,"9606.ENSP00000292427:900, 9606.ENSP00000290866:216, 9606.ENSP00000276449:629",0,0,0,0.00124769023217305,cur_127
CYP17A1,2593,3,1.623129185287166,2.63e-4,0.46804,2.1616,1.2356,"17,20-lyase deficiency, isolated[OMIM:202110]-Autosomal recessive inheritance | 17-alpha-hydroxylase/17,20-lyase deficiency[OMIM:202110]-Autosomal recessive inheritance","Supportive (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency[MONDO:0008730]-Autosomal recessive) | Strong, Supportive (46,XY disorder of sex development due to isolated 17,20-lyase deficiency[MONDO:0019597]-Autosomal recessive)",NULL,P:74; LP:26; VUS:51,NULL,NULL,NULL,hm (false); ht (false),0,349,0.09224318658280922,9606.ENSP00000216862:349,0,4.72876,4.719519999999999,0.231092480172034,cur_128
CYP24A1,2602,5,3.650566552923318,0,1.149,-0.72877,-1.1021,"Hypercalcemia, infantile, 1[OMIM:143880]-Autosomal recessive inheritance","Supportive (autosomal recessive infantile hypercalcemia[MONDO:0007749]-Autosomal recessive) | Strong, Strong (hypercalcemia, infantile, 1[MONDO:0020739]-Autosomal recessive)",NULL,P:21; LP:11; VUS:114,OMIM:143880 (tubulopathy: 0.399 | nephrocalcinosis: 0.389 | glomerulopathy: 0.033 | cyst_cilio: 0.031 | cakut: 0.02 | cancer: 0.01),OMIM:143880 (neonatal_or_pediatric: 0.402),OMIM:143880 (syndromic: 0.011 | growth: 0.182 | neurologic: 0.003),hm (true); ht (false),0.5,933,0.2138364779874214,"9606.ENSP00000358903:349, 9606.ENSP00000228606:292, 9606.ENSP00000269305:292",0,24.5577,12.7822,1.31848351668715,cur_129
CYP27B1,2606,4,2.3290101074695095,0,0.62872,1.6235,0.065547,"Vitamin D-dependent rickets, type I[OMIM:264700]-Autosomal recessive inheritance","Supportive (vitamin D-dependent rickets, type 1[MONDO:0009924]-Autosomal recessive) | Strong (vitamin D-dependent rickets, type 1A[MONDO:0020723]-Autosomal recessive)",NULL,P:37; LP:19; VUS:104,NULL,OMIM:264700 (neonatal_or_pediatric: 0.262),OMIM:264700 (syndromic: 0.039 | growth: 0.262 | skeletal: 0.043 | neurologic: 0.025),hm (true); ht (false),0.5,3544,0.6247379454926625,"9606.ENSP00000262367:457, 9606.ENSP00000362680:457, 9606.ENSP00000381098:292, 9606.ENSP00000215832:294, 9606.ENSP00000367817:292, 9606.ENSP00000337383:292, 9606.ENSP00000269305:292, 9606.ENSP00000252699:292, 9606.ENSP00000216862:292, 9606.ENSP00000287820:292, 9606.ENSP00000312987:292",0,3.4998199999999997,11.8876,0.574717545368624,cur_130
CYP2R1,20580,2,1.7684813486654547,0,0.79077,0.89895,0.48098,Rickets due to defect in vitamin D 25-hydroxylation deficiency[OMIM:600081]-Autosomal recessive inheritance,"Strong (rickets[MONDO:0005520]-Autosomal recessive) | Supportive (vitamin D-dependent rickets, type 1[MONDO:0009924]-Autosomal recessive)",NULL,P:12; LP:2; VUS:62,NULL,OMIM:600081 (neonatal_or_pediatric: 0.665),OMIM:600081 (syndromic: 0.027 | growth: 0.262 | skeletal: 0.039 | neurologic: 0.004),hm (false); ht (false),0,NULL,NULL,NULL,0.5,5.25404,3.5425800000000005,11.5338468764809,cur_131
DAAM2,18143,3,1.967648919227275,NULL,NULL,NULL,NULL,"Nephrotic syndrome, type 24[OMIM:619263]-Autosomal recessive inheritance","Strong (nephrotic syndrome, type 24[MONDO:0031008]-Autosomal recessive)",NULL,P:5; LP:0; VUS:79,OMIM:619263 (glomerulopathy: 0.151 | cancer: 0.03 | cakut: 0.012 | cyst_cilio: 0.01 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:619263 (neonatal_or_pediatric: 0.463),NULL,hm (false); ht (false),0,NULL,NULL,NULL,0.5,6.68376,7.983160000000001,65.1664510929678,cur_132
DACT1,17748,2,0.8143468478090599,NULL,NULL,NULL,NULL,Townes-Brocks syndrome 2[OMIM:617466]-Autosomal dominant inheritance,"Supportive (Townes-Brocks syndrome[MONDO:0007142]-Autosomal dominant) | Limited, Limited (Townes-Brocks syndrome 2[MONDO:0054582]-Autosomal dominant)",NULL,P:5; LP:2; VUS:48,OMIM:617466 (cakut: 0.077 | cancer: 0.02 | cyst_cilio: 0.008 | glomerulopathy: 0.002),NULL,OMIM:617466 (syndromic: 0.011 | skeletal: 0.036 | neurologic: 0.001),hm (true); ht (false),0,455,0.11320754716981132,"9606.ENSP00000269305:163, 9606.ENSP00000256474:292",0.5,5.03026,2.96702,24.3019011966365,cur_133
DCDC2,18141,5,4.457842313457734,0,0.77076,0.99766,0.43179,"Nephronophthisis 19[OMIM:616217]-Autosomal recessive inheritance | ?Deafness, autosomal recessive 66[OMIM:610212]-Autosomal recessive inheritance | Sclerosing cholangitis, neonatal[OMIM:617394]-Autosomal recessive inheritance","Definitive (ciliopathy[MONDO:0005308]-Autosomal recessive) | Limited, Limited (autosomal recessive nonsyndromic hearing loss 66[MONDO:0012442]-Autosomal recessive) | Strong, Strong (nephronophthisis 19[MONDO:0014537]-Autosomal recessive) | Supportive (isolated neonatal sclerosing cholangitis[MONDO:0018816]-Autosomal recessive) | Supportive (Senior-Boichis syndrome[MONDO:0019394]-Autosomal recessive) | Limited (nonsyndromic genetic hearing loss[MONDO:0019497]-Autosomal recessive) | Supportive (hearing loss, autosomal recessive[MONDO:0019588]-Autosomal recessive)",Definitive (ciliopathy[MONDO:0005308]-AR) | Limited (nonsyndromic genetic hearing loss[MONDO:0019497]-AR),P:16; LP:8; VUS:85,OMIM:616217 (cyst_cilio: 0.265 | glomerulopathy: 0.135 | cakut: 0.056 | tubulopathy: 0.042 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02); OMIM:617394 (cakut: 0.065 | cancer: 0.02 | cyst_cilio: 0.008 | glomerulopathy: 0.002),OMIM:610212 (antenatal_or_congenital: 0.821); OMIM:616217 (neonatal_or_pediatric: 0.402); OMIM:617394 (neonatal_or_pediatric: 0.537),OMIM:617394 (syndromic: 0.003 | neurologic: 0.006),hm (false); ht (false),0,240,0.050314465408805034,9606.ENSP00000474032:240,0.5,32.6334,18.9737,281.978257192359,cur_134
DDX59,25360,4,2.585469683224263,1e-6,0.56021,2.0373,0.77906,Orofaciodigital syndrome V[OMIM:174300]-Autosomal recessive inheritance,"Strong, Supportive (orofaciodigital syndrome V[MONDO:0008267]-Autosomal recessive)",NULL,P:4; LP:3; VUS:35,OMIM:174300 (cancer: 0.07 | cakut: 0.028 | cyst_cilio: 0.01 | glomerulopathy: 0.007),OMIM:174300 (antenatal_or_congenital: 0.821),OMIM:174300 (syndromic: 0.107 | skeletal: 0.116 | neurologic: 0.128),hm (false); ht (false),0,NULL,NULL,NULL,0.5,6.99348,4.73554,27.4266278154695,cur_135
DGKE,2852,4,3.660942958345292,5e-6,0.45309,2.8171,0.59049,"{Hemolytic uremic syndrome, atypical, susceptibility to, 7}[OMIM:615008]-Autosomal recessive inheritance | Nephrotic syndrome, type 7[OMIM:615008]-Autosomal recessive inheritance",Strong (nephrotic syndrome[MONDO:0005377]-Autosomal recessive) | Moderate (immunoglobulin-mediated membranoproliferative glomerulonephritis[MONDO:0014005]-Autosomal recessive) | Supportive (atypical hemolytic-uremic syndrome with DGKE deficiency[MONDO:0018159]-Autosomal recessive),NULL,P:19; LP:10; VUS:57,OMIM:615008 (glomerulopathy: 0.29 | complement: 0.25 | cyst_cilio: 0.129 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | nephrocalcinosis: 0.028),OMIM:615008 (neonatal_or_pediatric: 0.865 | adult: 0.049),NULL,hm (false); ht (false),0,NULL,NULL,NULL,0.5,2.33722,1.9303599999999999,18.3056010709057,cur_136
DHCR7,2860,4,3.1082692892673314,0,0.92831,0.30835,-0.45173,Smith-Lemli-Opitz syndrome[OMIM:270400]-Autosomal recessive inheritance,"Definitive, Definitive, Definitive, Definitive, Strong, Supportive (Smith-Lemli-Opitz syndrome[MONDO:0010035]-Autosomal recessive)",Definitive (Smith-Lemli-Opitz syndrome[MONDO:0010035]-AR),P:94; LP:138; VUS:195,OMIM:270400 (cakut: 0.29 | cyst_cilio: 0.157 | cancer: 0.14 | tubulopathy: 0.021 | glomerulopathy: 0.013 | nephrocalcinosis: 0.007),OMIM:270400 (antenatal_or_congenital: 0.821),OMIM:270400 (syndromic: 0.193 | growth: 0.614 | skeletal: 0.122 | neurologic: 0.217),hm (true); ht (false),0.5,1206,0.2830188679245283,"9606.ENSP00000322323:292, 9606.ENSP00000231509:292, 9606.ENSP00000417052:292, 9606.ENSP00000357283:167, 9606.ENSP00000227507:163",0.5,14.3415,10.007,13.2378222973952,cur_137
DLC1,2897,4,2.741276375666334,0.99948,0.15182,6.3788,-2.931,"Colorectal cancer, somatic[OMIM:114500]-NA","Limited (congenital heart defects, multiple types[MONDO:0000119]-Autosomal dominant) | No Known Disease Relationship (colorectal cancer[MONDO:0005575]-Unknown)",NULL,P:1; LP:0; VUS:142,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),NULL,NULL,hm (false); ht (false),0.5,2777,0.5262054507337526,"9606.ENSP00000264414:292, 9606.ENSP00000319756:985, 9606.ENSP00000451828:536, 9606.ENSP00000361021:292, 9606.ENSP00000339191:672",0.5,11.7906,5.66524,752.058534654545,cur_138
DLG5,2904,2,0.92931103380189,0.99948,0.16769,7.047,2.5887,NULL,Limited (ciliopathy[MONDO:0005308]-Autosomal dominant) | Limited (ciliopathy[MONDO:0005308]-Autosomal recessive) | Limited (congenital anomaly of kidney and urinary tract[MONDO:0019719]-Autosomal recessive),NULL,P:1; LP:0; VUS:81,NULL,NULL,NULL,hm (true); ht (false),0,163,0.008385744234800839,9606.ENSP00000410294:163,0.5,4.71094,6.29173,139.830317420333,cur_139
DMP1,2932,4,2.632436925470996,0,0.71892,1.1076,0.2734,"Hypophosphatemic rickets, AR[OMIM:241520]-Autosomal recessive inheritance","Definitive, Strong, Moderate (hypophosphatemic rickets, autosomal recessive, 1[MONDO:0009430]-Autosomal recessive) | Supportive (autosomal recessive hypophosphatemic rickets[MONDO:0017324]-Autosomal recessive)",NULL,P:8; LP:2; VUS:102,NULL,NULL,OMIM:241520 (syndromic: 0.002 | skeletal: 0.008),hm (true); ht (false),0.5,630,0.16142557651991615,9606.ENSP00000322323:630,0,0.00803324,0.00823385,NULL,cur_140
DNAJB11,14889,5,3.7866839237751817,NULL,NULL,NULL,NULL,Polycystic kidney disease 6 with or without polycystic liver disease[OMIM:618061]-Autosomal dominant inheritance,"Supportive (autosomal dominant polycystic kidney disease[MONDO:0004691]-Autosomal dominant) | Limited (ciliopathy[MONDO:0005308]-Autosomal recessive) | Strong, Strong, Strong, Moderate (polycystic kidney disease 6 with or without polycystic liver disease[MONDO:0054842]-Autosomal dominant)",Limited (ciliopathy[MONDO:0005308]-AR) | Strong (polycystic kidney disease 6 with or without polycystic liver disease[MONDO:0054842]-AD),P:7; LP:5; VUS:30,OMIM:618061 (cyst_cilio: 0.265 | glomerulopathy: 0.213 | tubulopathy: 0.168 | nephrocalcinosis: 0.16 | complement: 0.107 | cakut: 0.089 | cancer: 0.03),OMIM:618061 (adult: 0.218),OMIM:618061 (syndromic: 0 | skeletal: 0.001),hm (NA); ht (NA),0.5,4429,0.7023060796645703,"9606.ENSP00000357998:165, 9606.ENSP00000356319:292, 9606.ENSP00000317272:193, 9606.ENSP00000281171:199, 9606.ENSP00000281043:161, 9606.ENSP00000340466:241, 9606.ENSP00000236850:334, 9606.ENSP00000298552:737, 9606.ENSP00000322323:292, 9606.ENSP00000466134:231, 9606.ENSP00000231509:165, 9606.ENSP00000243253:382, 9606.ENSP00000363779:292, 9606.ENSP00000258173:422, 9606.ENSP00000297185:152, 9606.ENSP00000261584:171",0.5,15.4318,12.8416,34.275613348629,cur_141
DSTYK,29043,4,3.1015627666104995,0.51262,0.21844,4.9002,1.5861,"Spastic paraplegia 23, autosomal recessive[OMIM:270750]-Autosomal recessive inheritance | Congenital anomalies of kidney and urinary tract 1[OMIM:610805]-Autosomal dominant inheritance","Supportive (hereditary spastic paraplegia 23[MONDO:0010046]-Autosomal recessive) | Definitive, Limited (congenital anomalies of kidney and urinary tract 1[MONDO:0012561]-Autosomal dominant) | Limited (congenital anomalies of kidney and urinary tract 1[MONDO:0012561]-Autosomal recessive) | Moderate (complex hereditary spastic paraplegia[MONDO:0015150]-Autosomal recessive) | Supportive (renal agenesis, unilateral[MONDO:0019636]-Autosomal dominant)",Moderate (complex hereditary spastic paraplegia[MONDO:0015150]-AR),P:3; LP:2; VUS:77,OMIM:610805 (cakut: 0.266 | cyst_cilio: 0.178 | glomerulopathy: 0.135 | tubulopathy: 0.063 | cancer: 0.05 | complement: 0.036 | nephrocalcinosis: 0.021),OMIM:270750 (neonatal_or_pediatric: 0.262); OMIM:610805 (antenatal_or_congenital: 0.821),OMIM:270750 (syndromic: 0.054 | skeletal: 0.126 | neurologic: 0.065),hm (false); ht (false),0,NULL,NULL,NULL,0.5,6.8730199999999995,4.624140000000001,102.917042228987,cur_142
DYNC2H1,2962,5,3.8851762610231386,NULL,NULL,NULL,NULL,Short-rib thoracic dysplasia 3 with or without polydactyly[OMIM:613091]-Autosomal recessive inheritance | Short-rib thoracic dysplasia 3 with or without polydactyly[OMIM:613091]-Digenic inheritance,"Definitive, Definitive, Supportive (asphyxiating thoracic dystrophy 3[MONDO:0013127]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive) | Supportive (short rib-polydactyly syndrome, Majewski type[MONDO:0019662]-Autosomal recessive) | Supportive (short rib-polydactyly syndrome, Verma-Naumoff type[MONDO:0019664]-Autosomal recessive)",NULL,P:148; LP:138; VUS:718,OMIM:613091 (cyst_cilio: 0.105 | cakut: 0.081 | cancer: 0.04 | glomerulopathy: 0.009),NULL,OMIM:613091 (syndromic: 0.045 | growth: 0.25 | skeletal: 0.076 | neurologic: 0.007),hm (false); ht (false),0,NULL,NULL,NULL,0.5,2.3050599999999997,2.3979,160.36537177393,cur_143
DZIP1L,26551,5,3.791176375953612,0,0.98937,0.061059,0.10107,Polycystic kidney disease 5[OMIM:617610]-Autosomal recessive inheritance,"Strong, Supportive (autosomal recessive polycystic kidney disease[MONDO:0009889]-Autosomal recessive) | Strong (polycystic kidney disease 5[MONDO:0033281]-Autosomal recessive)",Strong (autosomal recessive polycystic kidney disease[MONDO:0009889]-AR),P:4; LP:2; VUS:72,OMIM:617610 (cyst_cilio: 0.252 | glomerulopathy: 0.14 | cakut: 0.069 | cancer: 0.06 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.035),OMIM:617610 (neonatal_or_pediatric: 0.865),NULL,hm (true); ht (false),0,NULL,NULL,NULL,0.5,4.77439,2.20686,16.8597725574176,cur_144
EGF,3229,3,2.454771295291538,0,0.5626,3.287,0.93836,"?Hypomagnesemia 4, renal[OMIM:611718]-Autosomal recessive inheritance",Limited (renal hypomagnesemia 4[MONDO:0012717]-Autosomal dominant) | Supportive (familial primary hypomagnesemia with normocalciuria and normocalcemia[MONDO:0018101]-Autosomal dominant),NULL,P:1; LP:0; VUS:169,NULL,NULL,OMIM:611718 (syndromic: 0.045 | neurologic: 0.094),hm (true); ht (true),1,8468,0.8532494758909853,"9606.ENSP00000380432:900, 9606.ENSP00000347942:260, 9606.ENSP00000254958:197, 9606.ENSP00000199280:167, 9606.ENSP00000290167:171, 9606.ENSP00000393312:543, 9606.ENSP00000354006:376, 9606.ENSP00000484824:424, 9606.ENSP00000410294:630, 9606.ENSP00000346839:725, 9606.ENSP00000297261:256, 9606.ENSP00000385675:501, 9606.ENSP00000357283:417, 9606.ENSP00000264664:916, 9606.ENSP00000237837:266, 9606.ENSP00000180166:904, 9606.ENSP00000339824:544, 9606.ENSP00000287139:271",0,43.5624,10.1729,2.74546110298653,cur_145
EHHADH,3247,4,2.668374310390409,0,0.66242,1.6754,-0.025899,?Fanconi renotubular syndrome 3[OMIM:615605]-Autosomal dominant inheritance,"Limited, Supportive (primary Fanconi syndrome[MONDO:0007600]-Autosomal dominant) | Limited (Fanconi renotubular syndrome 3[MONDO:0014275]-Autosomal dominant)",Limited (Fanconi renotubular syndrome 3[MONDO:0014275]-AD),P:1; LP:0; VUS:101,OMIM:615605 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:615605 (neonatal_or_pediatric: 0.402),OMIM:615605 (syndromic: 0.019 | growth: 0.341 | skeletal: 0.003),hm (false); ht (false),0,338,0.09014675052410902,"9606.ENSP00000437256:175, 9606.ENSP00000261167:163",0.5,15.1684,18.2209,22.256936859673502,cur_146
EMP2,3334,5,3.6315829143836065,0,1.2868,-0.7028,-0.44016,"Nephrotic syndrome, type 10[OMIM:615861]-Autosomal recessive inheritance","Strong (nephrotic syndrome[MONDO:0005377]-Autosomal recessive) | Limited (nephrotic syndrome, type 10[MONDO:0014373]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:2; LP:0; VUS:25,OMIM:615861 (glomerulopathy: 0.184 | complement: 0.036 | cancer: 0.03 | cakut: 0.008 | cyst_cilio: 0.003),NULL,NULL,hm (false); ht (false),0,NULL,NULL,NULL,0.5,13.4451,5.96116,51.3632499448472,cur_147
ENPP1,3356,5,3.6079658325588384,NULL,NULL,NULL,NULL,"{Obesity, susceptibility to}[OMIM:601665]-Autosomal dominant inheritance | {Obesity, susceptibility to}[OMIM:601665]-Autosomal recessive inheritance | {Obesity, susceptibility to}[OMIM:601665]-Multifactorial inheritance | Hypophosphatemic rickets, autosomal recessive, 2[OMIM:613312]-Autosomal recessive inheritance | {Diabetes mellitus, non-insulin-dependent, susceptibility to}[OMIM:125853]-Autosomal dominant inheritance | Arterial calcification, generalized, of infancy, 1[OMIM:208000]-Autosomal recessive inheritance | Cole disease[OMIM:615522]-Autosomal dominant inheritance","Definitive (arterial calcification, generalized, of infancy, 1[MONDO:0008817]-Autosomal recessive) | Supportive (autosomal recessive inherited pseudoxanthoma elasticum[MONDO:0009925]-Autosomal recessive) | Strong, Strong, Limited, Supportive (hypopigmentation-punctate palmoplantar keratoderma syndrome[MONDO:0014227]-Autosomal dominant) | Supportive (autosomal recessive hypophosphatemic rickets[MONDO:0017324]-Autosomal recessive) | Supportive (arterial calcification of infancy[MONDO:0018870]-Autosomal dominant)",NULL,P:41; LP:16; VUS:215,OMIM:208000 (cancer: 0.04 | cakut: 0.008 | cyst_cilio: 0.005); OMIM:613312 (tubulopathy: 0.028 | nephrocalcinosis: 0.014),OMIM:125853 (adult: 0.108); OMIM:208000 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.134); OMIM:613312 (neonatal_or_pediatric: 0.463); OMIM:615522 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.665),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:208000 (syndromic: 0.014 | growth: 0.258 | skeletal: 0.002); OMIM:601665 (syndromic: 0.003 | growth: 0.054); OMIM:613312 (syndromic: 0.021 | growth: 0.25 | skeletal: 0.02); OMIM:615522 (syndromic: 0.001 | skeletal: 0),hm (true); ht (true),0,NULL,NULL,NULL,0.5,2.27913,3.1686400000000003,82.3373965968304,cur_148
EVC,3497,2,1.2051776283829314,NULL,NULL,NULL,NULL,Ellis-van Creveld syndrome[OMIM:225500]-Autosomal recessive inheritance | ?Weyers acrofacial dysostosis[OMIM:193530]-Autosomal dominant inheritance,"Supportive (acrofacial dysostosis, Weyers type[MONDO:0008673]-Autosomal dominant) | Definitive (acrofacial dysostosis, Weyers type[MONDO:0008673]-Autosomal recessive) | Definitive, Strong, Supportive (Ellis-van Creveld syndrome[MONDO:0009162]-Autosomal recessive)",NULL,P:120; LP:124; VUS:394,NULL,NULL,OMIM:193530 (syndromic: 0.011 | growth: 0.006 | skeletal: 0.035); OMIM:225500 (syndromic: 0.035 | growth: 0.016 | skeletal: 0.039 | neurologic: 0.043),hm (false); ht (false),0.5,934,0.21593291404612158,9606.ENSP00000342144:934,0.5,16.7015,14.119000000000002,67.6446042737913,cur_149
EVC2,19747,2,1.2051776283829314,0,0.855,1.1066,-2.142,Ellis-van Creveld syndrome[OMIM:225500]-Autosomal recessive inheritance | Weyers acrofacial dysostosis[OMIM:193530]-Autosomal dominant inheritance,"Strong, Strong, Supportive (acrofacial dysostosis, Weyers type[MONDO:0008673]-Autosomal dominant) | Definitive (acrofacial dysostosis, Weyers type[MONDO:0008673]-Autosomal recessive) | Definitive, Definitive, Definitive, Strong, Supportive (Ellis-van Creveld syndrome[MONDO:0009162]-Autosomal recessive)",NULL,P:152; LP:121; VUS:372,NULL,NULL,OMIM:193530 (syndromic: 0.011 | growth: 0.006 | skeletal: 0.035); OMIM:225500 (syndromic: 0.035 | growth: 0.016 | skeletal: 0.039 | neurologic: 0.043),hm (false); ht (false),0.5,934,0.21593291404612158,9606.ENSP00000264956:934,0.5,2.63783,2.0108900000000003,34.2824804585906,cur_150
EYA1,3519,5,4.044887895896736,0.94588,0.16827,4.6023,1.0202,"Branchiootic syndrome 1[OMIM:602588]-Autosomal dominant inheritance | Branchiootorenal syndrome 1, with or without cataracts[OMIM:113650]-Autosomal dominant inheritance | Anterior segment anomalies with or without cataract[OMIM:602588]-Autosomal dominant inheritance | ?Otofaciocervical syndrome[OMIM:166780]-Autosomal dominant inheritance","Definitive, Supportive (branchio-oto-renal syndrome[MONDO:0007029]-Autosomal dominant) | Definitive, Strong (branchiootorenal syndrome 1[MONDO:0007236]-Autosomal dominant) | Strong (branchiootic syndrome 1[MONDO:0011258]-Autosomal dominant) | Supportive (branchiootic syndrome[MONDO:0018878]-Autosomal dominant) | Limited (otofaciocervical syndrome 1[MONDO:0024532]-Autosomal dominant)",Definitive (branchio-oto-renal syndrome[MONDO:0007029]-AD),P:95; LP:35; VUS:149,OMIM:113650 (cakut: 0.181 | cyst_cilio: 0.094 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.002),NULL,OMIM:113650 (syndromic: 0.023 | skeletal: 0.002 | neurologic: 0.005); OMIM:166780 (syndromic: 0.016 | skeletal: 0.005 | neurologic: 0.006); OMIM:602588 (syndromic: 0.003 | skeletal: 0.01),hm (true); ht (true),0,NULL,NULL,NULL,0.5,0.160262,0.12726800000000002,882.310037299458,cur_151
FAH,3579,5,3.232983933752496,NULL,NULL,NULL,NULL,"Tyrosinemia, type I[OMIM:276700]-Autosomal recessive inheritance","Definitive, Definitive, Definitive, Definitive, Definitive, Strong, Supportive (tyrosinemia type I[MONDO:0010161]-Autosomal recessive)",Definitive (tyrosinemia type I[MONDO:0010161]-AR),P:65; LP:66; VUS:131,OMIM:276700 (nephrocalcinosis: 0.292 | tubulopathy: 0.252 | glomerulopathy: 0.124 | cyst_cilio: 0.1 | complement: 0.071 | cakut: 0.065 | cancer: 0.06),NULL,OMIM:276700 (syndromic: 0.014 | growth: 0.262 | skeletal: 0.001 | neurologic: 0),hm (true); ht (false),0,221,0.04612159329140461,9606.ENSP00000445175:221,0,9.576189999999999,16.0477,9.25435006929786,cur_152
FAM20A,23015,4,2.678394435952199,0,0.56151,2.1001,-0.021121,"Amelogenesis imperfecta, type IG (enamel-renal syndrome)[OMIM:204690]-Autosomal recessive inheritance","Definitive, Strong, Strong, Supportive (amelogenesis imperfecta type 1G[MONDO:0008771]-Autosomal recessive)",NULL,P:17; LP:9; VUS:65,OMIM:204690 (nephrocalcinosis: 0.375 | tubulopathy: 0.35 | glomerulopathy: 0.104 | cyst_cilio: 0.1 | complement: 0.071 | cakut: 0.048 | cancer: 0.03),NULL,OMIM:204690 (syndromic: 0.003 | growth: 0.011 | skeletal: 0.002),hm (true); ht (false),0.5,1321,0.31236897274633124,"9606.ENSP00000226760:323, 9606.ENSP00000322323:998",0.5,15.3622,12.7701,16.8933056220388,cur_153
FAM20C,22140,3,1.8226918816045503,0.31465,0.23238,3.2995,1.0229,Raine syndrome[OMIM:259775]-Autosomal recessive inheritance,"Definitive, Strong, Strong, Moderate, Supportive (lethal osteosclerotic bone dysplasia[MONDO:0009821]-Autosomal recessive)",NULL,P:17; LP:2; VUS:127,OMIM:259775 (cakut: 0.097 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:259775 (antenatal_or_congenital: 0.821),OMIM:259775 (syndromic: 0.132 | growth: 0.25 | skeletal: 0.17 | neurologic: 0.088),hm (true); ht (false),1,13272,0.9748427672955975,"9606.ENSP00000381448:630, 9606.ENSP00000357048:292, 9606.ENSP00000362298:292, 9606.ENSP00000377836:499, 9606.ENSP00000466134:499, 9606.ENSP00000414398:292, 9606.ENSP00000347717:292, 9606.ENSP00000445306:292, 9606.ENSP00000218516:292, 9606.ENSP00000262374:292, 9606.ENSP00000245907:630, 9606.ENSP00000396688:499, 9606.ENSP00000340935:630, 9606.ENSP00000252486:499, 9606.ENSP00000237837:499, 9606.ENSP00000262613:292, 9606.ENSP00000356969:499, 9606.ENSP00000468308:998, 9606.ENSP00000226760:499, 9606.ENSP00000317674:630, 9606.ENSP00000236850:499, 9606.ENSP00000385675:630, 9606.ENSP00000337088:499, 9606.ENSP00000245451:499, 9606.ENSP00000323568:292, 9606.ENSP00000346839:630, 9606.ENSP00000243253:292, 9606.ENSP00000340466:292, 9606.ENSP00000361845:292",0.5,34.1962,53.745,32.1927267265788,cur_154
CCNQ,28434,3,1.936798371598746,NULL,NULL,NULL,NULL,STAR syndrome[OMIM:300707]-X-linked dominant inheritance,"Definitive, Supportive (syndactyly-telecanthus-anogenital and renal malformations syndrome[MONDO:0010408]-X-linked)",NULL,P:5; LP:2; VUS:8,OMIM:300707 (cakut: 0.173 | cyst_cilio: 0.026 | cancer: 0.02 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:300707 (antenatal_or_congenital: 0.821),OMIM:300707 (syndromic: 0.046 | growth: 0.398 | skeletal: 0.028 | neurologic: 0.001),hm (NA); ht (NA),0,NULL,NULL,NULL,0,NULL,NULL,NULL,cur_155
FAN1,29170,5,3.8295303880188727,0,0.86368,0.88087,-0.04736,"Interstitial nephritis, karyomegalic[OMIM:614817]-Autosomal recessive inheritance","Supportive (Lynch syndrome[MONDO:0005835]-Autosomal dominant) | Strong, Supportive (karyomegalic interstitial nephritis[MONDO:0013898]-Autosomal recessive) | Limited (hereditary nonpolyposis colon cancer[MONDO:0018630]-Autosomal dominant)",Limited (hereditary nonpolyposis colon cancer[MONDO:0018630]-AD),P:20; LP:7; VUS:85,OMIM:614817 (cyst_cilio: 0.249 | glomerulopathy: 0.182 | complement: 0.179 | tubulopathy: 0.077 | cakut: 0.056 | nephrocalcinosis: 0.049 | cancer: 0.02),NULL,NULL,hm (true); ht (false),0.5,5120,0.7526205450733753,"9606.ENSP00000289081:499, 9606.ENSP00000287647:966, 9606.ENSP00000246957:198, 9606.ENSP00000385021:499, 9606.ENSP00000373952:499, 9606.ENSP00000229769:499, 9606.ENSP00000294008:499, 9606.ENSP00000330875:499, 9606.ENSP00000310842:962",0.5,5.8558900000000005,4.91081,25.144092058821,cur_156
FAT1,3595,3,2.5147781813017813,0,0.33978,7.3469,-0.43053,NULL,NULL,NULL,P:5; LP:12; VUS:402,NULL,NULL,NULL,hm (true); ht (false),0.5,5151,0.7568134171907757,"9606.ENSP00000340913:331, 9606.ENSP00000352264:444, 9606.ENSP00000291582:263, 9606.ENSP00000356587:873, 9606.ENSP00000272190:167, 9606.ENSP00000417335:311, 9606.ENSP00000417132:292, 9606.ENSP00000352138:859, 9606.ENSP00000377862:418, 9606.ENSP00000256078:323, 9606.ENSP00000368190:870",0.5,14.7364,13.9491,151.468463441706,cur_157
FGA,3661,5,2.8673146362581563,NULL,NULL,NULL,NULL,"Hypodysfibrinogenemia, congenital[OMIM:616004]-NA | Dysfibrinogenemia, congenital[OMIM:616004]-NA | Amyloidosis, familial visceral[OMIM:105200]-Autosomal dominant inheritance | Afibrinogenemia, congenital[OMIM:202400]-Autosomal recessive inheritance","Strong (thrombophilia[MONDO:0002305]-Autosomal dominant) | Strong (thrombophilia[MONDO:0002305]-Autosomal recessive) | Moderate (familial visceral amyloidosis[MONDO:0007099]-Autosomal dominant) | Definitive, Supportive (congenital afibrinogenemia[MONDO:0008737]-Autosomal recessive) | Definitive, Supportive (familial dysfibrinogenemia[MONDO:0014452]-Autosomal dominant) | Supportive (familial hypofibrinogenemia[MONDO:0015096]-Autosomal dominant) | Definitive (congenital fibrinogen deficiency[MONDO:0018060]-Semidominant) | Supportive (AFib amyloidosis[MONDO:0019733]-Autosomal dominant)",Definitive (congenital fibrinogen deficiency[MONDO:0018060]-SD),P:23; LP:17; VUS:73,OMIM:105200 (complement: 0.179 | glomerulopathy: 0.173 | cancer: 0.05 | nephrocalcinosis: 0.042 | tubulopathy: 0.035 | cakut: 0.024 | cyst_cilio: 0.018),OMIM:202400 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.665),OMIM:105200 (syndromic: 0.002 | neurologic: 0.004); OMIM:202400 (syndromic: 0.001 | neurologic: 0),hm (false); ht (false),0,NULL,NULL,NULL,0,2.7416400000000003,1.74498,0.16822521148221,cur_158
FGF10,3666,2,1.226476073852192,0.93779,0,2.7513,0.85048,LADD syndrome 3[OMIM:620193]-NA | Aplasia of lacrimal and salivary glands[OMIM:180920]-Autosomal dominant inheritance,Supportive (LADD syndrome[MONDO:0007872]-Autosomal dominant) | Supportive (aplasia of lacrimal and salivary glands[MONDO:0008397]-Autosomal dominant) | Definitive (LADD syndrome 1[MONDO:0100302]-Autosomal dominant),NULL,P:10; LP:11; VUS:18,NULL,OMIM:620193 (antenatal_or_congenital: 0.821),OMIM:180920 (syndromic: 0.002); OMIM:620193 (syndromic: 0.011 | skeletal: 0.008),hm (true); ht (false),0.5,7266,0.8259958071278826,"9606.ENSP00000269305:163, 9606.ENSP00000237837:501, 9606.ENSP00000339824:754, 9606.ENSP00000369442:976, 9606.ENSP00000180166:420, 9606.ENSP00000265171:916, 9606.ENSP00000297261:223, 9606.ENSP00000386896:181, 9606.ENSP00000393312:990, 9606.ENSP00000245451:282, 9606.ENSP00000346839:410, 9606.ENSP00000252486:220, 9606.ENSP00000347942:231, 9606.ENSP00000410294:999",0.5,0.620426,0.11788699999999999,31.1649029701418,cur_159
FGF20,3677,4,2.529683364828851,0.81379,0,2.1837,-0.8742,?Renal hypodysplasia/aplasia 2[OMIM:615721]-Autosomal recessive inheritance,Supportive (bilateral renal agenesis[MONDO:0015986]-Autosomal recessive) | Limited (renal agenesis[MONDO:0018470]-Autosomal recessive),NULL,P:1; LP:1; VUS:24,OMIM:615721 (cakut: 0.016 | cyst_cilio: 0.005),OMIM:615721 (antenatal_or_congenital: 0.038),OMIM:615721 (syndromic: 0),hm (false); ht (false),0.5,6558,0.8071278825995807,"9606.ENSP00000252486:222, 9606.ENSP00000347942:319, 9606.ENSP00000410294:953, 9606.ENSP00000346839:418, 9606.ENSP00000264664:420, 9606.ENSP00000393312:991, 9606.ENSP00000237837:505, 9606.ENSP00000339824:850, 9606.ENSP00000369442:976, 9606.ENSP00000265171:904",0,0.0775856,0.0312074,0.280589011627745,cur_160
FGF23,3680,5,3.2384430448539834,0.031014,0.49929,1.1373,0.39751,"Tumoral calcinosis, hyperphosphatemic, familial, 2[OMIM:617993]-Autosomal recessive inheritance | Hypophosphatemic rickets, autosomal dominant[OMIM:193100]-Autosomal dominant inheritance","Strong, Moderate, Supportive (autosomal dominant hypophosphatemic rickets[MONDO:0008660]-Autosomal dominant) | Supportive (tumoral calcinosis, hyperphosphatemic, familial, 1[MONDO:0008897]-Autosomal recessive) | Strong, Strong, Moderate (tumoral calcinosis, hyperphosphatemic, familial, 2[MONDO:0060714]-Autosomal recessive)",NULL,P:8; LP:4; VUS:88,OMIM:617993 (tubulopathy: 0.028 | nephrocalcinosis: 0.014),NULL,OMIM:193100 (syndromic: 0.016 | growth: 0.25 | skeletal: 0.004); OMIM:617993 (syndromic: 0 | skeletal: 0.002),hm (true); ht (false),0.5,5665,0.7756813417190775,"9606.ENSP00000339824:912, 9606.ENSP00000180166:505, 9606.ENSP00000369442:999, 9606.ENSP00000322323:499, 9606.ENSP00000265171:266, 9606.ENSP00000312652:157, 9606.ENSP00000393312:999, 9606.ENSP00000264664:501, 9606.ENSP00000410294:827",0,0,0,0.129297596696461,cur_161
FGFR1,3688,3,1.975208574151117,NULL,NULL,NULL,NULL,"Pfeiffer syndrome[OMIM:101600]-Autosomal dominant inheritance | Hypogonadotropic hypogonadism 2 with or without anosmia[OMIM:147950]-Autosomal dominant inheritance | Jackson-Weiss syndrome[OMIM:123150]-Autosomal dominant inheritance | Hartsfield syndrome[OMIM:615465]-Autosomal dominant inheritance | Trigonocephaly 1[OMIM:190440]-Autosomal dominant inheritance | Osteoglophonic dysplasia[OMIM:166250]-Autosomal dominant inheritance | Encephalocraniocutaneous lipomatosis, somatic mosaic[OMIM:613001]-NA","Supportive (tooth agenesis[MONDO:0005486]-Autosomal dominant) | Definitive, Strong, Strong (Pfeiffer syndrome[MONDO:0007043]-Autosomal dominant) | Strong (Jackson-Weiss syndrome[MONDO:0007400]-Autosomal dominant) | Definitive (hypogonadotropic hypogonadism 7 with or without anosmia[MONDO:0007794]-Autosomal dominant) | Definitive, Definitive (hypogonadotropic hypogonadism 2 with or without anosmia[MONDO:0007844]-Autosomal dominant) | Definitive, Strong, Moderate, Limited, Supportive (osteoglophonic dwarfism[MONDO:0008150]-Autosomal dominant) | Supportive (septooptic dysplasia[MONDO:0008428]-Autosomal dominant) | Definitive (encephalocraniocutaneous lipomatosis[MONDO:0013074]-Autosomal dominant) | Definitive (encephalocraniocutaneous lipomatosis[MONDO:0013074]-Somatic mosaicism) | Definitive, Moderate, Moderate, Supportive (Hartsfield-Bixler-Demyer syndrome[MONDO:0014196]-Autosomal dominant) | Supportive (holoprosencephaly[MONDO:0016296]-Autosomal recessive) | Supportive (isolated trigonocephaly[MONDO:0018065]-Autosomal dominant) | Supportive (hypogonadotropic hypogonadism[MONDO:0018555]-Autosomal dominant) | Supportive (Kallmann syndrome[MONDO:0018800]-Autosomal dominant) | Definitive, Supportive (Pfeiffer syndrome type 1[MONDO:0019659]-Autosomal dominant)",Limited (osteoglophonic dwarfism[MONDO:0008150]-AD) | Moderate (Hartsfield-Bixler-Demyer syndrome[MONDO:0014196]-AD) | Definitive (Pfeiffer syndrome type 1[MONDO:0019659]-AD),P:110; LP:82; VUS:335,OMIM:613001 (cakut: 0.085 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:166250 (neonatal_or_pediatric: 0.665); OMIM:190440 (antenatal_or_congenital: 0.821); OMIM:613001 (antenatal_or_congenital: 0.821),OMIM:101600 (syndromic: 0.057 | skeletal: 0.032 | neurologic: 0.047); OMIM:123150 (syndromic: 0.014 | skeletal: 0.025); OMIM:147950 (syndromic: 0.05 | growth: 0.27 | skeletal: 0.017 | neurologic: 0.049); OMIM:166250 (syndromic: 0.104 | growth: 0.296 | skeletal: 0.137 | neurologic: 0.02); OMIM:190440 (syndromic: 0.07 | skeletal: 0.056 | neurologic: 0.089); OMIM:613001 (syndromic: 0.062 | skeletal: 0.004 | neurologic: 0.129); OMIM:615465 (syndromic: 0.067 | growth: 0.091 | skeletal: 0.059 | neurologic: 0.095),hm (false); ht (false),1,11378,0.939203354297694,"9606.ENSP00000264664:990, 9606.ENSP00000479904:486, 9606.ENSP00000237837:999, 9606.ENSP00000339824:742, 9606.ENSP00000180166:991, 9606.ENSP00000369442:999, 9606.ENSP00000410294:580, 9606.ENSP00000339191:330, 9606.ENSP00000319756:229, 9606.ENSP00000451828:292, 9606.ENSP00000265171:543, 9606.ENSP00000262367:753, 9606.ENSP00000262352:165, 9606.ENSP00000380432:307, 9606.ENSP00000256078:152, 9606.ENSP00000445175:748, 9606.ENSP00000362993:307, 9606.ENSP00000347942:210, 9606.ENSP00000362680:575, 9606.ENSP00000262648:980",0.5,30.3,18.0261,446.822188425799,cur_162
FGFR2,3689,3,2.6539863470960445,NULL,NULL,NULL,NULL,"Bent bone dysplasia syndrome[OMIM:614592]-Autosomal dominant inheritance | LADD syndrome 1[OMIM:149730]-Autosomal dominant inheritance | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis[OMIM:207410]-Autosomal dominant inheritance | Jackson-Weiss syndrome[OMIM:123150]-Autosomal dominant inheritance | Gastric cancer, somatic[OMIM:613659]-NA | Craniofacial-skeletal-dermatologic dysplasia[OMIM:101600]-Autosomal dominant inheritance | Apert syndrome[OMIM:101200]-Autosomal dominant inheritance | Pfeiffer syndrome[OMIM:101600]-Autosomal dominant inheritance | ?Scaphocephaly, maxillary retrusion, and impaired intellectual development[OMIM:609579]-NA | Beare-Stevenson cutis gyrata syndrome[OMIM:123790]-Autosomal dominant inheritance | Crouzon syndrome[OMIM:123500]-Autosomal dominant inheritance | Saethre-Chotzen syndrome[OMIM:101400]-Autosomal dominant inheritance","Definitive, Definitive, Strong, Strong, Supportive (Apert syndrome[MONDO:0007041]-Autosomal dominant) | Strong, Strong (Saethre-Chotzen syndrome[MONDO:0007042]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong, Strong (Pfeiffer syndrome[MONDO:0007043]-Autosomal dominant) | Definitive, Strong, Supportive (Jackson-Weiss syndrome[MONDO:0007400]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong, Strong, Supportive (Crouzon syndrome[MONDO:0007405]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (Beare-Stevenson cutis gyrata syndrome[MONDO:0007412]-Autosomal dominant) | Supportive (LADD syndrome[MONDO:0007872]-Autosomal dominant) | Supportive (Antley-Bixler syndrome[MONDO:0008803]-Autosomal dominant) | Strong, Supportive (familial scaphocephaly syndrome, McGillivray type[MONDO:0012307]-Autosomal dominant) | Moderate, Supportive (bent bone dysplasia syndrome 1[MONDO:0013815]-Autosomal dominant) | Supportive (Pfeiffer syndrome type 1[MONDO:0019659]-Autosomal dominant) | Supportive (Pfeiffer syndrome type 2[MONDO:0019660]-Autosomal dominant) | Supportive (Pfeiffer syndrome type 3[MONDO:0019661]-Autosomal dominant) | Definitive, Strong (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis[MONDO:0020667]-Autosomal dominant) | Definitive (LADD syndrome 1[MONDO:0100302]-Autosomal dominant) | Definitive (LADD syndrome 1[MONDO:0100302]-Mitochondrial)",Definitive (Apert syndrome[MONDO:0007041]-AD) | Definitive (Pfeiffer syndrome[MONDO:0007043]-AD) | Definitive (Crouzon syndrome[MONDO:0007405]-AD) | Definitive (Beare-Stevenson cutis gyrata syndrome[MONDO:0007412]-AD),P:80; LP:63; VUS:203,OMIM:101200 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002); OMIM:149730 (cancer: 0.05 | cakut: 0.044 | cyst_cilio: 0.008); OMIM:207410 (cancer: 0.02 | cakut: 0.008 | cyst_cilio: 0.008 | tubulopathy: 0.007),OMIM:101200 (antenatal_or_congenital: 0.821); OMIM:123790 (antenatal_or_congenital: 0.821); OMIM:614592 (antenatal_or_congenital: 0.821),OMIM:101200 (syndromic: 0.088 | growth: 0.009 | skeletal: 0.07 | neurologic: 0.075); OMIM:101400 (syndromic: 0.068 | growth: 0.25 | skeletal: 0.073 | neurologic: 0.042); OMIM:101600 (syndromic: 0.057 | skeletal: 0.032 | neurologic: 0.047); OMIM:123150 (syndromic: 0.014 | skeletal: 0.025); OMIM:123500 (syndromic: 0.068 | skeletal: 0.043 | neurologic: 0.088); OMIM:123790 (syndromic: 0.081 | skeletal: 0.022 | neurologic: 0.076); OMIM:149730 (syndromic: 0.026 | skeletal: 0.031); OMIM:207410 (syndromic: 0.06 | skeletal: 0.077 | neurologic: 0.047); OMIM:609579 (syndromic: 0.021 | skeletal: 0.006 | neurologic: 0.04); OMIM:614592 (syndromic: 0.021 | skeletal: 0.056),hm (true); ht (true),0.5,7413,0.8343815513626834,"9606.ENSP00000281043:268, 9606.ENSP00000264664:999, 9606.ENSP00000237837:827, 9606.ENSP00000339824:980, 9606.ENSP00000180166:953, 9606.ENSP00000369442:360, 9606.ENSP00000254958:313, 9606.ENSP00000392028:282, 9606.ENSP00000362680:308, 9606.ENSP00000262648:405, 9606.ENSP00000379204:345, 9606.ENSP00000393312:580, 9606.ENSP00000361467:163, 9606.ENSP00000265171:630",0.5,12.3669,7.27413,226.385566450949,cur_163
FGFR3,3690,2,1.4209065870720885,NULL,NULL,NULL,NULL,"Muenke syndrome[OMIM:602849]-Autosomal dominant inheritance | SADDAN[OMIM:616482]-Autosomal dominant inheritance | Hypochondroplasia[OMIM:146000]-Autosomal dominant inheritance | Thanatophoric dysplasia, type II[OMIM:187601]-Autosomal dominant inheritance | Nevus, epidermal, somatic[OMIM:162900]-NA | CATSHL syndrome[OMIM:610474]-Autosomal dominant inheritance | CATSHL syndrome[OMIM:610474]-Autosomal recessive inheritance | Thanatophoric dysplasia, type I[OMIM:187600]-Autosomal dominant inheritance | Spermatocytic seminoma, somatic[OMIM:273300]-NA | Bladder cancer, somatic[OMIM:109800]-NA | LADD syndrome 2[OMIM:620192]-Autosomal dominant inheritance | Achondroplasia[OMIM:100800]-Autosomal dominant inheritance | Cervical cancer, somatic[OMIM:603956]-NA | Colorectal cancer, somatic[OMIM:114500]-NA | Crouzon syndrome with acanthosis nigricans[OMIM:612247]-Autosomal dominant inheritance","Definitive, Definitive, Definitive, Strong, Supportive (Achondroplasia[MONDO:0007037]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (hypochondroplasia[MONDO:0007793]-Autosomal dominant) | Supportive (LADD syndrome[MONDO:0007872]-Autosomal dominant) | Definitive, Definitive, Strong, Strong, Supportive (thanatophoric dysplasia type 1[MONDO:0008546]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (thanatophoric dysplasia type 2[MONDO:0008547]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong, Strong, Supportive (Muenke syndrome[MONDO:0011274]-Autosomal dominant) | Definitive, Supportive (camptodactyly-tall stature-scoliosis-hearing loss syndrome[MONDO:0012504]-Autosomal dominant) | Moderate (camptodactyly-tall stature-scoliosis-hearing loss syndrome[MONDO:0012504]-Autosomal recessive) | Moderate (camptodactyly-tall stature-scoliosis-hearing loss syndrome[MONDO:0012504]-Semidominant) | Definitive, Definitive, Definitive, Strong, Strong, Supportive (Crouzon syndrome-acanthosis nigricans syndrome[MONDO:0012833]-Autosomal dominant) | Moderate, Supportive (severe achondroplasia-developmental delay-acanthosis nigricans syndrome[MONDO:0014658]-Autosomal dominant) | Supportive (isolated plagiocephaly[MONDO:0018113]-Autosomal dominant) | Supportive (isolated brachycephaly[MONDO:0018114]-Autosomal dominant) | Definitive (LADD syndrome 1[MONDO:0100302]-Autosomal dominant)",Definitive (Achondroplasia[MONDO:0007037]-AD) | Definitive (hypochondroplasia[MONDO:0007793]-AD) | Definitive (thanatophoric dysplasia type 1[MONDO:0008546]-AD) | Definitive (thanatophoric dysplasia type 2[MONDO:0008547]-AD) | Definitive (Muenke syndrome[MONDO:0011274]-AD) | Moderate (camptodactyly-tall stature-scoliosis-hearing loss syndrome[MONDO:0012504]-SD) | Definitive (Crouzon syndrome-acanthosis nigricans syndrome[MONDO:0012833]-AD) | Moderate (severe achondroplasia-developmental delay-acanthosis nigricans syndrome[MONDO:0014658]-AD),P:42; LP:25; VUS:281,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:100800 (antenatal_or_congenital: 0.821); OMIM:146000 (neonatal_or_pediatric: 0.2); OMIM:187600 (antenatal_or_congenital: 0.821); OMIM:187601 (antenatal_or_congenital: 0.035); OMIM:616482 (antenatal_or_congenital: 0.821),OMIM:100800 (syndromic: 0.047 | growth: 0.02 | skeletal: 0.088 | neurologic: 0.024); OMIM:146000 (syndromic: 0.051 | growth: 0.013 | skeletal: 0.075 | neurologic: 0.04); OMIM:187600 (syndromic: 0.06 | growth: 0.014 | skeletal: 0.079 | neurologic: 0.061); OMIM:187601 (syndromic: 0.025 | growth: 0.001 | skeletal: 0.054 | neurologic: 0.019); OMIM:602849 (syndromic: 0.106 | growth: 0.001 | skeletal: 0.074 | neurologic: 0.138); OMIM:610474 (syndromic: 0.083 | growth: 0.011 | skeletal: 0.109 | neurologic: 0.12); OMIM:612247 (syndromic: 0.011 | skeletal: 0.013 | neurologic: 0.006); OMIM:616482 (syndromic: 0.109 | growth: 0.038 | skeletal: 0.07 | neurologic: 0.162); OMIM:620192 (syndromic: 0.005 | skeletal: 0),hm (false); ht (false),0.5,7527,0.8385744234800838,"9606.ENSP00000392028:276, 9606.ENSP00000393312:742, 9606.ENSP00000265171:544, 9606.ENSP00000484824:705, 9606.ENSP00000410294:980, 9606.ENSP00000258173:290, 9606.ENSP00000264664:754, 9606.ENSP00000237837:912, 9606.ENSP00000369442:879, 9606.ENSP00000180166:850, 9606.ENSP00000255380:303, 9606.ENSP00000262648:292",0.5,34.5681,23.2259,22.5685813583195,cur_164
FH,3700,3,2.134320512576348,0.08824,0.27569,3.1312,1.2708,Leiomyomatosis and renal cell cancer[OMIM:150800]-Autosomal dominant inheritance | Fumarase deficiency[OMIM:606812]-Autosomal recessive inheritance,"Moderate (leiomyosarcoma[MONDO:0005058]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong, Supportive (hereditary leiomyomatosis and renal cell cancer[MONDO:0007888]-Autosomal dominant) | Definitive, Strong, Supportive (fumaric aciduria[MONDO:0011730]-Autosomal recessive) | Supportive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-Autosomal dominant) | Strong (pheochromocytoma-paraganglioma[MONDO:0035540]-Autosomal dominant)",Definitive (hereditary leiomyomatosis and renal cell cancer[MONDO:0007888]-AD),P:270; LP:147; VUS:673,OMIM:150800 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:606812 (cancer: 0.01),OMIM:606812 (antenatal_or_congenital: 0.03),OMIM:606812 (syndromic: 0.091 | growth: 0.171 | skeletal: 0.067 | neurologic: 0.121),hm (true); ht (false),0.5,1029,0.24737945492662475,"9606.ENSP00000264170:225, 9606.ENSP00000311505:292, 9606.ENSP00000445175:326, 9606.ENSP00000362413:186",0.5,64.1845,48.2765,31.3957499251545,cur_165
FLCN,27310,4,3.219656256954657,0.78892,0.18435000000000001,3.9363,1.1301,"Birt-Hogg-Dube syndrome[OMIM:135150]-Autosomal dominant inheritance | Colorectal cancer, somatic[OMIM:114500]-NA | Pneumothorax, primary spontaneous[OMIM:173600]-Autosomal dominant inheritance | Renal carcinoma, chromophobe, somatic[OMIM:144700]-NA","Strong (renal carcinoma[MONDO:0005206]-Autosomal dominant) | Limited (colorectal cancer[MONDO:0005575]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong, Strong, Supportive (Birt-Hogg-Dube syndrome[MONDO:0007607]-Autosomal dominant) | Strong, Moderate, Supportive (familial spontaneous pneumothorax[MONDO:0008259]-Autosomal dominant)",Definitive (Birt-Hogg-Dube syndrome[MONDO:0007607]-AD),P:293; LP:66; VUS:820,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:135150 (cancer: 0.17 | cyst_cilio: 0.105 | cakut: 0.048 | glomerulopathy: 0.009 | tubulopathy: 0.007); OMIM:144700 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),NULL,NULL,hm (false); ht (true),0.5,999,0.2389937106918239,"9606.ENSP00000231509:285, 9606.ENSP00000324856:268, 9606.ENSP00000358423:292, 9606.ENSP00000337088:154",0.5,14.1089,14.2039,16.3802524119771,cur_166
FN1,3778,5,3.7055148013926194,0.001404,0.2539,8.0006,1.646,"Spondylometaphyseal dysplasia, corner fracture type[OMIM:184255]-Autosomal dominant inheritance | Glomerulopathy with fibronectin deposits 2[OMIM:601894]-Autosomal dominant inheritance","Supportive (fibronectin glomerulopathy[MONDO:0007671]-Autosomal dominant) | Strong, Strong, Supportive (spondylometaphyseal dysplasia, 'corner fracture' type[MONDO:0008479]-Autosomal dominant) | Moderate, Moderate (glomerulopathy with fibronectin deposits 2[MONDO:0011165]-Autosomal dominant)",Moderate (glomerulopathy with fibronectin deposits 2[MONDO:0011165]-AD),P:12; LP:12; VUS:383,OMIM:601894 (glomerulopathy: 0.35 | cyst_cilio: 0.194 | tubulopathy: 0.175 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.085 | cancer: 0.05),OMIM:601894 (adult: 0.372 | neonatal_or_pediatric: 0.2),OMIM:184255 (syndromic: 0.03 | growth: 0.25 | skeletal: 0.056 | neurologic: 0.003),hm (false); ht (false),1,15202,0.9832285115303984,"9606.ENSP00000264664:410, 9606.ENSP00000297261:372, 9606.ENSP00000180166:418, 9606.ENSP00000216911:901, 9606.ENSP00000379204:416, 9606.ENSP00000307235:400, 9606.ENSP00000215832:507, 9606.ENSP00000252934:229, 9606.ENSP00000363773:292, 9606.ENSP00000262304:447, 9606.ENSP00000236850:723, 9606.ENSP00000264896:327, 9606.ENSP00000262648:292, 9606.ENSP00000317272:351, 9606.ENSP00000256474:666, 9606.ENSP00000308938:986, 9606.ENSP00000237014:200, 9606.ENSP00000367316:469, 9606.ENSP00000252486:152, 9606.ENSP00000252999:380, 9606.ENSP00000322323:630, 9606.ENSP00000256078:499, 9606.ENSP00000364979:189, 9606.ENSP00000362924:661, 9606.ENSP00000252699:346, 9606.ENSP00000265171:725, 9606.ENSP00000355627:292, 9606.ENSP00000385675:565, 9606.ENSP00000362680:677, 9606.ENSP00000313967:315, 9606.ENSP00000260010:814, 9606.ENSP00000358866:551",0.5,59.3276,26.5025,219.050295366255,cur_167
FOXC1,3800,3,2.1734427775085994,NULL,NULL,NULL,NULL,"Axenfeld-Rieger syndrome, type 3[OMIM:602482]-Autosomal dominant inheritance | Anterior segment dysgenesis 3, multiple subtypes[OMIM:601631]-Autosomal dominant inheritance","Supportive (isolated aniridia[MONDO:0007119]-Autosomal dominant) | Definitive, Strong (Axenfeld-Rieger syndrome type 3[MONDO:0011233]-Autosomal dominant) | Definitive, Supportive (Peters anomaly[MONDO:0011414]-Autosomal dominant) | Strong (aniridia[MONDO:0019172]-Autosomal dominant) | Supportive (Axenfeld-Rieger syndrome[MONDO:0019187]-Autosomal dominant) | Supportive (Rieger anomaly[MONDO:0019628]-Autosomal dominant) | Supportive (Axenfeld anomaly[MONDO:0020368]-Autosomal dominant) | Definitive, Definitive (anterior segment dysgenesis 3[MONDO:0024456]-Autosomal dominant)",Definitive (anterior segment dysgenesis 3[MONDO:0024456]-AD),P:86; LP:31; VUS:197,NULL,OMIM:601631 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.603 | adult: 0.372),OMIM:601631 (syndromic: 0.003 | skeletal: 0.002 | neurologic: 0.004); OMIM:602482 (syndromic: 0.011 | skeletal: 0.01 | neurologic: 0.004),hm (true); ht (true),0,NULL,NULL,NULL,0.5,24.8808,13.4059,139.451821506534,cur_168
FOXC2,3801,2,1.6290454760183073,NULL,NULL,NULL,NULL,Lymphedema-distichiasis syndrome[OMIM:153400]-Autosomal dominant inheritance | Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus[OMIM:153400]-Autosomal dominant inheritance,"Definitive, Strong, Strong, Limited, Supportive (lymphedema-distichiasis syndrome[MONDO:0007922]-Autosomal dominant)",NULL,P:32; LP:9; VUS:61,NULL,NULL,OMIM:153400 (syndromic: 0.022 | skeletal: 0.037 | neurologic: 0.004),hm (true); ht (false),0,NULL,NULL,NULL,0.5,6.06441,4.54971,21.3873674914135,cur_169
FOXI1,3815,4,2.5406205943608953,0.77268,0.10812,2.5135,0.72824,Enlarged vestibular aqueduct[OMIM:600791]-Autosomal recessive inheritance,"Limited (hearing loss disorder[MONDO:0005365]-Autosomal recessive) | Supportive (Pendred syndrome[MONDO:0010134]-Autosomal recessive) | Strong, Limited (autosomal recessive nonsyndromic hearing loss 4[MONDO:0010933]-Autosomal recessive) | Supportive (autosomal recessive distal renal tubular acidosis[MONDO:0018440]-Autosomal recessive) | Disputed Evidence (enlarged vestibular aqueduct syndrome[MONDO:0023069]-Autosomal recessive)",Limited (hearing loss disorder[MONDO:0005365]-AR) | Disputed (enlarged vestibular aqueduct syndrome[MONDO:0023069]-AR),P:1; LP:1; VUS:75,NULL,OMIM:600791 (antenatal_or_congenital: 0.821),NULL,hm (true); ht (false),0,615,0.1530398322851153,"9606.ENSP00000484803:165, 9606.ENSP00000360231:292, 9606.ENSP00000262367:158",0,24.0399,32.327,0.242875064144568,cur_170
FOXP1,3823,3,1.7183122758752345,NULL,NULL,NULL,NULL,Intellectual developmental disorder with language impairment with or without autistic features[OMIM:613670]-Autosomal dominant inheritance,"Definitive, Definitive, Definitive, Moderate (intellectual disability-severe speech delay-mild dysmorphism syndrome[MONDO:0013352]-Autosomal dominant)",Definitive (intellectual disability-severe speech delay-mild dysmorphism syndrome[MONDO:0013352]-AD),P:91; LP:51; VUS:218,NULL,OMIM:613670 (neonatal_or_pediatric: 0.402),OMIM:613670 (syndromic: 0.115 | growth: 0.053 | skeletal: 0.035 | neurologic: 0.184),hm (false); ht (false),0.5,4782,0.7295597484276729,"9606.ENSP00000217086:800, 9606.ENSP00000360231:186, 9606.ENSP00000368632:265, 9606.ENSP00000359319:165, 9606.ENSP00000365380:667, 9606.ENSP00000216911:292, 9606.ENSP00000312987:165, 9606.ENSP00000304286:165, 9606.ENSP00000354006:198, 9606.ENSP00000358262:292, 9606.ENSP00000269305:292, 9606.ENSP00000480291:165, 9606.ENSP00000405890:800, 9606.ENSP00000262426:165, 9606.ENSP00000251020:165",0.5,4.91512,2.90979,686.953997016102,cur_171
FRAS1,19185,5,3.921644492950671,NULL,NULL,NULL,NULL,Fraser syndrome 1[OMIM:219000]-Autosomal recessive inheritance,"Definitive, Supportive (Fraser syndrome[MONDO:0009046]-Autosomal recessive) | Supportive (renal agenesis, unilateral[MONDO:0019636]-Autosomal dominant) | Definitive (Fraser syndrome 1[MONDO:0054737]-Autosomal recessive)",Definitive (Fraser syndrome[MONDO:0009046]-AR),P:79; LP:43; VUS:642,OMIM:219000 (cakut: 0.093 | cyst_cilio: 0.037 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),NULL,OMIM:219000 (syndromic: 0.082 | skeletal: 0.053 | neurologic: 0.118),hm (true); ht (true),0,NULL,NULL,NULL,0.5,5.70031,4.64001,366.455279367166,cur_172
FREM1,23399,5,3.76690510566788,NULL,NULL,NULL,NULL,Manitoba oculotrichoanal syndrome[OMIM:248450]-Autosomal recessive inheritance | Bifid nose with or without anorectal and renal anomalies[OMIM:608980]-Autosomal recessive inheritance | Trigonocephaly 2[OMIM:614485]-Autosomal dominant inheritance,"Definitive, Moderate, Supportive (oculotrichoanal syndrome[MONDO:0009560]-Autosomal recessive) | Supportive (BNAR syndrome[MONDO:0012165]-Autosomal recessive) | Limited, Disputed Evidence (trigonocephaly 2[MONDO:0013774]-Autosomal dominant) | Supportive (isolated trigonocephaly[MONDO:0018065]-Autosomal dominant) | Supportive (renal agenesis, unilateral[MONDO:0019636]-Autosomal dominant)",NULL,P:13; LP:14; VUS:385,OMIM:608980 (cakut: 0.093 | cancer: 0.07 | cyst_cilio: 0.013 | tubulopathy: 0.007),OMIM:248450 (antenatal_or_congenital: 0.821),OMIM:248450 (syndromic: 0.027 | neurologic: 0.051); OMIM:608980 (syndromic: 0.012 | skeletal: 0.009 | neurologic: 0.006); OMIM:614485 (syndromic: 0.055 | skeletal: 0.052 | neurologic: 0.08),hm (true); ht (false),0.5,1668,0.36477987421383645,"9606.ENSP00000390436:345, 9606.ENSP00000381098:332, 9606.ENSP00000280481:991",0.5,7.22138,4.45441,599.4885809493,cur_173
FREM2,25396,5,3.804178975909866,0,0.36258,6.0469,-0.85877,"Fraser syndrome 2[OMIM:617666]-Autosomal recessive inheritance | Cryptophthalmos, unilateral or bilateral, isolated[OMIM:123570]-Autosomal recessive inheritance","Supportive (Fraser syndrome[MONDO:0009046]-Autosomal recessive) | Supportive (renal agenesis, unilateral[MONDO:0019636]-Autosomal dominant) | Definitive (Fraser syndrome 1[MONDO:0054737]-Autosomal recessive) | Moderate (Fraser syndrome 2[MONDO:0054738]-Autosomal recessive)",NULL,P:25; LP:18; VUS:542,OMIM:617666 (cakut: 0.21 | cancer: 0.1 | cyst_cilio: 0.052 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:617666 (antenatal_or_congenital: 0.821),OMIM:123570 (syndromic: 0); OMIM:617666 (syndromic: 0.011 | skeletal: 0.016),hm (true); ht (true),0.5,2296,0.4591194968553459,"9606.ENSP00000470972:190, 9606.ENSP00000414321:188, 9606.ENSP00000412940:991, 9606.ENSP00000381098:416, 9606.ENSP00000360997:163, 9606.ENSP00000481646:158, 9606.ENSP00000348849:190",0.5,3.4924800000000005,3.22192,81.429691147944,cur_174
FXYD2,4026,5,3.301813744973351,0.11431,0.38391,1.303,-0.15622,"Hypomagnesemia 2, renal[OMIM:154020]-Autosomal dominant inheritance","Moderate, Supportive (renal hypomagnesemia 2[MONDO:0007937]-Autosomal dominant)",Moderate (renal hypomagnesemia 2[MONDO:0007937]-AD),P:1; LP:0; VUS:16,OMIM:154020 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),NULL,OMIM:154020 (syndromic: 0.02 | skeletal: 0.001 | neurologic: 0.041),hm (false); ht (false),0.5,954,0.22012578616352202,9606.ENSP00000445306:954,0.5,574.806,299.041,34.5053334492555,cur_175
GALNT3,4125,5,2.629130575611276,0,0.58178,2.1557,0.3862,"Tumoral calcinosis, hyperphosphatemic, familial, 1[OMIM:211900]-Autosomal recessive inheritance","Strong, Strong, Strong, Supportive (tumoral calcinosis, hyperphosphatemic, familial, 1[MONDO:0008897]-Autosomal recessive) | Definitive (tumoral calcinosis, hyperphosphatemic, familial, 1[MONDO:0100252]-Autosomal recessive)",NULL,P:24; LP:6; VUS:122,OMIM:211900 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),OMIM:211900 (neonatal_or_pediatric: 0.2),OMIM:211900 (syndromic: 0.002 | skeletal: 0.005),hm (true); ht (false),0,165,0.018867924528301886,9606.ENSP00000231509:165,0,8.10871,3.30174,9.00936408694696,cur_176
GANAB,4138,5,3.9342347273550784,NULL,NULL,NULL,NULL,Polycystic kidney disease 3[OMIM:600666]-Autosomal dominant inheritance,"Supportive (autosomal dominant polycystic kidney disease[MONDO:0004691]-Autosomal dominant) | Definitive, Strong (polycystic kidney disease 3 with or without polycystic liver disease[MONDO:0010916]-Autosomal dominant)",Definitive (polycystic kidney disease 3 with or without polycystic liver disease[MONDO:0010916]-AD),P:14; LP:14; VUS:111,OMIM:600666 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:600666 (adult: 0.683 | neonatal_or_pediatric: 0.2),OMIM:600666 (syndromic: 0 | neurologic: 0.001),hm (false); ht (false),0.5,2525,0.49266247379454925,"9606.ENSP00000357048:193, 9606.ENSP00000414398:241, 9606.ENSP00000356319:292, 9606.ENSP00000260746:345, 9606.ENSP00000269305:163, 9606.ENSP00000466134:999, 9606.ENSP00000322323:292",0.5,105.96,75.5913,83.1517055452425,cur_177
GATA3,4172,5,4.210060798168941,0.89887,0.12337,3.2708,1.913,"Hypoparathyroidism, sensorineural deafness, and renal dysplasia[OMIM:146255]-Autosomal dominant inheritance","Definitive, Definitive, Strong, Strong, Supportive (hypoparathyroidism-deafness-renal disease syndrome[MONDO:0007797]-Autosomal dominant)",Definitive (hypoparathyroidism-deafness-renal disease syndrome[MONDO:0007797]-AD),P:53; LP:16; VUS:106,OMIM:146255 (nephrocalcinosis: 0.285 | tubulopathy: 0.238 | glomerulopathy: 0.208 | complement: 0.179 | cakut: 0.081 | cyst_cilio: 0.045 | cancer: 0.04),OMIM:146255 (antenatal_or_congenital: 0.821),OMIM:146255 (syndromic: 0.001 | skeletal: 0.002 | neurologic: 0.001),hm (true); ht (false),0.5,4189,0.6834381551362684,"9606.ENSP00000227507:410, 9606.ENSP00000252934:195, 9606.ENSP00000269305:252, 9606.ENSP00000405890:332, 9606.ENSP00000396688:363, 9606.ENSP00000365380:292, 9606.ENSP00000262367:457, 9606.ENSP00000360231:292, 9606.ENSP00000303511:364, 9606.ENSP00000484803:265, 9606.ENSP00000281043:161, 9606.ENSP00000362410:400, 9606.ENSP00000367203:406",0.5,29.73,21.0903,75.2898368723851,cur_178
GATM,4175,5,3.374478230519957,0.051418,0.28429,3.291,2.2888,Cerebral creatine deficiency syndrome 3[OMIM:612718]-Autosomal recessive inheritance | Fanconi renotubular syndrome 1[OMIM:134600]-Autosomal dominant inheritance,"Supportive (primary Fanconi syndrome[MONDO:0007600]-Autosomal dominant) | Definitive, Definitive, Moderate, Supportive (AGAT deficiency[MONDO:0012996]-Autosomal recessive) | Moderate (Fanconi renotubular syndrome 1[MONDO:0024525]-Autosomal dominant)",Definitive (AGAT deficiency[MONDO:0012996]-AR),P:9; LP:10; VUS:202,OMIM:134600 (nephrocalcinosis: 0.125 | tubulopathy: 0.112 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:134600 (neonatal_or_pediatric: 0.262); OMIM:612718 (neonatal_or_pediatric: 0.402),OMIM:134600 (syndromic: 0.014 | growth: 0.25 | skeletal: 0.002); OMIM:612718 (syndromic: 0.063 | growth: 0.171 | neurologic: 0.113),hm (true); ht (false),0,NULL,NULL,NULL,0.5,61.3935,135.608,10.5686220969981,cur_179
GCM2,4198,4,1.837639401062001,9.11e-4,0.44095,2.2066,0.67613,"Hypoparathyroidism, familial isolated 2[OMIM:618883]-Autosomal dominant inheritance | Hypoparathyroidism, familial isolated 2[OMIM:618883]-Autosomal recessive inheritance | Hyperparathyroidism 4[OMIM:617343]-Autosomal dominant inheritance",Supportive (familial isolated hypoparathyroidism due to agenesis of parathyroid gland[MONDO:0010618]-Autosomal recessive) | Supportive (familial isolated hyperparathyroidism[MONDO:0015027]-Autosomal dominant),NULL,P:7; LP:8; VUS:71,OMIM:617343 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),OMIM:617343 (adult: 0.218),OMIM:617343 (syndromic: 0.003 | skeletal: 0.009); OMIM:618883 (syndromic: 0 | neurologic: 0),hm (true); ht (false),0,365,0.09433962264150944,9606.ENSP00000362410:365,0,0.009102299999999999,0,0.241463814937066,cur_180
GDF6,4221,3,1.31434684780906,0.98833,0,3.3948,0.9343,"Microphthalmia with coloboma 6, digenic[OMIM:613703]-Autosomal dominant inheritance | Microphthalmia, isolated 4[OMIM:613094]-NA | Leber congenital amaurosis 17[OMIM:615360]-Autosomal recessive inheritance | Multiple synostoses syndrome 4[OMIM:617898]-Autosomal dominant inheritance | Klippel-Feil syndrome 1, autosomal dominant[OMIM:118100]-Autosomal dominant inheritance","Definitive (Klippel-Feil syndrome 1, autosomal dominant[MONDO:0007306]-Autosomal dominant) | Supportive (isolated Klippel-Feil syndrome[MONDO:0016520]-Autosomal dominant) | Supportive (Leber congenital amaurosis[MONDO:0018998]-Autosomal dominant)",NULL,P:2; LP:2; VUS:196,OMIM:118100 (cakut: 0.052 | cancer: 0.03 | cyst_cilio: 0.024 | tubulopathy: 0.007 | glomerulopathy: 0.002),NULL,OMIM:118100 (syndromic: 0.024 | skeletal: 0.052 | neurologic: 0.001); OMIM:613094 (syndromic: 0.001 | skeletal: 0.004); OMIM:613703 (syndromic: 0 | skeletal: 0); OMIM:617898 (syndromic: 0.005 | skeletal: 0.017),hm (false); ht (false),0,NULL,NULL,NULL,0,0.109929,0.09396610000000001,0.589845747742457,cur_181
GDNF,4232,3,2.0918606892368072,NULL,NULL,NULL,NULL,"{Hirschsprung disease, susceptibility to, 3}[OMIM:613711]-Autosomal dominant inheritance",NULL,NULL,P:0; LP:0; VUS:56,NULL,OMIM:613711 (antenatal_or_congenital: 0.821),OMIM:613711 (syndromic: 0.001 | neurologic: 0.001),hm (true); ht (true),0.5,3472,0.6184486373165619,"9606.ENSP00000347942:999, 9606.ENSP00000478927:476, 9606.ENSP00000366563:499, 9606.ENSP00000347591:999, 9606.ENSP00000362680:499",0.5,0.324518,0.445301,56.2081242053457,cur_182
GFRA1,4243,2,0.8143468478090599,0.1175,0.2653,3.2377,1.3928,Renal hypodysplasia/aplasia 4[OMIM:619887]-Autosomal recessive inheritance,Limited (renal hypodysplasia/aplasia 4[MONDO:0030822]-Autosomal recessive),NULL,P:3; LP:0; VUS:20,OMIM:619887 (cakut: 0.016 | cyst_cilio: 0.005),OMIM:619887 (antenatal_or_congenital: 0.851),OMIM:619887 (syndromic: 0),hm (true); ht (false),0.5,2996,0.5576519916142557,"9606.ENSP00000347942:999, 9606.ENSP00000362680:499, 9606.ENSP00000409007:999, 9606.ENSP00000366563:499",0.5,4.67477,2.90176,178.246125630777,cur_183
GLA,4296,5,4.58981890220079,0.99675,0,3.8048,1.8759,"Fabry disease, cardiac variant[OMIM:301500]-X-linked inheritance | Fabry disease[OMIM:301500]-X-linked inheritance","Definitive (Fabry disease[MONDO:0010526]-Autosomal dominant) | Definitive (Fabry disease[MONDO:0010526]-Mitochondrial) | Definitive, Definitive, Strong, Strong, Supportive (Fabry disease[MONDO:0010526]-X-linked)",Definitive (Fabry disease[MONDO:0010526]-XL),P:290; LP:174; VUS:231,OMIM:301500 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:301500 (neonatal_or_pediatric: 0.2),OMIM:301500 (syndromic: 0.022 | growth: 0.02 | neurologic: 0.045),hm (false); ht (false),0,591,0.1488469601677149,"9606.ENSP00000322323:292, 9606.ENSP00000360141:299",0.5,15.252,11.259,23.6407713676029,cur_184
GLI3,4319,5,3.778798170445651,0.99999,0.092871,6.1678,0.5222,"Greig cephalopolysyndactyly syndrome[OMIM:175700]-Autosomal dominant inheritance | Polydactyly, postaxial, types A1 and B[OMIM:174200]-Autosomal dominant inheritance | Pallister-Hall syndrome[OMIM:146510]-Autosomal dominant inheritance | Polydactyly, preaxial, type IV[OMIM:174700]-Autosomal dominant inheritance","Definitive, Definitive, Definitive, Supportive (Pallister-Hall syndrome[MONDO:0007804]-Autosomal dominant) | Definitive (polydactyly, postaxial, type A1[MONDO:0008266]-Autosomal dominant) | Moderate, Supportive (polysyndactyly 4[MONDO:0008272]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong, Strong, Supportive (Greig cephalopolysyndactyly syndrome[MONDO:0008287]-Autosomal dominant) | Supportive (acrocallosal syndrome[MONDO:0008708]-Autosomal recessive) | Supportive (tibial hemimelia[MONDO:0010144]-Autosomal dominant) | Supportive (postaxial polydactyly type A[MONDO:0019673]-Autosomal recessive)",NULL,P:104; LP:27; VUS:313,OMIM:146510 (cakut: 0.298 | cyst_cilio: 0.165 | cancer: 0.1 | glomerulopathy: 0.013 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:174200 (antenatal_or_congenital: 0.821); OMIM:174700 (antenatal_or_congenital: 0.821),OMIM:146510 (syndromic: 0.095 | growth: 0.352 | skeletal: 0.028 | neurologic: 0.095); OMIM:174200 (syndromic: 0.005 | skeletal: 0.019); OMIM:174700 (syndromic: 0.001 | skeletal: 0.002); OMIM:175700 (syndromic: 0.091 | skeletal: 0.07 | neurologic: 0.122),hm (true); ht (false),0.5,5793,0.7777777777777778,"9606.ENSP00000287538:773, 9606.ENSP00000356405:499, 9606.ENSP00000392028:292, 9606.ENSP00000368253:382, 9606.ENSP00000262367:457, 9606.ENSP00000377934:949, 9606.ENSP00000264414:499, 9606.ENSP00000451828:613, 9606.ENSP00000262426:407, 9606.ENSP00000390436:922",0.5,1.82086,1.0126899999999999,211.19634258768,cur_185
GLIS2,29450,5,4.248749003348832,NULL,NULL,NULL,NULL,Nephronophthisis 7[OMIM:611498]-NA,"Supportive (nephronophthisis 1[MONDO:0009728]-Autosomal recessive) | Strong, Limited, Limited (nephronophthisis 7[MONDO:0012680]-Autosomal recessive)",Limited (nephronophthisis 7[MONDO:0012680]-AR),P:3; LP:0; VUS:128,OMIM:611498 (cyst_cilio: 0.252 | glomerulopathy: 0.157 | tubulopathy: 0.056 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,NULL,hm (true); ht (false),0.5,2096,0.42348008385744235,"9606.ENSP00000317469:614, 9606.ENSP00000245157:292, 9606.ENSP00000451828:165, 9606.ENSP00000341292:403, 9606.ENSP00000317272:165, 9606.ENSP00000324856:165, 9606.ENSP00000408292:292",0.5,51.4474,35.579,24.1138551196258,cur_186
GNA11,4379,4,2.3782235108142524,0.88941,0.12543,3.2361,3.768,"Hypocalciuric hypercalcemia, type II[OMIM:145981]-Autosomal dominant inheritance | Hypocalcemia, autosomal dominant 2[OMIM:615361]-Autosomal dominant inheritance","Strong, Strong, Limited, Supportive (familial hypocalciuric hypercalcemia 2[MONDO:0007792]-Autosomal dominant) | Strong, Moderate (autosomal dominant hypocalcemia 2[MONDO:0014146]-Autosomal dominant) | Supportive (autosomal dominant hypocalcemia[MONDO:0018543]-Autosomal dominant)",NULL,P:12; LP:7; VUS:64,OMIM:145981 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),OMIM:615361 (adult: 0.218),OMIM:145981 (syndromic: 0 | skeletal: 0.001); OMIM:615361 (syndromic: 0.003 | growth: 0.034 | skeletal: 0.002 | neurologic: 0.002),hm (false); ht (false),0.5,2789,0.5303983228511531,"9606.ENSP00000356825:300, 9606.ENSP00000262613:292, 9606.ENSP00000384092:499, 9606.ENSP00000356319:292, 9606.ENSP00000315011:292, 9606.ENSP00000256078:161, 9606.ENSP00000360141:661, 9606.ENSP00000265748:292",0.5,37.7638,39.5527,80.7560249402259,cur_187
GNAS,4392,4,2.5795843024277945,NULL,NULL,NULL,NULL,"ACTH-independent macronodular adrenal hyperplasia[OMIM:219080]-Somatic mutation | Pituitary adenoma 3, multiple types, somatic[OMIM:617686]-NA | Pseudohypoparathyroidism Ic[OMIM:612462]-Autosomal dominant inheritance | Pseudohypoparathyroidism Ia[OMIM:103580]-Autosomal dominant inheritance | Osseous heteroplasia, progressive[OMIM:166350]-Autosomal dominant inheritance | Pseudohypoparathyroidism Ib[OMIM:603233]-Autosomal dominant inheritance | McCune-Albright syndrome, somatic, mosaic[OMIM:174800]-NA | Pseudopseudohypoparathyroidism[OMIM:612463]-Autosomal dominant inheritance","Definitive, Definitive, Strong, Supportive (Pseudohypoparathyroidism type 1A[MONDO:0007078]-Autosomal dominant) | Definitive (Pseudohypoparathyroidism type 1A[MONDO:0007078]-Mitochondrial) | Supportive, No Known Disease Relationship (progressive osseous heteroplasia[MONDO:0008153]-Autosomal dominant) | Definitive, Strong, Supportive (pseudohypoparathyroidism type 1B[MONDO:0011301]-Autosomal dominant) | Definitive (pseudohypoparathyroidism type 1B[MONDO:0011301]-Autosomal dominant inheritance with paternal imprinting) | Strong, Supportive (pseudohypoparathyroidism type 1C[MONDO:0012911]-Autosomal dominant) | Definitive (pseudohypoparathyroidism type 1C[MONDO:0012911]-Mitochondrial) | Moderate, Supportive (pseudopseudohypoparathyroidism[MONDO:0012912]-Autosomal dominant) | Definitive (pseudopseudohypoparathyroidism[MONDO:0012912]-Mitochondrial) | Definitive (McCune-Albright syndrome[MONDO:0018919]-Autosomal dominant) | Definitive (McCune-Albright syndrome[MONDO:0018919]-Somatic mosaicism) | Strong (McCune-Albright syndrome[MONDO:0018919]-Unknown) | Definitive (ACTH-independent macronodular adrenal hyperplasia 1[MONDO:0020735]-Somatic mosaicism)",NULL,P:112; LP:53; VUS:168,NULL,OMIM:103580 (neonatal_or_pediatric: 0.402); OMIM:166350 (neonatal_or_pediatric: 0.603); OMIM:219080 (adult: 0.218),OMIM:103580 (syndromic: 0.081 | growth: 0.293 | skeletal: 0.053 | neurologic: 0.085); OMIM:166350 (syndromic: 0.001 | skeletal: 0.002); OMIM:174800 (syndromic: 0.002 | growth: 0.001 | skeletal: 0.002 | neurologic: 0.001); OMIM:219080 (syndromic: 0.016 | growth: 0.008 | skeletal: 0.025 | neurologic: 0.015); OMIM:603233 (syndromic: 0.007 | growth: 0.043 | skeletal: 0.018); OMIM:612462 (syndromic: 0.079 | growth: 0.293 | skeletal: 0.047 | neurologic: 0.085); OMIM:612463 (syndromic: 0.059 | growth: 0.293 | skeletal: 0.045 | neurologic: 0.043),hm (false); ht (true),0.5,4145,0.6771488469601677,"9606.ENSP00000384092:356, 9606.ENSP00000360541:288, 9606.ENSP00000356319:292, 9606.ENSP00000362680:700, 9606.ENSP00000369647:499, 9606.ENSP00000269305:301, 9606.ENSP00000265748:292, 9606.ENSP00000218516:299, 9606.ENSP00000339191:165, 9606.ENSP00000417132:292, 9606.ENSP00000078429:661",0.5,174.67700000000002,109.573,800.618813886838,cur_188
GON7,20356,3,1.6216343161772309,0.007687,0.91222,0.1475,0.30545,Galloway-Mowat syndrome 9[OMIM:619603]-Autosomal recessive inheritance,NULL,NULL,P:2; LP:0; VUS:1,OMIM:619603 (glomerulopathy: 0.259 | cyst_cilio: 0.134 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:619603 (neonatal_or_pediatric: 0.665),OMIM:619603 (syndromic: 0.059 | skeletal: 0.055 | neurologic: 0.117),hm (NA); ht (NA),0.5,3156,0.5849056603773585,"9606.ENSP00000206542:998, 9606.ENSP00000361186:998, 9606.ENSP00000281043:161, 9606.ENSP00000349923:999",0,22.2563,12.8869,NULL,cur_189
GPC3,4451,4,3.1933445252271753,NULL,NULL,NULL,NULL,"Wilms tumor, somatic[OMIM:194070]-NA | Simpson-Golabi-Behmel syndrome, type 1[OMIM:312870]-X-linked recessive inheritance","Definitive, Supportive (Simpson-Golabi-Behmel syndrome[MONDO:0010731]-X-linked) | Definitive, Definitive, Strong (Simpson-Golabi-Behmel syndrome type 1[MONDO:0020602]-X-linked) | Definitive (Simpson-Golabi-Behmel syndrome type 1[MONDO:0020602]-X-linked recessive)",Definitive (Simpson-Golabi-Behmel syndrome[MONDO:0010731]-XL),P:34; LP:16; VUS:359,OMIM:194070 (cancer: 0.12 | complement: 0.036 | cakut: 0.008 | glomerulopathy: 0.007); OMIM:312870 (cancer: 0.17 | cakut: 0.145 | cyst_cilio: 0.129 | complement: 0.036 | glomerulopathy: 0.009 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),NULL,OMIM:312870 (syndromic: 0.111 | growth: 0.023 | skeletal: 0.118 | neurologic: 0.054),hm (false); ht (true),0.5,4556,0.7127882599580713,"9606.ENSP00000236850:499, 9606.ENSP00000380321:292, 9606.ENSP00000269305:307, 9606.ENSP00000264634:403, 9606.ENSP00000359583:499, 9606.ENSP00000231509:342, 9606.ENSP00000356969:499, 9606.ENSP00000484824:218, 9606.ENSP00000252486:499, 9606.ENSP00000322323:499, 9606.ENSP00000466775:499",1,86.6361,19.1762,1627.75253921265,cur_190
GREB1L,31042,4,2.366718507200249,NULL,NULL,NULL,NULL,"Deafness, autosomal dominant 80[OMIM:619274]-Autosomal dominant inheritance | Renal hypodysplasia/aplasia 3[OMIM:617805]-Autosomal dominant inheritance","Supportive (bilateral renal agenesis[MONDO:0015986]-Autosomal recessive) | Supportive (renal agenesis, unilateral[MONDO:0019636]-Autosomal dominant) | Definitive, Definitive, Moderate, Limited (renal hypodysplasia/aplasia 3[MONDO:0024520]-Autosomal dominant)",NULL,P:29; LP:18; VUS:74,OMIM:617805 (cakut: 0.278 | cancer: 0.15 | cyst_cilio: 0.05 | glomerulopathy: 0.009 | nephrocalcinosis: 0.007),OMIM:617805 (antenatal_or_congenital: 0.821); OMIM:619274 (antenatal_or_congenital: 0.821),NULL,hm (true); ht (true),0,NULL,NULL,NULL,0.5,0.615024,0.04636780000000001,134.182045201667,cur_191
GREM1,2001,2,1.611650122094572,NULL,NULL,NULL,NULL,NULL,"Definitive, Supportive (hereditary mixed polyposis syndrome[MONDO:0011023]-Autosomal dominant)",Definitive (hereditary mixed polyposis syndrome[MONDO:0011023]-AD),P:0; LP:0; VUS:102,NULL,NULL,NULL,hm (true); ht (false),0,NULL,NULL,NULL,0,0.509415,0.0493644,0.449611952383712,cur_192
GRHPR,4570,5,3.803978842847603,0,0.71895,1.064,0.7388,"Hyperoxaluria, primary, type II[OMIM:260000]-Autosomal recessive inheritance","Definitive, Definitive, Strong, Supportive (primary hyperoxaluria type 2[MONDO:0009824]-Autosomal recessive)",NULL,P:49; LP:55; VUS:72,OMIM:260000 (nephrocalcinosis: 0.333 | tubulopathy: 0.294 | complement: 0.214 | glomerulopathy: 0.144 | cyst_cilio: 0.081 | cakut: 0.065 | cancer: 0.03),NULL,NULL,hm (true); ht (false),0,495,0.12368972746331237,"9606.ENSP00000452762:238, 9606.ENSP00000346173:257",0.5,32.3636,39.4659,33.3715341030261,cur_193
GRIP1,18708,4,3.1867227735069226,NULL,NULL,NULL,NULL,Fraser syndrome 3[OMIM:617667]-Autosomal recessive inheritance,"Supportive (Fraser syndrome[MONDO:0009046]-Autosomal recessive) | Strong (Fraser syndrome 1[MONDO:0054737]-Autosomal recessive) | Definitive, Strong (Fraser syndrome 3[MONDO:0054739]-Autosomal recessive)",Definitive (Fraser syndrome 3[MONDO:0054739]-AR),P:4; LP:3; VUS:140,OMIM:617667 (cakut: 0.028 | cyst_cilio: 0.008),OMIM:617667 (antenatal_or_congenital: 0.03),OMIM:617667 (syndromic: 0.014 | skeletal: 0.03 | neurologic: 0.006),hm (true); ht (false),0.5,3830,0.6561844863731656,"9606.ENSP00000231509:723, 9606.ENSP00000262613:319, 9606.ENSP00000370719:384, 9606.ENSP00000287820:457, 9606.ENSP00000368727:323, 9606.ENSP00000228606:292, 9606.ENSP00000412940:332, 9606.ENSP00000280481:416, 9606.ENSP00000468002:292, 9606.ENSP00000262367:292",0.5,0.960733,1.09578,238.346448109442,cur_194
GSN,4620,5,3.0316703764163577,NULL,NULL,NULL,NULL,"Amyloidosis, Finnish type[OMIM:105120]-Autosomal dominant inheritance","Strong, Moderate, Supportive (Finnish type amyloidosis[MONDO:0007097]-Autosomal dominant) | Definitive (Finnish type amyloidosis[MONDO:0007097]-Autosomal recessive)",NULL,P:4; LP:3; VUS:266,OMIM:105120 (glomerulopathy: 0.191 | nephrocalcinosis: 0.111 | complement: 0.107 | tubulopathy: 0.105 | cyst_cilio: 0.068 | cancer: 0.05 | cakut: 0.048),OMIM:105120 (adult: 0.218),OMIM:105120 (syndromic: 0.002 | neurologic: 0.004),hm (true); ht (false),0.5,6292,0.7945492662473794,"9606.ENSP00000365891:610, 9606.ENSP00000216181:570, 9606.ENSP00000252486:400, 9606.ENSP00000452762:366, 9606.ENSP00000265748:292, 9606.ENSP00000237014:364, 9606.ENSP00000252699:292, 9606.ENSP00000269305:307, 9606.ENSP00000346839:661, 9606.ENSP00000377789:161, 9606.ENSP00000236850:224, 9606.ENSP00000364649:207, 9606.ENSP00000314299:222, 9606.ENSP00000362680:729, 9606.ENSP00000356319:292, 9606.ENSP00000358866:595",0.5,143.93,87.2242,63.2496426895169,cur_195
HAAO,4796,3,1.5695005782401632,0,0.7408,1.0808,-0.17737,"Vertebral, cardiac, renal, and limb defects syndrome 1[OMIM:617660]-Autosomal recessive inheritance","Supportive (congenital vertebral-cardiac-renal anomalies syndrome[MONDO:0020831]-Autosomal recessive) | Definitive, Strong, Limited (vertebral, cardiac, renal, and limb defects syndrome 1[MONDO:0060554]-Autosomal recessive)","Definitive (vertebral, cardiac, renal, and limb defects syndrome 1[MONDO:0060554]-AR)",P:4; LP:4; VUS:15,OMIM:617660 (cakut: 0.153 | cancer: 0.05 | cyst_cilio: 0.045 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:617660 (antenatal_or_congenital: 0.821),OMIM:617660 (syndromic: 0.073 | growth: 0.25 | skeletal: 0.05 | neurologic: 0.121),hm (true); ht (false),0,NULL,NULL,NULL,0.5,12.8094,24.802,28.3727085149316,cur_196
HNF1B,11630,5,4.85839909204867,NULL,NULL,NULL,NULL,Type 2 diabetes mellitus[OMIM:125853]-Autosomal dominant inheritance | Renal cysts and diabetes syndrome[OMIM:137920]-Autosomal dominant inheritance | {Renal cell carcinoma}[OMIM:144700]-NA,"Strong (diabetes mellitus, noninsulin-dependent[MONDO:0007455]-Autosomal dominant) | Definitive, Definitive, Strong, Strong, Supportive (renal cysts and diabetes syndrome[MONDO:0007669]-Autosomal dominant) | Supportive (renal hypomagnesemia 2[MONDO:0007937]-Autosomal dominant) | Supportive (medullary sponge kidney[MONDO:0015268]-Autosomal dominant) | Supportive (renal dysplasia, unilateral[MONDO:0019644]-Autosomal dominant) | Supportive (renal dysplasia, bilateral[MONDO:0019645]-Autosomal dominant) | Supportive (unilateral multicystic dysplastic kidney[MONDO:0019981]-Autosomal dominant) | Strong (transient neonatal diabetes mellitus[MONDO:0020525]-Autosomal dominant) | Strong (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal dominant)",Definitive (renal cysts and diabetes syndrome[MONDO:0007669]-AD),P:155; LP:82; VUS:126,OMIM:137920 (cyst_cilio: 0.289 | cakut: 0.27 | tubulopathy: 0.196 | glomerulopathy: 0.153 | nephrocalcinosis: 0.146 | cancer: 0.06 | complement: 0.036); OMIM:144700 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:125853 (adult: 0.108),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:137920 (syndromic: 0.005 | growth: 0.043 | skeletal: 0.001 | neurologic: 0.004),hm (false); ht (false),0.5,2619,0.5094339622641509,"9606.ENSP00000262367:581, 9606.ENSP00000359319:292, 9606.ENSP00000299299:670, 9606.ENSP00000269305:327, 9606.ENSP00000297316:292, 9606.ENSP00000245479:292, 9606.ENSP00000484803:165",0.5,90.4202,53.4655,63.0756218722886,cur_197
HNF4A,5024,5,3.658130469336187,NULL,NULL,NULL,NULL,"Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young[OMIM:616026]-Autosomal dominant inheritance | {Diabetes mellitus, noninsulin-dependent}[OMIM:125853]-Autosomal dominant inheritance | MODY, type I[OMIM:125850]-Autosomal dominant inheritance","Definitive, Definitive, Strong (maturity-onset diabetes of the young type 1[MONDO:0007452]-Autosomal dominant) | Strong (diabetes mellitus, noninsulin-dependent[MONDO:0007455]-Autosomal dominant) | Definitive, Strong (Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young[MONDO:0014458]-Autosomal dominant) | Definitive (monogenic diabetes[MONDO:0015967]-Autosomal dominant) | Supportive (hyperinsulinism due to HNF4A deficiency[MONDO:0016988]-Autosomal dominant) | Supportive (maturity-onset diabetes of the young[MONDO:0018911]-Autosomal dominant)",Definitive (monogenic diabetes[MONDO:0015967]-AD),P:41; LP:39; VUS:145,OMIM:616026 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),OMIM:125853 (adult: 0.108); OMIM:616026 (neonatal_or_pediatric: 0.134),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:616026 (syndromic: 0.014 | growth: 0.258 | skeletal: 0.002),hm (false); ht (false),0.5,6216,0.7924528301886793,"9606.ENSP00000228606:292, 9606.ENSP00000397908:667, 9606.ENSP00000360541:384, 9606.ENSP00000287820:339, 9606.ENSP00000297316:538, 9606.ENSP00000236850:413, 9606.ENSP00000322568:313, 9606.ENSP00000484803:165, 9606.ENSP00000294008:165, 9606.ENSP00000245907:292, 9606.ENSP00000362680:497, 9606.ENSP00000262367:823, 9606.ENSP00000231509:579, 9606.ENSP00000269305:457, 9606.ENSP00000215832:292",0.5,2.29446,11.3798,12.3147122930974,cur_198
HOGA1,25155,5,3.686408201780401,0,1.2412,-0.87444,-0.2785,"Hyperoxaluria, primary, type III[OMIM:613616]-Autosomal recessive inheritance","Definitive, Strong, Supportive (primary hyperoxaluria type 3[MONDO:0013327]-Autosomal recessive)",NULL,P:45; LP:34; VUS:113,OMIM:613616 (tubulopathy: 0.028 | nephrocalcinosis: 0.021),NULL,NULL,hm (true); ht (false),0,330,0.08385744234800839,9606.ENSP00000310873:330,0.5,31.5262,28.9048,18.5219828420892,cur_199
HOXA13,5102,4,2.3358594940778508,NULL,NULL,NULL,NULL,Hand-foot-genital syndrome[OMIM:140000]-Autosomal dominant inheritance | ?Guttmacher syndrome[OMIM:176305]-Autosomal dominant inheritance,"Definitive, Strong, Moderate, Supportive (hand-foot-genital syndrome[MONDO:0007698]-Autosomal dominant) | Supportive (Guttmacher syndrome[MONDO:0008301]-Autosomal dominant)",NULL,P:7; LP:3; VUS:61,OMIM:140000 (cakut: 0.137 | tubulopathy: 0.119 | nephrocalcinosis: 0.118 | complement: 0.107 | glomerulopathy: 0.084 | cyst_cilio: 0.079 | cancer: 0.02),NULL,OMIM:140000 (syndromic: 0.009 | skeletal: 0.032); OMIM:176305 (syndromic: 0.003 | skeletal: 0.009),hm (true); ht (false),0,NULL,NULL,NULL,0,0.0226669,0.0518182,0.0933018190111728,cur_200
HPRT1,5157,5,3.818079033281405,0.93728,0,2.7477,2.3178,"Hyperuricemia, HRPT-related[OMIM:300323]-X-linked recessive inheritance | Lesch-Nyhan syndrome[OMIM:300322]-X-linked recessive inheritance","Definitive, Definitive, Definitive, Strong, Supportive (Lesch-Nyhan syndrome[MONDO:0010298]-X-linked) | Definitive (Lesch-Nyhan syndrome[MONDO:0010298]-X-linked recessive) | Supportive (hypoxanthine guanine phosphoribosyltransferase partial deficiency[MONDO:0010299]-X-linked) | Definitive (hypoxanthine guanine phosphoribosyltransferase partial deficiency[MONDO:0010299]-X-linked recessive)",Definitive (Lesch-Nyhan syndrome[MONDO:0010298]-XL),P:56; LP:16; VUS:28,OMIM:300322 (nephrocalcinosis: 0.299 | tubulopathy: 0.259 | glomerulopathy: 0.029 | cakut: 0.02 | cancer: 0.01 | cyst_cilio: 0.008); OMIM:300323 (tubulopathy: 0.238 | nephrocalcinosis: 0.236 | glomerulopathy: 0.093 | cyst_cilio: 0.073 | complement: 0.071 | cakut: 0.052 | cancer: 0.03),OMIM:300322 (neonatal_or_pediatric: 0.865 | adult: 0.372),OMIM:300322 (syndromic: 0.119 | growth: 0.25 | skeletal: 0.005 | neurologic: 0.218); OMIM:300323 (syndromic: 0 | skeletal: 0),hm (false); ht (true),0.5,1080,0.24947589098532494,"9606.ENSP00000367615:919, 9606.ENSP00000281043:161",0.5,42.8852,24.5402,36.9523409320556,cur_201
HPSE2,18374,5,3.897779803423332,1.51e-4,0.41463,2.7939,0.2454,Urofacial syndrome 1[OMIM:236730]-Autosomal recessive inheritance,"Strong, Supportive (Ochoa syndrome[MONDO:0000463]-Autosomal recessive) | Definitive, Moderate (urofacial syndrome type 1[MONDO:0009368]-Autosomal recessive)",NULL,P:11; LP:4; VUS:44,OMIM:236730 (cakut: 0.097 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,OMIM:236730 (syndromic: 0.001),hm (true); ht (false),0.5,823,0.19916142557651992,"9606.ENSP00000437256:163, 9606.ENSP00000303511:161, 9606.ENSP00000377836:499",0.5,2.47759,0.170355,26.8382401206293,cur_202
HS2ST1,5193,2,1.1305255295663523,0.54475,0.20337,3.2739,1.5136,Neurofacioskeletal syndrome with or without renal agenesis[OMIM:619194]-Autosomal recessive inheritance,NULL,NULL,P:5; LP:0; VUS:13,OMIM:619194 (cakut: 0.089 | cancer: 0.02 | tubulopathy: 0.007 | cyst_cilio: 0.005),OMIM:619194 (antenatal_or_congenital: 0.821),OMIM:619194 (syndromic: 0.135 | growth: 0.013 | skeletal: 0.1 | neurologic: 0.153),hm (true); ht (false),0,NULL,NULL,NULL,0.5,5.52055,4.106,209.931647432492,cur_203
HSD11B2,5209,4,3.036932161010394,0.11777,0.31689,1.9477,1.0211,Apparent mineralocorticoid excess[OMIM:218030]-Autosomal recessive inheritance,"Strong, Supportive (apparent mineralocorticoid excess[MONDO:0009025]-Autosomal recessive)",NULL,P:11; LP:5; VUS:37,NULL,OMIM:218030 (neonatal_or_pediatric: 0.262),OMIM:218030 (syndromic: 0.03 | growth: 0.558),hm (true); ht (false),0,NULL,NULL,NULL,0.5,0.30849299999999996,0.370654,18.1055216782367,cur_204
HSD3B2,5218,3,1.2879252660116278,NULL,NULL,NULL,NULL,"Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency[OMIM:201810]-Autosomal recessive inheritance","Strong, Supportive (congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency[MONDO:0008727]-Autosomal recessive)",NULL,P:37; LP:16; VUS:43,NULL,OMIM:201810 (antenatal_or_congenital: 0.821),NULL,hm (NA); ht (NA),0.5,2202,0.4381551362683438,"9606.ENSP00000348849:345, 9606.ENSP00000481646:254, 9606.ENSP00000359345:343, 9606.ENSP00000414321:343, 9606.ENSP00000463784:238, 9606.ENSP00000470972:335, 9606.ENSP00000261167:165, 9606.ENSP00000437256:179",0,0.598693,0.538094,0.202793869041638,cur_205
HSPA9,5244,2,1.0162933198285249,0.96852,0.16143,4.7375,1.0372,"Even-plus syndrome[OMIM:616854]-Autosomal recessive inheritance | Anemia, sideroblastic, 4[OMIM:182170]-Autosomal dominant inheritance","Strong (autosomal dominant sideroblastic anemia[MONDO:0008422]-Autosomal dominant) | Moderate (autosomal dominant sideroblastic anemia[MONDO:0008422]-Autosomal recessive) | Strong, Limited, Supportive (even-plus syndrome[MONDO:0014801]-Autosomal recessive) | Supportive (autosomal recessive sideroblastic anemia[MONDO:0016828]-Autosomal recessive)",NULL,P:6; LP:3; VUS:16,OMIM:616854 (cakut: 0.153 | cancer: 0.05 | cyst_cilio: 0.045 | glomerulopathy: 0.007 | tubulopathy: 0.007),NULL,OMIM:616854 (syndromic: 0.057 | growth: 0.017 | skeletal: 0.026 | neurologic: 0.058),hm (false); ht (false),1,10143,0.9035639412997903,"9606.ENSP00000281043:161, 9606.ENSP00000364649:570, 9606.ENSP00000333946:195, 9606.ENSP00000349658:196, 9606.ENSP00000315118:227, 9606.ENSP00000310873:562, 9606.ENSP00000437256:292, 9606.ENSP00000414398:152, 9606.ENSP00000356405:292, 9606.ENSP00000346173:165, 9606.ENSP00000246957:428, 9606.ENSP00000371398:288, 9606.ENSP00000417132:457, 9606.ENSP00000216911:163, 9606.ENSP00000298552:345, 9606.ENSP00000363435:986, 9606.ENSP00000231509:292, 9606.ENSP00000358033:327, 9606.ENSP00000445175:189, 9606.ENSP00000311505:292, 9606.ENSP00000322316:226, 9606.ENSP00000246062:161, 9606.ENSP00000362424:292, 9606.ENSP00000357998:153, 9606.ENSP00000249442:720, 9606.ENSP00000227507:163, 9606.ENSP00000278935:165, 9606.ENSP00000452762:165, 9606.ENSP00000256078:171, 9606.ENSP00000451828:359, 9606.ENSP00000269305:989",0.5,121.87299999999999,92.4115,131.778871335407,cur_206
HYLS1,26558,3,2.1131550292047696,0,0.91765,0.29808,0.17686,Hydrolethalus syndrome[OMIM:236680]-Autosomal recessive inheritance,"Supportive (hydrolethalus syndrome[MONDO:0006037]-Autosomal recessive) | Definitive, Strong (hydrolethalus syndrome 1[MONDO:0009365]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive)",NULL,P:6; LP:10; VUS:104,OMIM:236680 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,OMIM:236680 (syndromic: 0.027 | growth: 0.102 | skeletal: 0.037 | neurologic: 0.012),hm (NA); ht (NA),0,224,0.04821802935010482,9606.ENSP00000303058:224,0,2.64708,1.69354,7.4057370217323,cur_207
CILK1,21219,3,1.818849225365014,NULL,NULL,NULL,NULL,"{Epilepsy, juvenile myoclonic, susceptibility to, 10}[OMIM:617924]-Autosomal dominant inheritance | Endocrine-cerebroosteodysplasia[OMIM:612651]-Autosomal recessive inheritance","Supportive (juvenile myoclonic epilepsy[MONDO:0009696]-Autosomal dominant) | Strong, Moderate, Supportive (endocrine-cerebro-osteodysplasia syndrome[MONDO:0012980]-Autosomal recessive)",NULL,P:2; LP:2; VUS:82,OMIM:612651 (cyst_cilio: 0.055 | cancer: 0.03 | cakut: 0.016 | glomerulopathy: 0.007),OMIM:612651 (antenatal_or_congenital: 0.038); OMIM:617924 (neonatal_or_pediatric: 0.597),OMIM:612651 (syndromic: 0.043 | skeletal: 0.072 | neurologic: 0.026); OMIM:617924 (syndromic: 0.007 | neurologic: 0.014),hm (true); ht (false),0.5,1103,0.2578616352201258,"9606.ENSP00000215832:457, 9606.ENSP00000269305:237, 9606.ENSP00000379204:238, 9606.ENSP00000260570:171",0,NULL,NULL,NULL,cur_208
IFT122,13556,4,2.961977639123234,NULL,NULL,NULL,NULL,Cranioectodermal dysplasia 1[OMIM:218330]-Autosomal recessive inheritance,"Supportive (cranioectodermal dysplasia[MONDO:0009032]-Autosomal recessive) | Definitive, Definitive, Strong (cranioectodermal dysplasia 1[MONDO:0021093]-Autosomal recessive)",Definitive (cranioectodermal dysplasia 1[MONDO:0021093]-AR),P:26; LP:15; VUS:274,OMIM:218330 (glomerulopathy: 0.151 | cyst_cilio: 0.142 | nephrocalcinosis: 0.062 | cakut: 0.052 | tubulopathy: 0.042 | complement: 0.036 | cancer: 0.02),OMIM:218330 (antenatal_or_congenital: 0.821),OMIM:218330 (syndromic: 0.083 | growth: 0.017 | skeletal: 0.101 | neurologic: 0.04),hm (false); ht (false),1,11479,0.9433962264150944,"9606.ENSP00000362121:599, 9606.ENSP00000396320:183, 9606.ENSP00000314444:999, 9606.ENSP00000380321:892, 9606.ENSP00000312778:540, 9606.ENSP00000243344:999, 9606.ENSP00000242591:581, 9606.ENSP00000231749:183, 9606.ENSP00000406012:999, 9606.ENSP00000260570:679, 9606.ENSP00000404122:540, 9606.ENSP00000393541:901, 9606.ENSP00000382717:999, 9606.ENSP00000311505:620, 9606.ENSP00000288139:183, 9606.ENSP00000238628:999, 9606.ENSP00000362424:583",0.5,NULL,NULL,50.4598218589126,cur_209
IFT140,29077,5,4.039434397878219,0,0.64444,2.873,-0.81057,Short-rib thoracic dysplasia 9 with or without polydactyly[OMIM:266920]-Autosomal recessive inheritance | Retinitis pigmentosa 80[OMIM:617781]-Autosomal recessive inheritance,"Strong (autosomal dominant polycystic kidney disease[MONDO:0004691]-Autosomal dominant) | Definitive, Supportive (short-rib thoracic dysplasia 9 with or without polydactyly[MONDO:0009964]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive) | Supportive (Leber congenital amaurosis[MONDO:0018998]-Autosomal dominant) | Supportive (retinitis pigmentosa[MONDO:0019200]-Autosomal dominant) | Definitive, Definitive (IFT140-related recessive ciliopathy[MONDO:0100509]-Autosomal recessive)",Strong (autosomal dominant polycystic kidney disease[MONDO:0004691]-AD) | Definitive (IFT140-related recessive ciliopathy[MONDO:0100509]-AR),P:83; LP:51; VUS:747,OMIM:266920 (cyst_cilio: 0.344 | complement: 0.179 | glomerulopathy: 0.151 | cakut: 0.137 | cancer: 0.05 | tubulopathy: 0.049 | nephrocalcinosis: 0.042),OMIM:266920 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.665); OMIM:617781 (neonatal_or_pediatric: 0.463 | adult: 0.372),OMIM:266920 (syndromic: 0.191 | growth: 0.438 | skeletal: 0.172 | neurologic: 0.177); OMIM:617781 (syndromic: 0.025 | skeletal: 0.001 | neurologic: 0.051),hm (false); ht (false),1,11592,0.9475890985324947,"9606.ENSP00000260570:540, 9606.ENSP00000396320:239, 9606.ENSP00000362121:682, 9606.ENSP00000334003:268, 9606.ENSP00000404122:540, 9606.ENSP00000231749:239, 9606.ENSP00000242591:771, 9606.ENSP00000362424:540, 9606.ENSP00000238628:999, 9606.ENSP00000288139:239, 9606.ENSP00000243344:999, 9606.ENSP00000382717:999, 9606.ENSP00000296266:999, 9606.ENSP00000393541:936, 9606.ENSP00000380321:799, 9606.ENSP00000314444:999, 9606.ENSP00000312778:804",0.5,10.7007,9.25022,57.4156518035678,cur_210
IFT172,30391,4,2.847071356727168,0,0.61948,3.7749,1.1855,Retinitis pigmentosa 71[OMIM:616394]-Autosomal recessive inheritance | Bardet-Biedl syndrome 20[OMIM:619471]-Autosomal recessive inheritance | Short-rib thoracic dysplasia 10 with or without polydactyly[OMIM:615630]-Autosomal recessive inheritance,"Definitive, Supportive (short-rib thoracic dysplasia 9 with or without polydactyly[MONDO:0009964]-Autosomal recessive) | Definitive, Moderate (short-rib thoracic dysplasia 10 with or without polydactyly[MONDO:0014284]-Autosomal recessive) | Moderate (retinitis pigmentosa 71[MONDO:0014618]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive) | Supportive (retinitis pigmentosa[MONDO:0019200]-Autosomal dominant)",NULL,P:68; LP:33; VUS:643,OMIM:615630 (cyst_cilio: 0.11 | nephrocalcinosis: 0.042 | tubulopathy: 0.042 | complement: 0.036 | glomerulopathy: 0.027 | cakut: 0.02),OMIM:619471 (antenatal_or_congenital: 0.821),OMIM:615630 (syndromic: 0.057 | growth: 0.293 | skeletal: 0.036 | neurologic: 0.065); OMIM:616394 (syndromic: 0.01 | skeletal: 0.036); OMIM:619471 (syndromic: 0.04 | growth: 0.043 | skeletal: 0.013 | neurologic: 0.072),hm (true); ht (false),1,10364,0.9161425576519916,"9606.ENSP00000269305:163, 9606.ENSP00000349458:171, 9606.ENSP00000334003:272, 9606.ENSP00000404122:973, 9606.ENSP00000242591:986, 9606.ENSP00000243344:540, 9606.ENSP00000296266:679, 9606.ENSP00000314444:540, 9606.ENSP00000312778:998, 9606.ENSP00000362121:982, 9606.ENSP00000362424:994, 9606.ENSP00000238628:540, 9606.ENSP00000262613:233, 9606.ENSP00000382717:540, 9606.ENSP00000393541:980, 9606.ENSP00000304941:233, 9606.ENSP00000406012:540",0.5,11.5689,8.72705,56.1938788010261,cur_211
IFT27,18626,4,2.6651953323351862,6e-6,0.81128,0.58248,0.21643,Bardet-Biedl syndrome 19[OMIM:615996]-Autosomal recessive inheritance,"Limited, Limited (Bardet-Biedl syndrome 19[MONDO:0014447]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:8; LP:2; VUS:62,OMIM:615996 (cakut: 0.202 | cyst_cilio: 0.118 | nephrocalcinosis: 0.118 | tubulopathy: 0.112 | glomerulopathy: 0.089 | complement: 0.071 | cancer: 0.05),OMIM:615996 (antenatal_or_congenital: 0.821),OMIM:615996 (syndromic: 0.068 | growth: 0.043 | skeletal: 0.007 | neurologic: 0.132),hm (false); ht (false),1,12089,0.9622641509433962,"9606.ENSP00000242591:998, 9606.ENSP00000260570:980, 9606.ENSP00000404122:998, 9606.ENSP00000317469:230, 9606.ENSP00000406012:936, 9606.ENSP00000377769:472, 9606.ENSP00000382717:900, 9606.ENSP00000362424:995, 9606.ENSP00000238628:900, 9606.ENSP00000362121:998, 9606.ENSP00000296266:901, 9606.ENSP00000314444:900, 9606.ENSP00000312778:981, 9606.ENSP00000243344:900",0.5,14.4428,9.40509,17.3714395210091,cur_212
IFT43,29669,5,4.253220998051782,NULL,NULL,NULL,NULL,?Cranioectodermal dysplasia 3[OMIM:614099]-Autosomal recessive inheritance | ?Retinitis pigmentosa 81[OMIM:617871]-Autosomal recessive inheritance | Short-rib thoracic dysplasia 18 with polydactyly[OMIM:617866]-Autosomal recessive inheritance,Supportive (cranioectodermal dysplasia[MONDO:0009032]-Autosomal recessive) | Definitive (cranioectodermal dysplasia 3[MONDO:0013573]-Autosomal recessive),NULL,P:11; LP:7; VUS:86,OMIM:614099 (cyst_cilio: 0.223 | glomerulopathy: 0.135 | tubulopathy: 0.042 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02); OMIM:617866 (cyst_cilio: 0.094 | cakut: 0.028 | cancer: 0.01 | glomerulopathy: 0.007),OMIM:617871 (neonatal_or_pediatric: 0.262),OMIM:614099 (syndromic: 0.049 | growth: 0.267 | skeletal: 0.109); OMIM:617866 (syndromic: 0.04 | skeletal: 0.075 | neurologic: 0.018),hm (NA); ht (NA),1,10360,0.9140461215932913,"9606.ENSP00000362424:540, 9606.ENSP00000260570:540, 9606.ENSP00000362121:540, 9606.ENSP00000404122:540, 9606.ENSP00000243344:999, 9606.ENSP00000382717:999, 9606.ENSP00000231749:437, 9606.ENSP00000296266:999, 9606.ENSP00000393541:900, 9606.ENSP00000242591:540, 9606.ENSP00000380321:571, 9606.ENSP00000314444:999, 9606.ENSP00000317469:215, 9606.ENSP00000406012:999, 9606.ENSP00000312778:542",0.5,23.6643,15.7897,75.8930699693245,cur_213
IFT74,21424,3,1.6159520787300394,NULL,NULL,NULL,NULL,Bardet-Biedl syndrome 22[OMIM:617119]-Autosomal recessive inheritance | Spermatogenic failure 58[OMIM:619585]-Autosomal recessive inheritance | Joubert syndrome 40[OMIM:619582]-Autosomal recessive inheritance,Definitive (Bardet-Biedl syndrome 22[MONDO:0014926]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive),NULL,P:26; LP:13; VUS:207,NULL,OMIM:619582 (antenatal_or_congenital: 0.821); OMIM:619585 (adult: 0.372),OMIM:617119 (syndromic: 0.052 | growth: 0.05 | skeletal: 0.07 | neurologic: 0.09); OMIM:619582 (syndromic: 0.062 | skeletal: 0.004 | neurologic: 0.114),hm (false); ht (false),1,10437,0.9182389937106918,"9606.ENSP00000362121:998, 9606.ENSP00000296266:540, 9606.ENSP00000380321:292, 9606.ENSP00000314444:540, 9606.ENSP00000312778:984, 9606.ENSP00000243344:742, 9606.ENSP00000242591:999, 9606.ENSP00000406012:540, 9606.ENSP00000377769:594, 9606.ENSP00000260570:973, 9606.ENSP00000413017:173, 9606.ENSP00000393541:998, 9606.ENSP00000382717:540, 9606.ENSP00000362424:984, 9606.ENSP00000238628:540",0.5,13.7948,7.9939100000000005,97.1087684621006,cur_214
IFT81,14313,2,1.3275625656214252,0,0.5705,2.6347,0.82819,Short-rib thoracic dysplasia 19 with or without polydactyly[OMIM:617895]-Autosomal recessive inheritance,Limited (ciliopathy[MONDO:0005308]-Autosomal recessive),NULL,P:21; LP:9; VUS:201,NULL,NULL,OMIM:617895 (syndromic: 0.032 | skeletal: 0.05),hm (false); ht (false),1,11704,0.9517819706498952,"9606.ENSP00000404122:999, 9606.ENSP00000262457:230, 9606.ENSP00000260570:986, 9606.ENSP00000297837:150, 9606.ENSP00000367203:202, 9606.ENSP00000362121:997, 9606.ENSP00000243344:562, 9606.ENSP00000268057:303, 9606.ENSP00000312778:990, 9606.ENSP00000296266:581, 9606.ENSP00000380321:292, 9606.ENSP00000314444:540, 9606.ENSP00000482306:153, 9606.ENSP00000406012:771, 9606.ENSP00000338766:153, 9606.ENSP00000377769:590, 9606.ENSP00000459943:150, 9606.ENSP00000362424:977, 9606.ENSP00000238628:540, 9606.ENSP00000382717:540, 9606.ENSP00000393541:998",0.5,7.0322,4.6923900000000005,88.1418468873335,cur_215
INF2,23791,5,4.62555396531914,0.97346,0.18091,5.6431,2.3077,"Glomerulosclerosis, focal segmental, 5[OMIM:613237]-NA | Charcot-Marie-Tooth disease, dominant intermediate E[OMIM:614455]-Autosomal dominant inheritance","Definitive, Supportive (Charcot-Marie-Tooth disease dominant intermediate E[MONDO:0013758]-Autosomal dominant) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",Definitive (Charcot-Marie-Tooth disease dominant intermediate E[MONDO:0013758]-AD),P:26; LP:28; VUS:489,OMIM:613237 (glomerulopathy: 0.253 | cyst_cilio: 0.134 | tubulopathy: 0.077 | cancer: 0.05 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028); OMIM:614455 (glomerulopathy: 0.224 | cyst_cilio: 0.134 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:613237 (adult: 0.218); OMIM:614455 (adult: 0.372 | neonatal_or_pediatric: 0.2),OMIM:614455 (syndromic: 0.014 | skeletal: 0.003 | neurologic: 0.027),hm (false); ht (false),0.5,2669,0.5136268343815513,"9606.ENSP00000264896:163, 9606.ENSP00000356319:292, 9606.ENSP00000358866:201, 9606.ENSP00000368190:153, 9606.ENSP00000377789:163, 9606.ENSP00000265748:506, 9606.ENSP00000288235:364, 9606.ENSP00000252699:336, 9606.ENSP00000379616:161, 9606.ENSP00000216181:330",0.5,19.9995,24.636999999999997,28.7634115179193,cur_216
INPP5E,21474,5,3.799492211731466,0.003105,0.37385,2.684,0.50742,"Joubert syndrome 1[OMIM:213300]-Autosomal recessive inheritance | Mental retardation, truncal obesity, retinal dystrophy, and micropenis[OMIM:610156]-Autosomal recessive inheritance","Definitive, Definitive, Strong (Joubert syndrome 1[MONDO:0008944]-Autosomal recessive) | Supportive (COACH syndrome 1[MONDO:0008996]-Autosomal recessive) | Definitive, Moderate, Moderate, Moderate, Supportive (MORM syndrome[MONDO:0012423]-Autosomal recessive) | Supportive (Joubert syndrome with ocular defect[MONDO:0016364]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive)",Definitive (Joubert syndrome 1[MONDO:0008944]-AR) | Moderate (MORM syndrome[MONDO:0012423]-AR),P:35; LP:30; VUS:322,OMIM:213300 (cyst_cilio: 0.1 | cancer: 0.05 | cakut: 0.044 | glomerulopathy: 0.027 | nephrocalcinosis: 0.014 | tubulopathy: 0.007),OMIM:610156 (neonatal_or_pediatric: 0.402),OMIM:213300 (syndromic: 0.12 | skeletal: 0.084 | neurologic: 0.192); OMIM:610156 (syndromic: 0.018 | growth: 0.009 | neurologic: 0.036),hm (true); ht (false),0.5,3307,0.6016771488469602,"9606.ENSP00000377769:900, 9606.ENSP00000360154:900, 9606.ENSP00000438273:313, 9606.ENSP00000264499:239, 9606.ENSP00000287600:955",0,9.45481,7.53735,8.31318866798327,cur_217
INVS,17870,5,4.350589381282346,0,0.69322,2.0199,1.069,"Nephronophthisis 2, infantile[OMIM:602088]-Autosomal recessive inheritance","Definitive, Strong, Supportive (nephronophthisis 2[MONDO:0011190]-Autosomal recessive) | Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive) | Strong (nephronophthisis[MONDO:0019005]-Autosomal recessive)",Definitive (nephronophthisis 2[MONDO:0011190]-AR),P:42; LP:17; VUS:376,OMIM:602088 (cyst_cilio: 0.291 | glomerulopathy: 0.137 | cakut: 0.065 | cancer: 0.05 | tubulopathy: 0.042 | complement: 0.036 | nephrocalcinosis: 0.021),NULL,NULL,hm (true); ht (false),0.5,5127,0.7547169811320755,"9606.ENSP00000243578:292, 9606.ENSP00000216911:157, 9606.ENSP00000268766:787, 9606.ENSP00000451828:410, 9606.ENSP00000367398:663, 9606.ENSP00000338766:673, 9606.ENSP00000242591:230, 9606.ENSP00000297837:790, 9606.ENSP00000367721:295, 9606.ENSP00000313169:538, 9606.ENSP00000278935:292",0.5,3.64675,3.8385199999999995,218.328128495288,cur_218
IQCB1,28949,5,4.158601030298463,0,0.64206,2.0698,0.30911,Senior-Loken syndrome 5[OMIM:609254]-Autosomal recessive inheritance,"Definitive (Leber congenital amaurosis 9[MONDO:0012056]-Autosomal recessive) | Strong, Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive) | Supportive (Leber congenital amaurosis[MONDO:0018998]-Autosomal dominant)",NULL,P:40; LP:11; VUS:211,OMIM:609254 (cyst_cilio: 0.223 | glomerulopathy: 0.135 | tubulopathy: 0.042 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,NULL,hm (NA); ht (NA),1,9281,0.8805031446540881,"9606.ENSP00000355499:381, 9606.ENSP00000362413:292, 9606.ENSP00000386857:153, 9606.ENSP00000317469:292, 9606.ENSP00000367398:239, 9606.ENSP00000245157:292, 9606.ENSP00000362298:292, 9606.ENSP00000252934:662, 9606.ENSP00000408292:457, 9606.ENSP00000242067:292, 9606.ENSP00000482306:292, 9606.ENSP00000268057:292, 9606.ENSP00000296266:620, 9606.ENSP00000310668:156, 9606.ENSP00000445306:292, 9606.ENSP00000386264:293, 9606.ENSP00000258173:248, 9606.ENSP00000297185:292, 9606.ENSP00000313169:324, 9606.ENSP00000216181:293, 9606.ENSP00000264499:292, 9606.ENSP00000433157:191, 9606.ENSP00000338766:502, 9606.ENSP00000295240:292, 9606.ENSP00000355518:292, 9606.ENSP00000358866:292, 9606.ENSP00000448012:966",0.5,18.1057,9.50049,85.096300569392,cur_219
ITGA3,6139,5,3.886691945334238,NULL,NULL,NULL,NULL,"Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome[OMIM:614748]-Autosomal recessive inheritance","Definitive, Strong, Strong, Strong, Strong, Supportive (pidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome[MONDO:0013881]-Autosomal recessive)",NULL,P:5; LP:8; VUS:83,OMIM:614748 (glomerulopathy: 0.31 | nephrocalcinosis: 0.167 | tubulopathy: 0.147 | complement: 0.107 | cyst_cilio: 0.105 | cakut: 0.06 | cancer: 0.05),OMIM:614748 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.537),OMIM:614748 (syndromic: 0.028 | skeletal: 0.054 | neurologic: 0.029),hm (true); ht (false),0,NULL,NULL,NULL,0.5,72.3542,77.734,40.2427222323712,cur_220
ITGA8,6144,5,3.6051084649645464,0,0.49183,3.7385,-0.27171,Renal hypodysplasia/aplasia 1[OMIM:191830]-Autosomal recessive inheritance,"Supportive (bilateral renal agenesis[MONDO:0015986]-Autosomal recessive) | Strong, Strong (renal hypodysplasia/aplasia 1[MONDO:0024519]-Autosomal recessive)",NULL,P:5; LP:4; VUS:98,OMIM:191830 (cakut: 0.069 | cyst_cilio: 0.024 | glomerulopathy: 0.002),OMIM:191830 (antenatal_or_congenital: 0.821),OMIM:191830 (syndromic: 0.003 | skeletal: 0.01),hm (true); ht (true),0.5,3690,0.6415094339622641,"9606.ENSP00000360997:225, 9606.ENSP00000252699:650, 9606.ENSP00000364979:415, 9606.ENSP00000358866:650, 9606.ENSP00000386896:540, 9606.ENSP00000346839:469, 9606.ENSP00000200181:741",0.5,2.70114,2.00754,829.395271723481,cur_221
ITGB4,6158,2,1.9365730391615747,0,0.50549,4.3236,0.37378,"Epidermolysis bullosa, junctional 5B, with pyloric atresia[OMIM:226730]-Autosomal recessive inheritance | Epidermolysis bullosa, junctional 5A, intermediate[OMIM:619816]-Autosomal recessive inheritance","Supportive (aplasia cutis congenita[MONDO:0007145]-Autosomal dominant) | Strong (junctional epidermolysis bullosa, non-Herlitz type[MONDO:0009180]-Autosomal recessive) | Definitive, Strong, Supportive (junctional epidermolysis bullosa with pyloric atresia[MONDO:0009183]-Autosomal recessive) | Supportive (epidermolysis bullosa simplex 5C, with pyloric atresia[MONDO:0012807]-Autosomal recessive) | Supportive (localized junctional epidermolysis bullosa, non-Herlitz type[MONDO:0016673]-Autosomal recessive) | Supportive (generalized junctional epidermolysis bullosa non-Herlitz type[MONDO:0019307]-Autosomal recessive)",NULL,P:40; LP:10; VUS:292,NULL,OMIM:226730 (antenatal_or_congenital: 0.821); OMIM:619816 (antenatal_or_congenital: 0.821),OMIM:226730 (syndromic: 0.003 | skeletal: 0.009); OMIM:619816 (syndromic: 0),hm (true); ht (false),0.5,4395,0.6981132075471698,"9606.ENSP00000358866:855, 9606.ENSP00000386896:999, 9606.ENSP00000252699:650, 9606.ENSP00000367316:741, 9606.ENSP00000252999:499, 9606.ENSP00000339191:651",0,8.80209,5.07907,6.58540529151772,cur_222
ITSN1,6183,3,2.3055731603812792,1,0.14559,8.3002,3.6138,NULL,NULL,NULL,P:3; LP:5; VUS:81,NULL,NULL,NULL,hm (false); ht (false),0.5,3261,0.5932914046121593,"9606.ENSP00000264634:499, 9606.ENSP00000381098:384, 9606.ENSP00000260746:369, 9606.ENSP00000369647:499, 9606.ENSP00000365891:726, 9606.ENSP00000466134:165, 9606.ENSP00000256078:390, 9606.ENSP00000347244:229",0.5,2.91201,2.6330400000000003,237.502940720993,cur_223
ITSN2,6184,4,2.0891916446901657,0,0.37828,5.998,1.1179,NULL,NULL,NULL,P:0; LP:0; VUS:77,NULL,NULL,NULL,hm (true); ht (false),0.5,3024,0.559748427672956,"9606.ENSP00000256078:369, 9606.ENSP00000231509:165, 9606.ENSP00000397908:208, 9606.ENSP00000365891:457, 9606.ENSP00000369647:499, 9606.ENSP00000260746:369, 9606.ENSP00000370719:229, 9606.ENSP00000355627:229, 9606.ENSP00000264634:499",0.5,10.1227,7.775810000000001,107.781575886496,cur_224
JAG1,6188,5,3.5888234701062895,1,0.063704,6.8751,3.2459,"?Deafness, congenital heart defects, and posterior embryotoxon[OMIM:617992]-Autosomal dominant inheritance | Charcot-Marie-Tooth disease, axonal, type 2HH[OMIM:619574]-Autosomal dominant inheritance | Alagille syndrome 1[OMIM:118450]-Autosomal dominant inheritance | Tetralogy of Fallot[OMIM:187500]-Autosomal dominant inheritance","Supportive (tetralogy of fallot[MONDO:0008542]-Autosomal dominant) | Definitive, Definitive, Strong (Alagille syndrome due to a JAG1 point mutation[MONDO:0016862]-Autosomal dominant) | Limited (Charcot-Marie-Tooth disease, axonal, Type 2HH[MONDO:0030458]-Autosomal dominant)",NULL,P:278; LP:58; VUS:489,OMIM:118450 (cakut: 0.266 | glomerulopathy: 0.231 | cyst_cilio: 0.197 | cancer: 0.09 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:118450 (neonatal_or_pediatric: 0.665); OMIM:617992 (antenatal_or_congenital: 0.821); OMIM:619574 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.262),OMIM:118450 (syndromic: 0.051 | growth: 0.171 | skeletal: 0.023 | neurologic: 0.041); OMIM:187500 (syndromic: 0.005 | skeletal: 0.011); OMIM:619574 (syndromic: 0.028 | skeletal: 0.045 | neurologic: 0.032),hm (false); ht (false),0.5,3133,0.5807127882599581,"9606.ENSP00000265171:197, 9606.ENSP00000392028:292, 9606.ENSP00000256646:997, 9606.ENSP00000264731:228, 9606.ENSP00000227507:340, 9606.ENSP00000313875:766, 9606.ENSP00000410294:313",0.5,33.7363,11.7313,101.783478782958,cur_225
KANK1,19309,2,1.6250078210958776,NULL,NULL,NULL,NULL,"Cerebral palsy, spastic quadriplegic, 2[OMIM:612900]-NA","Limited (cerebral palsy, spastic quadriplegic, 2[MONDO:0013033]-Autosomal dominant) | Limited (cerebral palsy, spastic quadriplegic, 2[MONDO:0013033]-Autosomal dominant inheritance with maternal imprinting HP:0012275) | Supportive (spastic quadriplegic cerebral palsy[MONDO:0016215]-Autosomal recessive)",NULL,P:0; LP:1; VUS:337,NULL,OMIM:612900 (antenatal_or_congenital: 0.821),OMIM:612900 (syndromic: 0.032 | neurologic: 0.066),hm (NA); ht (NA),0.5,1120,0.2641509433962264,"9606.ENSP00000451828:292, 9606.ENSP00000377789:303, 9606.ENSP00000468002:250, 9606.ENSP00000360195:275",0.5,10.2288,11.7174,260.613306535952,cur_226
KANK2,29300,4,2.515382598252789,NULL,NULL,NULL,NULL,"Nephrotic syndrome, type 16[OMIM:617783]-Autosomal recessive inheritance | Palmoplantar keratoderma and woolly hair[OMIM:616099]-Autosomal recessive inheritance",Supportive (wooly hair-palmoplantar keratoderma syndrome[MONDO:0014492]-Autosomal recessive),NULL,P:3; LP:0; VUS:118,OMIM:617783 (complement: 0.179 | glomerulopathy: 0.175 | tubulopathy: 0.035 | cancer: 0.03 | nephrocalcinosis: 0.028 | cakut: 0.024 | cyst_cilio: 0.013),OMIM:617783 (neonatal_or_pediatric: 0.262),OMIM:616099 (syndromic: 0.004),hm (NA); ht (NA),0.5,1215,0.2851153039832285,"9606.ENSP00000377789:179, 9606.ENSP00000477725:250, 9606.ENSP00000264499:202, 9606.ENSP00000381098:292, 9606.ENSP00000356319:292",0.5,35.1871,22.7477,91.1594647781838,cur_227
KANK4,27263,2,1.555449696713058,0,0.55105,2.5063,0.20258,NULL,NULL,NULL,P:0; LP:0; VUS:77,NULL,NULL,NULL,hm (NA); ht (NA),0,275,0.05870020964360587,9606.ENSP00000477725:275,0.5,0.219108,0.22110500000000002,64.3981710301709,cur_228
KCNA1,6218,3,1.6512726481492856,0.076028,0.31897,2.2348,3.3255,Episodic ataxia/myokymia syndrome[OMIM:160120]-Autosomal dominant inheritance,"Supportive (episodic kinesigenic dyskinesia 1[MONDO:0007494]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (episodic ataxia type 1[MONDO:0008047]-Autosomal dominant) | Supportive (isolated autosomal dominant hypomagnesemia, Glaudemans type[MONDO:0016048]-Autosomal dominant) | Supportive (developmental and epileptic encephalopathy[MONDO:0100062]-Autosomal dominant)",Definitive (episodic ataxia type 1[MONDO:0008047]-AD),P:20; LP:13; VUS:283,NULL,OMIM:160120 (neonatal_or_pediatric: 0.2),OMIM:160120 (syndromic: 0.023 | neurologic: 0.048),hm (false); ht (false),0.5,1087,0.25366876310272535,"9606.ENSP00000414321:228, 9606.ENSP00000470972:228, 9606.ENSP00000359345:228, 9606.ENSP00000481646:175, 9606.ENSP00000348849:228",0,0.059898400000000004,0.0121765,0.402172449367397,cur_229
KCNJ1,6255,5,3.878684753786085,NULL,NULL,NULL,NULL,"Bartter syndrome, type 2[OMIM:241200]-Autosomal recessive inheritance",Strong (Bartter disease type 2[MONDO:0009424]-Autosomal recessive) | Supportive (antenatal Bartter syndrome[MONDO:0100343]-Autosomal recessive),NULL,P:13; LP:14; VUS:86,OMIM:241200 (nephrocalcinosis: 0.264 | tubulopathy: 0.252 | cyst_cilio: 0.026 | glomerulopathy: 0.022 | cancer: 0.01 | cakut: 0.008),OMIM:241200 (neonatal_or_pediatric: 0.134),OMIM:241200 (syndromic: 0.106 | growth: 0.467 | skeletal: 0.04 | neurologic: 0.134),hm (true); ht (false),0.5,2714,0.5178197064989518,"9606.ENSP00000003084:735, 9606.ENSP00000262613:292, 9606.ENSP00000246914:299, 9606.ENSP00000420194:327, 9606.ENSP00000465295:499, 9606.ENSP00000402152:187, 9606.ENSP00000365256:375",0,91.2442,40.6043,3.56715046610182,cur_230
KCNJ10,6256,4,2.7950440506281096,NULL,NULL,NULL,NULL,"Enlarged vestibular aqueduct, digenic[OMIM:600791]-Autosomal recessive inheritance | SESAME syndrome[OMIM:612780]-Autosomal recessive inheritance","Supportive (Pendred syndrome[MONDO:0010134]-Autosomal recessive) | Definitive, Definitive, Strong, Strong, Strong, Supportive (EAST syndrome[MONDO:0013005]-Autosomal recessive) | Disputed Evidence (enlarged vestibular aqueduct syndrome[MONDO:0023069]-Autosomal dominant)",Definitive (EAST syndrome[MONDO:0013005]-AR) | Disputed (enlarged vestibular aqueduct syndrome[MONDO:0023069]-AD),P:12; LP:10; VUS:207,OMIM:612780 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:600791 (antenatal_or_congenital: 0.821); OMIM:612780 (neonatal_or_pediatric: 0.402),OMIM:612780 (syndromic: 0.102 | growth: 0.25 | neurologic: 0.186),hm (true); ht (false),0,NULL,NULL,NULL,0,0.196765,0.050821899999999996,1.08708289256727,cur_231
KCNJ16,6262,2,1.4033762186637777,NULL,NULL,NULL,NULL,Hypokalemic tubulopathy and deafness[OMIM:619406]-Autosomal recessive inheritance,"Strong (hypokalemic alkalosis, familial, with specific renal tubulopathy[MONDO:0009423]-Autosomal recessive) | Moderate (NA[NA]-Autosomal recessive)","Strong (hypokalemic alkalosis, familial, with specific renal tubulopathy[MONDO:0009423]-AR)",P:6; LP:1; VUS:0,NULL,NULL,OMIM:619406 (syndromic: 0.028 | neurologic: 0.058),hm (false); ht (false),0.5,998,0.23689727463312368,"9606.ENSP00000433295:499, 9606.ENSP00000376432:499",0.5,92.1996,53.4062,26.5041209801489,cur_232
KCNJ5,6266,4,2.80044737253193,3.36e-4,0.60797,1.2327,1.3289,"Long QT syndrome 13[OMIM:613485]-Autosomal dominant inheritance | Hyperaldosteronism, familial, type III[OMIM:613677]-Autosomal dominant inheritance","Disputed Evidence (long QT syndrome[MONDO:0002442]-Autosomal dominant) | Supportive (Andersen-Tawil syndrome[MONDO:0008222]-Autosomal dominant) | Limited (long QT syndrome 13[MONDO:0013279]-Autosomal dominant) | Moderate, Supportive (familial hyperaldosteronism type III[MONDO:0013359]-Autosomal dominant)",Disputed (long QT syndrome[MONDO:0002442]-AD),P:5; LP:3; VUS:213,OMIM:613677 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:613485 (neonatal_or_pediatric: 0.134 | adult: 0.049),OMIM:613677 (syndromic: 0 | neurologic: 0.001),hm (false); ht (false),0,499,0.12578616352201258,9606.ENSP00000465295:499,0,6.2941199999999995,0.529281,0.900042299463358,cur_233
KDM6A,12637,4,2.2526965768678147,NULL,NULL,NULL,NULL,Kabuki syndrome 2[OMIM:300867]-X-linked dominant inheritance,"Definitive, Definitive, Strong, Strong (Kabuki syndrome 2[MONDO:0010465]-X-linked) | Definitive (Kabuki syndrome 2[MONDO:0010465]-X-linked dominant) | Supportive (Kabuki syndrome[MONDO:0016512]-Autosomal dominant)",Definitive (Kabuki syndrome 2[MONDO:0010465]-XL),P:83; LP:43; VUS:260,OMIM:300867 (cancer: 0.07 | cakut: 0.028 | cyst_cilio: 0.01 | glomerulopathy: 0.007),NULL,OMIM:300867 (syndromic: 0.145 | growth: 0.412 | skeletal: 0.107 | neurologic: 0.162),hm (false); ht (false),0.5,4753,0.7253668763102725,"9606.ENSP00000362121:194, 9606.ENSP00000362410:292, 9606.ENSP00000227507:169, 9606.ENSP00000262367:357, 9606.ENSP00000269305:292, 9606.ENSP00000337088:325, 9606.ENSP00000242591:202, 9606.ENSP00000368632:406, 9606.ENSP00000356405:257, 9606.ENSP00000246957:403, 9606.ENSP00000417132:292, 9606.ENSP00000298552:403, 9606.ENSP00000231509:165, 9606.ENSP00000301067:996",0.5,5.19448,3.7651,290.551987510803,cur_234
KIAA0586,19960,5,2.974654487672623,NULL,NULL,NULL,NULL,Short-rib thoracic dysplasia 14 with polydactyly[OMIM:616546]-Autosomal recessive inheritance | Joubert syndrome 23[OMIM:616490]-Autosomal recessive inheritance,"Definitive (Joubert syndrome 17[MONDO:0013824]-Autosomal recessive) | Definitive, Strong (Joubert syndrome 23[MONDO:0014664]-Autosomal recessive) | Strong, Moderate (short-rib thoracic dysplasia 14 with polydactyly[MONDO:0014688]-Autosomal recessive) | Supportive (Joubert syndrome with Jeune asphyxiating thoracic dystrophy[MONDO:0018342]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive)",NULL,P:75; LP:31; VUS:625,OMIM:616546 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:616546 (antenatal_or_congenital: 0.821),OMIM:616490 (syndromic: 0.026 | skeletal: 0.003 | neurologic: 0.052); OMIM:616546 (syndromic: 0.046 | skeletal: 0.033 | neurologic: 0.051),hm (NA); ht (NA),0.5,1017,0.2431865828092243,"9606.ENSP00000355250:165, 9606.ENSP00000448012:292, 9606.ENSP00000303058:560",0.5,2.02127,1.5739100000000001,54.3845178526329,cur_235
KIAA0753,29110,3,1.6864634228016162,0,0.86629,0.91266,0.20661,?Orofaciodigital syndrome XV[OMIM:617127]-Autosomal recessive inheritance | ?Joubert syndrome 38[OMIM:619476]-Autosomal recessive inheritance | Short-rib thoracic dysplasia 21 without polydactyly[OMIM:619479]-Autosomal recessive inheritance,Supportive (orofaciodigital syndrome type 6[MONDO:0010176]-Autosomal recessive) | Strong (orofaciodigital syndrome XV[MONDO:0014932]-Autosomal recessive) | Limited (Jeune syndrome[MONDO:0018770]-Autosomal recessive),NULL,P:17; LP:13; VUS:164,OMIM:617127 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:617127 (antenatal_or_congenital: 0.821); OMIM:619479 (antenatal_or_congenital: 0.077),OMIM:617127 (syndromic: 0.025 | skeletal: 0.009 | neurologic: 0.024); OMIM:619476 (syndromic: 0.058 | growth: 0.25 | skeletal: 0.016 | neurologic: 0.062); OMIM:619479 (syndromic: 0.06 | growth: 0.013 | skeletal: 0.055 | neurologic: 0.052),hm (NA); ht (NA),0.5,1459,0.32914046121593293,"9606.ENSP00000344314:737, 9606.ENSP00000346359:165, 9606.ENSP00000360540:196, 9606.ENSP00000482968:165, 9606.ENSP00000262210:196",0.5,10.9056,5.34565,46.1753732878705,cur_236
KIF14,19181,4,3.04846078672637,4.1e-5,0.30277,5.6312,0.76923,"Microcephaly 20, primary, autosomal recessive[OMIM:617914]-Autosomal recessive inheritance | ?Meckel syndrome 12[OMIM:616258]-Autosomal recessive inheritance","Moderate, Supportive (lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome[MONDO:0014552]-Autosomal recessive) | Definitive, Supportive (autosomal recessive primary microcephaly[MONDO:0016660]-Autosomal recessive)",NULL,P:11; LP:7; VUS:125,OMIM:616258 (cakut: 0.105 | cyst_cilio: 0.045 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004); OMIM:617914 (cakut: 0.117 | cyst_cilio: 0.076 | cancer: 0.03 | glomerulopathy: 0.011 | tubulopathy: 0.007),OMIM:616258 (antenatal_or_congenital: 0.03); OMIM:617914 (neonatal_or_pediatric: 0.397 | antenatal_or_congenital: 0.03),OMIM:616258 (syndromic: 0.049 | growth: 0.102 | skeletal: 0.083 | neurologic: 0.043); OMIM:617914 (syndromic: 0.076 | growth: 0.352 | skeletal: 0.049 | neurologic: 0.118),hm (false); ht (false),1,17592,0.9937106918238994,"9606.ENSP00000360532:292, 9606.ENSP00000452762:292, 9606.ENSP00000265748:292, 9606.ENSP00000392028:292, 9606.ENSP00000261396:292, 9606.ENSP00000362924:292, 9606.ENSP00000288235:292, 9606.ENSP00000292427:292, 9606.ENSP00000482968:292, 9606.ENSP00000348849:292, 9606.ENSP00000360540:338, 9606.ENSP00000264414:292, 9606.ENSP00000377934:540, 9606.ENSP00000252699:292, 9606.ENSP00000379616:292, 9606.ENSP00000323421:292, 9606.ENSP00000349781:292, 9606.ENSP00000355922:362, 9606.ENSP00000216181:292, 9606.ENSP00000229179:292, 9606.ENSP00000274813:292, 9606.ENSP00000472847:292, 9606.ENSP00000376410:292, 9606.ENSP00000362680:292, 9606.ENSP00000345751:292, 9606.ENSP00000360141:292, 9606.ENSP00000249442:292, 9606.ENSP00000358866:292, 9606.ENSP00000357048:292, 9606.ENSP00000340466:292, 9606.ENSP00000414321:292, 9606.ENSP00000470972:292, 9606.ENSP00000463784:292, 9606.ENSP00000359345:292, 9606.ENSP00000377789:292, 9606.ENSP00000357283:292, 9606.ENSP00000380911:292, 9606.ENSP00000078429:292, 9606.ENSP00000408292:292, 9606.ENSP00000481646:292, 9606.ENSP00000306999:292, 9606.ENSP00000363435:292, 9606.ENSP00000468002:292, 9606.ENSP00000339191:292, 9606.ENSP00000397908:292, 9606.ENSP00000346173:292, 9606.ENSP00000363779:292, 9606.ENSP00000368727:292, 9606.ENSP00000246957:292, 9606.ENSP00000245544:292, 9606.ENSP00000344314:292, 9606.ENSP00000352264:292, 9606.ENSP00000310668:292, 9606.ENSP00000348984:292, 9606.ENSP00000265970:292, 9606.ENSP00000445306:292, 9606.ENSP00000414398:292, 9606.ENSP00000351015:292, 9606.ENSP00000269601:292",0.5,0.0417604,0.0350034,37.9811400452009,cur_237
KIF7,30497,3,2.765597880763518,0,0.71773,2.0246,-0.68939,Joubert syndrome 12[OMIM:200990]-Autosomal recessive inheritance | Acrocallosal syndrome[OMIM:200990]-Autosomal recessive inheritance | ?Hydrolethalus syndrome 2[OMIM:614120]-Autosomal recessive inheritance | ?Al-Gazali-Bakalinova syndrome[OMIM:607131]-Autosomal recessive inheritance,"Supportive (hydrolethalus syndrome[MONDO:0006037]-Autosomal recessive) | Definitive, Moderate, Supportive (acrocallosal syndrome[MONDO:0008708]-Autosomal recessive) | Supportive (orofaciodigital syndrome type 6[MONDO:0010176]-Autosomal recessive) | Supportive (multiple epiphyseal dysplasia, Al-Gazali type[MONDO:0011778]-Autosomal recessive) | Moderate (hydrolethalus syndrome 2[MONDO:0013585]-Autosomal recessive)",NULL,P:47; LP:18; VUS:727,NULL,OMIM:607131 (antenatal_or_congenital: 0.821); OMIM:614120 (antenatal_or_congenital: 0.077),OMIM:200990 (syndromic: 0.151 | growth: 0.296 | skeletal: 0.091 | neurologic: 0.094); OMIM:607131 (syndromic: 0.083 | skeletal: 0.098 | neurologic: 0.09); OMIM:614120 (syndromic: 0.028 | skeletal: 0.035 | neurologic: 0.027),hm (false); ht (false),0.5,3105,0.5744234800838575,"9606.ENSP00000356319:540, 9606.ENSP00000390436:976, 9606.ENSP00000448012:292, 9606.ENSP00000268057:183, 9606.ENSP00000231509:165, 9606.ENSP00000379258:949",0.5,3.21888,2.04334,36.5212240052179,cur_238
KIRREL1,15734,2,1.687314191193802,0.99855,0.10913,4.9979,2.6053,"Nephrotic syndrome, type 23[OMIM:619201]-Autosomal recessive inheritance",NULL,NULL,P:2; LP:0; VUS:22,OMIM:619201 (glomerulopathy: 0.182 | cancer: 0.03 | cakut: 0.012 | cyst_cilio: 0.01 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:619201 (neonatal_or_pediatric: 0.463),NULL,hm (true); ht (false),0.5,5619,0.7735849056603774,"9606.ENSP00000368190:998, 9606.ENSP00000340913:220, 9606.ENSP00000417335:349, 9606.ENSP00000346151:499, 9606.ENSP00000256078:231, 9606.ENSP00000356587:980, 9606.ENSP00000406229:859, 9606.ENSP00000352264:984, 9606.ENSP00000252699:499",0,NULL,NULL,NULL,cur_239
KL,6344,5,2.905587892808194,2.24e-4,0.35707,3.5949,0.95631,"?Tumoral calcinosis, hyperphosphatemic, familial, 3[OMIM:617994]-Autosomal recessive inheritance","Supportive (tumoral calcinosis, hyperphosphatemic, familial, 1[MONDO:0008897]-Autosomal recessive) | Limited, Limited (tumoral calcinosis, hyperphosphatemic, familial, 3[MONDO:0060715]-Autosomal recessive)",NULL,P:0; LP:1; VUS:203,OMIM:617994 (tubulopathy: 0.245 | nephrocalcinosis: 0.201 | cyst_cilio: 0.029 | cakut: 0.02 | glomerulopathy: 0.016 | cancer: 0.01),NULL,OMIM:617994 (syndromic: 0.005 | skeletal: 0.012 | neurologic: 0.004),hm (true); ht (true),0.5,6563,0.8113207547169812,"9606.ENSP00000339824:879, 9606.ENSP00000180166:976, 9606.ENSP00000264634:414, 9606.ENSP00000237837:999, 9606.ENSP00000272190:297, 9606.ENSP00000290167:663, 9606.ENSP00000393312:999, 9606.ENSP00000264664:976, 9606.ENSP00000410294:360",0,10.7393,18.7334,6.86753997263464,cur_240
KLHL3,6354,3,2.29367086895435,0.94479,0.1603,4.3456,2.9931,"Pseudohypoaldosteronism, type IID[OMIM:614495]-Autosomal dominant inheritance | Pseudohypoaldosteronism, type IID[OMIM:614495]-Autosomal recessive inheritance","Strong, Supportive (pseudohypoaldosteronism type 2D[MONDO:0013781]-Autosomal dominant)",NULL,P:26; LP:6; VUS:114,NULL,OMIM:614495 (adult: 0.372),NULL,hm (true); ht (true),0.5,3631,0.6352201257861635,"9606.ENSP00000402152:292, 9606.ENSP00000245157:161, 9606.ENSP00000451828:292, 9606.ENSP00000341292:457, 9606.ENSP00000246914:802, 9606.ENSP00000245479:292, 9606.ENSP00000448012:171, 9606.ENSP00000231509:165, 9606.ENSP00000264414:999",0.5,2.79885,4.89266,24.1246883274268,cur_241
KMT2D,7133,5,2.790514892292371,1,0.066852,12.953,3.7288,"Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome[OMIM:620186]-Autosomal dominant inheritance | Kabuki syndrome 1[OMIM:147920]-Autosomal dominant inheritance","Definitive, Definitive, Definitive, Definitive (Kabuki syndrome 1[MONDO:0007843]-Autosomal dominant) | Supportive (Kabuki syndrome[MONDO:0016512]-Autosomal dominant) | Moderate (choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome[MONDO:0035651]-Autosomal dominant)",Definitive (Kabuki syndrome 1[MONDO:0007843]-AD),P:609; LP:247; VUS:1203,OMIM:147920 (cakut: 0.113 | cancer: 0.02 | cyst_cilio: 0.016 | tubulopathy: 0.014 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:147920 (antenatal_or_congenital: 0.899); OMIM:620186 (antenatal_or_congenital: 0.063),OMIM:147920 (syndromic: 0.16 | growth: 0.375 | skeletal: 0.132 | neurologic: 0.193); OMIM:620186 (syndromic: 0.094 | growth: 0.352 | skeletal: 0.046 | neurologic: 0.024),hm (false); ht (false),0.5,3561,0.6268343815513627,"9606.ENSP00000337088:930, 9606.ENSP00000264731:349, 9606.ENSP00000363435:206, 9606.ENSP00000451828:292, 9606.ENSP00000269305:181, 9606.ENSP00000231509:457, 9606.ENSP00000262367:150, 9606.ENSP00000367203:996",0.5,8.574580000000001,6.47876,51.1214052702044,cur_242
KYNU,6469,3,1.879710648585988,0,0.98144,0.090223,-0.41338,"?Hydroxykynureninuria[OMIM:236800]-Autosomal recessive inheritance | Vertebral, cardiac, renal, and limb defects syndrome 2[OMIM:617661]-Autosomal recessive inheritance","Limited, Supportive (encephalopathy due to hydroxykynureninuria[MONDO:0009372]-Autosomal recessive) | Supportive (congenital vertebral-cardiac-renal anomalies syndrome[MONDO:0020831]-Autosomal recessive) | Definitive, Limited (vertebral, cardiac, renal, and limb defects syndrome 2[MONDO:0060555]-Autosomal recessive)","Definitive (vertebral, cardiac, renal, and limb defects syndrome 2[MONDO:0060555]-AR)",P:11; LP:12; VUS:16,OMIM:617661 (cakut: 0.153 | cyst_cilio: 0.055 | cancer: 0.05 | tubulopathy: 0.049 | nephrocalcinosis: 0.042 | complement: 0.036 | glomerulopathy: 0.024),OMIM:236800 (neonatal_or_pediatric: 0.134); OMIM:617661 (antenatal_or_congenital: 0.821),OMIM:617661 (syndromic: 0.051 | growth: 0.267 | skeletal: 0.077 | neurologic: 0.049),hm (true); ht (false),0.5,781,0.19077568134171907,"9606.ENSP00000452762:175, 9606.ENSP00000347942:189, 9606.ENSP00000445175:192, 9606.ENSP00000355518:225",0,0.33064,0.55204,9.23758079500092,cur_243
LAGE3,26058,5,2.993151894157194,0.12721,0.59501,0.48652,0.40929,"Galloway-Mowat syndrome 2, X-linked[OMIM:301006]-X-linked recessive inheritance","Supportive (Galloway-Mowat syndrome[MONDO:0009627]-Autosomal recessive) | Strong, Limited, Limited (Galloway-Mowat syndrome 2, X-linked[MONDO:0033006]-X-linked) | Limited (Galloway-Mowat syndrome 2, X-linked[MONDO:0033006]-X-linked recessive)",NULL,P:3; LP:0; VUS:25,OMIM:301006 (glomerulopathy: 0.355 | cyst_cilio: 0.136 | cakut: 0.056 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:301006 (neonatal_or_pediatric: 0.665),OMIM:301006 (syndromic: 0.142 | growth: 0.352 | skeletal: 0.071 | neurologic: 0.197),hm (NA); ht (NA),0.5,3377,0.610062893081761,"9606.ENSP00000413017:380, 9606.ENSP00000361186:999, 9606.ENSP00000306320:999, 9606.ENSP00000206542:999",0,18.2775,12.0872,7.86411901370084,cur_244
LAMA5,6485,5,3.092688043536776,0.006474,0.24162,9.4834,-0.27216,"Nephrotic syndrome, type 26[OMIM:620049]-Autosomal recessive inheritance | ?Bent bone dysplasia syndrome 2[OMIM:620076]-Autosomal recessive inheritance","Moderate (nephrotic syndrome, IIa 26[MONDO:0031061]-Autosomal recessive) | Supportive (LAMA5-related multisystemic syndrome[MONDO:0033856]-Autosomal dominant)",NULL,P:3; LP:12; VUS:513,OMIM:620049 (glomerulopathy: 0.368 | cyst_cilio: 0.136 | cakut: 0.056 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:620049 (neonatal_or_pediatric: 0.262); OMIM:620076 (antenatal_or_congenital: 0.821),OMIM:620076 (syndromic: 0.029 | growth: 0.102 | skeletal: 0.054),hm (true); ht (false),0.5,1851,0.389937106918239,"9606.ENSP00000386896:972, 9606.ENSP00000346839:380, 9606.ENSP00000200181:499",0.5,56.1296,50.6411,32.3878336784202,cur_245
LAMB2,6487,5,4.615359340666684,NULL,NULL,NULL,NULL,"Nephrotic syndrome, type 5, with or without ocular abnormalities[OMIM:614199]-NA | Pierson syndrome[OMIM:609049]-Autosomal recessive inheritance","Definitive, Strong, Supportive (Pierson syndrome[MONDO:0012184]-Autosomal recessive) | Strong (LAMB2-related infantile-onset nephrotic syndrome[MONDO:0013621]-Autosomal recessive)",NULL,P:44; LP:27; VUS:522,OMIM:609049 (glomerulopathy: 0.279 | cyst_cilio: 0.157 | cakut: 0.06 | cancer: 0.05 | tubulopathy: 0.042 | complement: 0.036 | nephrocalcinosis: 0.021); OMIM:614199 (glomerulopathy: 0.237 | cyst_cilio: 0.126 | cancer: 0.05 | cakut: 0.044 | tubulopathy: 0.042 | complement: 0.036 | nephrocalcinosis: 0.021),OMIM:609049 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.134),OMIM:609049 (syndromic: 0.055 | skeletal: 0.053 | neurologic: 0.116),hm (true); ht (false),0,NULL,NULL,NULL,0.5,71.7121,74.7779,88.1195701020669,cur_246
LCAT,6522,5,3.4935135386871963,0.08102,0.29223,2.7129,1.324,Fish-eye disease[OMIM:136120]-Autosomal recessive inheritance | Norum disease[OMIM:245900]-Autosomal recessive inheritance,"Definitive, Supportive (fish eye disease[MONDO:0007620]-Autosomal recessive) | Supportive (Norum disease[MONDO:0009515]-Autosomal recessive) | Definitive (LCAT deficiency[MONDO:0018999]-Autosomal recessive)",NULL,P:21; LP:5; VUS:65,OMIM:245900 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:245900 (adult: 0.218),NULL,hm (true); ht (true),0.5,4205,0.6855345911949685,"9606.ENSP00000252486:837, 9606.ENSP00000236850:990, 9606.ENSP00000356969:871, 9606.ENSP00000317674:720, 9606.ENSP00000466775:787",0.5,38.6475,16.7766,10.2272889727265,cur_247
LIFR,6597,4,2.5527491126156656,NULL,NULL,NULL,NULL,Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome[OMIM:601559]-Autosomal recessive inheritance,"Definitive, Supportive (Stüve-Wiedemann syndrome[MONDO:0011108]-Autosomal recessive) | Definitive (Stüve-Wiedemann syndrome 1[MONDO:0800043]-Autosomal recessive)",Definitive (obsolete Stüve-Wiedemann syndrome[MONDO:0011108]-AR),P:64; LP:30; VUS:313,NULL,OMIM:601559 (antenatal_or_congenital: 0.821),OMIM:601559 (syndromic: 0.123 | growth: 0.25 | skeletal: 0.167 | neurologic: 0.093),hm (true); ht (true),0,NULL,NULL,NULL,0.5,11.6633,7.419739999999999,187.271633468021,cur_248
LMNA,6636,3,2.38380172730081,0.9994,0.066263,4.7536,2.3673,"Mandibuloacral dysplasia[OMIM:248370]-Autosomal recessive inheritance | Heart-hand syndrome, Slovenian type[OMIM:610140]-Autosomal dominant inheritance | Cardiomyopathy, dilated, 1A[OMIM:115200]-Autosomal dominant inheritance | Emery-Dreifuss muscular dystrophy 3, autosomal recessive[OMIM:616516]-Autosomal recessive inheritance | Restrictive dermopathy 2[OMIM:619793]-NA | Charcot-Marie-Tooth disease, type 2B1[OMIM:605588]-Autosomal recessive inheritance | Emery-Dreifuss muscular dystrophy 2, autosomal dominant[OMIM:181350]-Autosomal dominant inheritance | Hutchinson-Gilford progeria[OMIM:176670]-Autosomal dominant inheritance | Lipodystrophy, familial partial, type 2[OMIM:151660]-Autosomal dominant inheritance | Muscular dystrophy, congenital[OMIM:613205]-Autosomal dominant inheritance | Malouf syndrome[OMIM:212112]-Autosomal dominant inheritance","Strong (atrioventricular block[MONDO:0000465]-Autosomal dominant) | Definitive (dilated cardiomyopathy[MONDO:0005021]-Autosomal dominant) | Definitive, Definitive, Supportive (dilated cardiomyopathy 1A[MONDO:0007269]-Autosomal dominant) | Definitive, Strong, Supportive (familial partial lipodystrophy, Dunnigan type[MONDO:0007906]-Autosomal dominant) | Definitive, Supportive (Hutchinson-Gilford progeria syndrome[MONDO:0008310]-Autosomal dominant) | Moderate (Hutchinson-Gilford progeria syndrome[MONDO:0008310]-Semidominant) | Supportive (autosomal recessive Emery-Dreifuss muscular dystrophy[MONDO:0008406]-Autosomal recessive) | Supportive (dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome[MONDO:0008915]-Autosomal recessive) | Supportive (mandibuloacral dysplasia with type A lipodystrophy[MONDO:0009557]-Autosomal recessive) | Supportive (lethal restrictive dermopathy[MONDO:0010143]-Autosomal dominant) | Moderate, Limited, Supportive (Charcot-Marie-Tooth disease type 2B1[MONDO:0011569]-Autosomal recessive) | Moderate, Limited, Supportive (heart-hand syndrome, Slovenian type[MONDO:0012417]-Autosomal dominant) | Supportive (congenital muscular dystrophy due to LMNA mutation[MONDO:0013178]-Autosomal dominant) | Supportive (familial isolated dilated cardiomyopathy[MONDO:0015470]-Autosomal dominant) | Limited (arrhythmogenic right ventricular cardiomyopathy[MONDO:0016587]-Autosomal dominant) | Supportive (autosomal semi-dominant severe lipodystrophic laminopathy[MONDO:0017230]-Semidominant) | Supportive (LMNA-related cardiocutaneous progeria syndrome[MONDO:0018203]-Autosomal dominant) | Supportive (atypical Werner syndrome[MONDO:0019321]-Autosomal dominant) | Supportive (autosomal dominant Emery-Dreifuss muscular dystrophy[MONDO:0020336]-Autosomal dominant) | Definitive (Emery-Dreifuss muscular dystrophy 2, autosomal dominant[MONDO:0021569]-Autosomal dominant) | Definitive (Emery-Dreifuss muscular dystrophy 2, autosomal dominant[MONDO:0021569]-Semidominant) | Limited (restrictive dermopathy 1[MONDO:0800042]-Autosomal dominant)",Definitive (dilated cardiomyopathy[MONDO:0005021]-AD) | Limited (arrhythmogenic right ventricular cardiomyopathy[MONDO:0016587]-AD),P:288; LP:192; VUS:645,NULL,OMIM:115200 (adult: 0.575); OMIM:151660 (neonatal_or_pediatric: 0.463 | adult: 0.372); OMIM:181350 (adult: 0.049); OMIM:212112 (neonatal_or_pediatric: 0.262); OMIM:248370 (neonatal_or_pediatric: 0.463); OMIM:613205 (neonatal_or_pediatric: 0.865); OMIM:616516 (neonatal_or_pediatric: 0.262); OMIM:619793 (antenatal_or_congenital: 0.899),OMIM:151660 (syndromic: 0.001 | neurologic: 0); OMIM:176670 (syndromic: 0.019 | growth: 0.091 | skeletal: 0.038); OMIM:181350 (syndromic: 0.003 | skeletal: 0.012); OMIM:212112 (syndromic: 0.027 | skeletal: 0.022 | neurologic: 0.04); OMIM:248370 (syndromic: 0.042 | growth: 0.125 | skeletal: 0.077); OMIM:605588 (syndromic: 0.015 | skeletal: 0.008 | neurologic: 0.027); OMIM:610140 (syndromic: 0.007 | skeletal: 0.026); OMIM:613205 (syndromic: 0.02 | growth: 0.171 | skeletal: 0.007 | neurologic: 0.017); OMIM:616516 (syndromic: 0.015 | skeletal: 0.043 | neurologic: 0.007); OMIM:619793 (syndromic: 0.008 | growth: 0.102 | skeletal: 0.005),hm (true); ht (false),0.5,6034,0.7840670859538784,"9606.ENSP00000227507:204, 9606.ENSP00000361845:487, 9606.ENSP00000269305:374, 9606.ENSP00000265171:417, 9606.ENSP00000347717:167, 9606.ENSP00000265748:359, 9606.ENSP00000261396:595, 9606.ENSP00000358866:238, 9606.ENSP00000356319:292, 9606.ENSP00000421491:329, 9606.ENSP00000268261:163, 9606.ENSP00000229179:204, 9606.ENSP00000357998:188, 9606.ENSP00000477829:336, 9606.ENSP00000361021:292, 9606.ENSP00000339191:163, 9606.ENSP00000362413:221, 9606.ENSP00000386857:209, 9606.ENSP00000287600:237, 9606.ENSP00000367615:159, 9606.ENSP00000239891:163, 9606.ENSP00000281043:237",0.5,64.592,45.7923,217.289541200626,cur_249
LMX1B,6654,5,4.619529868933598,NULL,NULL,NULL,NULL,Focal segmental glomerulosclerosis 10[OMIM:256020]-Autosomal dominant inheritance | Nail-patella syndrome[OMIM:161200]-Autosomal dominant inheritance,"Definitive, Definitive, Supportive (nail-patella syndrome[MONDO:0008061]-Autosomal dominant) | Supportive (nail-patella-like renal disease[MONDO:0009724]-Autosomal dominant)",Definitive (nail-patella syndrome[MONDO:0008061]-AD),P:69; LP:21; VUS:190,OMIM:161200 (glomerulopathy: 0.251 | complement: 0.25 | tubulopathy: 0.14 | nephrocalcinosis: 0.139 | cyst_cilio: 0.081 | cakut: 0.065 | cancer: 0.05); OMIM:256020 (glomerulopathy: 0.328 | cyst_cilio: 0.205 | tubulopathy: 0.154 | nephrocalcinosis: 0.139 | complement: 0.107 | cakut: 0.089 | cancer: 0.05),OMIM:256020 (adult: 0.683 | neonatal_or_pediatric: 0.2),OMIM:161200 (syndromic: 0.04 | growth: 0.25 | skeletal: 0.07 | neurologic: 0),hm (true); ht (true),0.5,1202,0.27882599580712786,"9606.ENSP00000359319:607, 9606.ENSP00000405890:595",0.5,0.32656399999999997,3.21623,23.0679676980809,cur_250
LRIG2,20889,5,3.5101814443620203,0,0.68344,2.0992,0.48219,Urofacial syndrome 2[OMIM:615112]-Autosomal recessive inheritance,Supportive (Ochoa syndrome[MONDO:0000463]-Autosomal recessive) | Strong (urofacial syndrome type 1[MONDO:0009368]-Autosomal recessive) | Strong (urofacial syndrome 2[MONDO:0014049]-Autosomal recessive),NULL,P:5; LP:4; VUS:42,OMIM:615112 (cakut: 0.177 | nephrocalcinosis: 0.118 | tubulopathy: 0.105 | cyst_cilio: 0.089 | glomerulopathy: 0.084 | complement: 0.071 | cancer: 0.02),OMIM:615112 (neonatal_or_pediatric: 0.865),OMIM:615112 (syndromic: 0),hm (false); ht (false),0,183,0.03563941299790356,9606.ENSP00000347942:183,0.5,3.6122900000000002,2.6943900000000003,57.926991561474,cur_251
LRP2,6694,5,2.663360026404471,NULL,NULL,NULL,NULL,Donnai-Barrow syndrome[OMIM:222448]-Autosomal recessive inheritance,"Definitive, Strong, Supportive (Donnai-Barrow syndrome[MONDO:0009104]-Autosomal recessive) | Limited (intellectual disability, autosomal dominant 40[MONDO:0014699]-Autosomal dominant) | Moderate (Stickler syndrome[MONDO:0019354]-Autosomal dominant)",NULL,P:41; LP:37; VUS:1419,NULL,OMIM:222448 (antenatal_or_congenital: 0.821),OMIM:222448 (syndromic: 0.076 | skeletal: 0.03 | neurologic: 0.1),hm (true); ht (true),0,NULL,NULL,NULL,0.5,7.76883,20.6905,84.4947919684635,cur_252
LRP4,6696,4,2.759346853262769,1e-6,0.30655,6.3569,3.0632,"?Myasthenic syndrome, congenital, 17[OMIM:616304]-Autosomal recessive inheritance | Sclerosteosis 2[OMIM:614305]-Autosomal dominant inheritance | Sclerosteosis 2[OMIM:614305]-Autosomal recessive inheritance | Cenani-Lenz syndactyly syndrome[OMIM:212780]-Autosomal recessive inheritance","Definitive, Strong, Supportive (Cenani-Lenz syndactyly syndrome[MONDO:0008931]-Autosomal recessive) | Limited (sclerosteosis 2[MONDO:0013679]-Semidominant) | Strong, Strong (congenital myasthenic syndrome 17[MONDO:0014578]-Autosomal recessive) | Supportive (sclerosteosis[MONDO:0017838]-Autosomal recessive) | Supportive (postsynaptic congenital myasthenic syndrome[MONDO:0020344]-Autosomal recessive)",NULL,P:12; LP:8; VUS:523,OMIM:212780 (cakut: 0.149 | cancer: 0.08 | cyst_cilio: 0.045 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:212780 (antenatal_or_congenital: 0.821); OMIM:616304 (antenatal_or_congenital: 0.821),OMIM:212780 (syndromic: 0.042 | skeletal: 0.106 | neurologic: 0.003); OMIM:614305 (syndromic: 0.018 | skeletal: 0.045 | neurologic: 0.009); OMIM:616304 (syndromic: 0.006 | neurologic: 0.012),hm (true); ht (false),0,271,0.05450733752620545,9606.ENSP00000380321:271,0.5,1.44407,0.757781,58.8509940170129,cur_253
LRP5,6697,4,2.86372359122962,0.50992,0.22125,5.9419,1.6684,"Osteopetrosis, autosomal dominant 1[OMIM:607634]-Autosomal dominant inheritance | [Bone mineral density variability 1][OMIM:601884]-Autosomal dominant inheritance | Polycystic liver disease 4 with or without kidney cysts[OMIM:617875]-Autosomal dominant inheritance | Endosteal hyperostosis[OMIM:144750]-Autosomal dominant inheritance | Osteoporosis-pseudoglioma syndrome[OMIM:259770]-Autosomal recessive inheritance | Exudative vitreoretinopathy 4[OMIM:601813]-Autosomal dominant inheritance | Exudative vitreoretinopathy 4[OMIM:601813]-Autosomal recessive inheritance","Definitive, Strong, Supportive (autosomal dominant osteosclerosis, Worth type[MONDO:0007764]-Autosomal dominant) | Supportive (polycystic liver disease 1[MONDO:0008265]-Autosomal dominant) | Supportive (hyperostosis corticalis generalisata[MONDO:0009395]-Autosomal dominant) | Definitive, Definitive, Supportive (osteoporosis-pseudoglioma syndrome[MONDO:0009820]-Autosomal recessive) | Definitive (exudative vitreoretinopathy 4[MONDO:0011151]-Autosomal dominant) | Definitive (exudative vitreoretinopathy 4[MONDO:0011151]-Semidominant) | Strong (exudative vitreoretinopathy 4[MONDO:0011151]-Unknown) | Definitive, Moderate, Supportive (autosomal dominant osteopetrosis 1[MONDO:0011877]-Autosomal dominant) | Supportive (osteosclerosis-developmental delay-craniosynostosis syndrome[MONDO:0015800]-Autosomal dominant) | Definitive (inherited retinal dystrophy[MONDO:0019118]-Autosomal recessive) | Supportive (exudative vitreoretinopathy[MONDO:0019516]-Autosomal dominant) | Definitive (bone mineral density quantitative trait locus 1[MONDO:0044271]-Autosomal dominant) | Strong, Limited (polycystic liver disease 4 with or without kidney cysts[MONDO:0044327]-Autosomal dominant)",Definitive (inherited retinal dystrophy[MONDO:0019118]-AR) | Limited (polycystic liver disease 4 with or without kidney cysts[MONDO:0044327]-AD),P:103; LP:69; VUS:790,OMIM:617875 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:259770 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402); OMIM:601813 (neonatal_or_pediatric: 0.402),OMIM:144750 (syndromic: 0.003 | growth: 0.009 | skeletal: 0.002); OMIM:259770 (syndromic: 0.059 | growth: 0.25 | skeletal: 0.148 | neurologic: 0.037); OMIM:601813 (syndromic: 0.003 | skeletal: 0.009); OMIM:607634 (syndromic: 0.004 | skeletal: 0.009 | neurologic: 0.002),hm (false); ht (false),0.5,3208,0.589098532494759,"9606.ENSP00000264634:933, 9606.ENSP00000308938:186, 9606.ENSP00000290167:527, 9606.ENSP00000362680:432, 9606.ENSP00000290015:279, 9606.ENSP00000264896:228, 9606.ENSP00000252486:623",0.5,12.710999999999999,17.084,95.5920674626505,cur_254
LYZ,6740,5,3.1522067118492187,3e-6,1.0797,-0.20104,0.73158,"Amyloidosis, renal[OMIM:105200]-Autosomal dominant inheritance","Strong, Moderate (familial visceral amyloidosis[MONDO:0007099]-Autosomal dominant) | Supportive (ALys amyloidosis[MONDO:0019732]-Autosomal dominant)",NULL,P:5; LP:0; VUS:33,OMIM:105200 (complement: 0.179 | glomerulopathy: 0.173 | cancer: 0.05 | nephrocalcinosis: 0.042 | tubulopathy: 0.035 | cakut: 0.024 | cyst_cilio: 0.018),NULL,OMIM:105200 (syndromic: 0.002 | neurologic: 0.004),hm (false); ht (false),0.5,1238,0.29350104821802936,"9606.ENSP00000245907:261, 9606.ENSP00000216911:161, 9606.ENSP00000281043:161, 9606.ENSP00000269305:224, 9606.ENSP00000236850:266, 9606.ENSP00000265593:165",0,3.9115900000000003,4.2919,7.87915666469597,cur_255
LZTFL1,6741,4,3.5301834993376593,0.059115,0.29113,2.9821,1.6491,Bardet-Biedl syndrome 17[OMIM:615994]-Autosomal recessive inheritance,"Strong, Strong, Moderate (Bardet-Biedl syndrome 17[MONDO:0014445]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:9; LP:5; VUS:76,OMIM:615994 (cyst_cilio: 0.241 | tubulopathy: 0.161 | glomerulopathy: 0.14 | nephrocalcinosis: 0.097 | cakut: 0.089 | cancer: 0.05 | complement: 0.036),OMIM:615994 (antenatal_or_congenital: 0.821),OMIM:615994 (syndromic: 0.056 | growth: 0.043 | skeletal: 0.025 | neurologic: 0.098),hm (true); ht (false),0.5,6387,0.7987421383647799,"9606.ENSP00000268057:839, 9606.ENSP00000242067:909, 9606.ENSP00000245157:829, 9606.ENSP00000317469:824, 9606.ENSP00000295240:844, 9606.ENSP00000264499:821, 9606.ENSP00000482306:822, 9606.ENSP00000433157:499",0.5,7.474480000000001,5.18895,19.2607964220324,cur_256
MAFB,6408,5,2.8773264489016697,0.90304,0,2.5441,2.1673,Duane retraction syndrome 3[OMIM:617041]-Autosomal dominant inheritance | Multicentric carpotarsal osteolysis syndrome[OMIM:166300]-Autosomal dominant inheritance,"Supportive (Duane retraction syndrome[MONDO:0007473]-Autosomal dominant) | Definitive, Moderate, Supportive (multicentric carpo-tarsal osteolysis with or without nephropathy[MONDO:0008152]-Autosomal dominant)",NULL,P:12; LP:6; VUS:80,OMIM:166300 (glomerulopathy: 0.213 | cyst_cilio: 0.194 | tubulopathy: 0.147 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.077 | cancer: 0.02),OMIM:166300 (neonatal_or_pediatric: 0.865 | adult: 0.372),OMIM:166300 (syndromic: 0.016 | skeletal: 0.041 | neurologic: 0.006); OMIM:617041 (syndromic: 0),hm (true); ht (false),0.5,1799,0.38155136268343814,"9606.ENSP00000262367:348, 9606.ENSP00000368805:365, 9606.ENSP00000290167:394, 9606.ENSP00000368632:400, 9606.ENSP00000367203:292",0.5,9.95637,17.4219,65.4764845707011,cur_257
MAGED2,16353,5,3.090334729411268,0.99538,0.049203,3.972,2.3381,"Bartter syndrome, type 5, antenatal, transient[OMIM:300971]-X-linked recessive inheritance",Strong (Bartter disease type 5[MONDO:0010503]-X-linked) | Supportive (antenatal Bartter syndrome[MONDO:0100343]-Autosomal recessive),NULL,P:6; LP:3; VUS:31,OMIM:300971 (tubulopathy: 0.14 | nephrocalcinosis: 0.09 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),NULL,NULL,hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,138.23,95.9512,157.712311701599,cur_258
MAGI2,18957,5,3.602852608544867,0.99943,0.147,6.1848,1.8148,"Nephrotic syndrome, type 15[OMIM:617609]-Autosomal recessive inheritance",Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant) | Limited (nephrotic syndrome 15[MONDO:0033262]-Autosomal recessive),NULL,P:3; LP:1; VUS:124,OMIM:617609 (glomerulopathy: 0.186 | cyst_cilio: 0.129 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),OMIM:617609 (neonatal_or_pediatric: 0.402),NULL,hm (true); ht (false),0.5,2376,0.46540880503144655,"9606.ENSP00000368190:499, 9606.ENSP00000352138:499, 9606.ENSP00000361021:958, 9606.ENSP00000358866:420",0.5,0.979699,0.906646,784.486833330848,cur_259
MAPKBP1,29536,4,3.0319094031358067,NULL,NULL,NULL,NULL,Nephronophthisis 20[OMIM:617271]-Autosomal recessive inheritance,Supportive (nephronophthisis 1[MONDO:0009728]-Autosomal recessive) | Strong (nephronophthisis 20[MONDO:0014997]-Autosomal recessive) | Supportive (late-onset nephronophthisis[MONDO:0019742]-Autosomal recessive),Strong (nephronophthisis 20[MONDO:0014997]-AR),P:7; LP:1; VUS:115,OMIM:617271 (cyst_cilio: 0.391 | glomerulopathy: 0.22 | cakut: 0.19 | tubulopathy: 0.154 | nephrocalcinosis: 0.132 | complement: 0.107 | cancer: 0.05),OMIM:617271 (adult: 0.372 | neonatal_or_pediatric: 0.2),OMIM:617271 (syndromic: 0.01 | skeletal: 0.036),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,7.8486,5.77689,79.9326862295786,cur_260
MEFV,6998,5,3.549680606534964,0,0.80862,0.9861,-1.7163,"Neutrophilic dermatosis, acute febrile[OMIM:608068]-Autosomal dominant inheritance | Familial Mediterranean fever, AR[OMIM:249100]-Autosomal recessive inheritance | Familial Mediterranean fever, AD[OMIM:134610]-Autosomal dominant inheritance",Definitive (autosomal recessive familial Mediterranean fever[MONDO:0009572]-Autosomal recessive) | Supportive (familial Mediterranean fever[MONDO:0018088]-Autosomal dominant) | Definitive (familial Mediterranean fever[MONDO:0018088]-Autosomal recessive) | Definitive (familial Mediterranean fever[MONDO:0018088]-Semidominant),Definitive (familial Mediterranean fever[MONDO:0018088]-SD),P:13; LP:11; VUS:373,OMIM:134610 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.091 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02); OMIM:249100 (glomerulopathy: 0.246 | cyst_cilio: 0.126 | cancer: 0.05 | cakut: 0.044 | tubulopathy: 0.042 | complement: 0.036 | nephrocalcinosis: 0.021),OMIM:134610 (neonatal_or_pediatric: 0.2); OMIM:249100 (neonatal_or_pediatric: 0.865 | adult: 0.372); OMIM:608068 (neonatal_or_pediatric: 0.262),OMIM:134610 (syndromic: 0 | skeletal: 0.001); OMIM:249100 (syndromic: 0.002 | skeletal: 0.003 | neurologic: 0.003),hm (false); ht (false),0.5,1297,0.3060796645702306,"9606.ENSP00000365891:304, 9606.ENSP00000337383:993",0,0.504115,0.43214300000000005,0.40740034778691,cur_261
MEN1,7010,2,1.422303266526794,NULL,NULL,NULL,NULL,Multiple endocrine neoplasia 1[OMIM:131100]-Autosomal dominant inheritance,"Definitive, Definitive, Strong, Limited, Supportive (multiple endocrine neoplasia type 1[MONDO:0007540]-Autosomal dominant) | Supportive (familial isolated hyperparathyroidism[MONDO:0015027]-Autosomal dominant) | Supportive (pituitary gigantism[MONDO:0020479]-Autosomal dominant)",Definitive (multiple endocrine neoplasia type 1[MONDO:0007540]-AD),P:395; LP:143; VUS:850,NULL,OMIM:131100 (adult: 0.218),OMIM:131100 (syndromic: 0.001 | neurologic: 0.001),hm (false); ht (false),0.5,5020,0.7442348008385744,"9606.ENSP00000269305:292, 9606.ENSP00000301067:930, 9606.ENSP00000451828:371, 9606.ENSP00000285071:154, 9606.ENSP00000322323:499, 9606.ENSP00000265748:225, 9606.ENSP00000216181:570, 9606.ENSP00000261584:169, 9606.ENSP00000348984:454, 9606.ENSP00000367203:325, 9606.ENSP00000287647:870, 9606.ENSP00000373952:161",0.5,16.6524,14.0112,17.7708805198431,cur_262
MET,7029,4,2.1797314631936753,NULL,NULL,NULL,NULL,"Renal cell carcinoma, papillary, 1, familial and somatic[OMIM:605074]-NA | ?Arthrogryposis, distal, type 11[OMIM:620019]-Autosomal dominant inheritance | Hepatocellular carcinoma, childhood type, somatic[OMIM:114550]-NA | {Osteofibrous dysplasia, susceptibility to}[OMIM:607278]-Autosomal dominant inheritance | ?Deafness, autosomal recessive 97[OMIM:616705]-Autosomal recessive inheritance","Definitive, Definitive (hereditary papillary renal cell carcinoma[MONDO:0003789]-Autosomal dominant) | Limited, Supportive (osteofibrous dysplasia[MONDO:0011806]-Autosomal dominant) | Limited, Limited (autosomal recessive nonsyndromic hearing loss 97[MONDO:0014739]-Autosomal recessive) | Definitive, Strong, Supportive (papillary renal cell carcinoma[MONDO:0017884]-Autosomal dominant) | Limited (nonsyndromic genetic hearing loss[MONDO:0019497]-Autosomal recessive) | Supportive (hearing loss, autosomal recessive[MONDO:0019588]-Autosomal recessive) | Limited (arthrogryposis, distal, IIa 11[MONDO:0031045]-Autosomal dominant) | Disputed Evidence (complex neurodevelopmental disorder[MONDO:0100038]-Autosomal dominant)",Definitive (papillary renal cell carcinoma[MONDO:0017884]-AD) | Limited (nonsyndromic genetic hearing loss[MONDO:0019497]-AR) | Disputed (complex neurodevelopmental disorder[MONDO:0100038]-AD),P:12; LP:10; VUS:1793,OMIM:605074 (cancer: 0.02),OMIM:607278 (antenatal_or_congenital: 0.821); OMIM:620019 (antenatal_or_congenital: 0.821),OMIM:607278 (syndromic: 0.004 | skeletal: 0.015); OMIM:620019 (syndromic: 0.003 | skeletal: 0.012),hm (true); ht (true),0.5,4041,0.6687631027253669,"9606.ENSP00000362680:909, 9606.ENSP00000324856:183, 9606.ENSP00000414398:193, 9606.ENSP00000346839:351, 9606.ENSP00000262366:165, 9606.ENSP00000281171:224, 9606.ENSP00000385675:669, 9606.ENSP00000256078:216, 9606.ENSP00000269305:194, 9606.ENSP00000243253:165, 9606.ENSP00000319756:151, 9606.ENSP00000484824:329, 9606.ENSP00000339191:292",0.5,12.8225,11.0251,41.031172617236,cur_263
MKKS,7108,5,4.461235954279683,0,0.8349,0.64846,-0.051993,McKusick-Kaufman syndrome[OMIM:236700]-Autosomal recessive inheritance | Bardet-Biedl syndrome 6[OMIM:605231]-Autosomal recessive inheritance,"Definitive, Supportive (McKusick-Kaufman syndrome[MONDO:0009367]-Autosomal recessive) | Strong (Bardet-Biedl syndrome 6[MONDO:0011523]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:57; LP:20; VUS:209,OMIM:236700 (cakut: 0.109 | cyst_cilio: 0.081 | cancer: 0.03 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002); OMIM:605231 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:605231 (antenatal_or_congenital: 0.821),OMIM:236700 (syndromic: 0.004 | skeletal: 0.013 | neurologic: 0.001); OMIM:605231 (syndromic: 0.024 | growth: 0.043 | skeletal: 0.009 | neurologic: 0.04),hm (true); ht (false),0.5,2429,0.480083857442348,"9606.ENSP00000413017:292, 9606.ENSP00000264499:457, 9606.ENSP00000281043:161, 9606.ENSP00000297185:161, 9606.ENSP00000438273:901, 9606.ENSP00000245157:457",0.5,15.0046,11.2342,14.7516021191701,cur_264
MKS1,7121,5,3.9380949100034983,0,0.76431,1.3453,0.49195,Bardet-Biedl syndrome 13[OMIM:615990]-Autosomal recessive inheritance | Meckel syndrome 1[OMIM:249000]-Autosomal recessive inheritance | Joubert syndrome 28[OMIM:617121]-Autosomal recessive inheritance,"Definitive (Meckel syndrome, type 1[MONDO:0009571]-Autosomal recessive) | Definitive, Strong (Bardet-Biedl syndrome 13[MONDO:0014441]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Supportive (Joubert syndrome with ocular defect[MONDO:0016364]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",NULL,P:79; LP:72; VUS:307,OMIM:249000 (cyst_cilio: 0.073 | cancer: 0.06 | cakut: 0.056),OMIM:249000 (antenatal_or_congenital: 0.03); OMIM:617121 (antenatal_or_congenital: 0.899),OMIM:249000 (syndromic: 0.113 | growth: 0.102 | skeletal: 0.125 | neurologic: 0.141); OMIM:615990 (syndromic: 0.047 | growth: 0.043 | skeletal: 0.003 | neurologic: 0.091); OMIM:617121 (syndromic: 0.082 | skeletal: 0.009 | neurologic: 0.147),hm (true); ht (false),1,10771,0.9203354297693921,"9606.ENSP00000436596:171, 9606.ENSP00000448012:786, 9606.ENSP00000258173:926, 9606.ENSP00000243578:930, 9606.ENSP00000403465:951, 9606.ENSP00000367398:555, 9606.ENSP00000314116:793, 9606.ENSP00000261499:985, 9606.ENSP00000313169:607, 9606.ENSP00000483364:933, 9606.ENSP00000380779:992, 9606.ENSP00000356405:292, 9606.ENSP00000389998:894, 9606.ENSP00000304941:956",0.5,9.96893,6.9714,12.1152576525129,cur_265
MMACHC,24525,5,3.051107515452051,0,1.2143,-0.76444,-1.0759,"Methylmalonic aciduria and homocystinuria, cblC type[OMIM:277400]-Autosomal recessive inheritance","Definitive, Definitive, Definitive, Strong, Strong, Supportive (methylmalonic aciduria and homocystinuria type cblC[MONDO:0010184]-Autosomal recessive)",Definitive (methylmalonic aciduria and homocystinuria type cblC[MONDO:0010184]-AR),P:88; LP:54; VUS:175,OMIM:277400 (complement: 0.214 | glomerulopathy: 0.157 | nephrocalcinosis: 0.153 | tubulopathy: 0.14 | cyst_cilio: 0.087 | cakut: 0.056 | cancer: 0.02),OMIM:277400 (neonatal_or_pediatric: 0.402),OMIM:277400 (syndromic: 0.107 | growth: 0.171 | skeletal: 0.049 | neurologic: 0.188),hm (false); ht (false),0,NULL,NULL,NULL,0,4.2072199999999995,2.15382,3.63012458679635,cur_266
MOCOS,18234,3,1.8522828517420844,0,0.85936,0.79527,-0.44985,"Xanthinuria, type II[OMIM:603592]-Autosomal recessive inheritance","Definitive, Strong, Supportive (xanthinuria type II[MONDO:0011346]-Autosomal recessive)",Definitive (xanthinuria type II[MONDO:0011346]-AR),P:10; LP:6; VUS:137,OMIM:603592 (tubulopathy: 0.238 | nephrocalcinosis: 0.236 | glomerulopathy: 0.093 | cyst_cilio: 0.073 | complement: 0.071 | cakut: 0.052 | cancer: 0.03),OMIM:603592 (neonatal_or_pediatric: 0.463 | adult: 0.203),NULL,hm (true); ht (false),0,NULL,NULL,NULL,0,1.72518,1.17965,2.98125025799334,cur_267
MTX2,7506,2,0.6467438515543782,0.019208,0.34285,2.5475,0.83834,Mandibuloacral dysplasia progeroid syndrome[OMIM:619127]-Autosomal recessive inheritance,Supportive (mandibuloacral dysplasia[MONDO:0016584]-Autosomal recessive) | Strong (mandibuloacral dysplasia progeroid syndrome[MONDO:0030880]-Autosomal recessive),NULL,P:5; LP:0; VUS:9,OMIM:619127 (glomerulopathy: 0.095 | cancer: 0.03 | cakut: 0.012 | cyst_cilio: 0.008 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:619127 (neonatal_or_pediatric: 0.665),OMIM:619127 (syndromic: 0.081 | growth: 0.284 | skeletal: 0.107 | neurologic: 0.001),hm (NA); ht (NA),0.5,1469,0.33542976939203356,"9606.ENSP00000356319:292, 9606.ENSP00000303058:165, 9606.ENSP00000297185:720, 9606.ENSP00000265748:292",0.5,41.2831,29.4995,91.3026103415339,cur_268
MUC1,7508,5,3.859408262709716,NULL,NULL,NULL,NULL,"Tubulointerstitial kidney disease, autosomal dominant, 2[OMIM:174000]-Autosomal dominant inheritance","Definitive, Moderate, Supportive (tubulointerstitial kidney disease, autosomal dominant, 2[MONDO:0020726]-Autosomal dominant) | Limited (tubulointerstitial kidney disease, autosomal dominant, 2[MONDO:0020726]-Unknown)","Definitive (tubulointerstitial kidney disease, autosomal dominant, 2[MONDO:0020726]-AD)",P:1; LP:1; VUS:36,OMIM:174000 (cyst_cilio: 0.265 | glomerulopathy: 0.18 | cakut: 0.137 | tubulopathy: 0.084 | nephrocalcinosis: 0.069 | cancer: 0.05 | complement: 0.036),OMIM:174000 (adult: 0.218),OMIM:174000 (syndromic: 0.002 | skeletal: 0.001 | neurologic: 0.004),hm (false); ht (false),0.5,5068,0.7484276729559748,"9606.ENSP00000377836:218, 9606.ENSP00000265171:424, 9606.ENSP00000269305:901, 9606.ENSP00000317272:329, 9606.ENSP00000362680:983, 9606.ENSP00000260010:171, 9606.ENSP00000199280:301, 9606.ENSP00000339824:705, 9606.ENSP00000287820:292, 9606.ENSP00000368727:248, 9606.ENSP00000385675:306, 9606.ENSP00000389998:190",0.5,141.889,95.0667,13.0506100922525,cur_269
MMUT,7526,4,2.433862700118316,0,0.92939,0.40151,0.22855,"Methylmalonic aciduria, mut(0) type[OMIM:251000]-Autosomal recessive inheritance","Definitive, Definitive (methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency[MONDO:0009612]-Autosomal recessive) | Supportive (vitamin B12-unresponsive methylmalonic acidemia type mut0[MONDO:0017360]-Autosomal recessive) | Supportive (vitamin B12-unresponsive methylmalonic acidemia type mut-[MONDO:0019267]-Autosomal recessive)",Definitive (methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency[MONDO:0009612]-AR),P:213; LP:138; VUS:207,OMIM:251000 (cyst_cilio: 0.139 | glomerulopathy: 0.131 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),OMIM:251000 (neonatal_or_pediatric: 0.134),OMIM:251000 (syndromic: 0.039 | growth: 0.171 | neurologic: 0.062),hm (true); ht (true),0.5,816,0.1949685534591195,"9606.ENSP00000356319:292, 9606.ENSP00000356399:165, 9606.ENSP00000269305:359",0,NULL,NULL,NULL,cur_270
MYH11,7569,2,1.0259573347004456,NULL,NULL,NULL,NULL,"Megacystis-microcolon-intestinal hypoperistalsis syndrome 2[OMIM:619351]-Autosomal recessive inheritance | Aortic aneurysm, familial thoracic 4[OMIM:132900]-Autosomal dominant inheritance | Visceral myopathy 2[OMIM:619350]-Autosomal dominant inheritance","Strong (aortic aneurysm, familial thoracic 4[MONDO:0007568]-Autosomal dominant) | Supportive (megacystis-microcolon-intestinal hypoperistalsis syndrome[MONDO:0007960]-Autosomal dominant) | Definitive, Supportive (familial thoracic aortic aneurysm and aortic dissection[MONDO:0019625]-Autosomal dominant) | Strong (megacystis-microcolon-intestinal hypoperistalsis syndrome 2[MONDO:0025708]-Autosomal recessive)",Definitive (familial thoracic aortic aneurysm and aortic dissection[MONDO:0019625]-AD),P:28; LP:30; VUS:1217,OMIM:619351 (complement: 0.179 | cakut: 0.02 | glomerulopathy: 0.009 | nephrocalcinosis: 0.007 | cyst_cilio: 0.003),OMIM:619351 (antenatal_or_congenital: 0.077),OMIM:132900 (syndromic: 0.001 | neurologic: 0.002); OMIM:619350 (syndromic: 0.005 | neurologic: 0.01),hm (true); ht (false),0.5,3109,0.5765199161425576,"9606.ENSP00000216181:921, 9606.ENSP00000265748:292, 9606.ENSP00000294008:165, 9606.ENSP00000376410:161, 9606.ENSP00000356319:292, 9606.ENSP00000386857:910, 9606.ENSP00000288235:207, 9606.ENSP00000358866:161",0.5,NULL,NULL,11.6889387554131,cur_271
MYH9,7579,5,4.198500979222601,1,0.038313,9.1057,3.473,"Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss[OMIM:155100]-Autosomal dominant inheritance | Deafness, autosomal dominant 17[OMIM:603622]-Autosomal dominant inheritance","Strong (May-Hegglin anomaly[MONDO:0007954]-Autosomal dominant) | Definitive, Definitive, Supportive (macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss[MONDO:0015912]-Autosomal dominant) | Supportive (autosomal dominant nonsyndromic hearing loss[MONDO:0019587]-Autosomal dominant)",Definitive (macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss[MONDO:0015912]-AD),P:29; LP:35; VUS:355,OMIM:155100 (cyst_cilio: 0.018 | cancer: 0.01 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:155100 (antenatal_or_congenital: 0.821); OMIM:603622 (neonatal_or_pediatric: 0.2),OMIM:155100 (syndromic: 0.001),hm (true); ht (true),1,10313,0.9119496855345912,"9606.ENSP00000288235:365, 9606.ENSP00000362924:570, 9606.ENSP00000386857:910, 9606.ENSP00000451828:342, 9606.ENSP00000363435:194, 9606.ENSP00000269305:392, 9606.ENSP00000252699:447, 9606.ENSP00000265748:420, 9606.ENSP00000380911:163, 9606.ENSP00000246957:190, 9606.ENSP00000355499:500, 9606.ENSP00000379616:921, 9606.ENSP00000365891:452, 9606.ENSP00000362413:224, 9606.ENSP00000356405:426, 9606.ENSP00000290866:508, 9606.ENSP00000358866:366, 9606.ENSP00000356319:292, 9606.ENSP00000354006:292, 9606.ENSP00000265970:177, 9606.ENSP00000376410:330, 9606.ENSP00000311505:293, 9606.ENSP00000377789:201, 9606.ENSP00000337088:570, 9606.ENSP00000362424:292, 9606.ENSP00000281043:161, 9606.ENSP00000003084:315",0.5,38.1948,11.2376,224.665706387801,cur_272
MYO1E,7599,5,4.023571862532509,6.8e-5,0.30667,5.3166,0.16925,"Glomerulosclerosis, focal segmental, 6[OMIM:614131]-Autosomal recessive inheritance","Strong, Strong (focal segmental glomerulosclerosis 6[MONDO:0013589]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:6; LP:6; VUS:160,OMIM:614131 (glomerulopathy: 0.399 | complement: 0.179 | cyst_cilio: 0.173 | tubulopathy: 0.098 | cakut: 0.073 | nephrocalcinosis: 0.056 | cancer: 0.05),OMIM:614131 (neonatal_or_pediatric: 0.463),NULL,hm (true); ht (false),0.5,3306,0.59958071278826,"9606.ENSP00000356319:292, 9606.ENSP00000358866:189, 9606.ENSP00000252699:321, 9606.ENSP00000265748:511, 9606.ENSP00000376410:364, 9606.ENSP00000256078:165, 9606.ENSP00000377789:207, 9606.ENSP00000363779:345, 9606.ENSP00000216181:365, 9606.ENSP00000379616:207, 9606.ENSP00000365891:340",0.5,10.3843,10.199,234.108834261645,cur_273
MYOCD,16067,3,1.8463794505609197,0.33364,0.22834,4.7321,0.33604,"Megabladder, congenital[OMIM:618719]-Autosomal dominant inheritance","Limited (megabladder, congenital[MONDO:0032879]-Autosomal dominant)",NULL,P:2; LP:1; VUS:35,OMIM:618719 (cyst_cilio: 0.163 | glomerulopathy: 0.135 | cakut: 0.065 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,NULL,hm (false); ht (true),0.5,1026,0.24528301886792453,"9606.ENSP00000361021:387, 9606.ENSP00000262426:476, 9606.ENSP00000269305:163",0.5,0.8001659999999999,0.256253,18.4694025062697,cur_274
NADSYN1,29832,3,1.6216343161772309,0,0.69914,1.8861,0.70996,"Vertebral, cardiac, renal, and limb defects syndrome 3[OMIM:618845]-Autosomal recessive inheritance","Supportive (congenital vertebral-cardiac-renal anomalies syndrome[MONDO:0020831]-Autosomal recessive) | Moderate (vertebral, cardiac, renal, and limb defects syndrome 3[MONDO:0030077]-Autosomal recessive)",NULL,P:7; LP:3; VUS:46,OMIM:618845 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.008 | tubulopathy: 0.007),NULL,OMIM:618845 (syndromic: 0.003 | skeletal: 0.01),hm (NA); ht (NA),0,163,0.008385744234800839,9606.ENSP00000269305:163,0.5,13.7349,11.9124,15.7979972458995,cur_275
NDUFAF6,28625,2,0.7169685706555018,0,0.75313,0.95042,0.57244,"Mitochondrial complex I deficiency, nuclear type 17[OMIM:618239]-Autosomal recessive inheritance | Fanconi renotubular syndrome 5[OMIM:618913]-Autosomal recessive inheritance","Supportive (primary Fanconi syndrome[MONDO:0007600]-Autosomal dominant) | Definitive (Leigh syndrome[MONDO:0009723]-Autosomal recessive) | Supportive (Leigh syndrome with leukodystrophy[MONDO:0016815]-Autosomal recessive) | Limited (Fanconi renotubular syndrome 5[MONDO:0030056]-Autosomal recessive) | Moderate (mitochondrial complex 1 deficiency, nuclear type 17[MONDO:0032622]-Autosomal recessive)",Definitive (Leigh syndrome[MONDO:0009723]-AR),P:19; LP:10; VUS:96,OMIM:618913 (cyst_cilio: 0.144 | glomerulopathy: 0.135 | tubulopathy: 0.056 | cakut: 0.044 | complement: 0.036 | nephrocalcinosis: 0.035 | cancer: 0.02),OMIM:618239 (neonatal_or_pediatric: 0.665); OMIM:618913 (neonatal_or_pediatric: 0.2),OMIM:618239 (syndromic: 0.081 | skeletal: 0.036 | neurologic: 0.146); OMIM:618913 (syndromic: 0.002 | skeletal: 0.006),hm (NA); ht (NA),0,198,0.041928721174004195,9606.ENSP00000389998:198,0.5,3.4318699999999995,2.19639,98.9757774023918,cur_276
NEK1,7744,4,3.264296892208207,0,0.68272,2.5411,1.0701,"Short-rib thoracic dysplasia 6 with or without polydactyly[OMIM:263520]-Autosomal recessive inheritance | Short-rib thoracic dysplasia 6 with or without polydactyly[OMIM:263520]-Digenic inheritance | {Amyotrophic lateral sclerosis, susceptibility to, 24}[OMIM:617892]-Autosomal dominant inheritance","Supportive (orofaciodigital syndrome type II[MONDO:0009642]-Autosomal recessive) | Definitive, Strong (short-rib thoracic dysplasia 6 with or without polydactyly[MONDO:0009894]-Autosomal recessive) | Supportive (short rib-polydactyly syndrome, Majewski type[MONDO:0019662]-Autosomal recessive) | Definitive, Moderate (amyotrophic lateral sclerosis, susceptibility to, 24[MONDO:0054750]-Autosomal dominant)","Definitive (amyotrophic lateral sclerosis, susceptibility to, 24[MONDO:0054750]-AD)",P:35; LP:25; VUS:232,OMIM:263520 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:617892 (adult: 0.311),OMIM:263520 (syndromic: 0.044 | skeletal: 0.057 | neurologic: 0.046); OMIM:617892 (syndromic: 0.025 | neurologic: 0.053),hm (true); ht (false),0,390,0.09853249475890985,"9606.ENSP00000281043:161, 9606.ENSP00000219476:229",0.5,3.5402699999999996,2.77862,123.720664116456,cur_277
NEK8,13387,5,4.749258987985051,0,0.54404,2.497,1.1453,Renal-hepatic-pancreatic dysplasia 2[OMIM:615415]-Autosomal recessive inheritance | ?Nephronophthisis 9[OMIM:613824]-NA,"Supportive (nephronophthisis 2[MONDO:0011190]-Autosomal recessive) | Strong (nephronophthisis 9[MONDO:0013444]-Autosomal recessive) | Definitive, Strong (renal-hepatic-pancreatic dysplasia 2[MONDO:0014174]-Autosomal recessive) | Supportive (renal-hepatic-pancreatic dysplasia[MONDO:0017417]-Autosomal recessive)",Definitive (renal-hepatic-pancreatic dysplasia 2[MONDO:0014174]-AR),P:15; LP:11; VUS:149,OMIM:613824 (cyst_cilio: 0.228 | glomerulopathy: 0.135 | tubulopathy: 0.042 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02); OMIM:615415 (cyst_cilio: 0.031 | cancer: 0.03 | cakut: 0.016 | glomerulopathy: 0.007),OMIM:615415 (antenatal_or_congenital: 0.851),OMIM:615415 (syndromic: 0.001 | skeletal: 0.005),hm (true); ht (true),0.5,3510,0.6226415094339622,"9606.ENSP00000362993:384, 9606.ENSP00000338766:918, 9606.ENSP00000256474:292, 9606.ENSP00000297837:968, 9606.ENSP00000262457:787, 9606.ENSP00000285379:161",0.5,10.2514,9.470369999999999,20.0962608721651,cur_278
NFIA,7784,3,1.6686540259883689,NULL,NULL,NULL,NULL,Brain malformations with or without urinary tract defects[OMIM:613735]-Autosomal dominant inheritance,"Definitive, Strong, Strong (chromosome 1p32-p31 deletion syndrome[MONDO:0013396]-Autosomal dominant) | Definitive (brain malformations with or without urinary tract defects[MONDO:0100478]-Autosomal dominant)",Definitive (brain malformations with or without urinary tract defects[MONDO:0100478]-AD),P:24; LP:23; VUS:73,OMIM:613735 (cakut: 0.226 | cyst_cilio: 0.058 | cancer: 0.05 | glomerulopathy: 0.007 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:613735 (neonatal_or_pediatric: 0.402),OMIM:613735 (syndromic: 0.116 | growth: 0.171 | skeletal: 0.016 | neurologic: 0.171),hm (true); ht (true),0.5,2673,0.5157232704402516,"9606.ENSP00000359319:292, 9606.ENSP00000414321:205, 9606.ENSP00000368632:292, 9606.ENSP00000304286:292, 9606.ENSP00000348984:205, 9606.ENSP00000231509:165, 9606.ENSP00000245479:744, 9606.ENSP00000484803:186, 9606.ENSP00000297316:292",0.5,4.60056,3.6955,397.881758145856,cur_279
NIPBL,28862,4,2.3222572463238818,1,0.006653,11.286,5.5737,Cornelia de Lange syndrome 1[OMIM:122470]-Autosomal dominant inheritance,"Definitive, Strong (Cornelia de Lange syndrome 1[MONDO:0007387]-Autosomal dominant) | Definitive, Supportive (Cornelia de Lange syndrome[MONDO:0016033]-Autosomal dominant)",Definitive (Cornelia de Lange syndrome[MONDO:0016033]-AD),P:350; LP:124; VUS:440,OMIM:122470 (cakut: 0.226 | cyst_cilio: 0.136 | cancer: 0.1 | nephrocalcinosis: 0.014 | glomerulopathy: 0.013 | tubulopathy: 0.007),NULL,OMIM:122470 (syndromic: 0.155 | growth: 0.352 | skeletal: 0.139 | neurologic: 0.134),hm (false); ht (false),0.5,1576,0.3522012578616352,"9606.ENSP00000231509:417, 9606.ENSP00000306999:161, 9606.ENSP00000323421:998",0.5,9.71102,5.78346,407.130047511757,cur_280
NLRP3,16400,5,3.390602964560015,8.11e-4,0.32627,3.9408,2.1417,"CINCA syndrome[OMIM:607115]-Autosomal dominant inheritance | Familial cold inflammatory syndrome 1[OMIM:120100]-Autosomal dominant inheritance | Keratoendothelitis fugax hereditaria[OMIM:148200]-Autosomal dominant inheritance | Deafness, autosomal dominant 34, with or without inflammation[OMIM:617772]-Autosomal dominant inheritance | Muckle-Wells syndrome[OMIM:191900]-Autosomal dominant inheritance","Strong (familial cold autoinflammatory syndrome 1[MONDO:0007349]-Autosomal dominant) | Limited (keratitis fugax hereditaria[MONDO:0007849]-Autosomal dominant) | Supportive (Muckle-Wells syndrome[MONDO:0008633]-Autosomal dominant) | Definitive, Strong, Supportive (CINCA syndrome[MONDO:0011776]-Autosomal dominant) | Definitive (cryopyrin-associated periodic syndrome[MONDO:0016168]-Autosomal dominant) | Supportive (familial cold autoinflammatory syndrome[MONDO:0018768]-Autosomal dominant)",NULL,P:30; LP:28; VUS:373,OMIM:120100 (glomerulopathy: 0.009); OMIM:191900 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.091 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:120100 (neonatal_or_pediatric: 0.402); OMIM:148200 (adult: 0.372 | neonatal_or_pediatric: 0.2); OMIM:191900 (neonatal_or_pediatric: 0.463); OMIM:607115 (neonatal_or_pediatric: 0.799); OMIM:617772 (adult: 0.372),OMIM:120100 (syndromic: 0.002 | skeletal: 0.003 | neurologic: 0.002); OMIM:148200 (syndromic: 0.002 | neurologic: 0.004); OMIM:191900 (syndromic: 0.015 | growth: 0.25 | skeletal: 0.002); OMIM:607115 (syndromic: 0.03 | growth: 0.091 | skeletal: 0.018 | neurologic: 0.042); OMIM:617772 (syndromic: 0.002 | skeletal: 0.003 | neurologic: 0.002),hm (false); ht (false),0.5,2159,0.43186582809224316,"9606.ENSP00000260010:237, 9606.ENSP00000362680:292, 9606.ENSP00000269305:345, 9606.ENSP00000219596:993, 9606.ENSP00000228606:292",0,0.480627,0.321581,6.47634563357747,cur_281
NOS1AP,16859,2,1.6776501763218812,0.61424,0.20128,3.689,2.0372,"Nephrotic syndrome, type 22[OMIM:619155]-Autosomal recessive inheritance","Limited (nephrotic syndrome, type 22[MONDO:0030895]-Autosomal recessive)",NULL,P:2; LP:0; VUS:21,OMIM:619155 (glomerulopathy: 0.299 | cyst_cilio: 0.134 | tubulopathy: 0.077 | cancer: 0.05 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:619155 (neonatal_or_pediatric: 0.537),NULL,hm (false); ht (false),0,NULL,NULL,NULL,0.5,0.723286,0.545017,125.613847893619,cur_282
NOTCH2,7882,5,4.01983195354185,1,0.058619,8.8255,3.5024,Alagille syndrome 2[OMIM:610205]-Autosomal dominant inheritance | Hajdu-Cheney syndrome[OMIM:102500]-Autosomal dominant inheritance,"Definitive, Strong, Supportive (Acroosteolysis dominant type[MONDO:0007057]-Autosomal dominant) | Moderate (Alagille syndrome[MONDO:0007318]-Autosomal dominant) | Strong (Alagille syndrome due to a NOTCH2 point mutation[MONDO:0012439]-Autosomal dominant)",NULL,P:54; LP:16; VUS:517,OMIM:102500 (cyst_cilio: 0.155 | cakut: 0.056 | cancer: 0.04 | glomerulopathy: 0.007 | tubulopathy: 0.007); OMIM:610205 (complement: 0.214 | cyst_cilio: 0.213 | cakut: 0.198 | nephrocalcinosis: 0.16 | tubulopathy: 0.147 | glomerulopathy: 0.137 | cancer: 0.05),NULL,OMIM:102500 (syndromic: 0.142 | growth: 0.421 | skeletal: 0.1 | neurologic: 0.097); OMIM:610205 (syndromic: 0.006),hm (true); ht (true),0.5,2803,0.5345911949685535,"9606.ENSP00000254958:997, 9606.ENSP00000260010:216, 9606.ENSP00000386896:238, 9606.ENSP00000420194:292, 9606.ENSP00000364860:163, 9606.ENSP00000418735:171, 9606.ENSP00000262367:563, 9606.ENSP00000256078:163",0.5,8.21947,4.62321,281.624027171981,cur_283
NPHP1,7905,5,4.910894949856732,NULL,NULL,NULL,NULL,"Joubert syndrome 4[OMIM:609583]-Autosomal recessive inheritance | Nephronophthisis 1, juvenile[OMIM:256100]-Autosomal recessive inheritance | Senior-Loken syndrome-1[OMIM:266900]-Autosomal recessive inheritance","Definitive, Definitive, Supportive (nephronophthisis 1[MONDO:0009728]-Autosomal recessive) | Definitive, Moderate, Supportive (Joubert syndrome with renal defect[MONDO:0012308]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive)",Definitive (nephronophthisis 1[MONDO:0009728]-AR),P:42; LP:20; VUS:309,OMIM:256100 (cyst_cilio: 0.32 | tubulopathy: 0.168 | glomerulopathy: 0.162 | nephrocalcinosis: 0.111 | cakut: 0.048 | complement: 0.036 | cancer: 0.02); OMIM:266900 (cyst_cilio: 0.341 | tubulopathy: 0.28 | glomerulopathy: 0.222 | nephrocalcinosis: 0.222 | complement: 0.107 | cakut: 0.089 | cancer: 0.02); OMIM:609583 (cyst_cilio: 0.294 | glomerulopathy: 0.217 | tubulopathy: 0.147 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.081 | cancer: 0.02),OMIM:266900 (adult: 0.372 | neonatal_or_pediatric: 0.2); OMIM:609583 (antenatal_or_congenital: 0.821),OMIM:256100 (syndromic: 0.005 | growth: 0.091 | neurologic: 0.001); OMIM:266900 (syndromic: 0.02 | neurologic: 0.041); OMIM:609583 (syndromic: 0.039 | neurologic: 0.081),hm (true); ht (false),1,9440,0.8867924528301887,"9606.ENSP00000278935:292, 9606.ENSP00000336655:422, 9606.ENSP00000258173:327, 9606.ENSP00000262457:538, 9606.ENSP00000261499:621, 9606.ENSP00000367398:996, 9606.ENSP00000376827:607, 9606.ENSP00000403465:288, 9606.ENSP00000262304:599, 9606.ENSP00000311505:324, 9606.ENSP00000389998:806, 9606.ENSP00000314116:302, 9606.ENSP00000338766:642, 9606.ENSP00000324856:738, 9606.ENSP00000310668:161, 9606.ENSP00000358866:328, 9606.ENSP00000448012:609, 9606.ENSP00000386264:420, 9606.ENSP00000243578:420",0.5,4.64401,3.6141300000000003,34.6287943946162,cur_284
NPHP3,7907,5,4.916135445113472,0,0.49536,4.0957,0.86354,Nephronophthisis 3[OMIM:604387]-Autosomal recessive inheritance | Renal-hepatic-pancreatic dysplasia 1[OMIM:208540]-Autosomal recessive inheritance | Meckel syndrome 7[OMIM:267010]-Autosomal recessive inheritance,Supportive (NPHP3-related Meckel-like syndrome[MONDO:0009966]-Autosomal recessive) | Supportive (nephronophthisis 2[MONDO:0011190]-Autosomal recessive) | Definitive (nephronophthisis 3[MONDO:0011456]-Autosomal recessive) | Supportive (renal-hepatic-pancreatic dysplasia[MONDO:0017417]-Autosomal recessive) | Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive) | Definitive (nephronophthisis[MONDO:0019005]-Autosomal recessive) | Supportive (late-onset nephronophthisis[MONDO:0019742]-Autosomal recessive),Definitive (nephronophthisis[MONDO:0019005]-AR),P:80; LP:44; VUS:534,OMIM:208540 (cyst_cilio: 0.302 | glomerulopathy: 0.22 | cakut: 0.165 | tubulopathy: 0.147 | nephrocalcinosis: 0.132 | complement: 0.107 | cancer: 0.06); OMIM:267010 (cyst_cilio: 0.139 | glomerulopathy: 0.131 | cakut: 0.065 | tubulopathy: 0.049 | complement: 0.036 | cancer: 0.03 | nephrocalcinosis: 0.021); OMIM:604387 (cyst_cilio: 0.388 | tubulopathy: 0.308 | glomerulopathy: 0.288 | complement: 0.25 | nephrocalcinosis: 0.25 | cakut: 0.105 | cancer: 0.02),OMIM:208540 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402),OMIM:208540 (syndromic: 0.002 | skeletal: 0.004 | neurologic: 0.002); OMIM:267010 (syndromic: 0.005 | skeletal: 0.009 | neurologic: 0.003); OMIM:604387 (syndromic: 0 | neurologic: 0.001),hm (true); ht (true),1,8361,0.8511530398322851,"9606.ENSP00000311505:502, 9606.ENSP00000482306:374, 9606.ENSP00000448012:433, 9606.ENSP00000268057:436, 9606.ENSP00000362121:194, 9606.ENSP00000260746:565, 9606.ENSP00000268766:918, 9606.ENSP00000278935:297, 9606.ENSP00000313169:642, 9606.ENSP00000297837:897, 9606.ENSP00000367721:381, 9606.ENSP00000356405:244, 9606.ENSP00000262457:673, 9606.ENSP00000242591:153, 9606.ENSP00000317469:442, 9606.ENSP00000367398:594, 9606.ENSP00000245157:451, 9606.ENSP00000417132:165",0.5,11.4243,8.41465,103.004543629485,cur_285
NPHP4,19104,5,4.826031071999589,0,0.78155,1.6669,-0.24249,Senior-Loken syndrome 4[OMIM:606996]-Autosomal recessive inheritance | Nephronophthisis 4[OMIM:606966]-Autosomal recessive inheritance,"Supportive (nephronophthisis 1[MONDO:0009728]-Autosomal recessive) | Definitive, Definitive (nephronophthisis 4[MONDO:0011752]-Autosomal recessive) | Definitive (Senior-Loken syndrome 4[MONDO:0011756]-Autosomal recessive) | Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive)",Definitive (nephronophthisis 4[MONDO:0011752]-AR),P:67; LP:40; VUS:773,OMIM:606966 (cyst_cilio: 0.31 | tubulopathy: 0.168 | glomerulopathy: 0.162 | nephrocalcinosis: 0.111 | cakut: 0.048 | complement: 0.036 | cancer: 0.02); OMIM:606996 (cyst_cilio: 0.247 | tubulopathy: 0.154 | glomerulopathy: 0.14 | nephrocalcinosis: 0.097 | cakut: 0.048 | complement: 0.036 | cancer: 0.02),NULL,OMIM:606966 (syndromic: 0.005 | growth: 0.091 | neurologic: 0.001); OMIM:606996 (syndromic: 0 | neurologic: 0.001),hm (true); ht (false),0.5,7185,0.8238993710691824,"9606.ENSP00000243578:400, 9606.ENSP00000338766:594, 9606.ENSP00000386264:266, 9606.ENSP00000314116:256, 9606.ENSP00000334003:500, 9606.ENSP00000262457:663, 9606.ENSP00000261499:547, 9606.ENSP00000389998:696, 9606.ENSP00000311505:239, 9606.ENSP00000448012:693, 9606.ENSP00000258173:295, 9606.ENSP00000403465:193, 9606.ENSP00000313169:996, 9606.ENSP00000278935:292, 9606.ENSP00000376827:555",0.5,4.90315,3.7502699999999995,29.274854789684,cur_286
NPHS1,7908,5,4.185246072003746,0,0.52087,3.534,0.40824,"Nephrotic syndrome, type 1[OMIM:256300]-Autosomal recessive inheritance","Strong (nephrotic syndrome[MONDO:0005377]-Autosomal recessive) | Definitive, Definitive, Supportive (congenital nephrotic syndrome, Finnish type[MONDO:0009732]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:143; LP:211; VUS:243,OMIM:256300 (glomerulopathy: 0.16 | nephrocalcinosis: 0.139 | tubulopathy: 0.126 | cyst_cilio: 0.102 | complement: 0.071 | cakut: 0.048 | cancer: 0.02),OMIM:256300 (antenatal_or_congenital: 0.821),OMIM:256300 (syndromic: 0.007 | growth: 0.137),hm (true); ht (true),1,9300,0.8825995807127882,"9606.ENSP00000377789:278, 9606.ENSP00000356587:987, 9606.ENSP00000367817:303, 9606.ENSP00000406229:870, 9606.ENSP00000340913:919, 9606.ENSP00000352264:993, 9606.ENSP00000252699:914, 9606.ENSP00000360431:331, 9606.ENSP00000352138:998, 9606.ENSP00000339191:605, 9606.ENSP00000206542:437, 9606.ENSP00000262418:286, 9606.ENSP00000365891:339, 9606.ENSP00000417335:388, 9606.ENSP00000346151:499, 9606.ENSP00000376410:153",0.5,3.13043,36.7847,72.932035279674,cur_287
NPHS2,13394,5,4.163087251432297,0,0.76304,0.97359,0.68612,"Nephrotic syndrome, type 2[OMIM:600995]-Autosomal recessive inheritance","Definitive, Definitive, Definitive, Strong (nephrotic syndrome, type 2[MONDO:0010974]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:63; LP:62; VUS:86,OMIM:600995 (glomerulopathy: 0.333 | cyst_cilio: 0.134 | cakut: 0.056 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:600995 (neonatal_or_pediatric: 0.463),NULL,hm (true); ht (false),0.5,6570,0.8134171907756813,"9606.ENSP00000252699:739, 9606.ENSP00000352264:990, 9606.ENSP00000406229:873, 9606.ENSP00000367817:286, 9606.ENSP00000229179:303, 9606.ENSP00000340913:977, 9606.ENSP00000377789:159, 9606.ENSP00000413908:276, 9606.ENSP00000368190:987, 9606.ENSP00000352138:980",0.5,22.8777,174.96400000000003,52.1245523813483,cur_288
NR3C1,7978,3,1.928769941041926,NULL,NULL,NULL,NULL,Glucocorticoid resistance[OMIM:615962]-Autosomal dominant inheritance,"Strong, Strong, Strong, Supportive (glucocorticoid resistance[MONDO:0014421]-Autosomal dominant)",NULL,P:11; LP:2; VUS:123,NULL,OMIM:615962 (adult: 0.372),OMIM:615962 (syndromic: 0.002 | neurologic: 0.004),hm (false); ht (true),1,16102,0.9874213836477987,"9606.ENSP00000347244:165, 9606.ENSP00000360231:165, 9606.ENSP00000363435:165, 9606.ENSP00000285071:285, 9606.ENSP00000405890:486, 9606.ENSP00000301067:457, 9606.ENSP00000397908:408, 9606.ENSP00000339191:547, 9606.ENSP00000290866:216, 9606.ENSP00000246957:316, 9606.ENSP00000287820:513, 9606.ENSP00000363779:165, 9606.ENSP00000479904:165, 9606.ENSP00000376465:165, 9606.ENSP00000381098:723, 9606.ENSP00000245907:292, 9606.ENSP00000349658:292, 9606.ENSP00000314129:165, 9606.ENSP00000352264:197, 9606.ENSP00000414398:165, 9606.ENSP00000445306:292, 9606.ENSP00000349823:165, 9606.ENSP00000367815:165, 9606.ENSP00000359297:165, 9606.ENSP00000351015:165, 9606.ENSP00000312397:165, 9606.ENSP00000236850:292, 9606.ENSP00000392028:165, 9606.ENSP00000264499:165, 9606.ENSP00000265748:189, 9606.ENSP00000452762:165, 9606.ENSP00000262367:630, 9606.ENSP00000368253:229, 9606.ENSP00000282516:417, 9606.ENSP00000348849:292, 9606.ENSP00000451828:450, 9606.ENSP00000350815:861, 9606.ENSP00000347717:292, 9606.ENSP00000252699:309, 9606.ENSP00000377836:342, 9606.ENSP00000269305:782, 9606.ENSP00000377934:165, 9606.ENSP00000361845:292, 9606.ENSP00000323421:210, 9606.ENSP00000426978:165, 9606.ENSP00000256474:165, 9606.ENSP00000205557:165, 9606.ENSP00000251020:165, 9606.ENSP00000297185:292, 9606.ENSP00000312987:579, 9606.ENSP00000357998:165, 9606.ENSP00000367203:165, 9606.ENSP00000252590:165, 9606.ENSP00000377862:165, 9606.ENSP00000262210:165, 9606.ENSP00000459943:165, 9606.ENSP00000382717:165",0.5,8.16735,5.35466,98.6419136405181,cur_289
NR3C2,7979,4,3.309985989064211,0.83739,0.19414,4.7937,2.0951,"Pseudohypoaldosteronism type I, autosomal dominant[OMIM:177735]-Autosomal dominant inheritance | Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy[OMIM:605115]-NA","Definitive, Definitive, Definitive, Supportive (autosomal dominant pseudohypoaldosteronism type 1[MONDO:0008329]-Autosomal dominant) | Limited (pseudohyperaldosteronism type 2[MONDO:0011517]-Autosomal dominant)",Definitive (autosomal dominant pseudohypoaldosteronism type 1[MONDO:0008329]-AD) | Limited (pseudohyperaldosteronism type 2[MONDO:0011517]-AD),P:25; LP:13; VUS:109,NULL,OMIM:177735 (neonatal_or_pediatric: 0.134),OMIM:177735 (syndromic: 0.009 | growth: 0.171),hm (true); ht (true),0.5,2059,0.4192872117400419,"9606.ENSP00000231509:861, 9606.ENSP00000355627:614, 9606.ENSP00000262367:292, 9606.ENSP00000339191:292",0.5,7.369489999999999,5.36992,129.788736745971,cur_290
NUP107,29914,5,4.17901175230969,0,0.41079,4.3437,1.885,"?Ovarian dysgenesis 6[OMIM:618078]-Autosomal recessive inheritance | Galloway-Mowat syndrome 7[OMIM:618348]-Autosomal recessive inheritance | Nephrotic syndrome, type 11[OMIM:616730]-Autosomal recessive inheritance","Supportive (46 XX gonadal dysgenesis[MONDO:0009299]-Autosomal dominant) | Supportive (Galloway-Mowat syndrome[MONDO:0009627]-Autosomal recessive) | Moderate (nephrotic syndrome, type 11[MONDO:0014752]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant) | Limited, Limited (Galloway-Mowat syndrome 7[MONDO:0032692]-Autosomal recessive) | Limited (ovarian dysgenesis 6[MONDO:0054850]-Autosomal recessive)",NULL,P:9; LP:7; VUS:73,OMIM:616730 (glomerulopathy: 0.395 | cyst_cilio: 0.165 | tubulopathy: 0.063 | cakut: 0.056 | cancer: 0.05 | complement: 0.036 | nephrocalcinosis: 0.028); OMIM:618348 (glomerulopathy: 0.395 | cyst_cilio: 0.165 | tubulopathy: 0.063 | cakut: 0.056 | cancer: 0.05 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:618078 (neonatal_or_pediatric: 0.2); OMIM:618348 (neonatal_or_pediatric: 0.2),OMIM:616730 (syndromic: 0.066 | skeletal: 0.039 | neurologic: 0.071); OMIM:618348 (syndromic: 0.119 | growth: 0.25 | skeletal: 0.112 | neurologic: 0.14),hm (false); ht (false),0.5,6560,0.8092243186582809,"9606.ENSP00000243253:163, 9606.ENSP00000367721:999, 9606.ENSP00000285968:991, 9606.ENSP00000355922:292, 9606.ENSP00000245544:999, 9606.ENSP00000357283:204, 9606.ENSP00000261396:999, 9606.ENSP00000256078:163, 9606.ENSP00000365380:165, 9606.ENSP00000310668:990, 9606.ENSP00000356319:292, 9606.ENSP00000356587:303",0.5,15.2432,9.37045,86.2922629477578,cur_291
NUP133,18016,4,3.2603721887686805,9.3e-5,0.30814,5.1651,1.024,"?Galloway-Mowat syndrome 8[OMIM:618349]-Autosomal recessive inheritance | Nephrotic syndrome, type 18[OMIM:618177]-Autosomal recessive inheritance","Supportive (Galloway-Mowat syndrome[MONDO:0009627]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant) | Strong, Limited (Galloway-Mowat syndrome 8[MONDO:0032693]-Autosomal recessive)",NULL,P:1; LP:5; VUS:89,OMIM:618177 (glomerulopathy: 0.259 | cyst_cilio: 0.136 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028); OMIM:618349 (glomerulopathy: 0.399 | complement: 0.179 | cyst_cilio: 0.173 | tubulopathy: 0.098 | cakut: 0.073 | nephrocalcinosis: 0.056 | cancer: 0.05),OMIM:618177 (neonatal_or_pediatric: 0.463); OMIM:618349 (neonatal_or_pediatric: 0.397),OMIM:618349 (syndromic: 0.069 | skeletal: 0.053 | neurologic: 0.137),hm (false); ht (false),0.5,7043,0.8197064989517819,"9606.ENSP00000269305:163, 9606.ENSP00000310668:954, 9606.ENSP00000356319:292, 9606.ENSP00000229179:999, 9606.ENSP00000365380:165, 9606.ENSP00000245544:999, 9606.ENSP00000355922:694, 9606.ENSP00000479904:239, 9606.ENSP00000357283:595, 9606.ENSP00000285968:944, 9606.ENSP00000367721:999",0.5,11.6751,7.806839999999999,64.6080083278472,cur_292
NUP160,18017,3,2.217733418052269,7e-6,0.30413,6.0758,1.0446,"?Nephrotic syndrome, type 19[OMIM:618178]-Autosomal recessive inheritance","Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant) | Strong, Limited (nephrotic syndrome, type 19[MONDO:0032582]-Autosomal recessive)",NULL,P:4; LP:0; VUS:125,OMIM:618178 (glomerulopathy: 0.133 | cancer: 0.03 | cakut: 0.012 | cyst_cilio: 0.01 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:618178 (neonatal_or_pediatric: 0.2),NULL,hm (false); ht (false),0.5,6157,0.790356394129979,"9606.ENSP00000269305:163, 9606.ENSP00000310668:939, 9606.ENSP00000229179:999, 9606.ENSP00000365380:165, 9606.ENSP00000265748:292, 9606.ENSP00000261396:999, 9606.ENSP00000245544:999, 9606.ENSP00000338766:381, 9606.ENSP00000285968:925, 9606.ENSP00000262457:295",0.5,11.0435,6.32201,206.921194386652,cur_293
NUP205,18658,4,2.78052670943921,1,0.15675,8.3734,1.3537,"?Nephrotic syndrome, type 13[OMIM:616893]-Autosomal recessive inheritance","Limited (nephrotic syndrome, type 13[MONDO:0014818]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant) | Strong (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal recessive)",NULL,P:1; LP:1; VUS:136,OMIM:616893 (glomerulopathy: 0.259 | cyst_cilio: 0.136 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),NULL,NULL,hm (NA); ht (NA),0.5,4837,0.7337526205450734,"9606.ENSP00000310668:999, 9606.ENSP00000229179:991, 9606.ENSP00000261396:944, 9606.ENSP00000245544:978, 9606.ENSP00000367721:925",0.5,10.9356,6.75813,67.3211033004516,cur_294
NUP85,8734,3,2.3136608038901785,1,0.046109,5.8216,0.75518,"Nephrotic syndrome, type 17[OMIM:618176]-Autosomal recessive inheritance","No Known Disease Relationship (Tourette syndrome[MONDO:0007661]-Unknown) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant) | Limited (nephrotic syndrome, type 17[MONDO:0032580]-Autosomal recessive)",NULL,P:1; LP:2; VUS:60,OMIM:618176 (glomerulopathy: 0.288 | cyst_cilio: 0.136 | tubulopathy: 0.077 | cancer: 0.05 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:618176 (neonatal_or_pediatric: 0.463),OMIM:618176 (syndromic: 0.013 | growth: 0.25),hm (false); ht (false),0.5,5518,0.7714884696016772,"9606.ENSP00000356319:292, 9606.ENSP00000310668:981, 9606.ENSP00000229179:999, 9606.ENSP00000261396:999, 9606.ENSP00000426978:270, 9606.ENSP00000367721:999, 9606.ENSP00000285968:978",0.5,20.8168,10.556,28.5562867497354,cur_295
NUP93,28958,5,3.799492211731466,2e-6,0.38084,4.0526,1.2994,"Nephrotic syndrome, type 12[OMIM:616892]-Autosomal recessive inheritance","Strong, Moderate (nephrotic syndrome, type 12[MONDO:0014817]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant) | Strong (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal recessive)",NULL,P:6; LP:7; VUS:56,OMIM:616892 (glomerulopathy: 0.304 | complement: 0.179 | cyst_cilio: 0.147 | tubulopathy: 0.084 | cakut: 0.065 | nephrocalcinosis: 0.056 | cancer: 0.05),NULL,NULL,hm (NA); ht (NA),0.5,6542,0.8029350104821803,"9606.ENSP00000285968:999, 9606.ENSP00000367721:939, 9606.ENSP00000313169:161, 9606.ENSP00000245544:981, 9606.ENSP00000265748:292, 9606.ENSP00000265351:243, 9606.ENSP00000261396:954, 9606.ENSP00000311505:156, 9606.ENSP00000291582:362, 9606.ENSP00000229179:990, 9606.ENSP00000448012:173, 9606.ENSP00000356319:292",0.5,16.5961,10.2542,60.1033928820235,cur_296
NXF5,8075,2,1.324407947331511,NULL,NULL,NULL,NULL,NULL,NULL,NULL,P:0; LP:0; VUS:22,NULL,NULL,NULL,hm (NA); ht (NA),0,435,0.10272536687631027,"9606.ENSP00000245544:270, 9606.ENSP00000231509:165",0,0.26934400000000003,0.199904,0.287428136066848,cur_297
OCRL,8108,5,4.568801890282421,0.99999,0.049158,5.6201,2.9631,Dent disease 2[OMIM:300555]-X-linked recessive inheritance | Lowe syndrome[OMIM:309000]-X-linked recessive inheritance,"Definitive, Definitive, Strong, Supportive (Dent disease type 2[MONDO:0010359]-X-linked) | Definitive (Dent disease type 2[MONDO:0010359]-X-linked recessive) | Definitive, Definitive, Definitive, Definitive, Strong, Supportive (oculocerebrorenal syndrome[MONDO:0010645]-X-linked) | Definitive (oculocerebrorenal syndrome[MONDO:0010645]-X-linked recessive)",Definitive (oculocerebrorenal syndrome[MONDO:0010645]-XL),P:74; LP:42; VUS:115,OMIM:300555 (nephrocalcinosis: 0.215 | tubulopathy: 0.168 | glomerulopathy: 0.051 | complement: 0.036 | cakut: 0.024 | cyst_cilio: 0.016 | cancer: 0.01); OMIM:309000 (glomerulopathy: 0.213 | cyst_cilio: 0.194 | tubulopathy: 0.168 | nephrocalcinosis: 0.139 | complement: 0.107 | cakut: 0.081 | cancer: 0.02),OMIM:300555 (neonatal_or_pediatric: 0.262); OMIM:309000 (antenatal_or_congenital: 0.821),OMIM:300555 (syndromic: 0.015 | growth: 0.25 | neurologic: 0.004); OMIM:309000 (syndromic: 0.125 | growth: 0.455 | skeletal: 0.084 | neurologic: 0.162),hm (false); ht (false),0.5,2181,0.4339622641509434,"9606.ENSP00000360777:900, 9606.ENSP00000364860:163, 9606.ENSP00000269305:163, 9606.ENSP00000451828:456, 9606.ENSP00000349781:499",0.5,13.1387,8.85872,14.9867843463113,cur_298
OFD1,2567,5,4.09398798577922,0.95968,0.17119,4.9112,0.31954,"Simpson-Golabi-Behmel syndrome, type 2[OMIM:300209]-X-linked recessive inheritance | ?Retinitis pigmentosa 23[OMIM:300424]-X-linked recessive inheritance | Orofaciodigital syndrome I[OMIM:311200]-X-linked dominant inheritance | Joubert syndrome 10[OMIM:300804]-X-linked recessive inheritance","Definitive (ciliopathy[MONDO:0005308]-X-linked) | Supportive (orofaciodigital syndrome type 6[MONDO:0010176]-Autosomal recessive) | Limited (Simpson-Golabi-Behmel syndrome type 2[MONDO:0010265]-X-linked) | Definitive (Simpson-Golabi-Behmel syndrome type 2[MONDO:0010265]-X-linked recessive) | Strong (retinitis pigmentosa 23[MONDO:0010320]-X-linked) | Definitive (Joubert syndrome 10[MONDO:0010431]-X-linked) | Definitive (Joubert syndrome 10[MONDO:0010431]-X-linked recessive) | Definitive, Strong, Supportive (orofaciodigital syndrome I[MONDO:0010702]-X-linked) | Definitive (orofaciodigital syndrome I[MONDO:0010702]-X-linked dominant) | Supportive (primary ciliary dyskinesia[MONDO:0016575]-Autosomal dominant) | Supportive (retinitis pigmentosa[MONDO:0019200]-Autosomal dominant)",Definitive (ciliopathy[MONDO:0005308]-XL),P:92; LP:33; VUS:313,OMIM:311200 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:300209 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402); OMIM:300424 (neonatal_or_pediatric: 0.463); OMIM:311200 (antenatal_or_congenital: 0.821),OMIM:300209 (syndromic: 0.052 | growth: 0.043 | skeletal: 0.026 | neurologic: 0.069); OMIM:300424 (syndromic: 0.002 | neurologic: 0.004); OMIM:300804 (syndromic: 0.081 | growth: 0.091 | skeletal: 0.037 | neurologic: 0.099); OMIM:311200 (syndromic: 0.133 | growth: 0.25 | skeletal: 0.108 | neurologic: 0.137),hm (false); ht (false),0.5,4751,0.7232704402515723,"9606.ENSP00000403465:292, 9606.ENSP00000334379:434, 9606.ENSP00000355499:863, 9606.ENSP00000216911:212, 9606.ENSP00000265748:292, 9606.ENSP00000356319:292, 9606.ENSP00000341292:234, 9606.ENSP00000262210:449, 9606.ENSP00000451828:199, 9606.ENSP00000448012:292, 9606.ENSP00000268057:163, 9606.ENSP00000355250:737, 9606.ENSP00000269305:292",0.5,19.2625,12.867,64.5128190819049,cur_299
OSGEP,18028,5,3.321972510705364,0,0.69349,1.2762,0.75927,Galloway-Mowat syndrome 3[OMIM:617729]-Autosomal recessive inheritance,"Supportive (Galloway-Mowat syndrome[MONDO:0009627]-Autosomal recessive) | Strong, Strong (Galloway-Mowat syndrome 3[MONDO:0033007]-Autosomal recessive)",NULL,P:6; LP:11; VUS:57,OMIM:617729 (glomerulopathy: 0.288 | cyst_cilio: 0.131 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.044 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:617729 (antenatal_or_congenital: 0.821),OMIM:617729 (syndromic: 0.195 | growth: 0.523 | skeletal: 0.12 | neurologic: 0.246),hm (NA); ht (NA),0.5,4491,0.7064989517819706,"9606.ENSP00000306320:998, 9606.ENSP00000361186:999, 9606.ENSP00000362135:254, 9606.ENSP00000349923:999, 9606.ENSP00000285379:390, 9606.ENSP00000413017:414, 9606.ENSP00000368190:437",0.5,19.9178,13.3114,32.6421465683026,cur_300
OXGR1,4531,2,1.1436601770586552,NULL,NULL,NULL,NULL,"Nephrolithiasis, calcium oxalate, 2, with nephrocalcinosis[OMIM:620374]-Autosomal dominant inheritance",NULL,NULL,P:3; LP:0; VUS:16,OMIM:620374 (nephrocalcinosis: 0.299 | tubulopathy: 0.259 | glomerulopathy: 0.029 | cakut: 0.02 | cancer: 0.01 | cyst_cilio: 0.008),OMIM:620374 (adult: 0.683 | neonatal_or_pediatric: 0.2),NULL,hm (true); ht (false),0,NULL,NULL,NULL,0,2.03772,1.94382,1.77827098040854,cur_301
PAX2,8616,5,4.834140432518588,NULL,NULL,NULL,NULL,"Glomerulosclerosis, focal segmental, 7[OMIM:616002]-Autosomal dominant inheritance | Papillorenal syndrome[OMIM:120330]-Autosomal dominant inheritance","Definitive, Strong, Strong, Moderate, Supportive (renal coloboma syndrome[MONDO:0007352]-Autosomal dominant) | Definitive (focal segmental glomerulosclerosis 7[MONDO:0014451]-Autosomal dominant) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",Definitive (focal segmental glomerulosclerosis 7[MONDO:0014451]-AD),P:43; LP:34; VUS:144,OMIM:120330 (cakut: 0.298 | cyst_cilio: 0.291 | glomerulopathy: 0.217 | tubulopathy: 0.217 | nephrocalcinosis: 0.215 | complement: 0.179 | cancer: 0.13); OMIM:616002 (glomerulopathy: 0.337 | cyst_cilio: 0.171 | cakut: 0.145 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:120330 (antenatal_or_congenital: 0.821); OMIM:616002 (adult: 0.218),OMIM:120330 (syndromic: 0.067 | growth: 0.25 | skeletal: 0.046 | neurologic: 0.084),hm (true); ht (true),0.5,2272,0.4570230607966457,"9606.ENSP00000264499:229, 9606.ENSP00000360231:292, 9606.ENSP00000245157:229, 9606.ENSP00000317469:229, 9606.ENSP00000268057:229, 9606.ENSP00000484803:165, 9606.ENSP00000480291:292, 9606.ENSP00000347684:607",0.5,57.9495,52.7587,744.304778880028,cur_302
PBX1,8632,5,3.561631576184093,0.99527,0.081067,4.2296,3.8266,"Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay[OMIM:617641]-Autosomal dominant inheritance","Definitive, Strong, Strong (congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay[MONDO:0060549]-Autosomal dominant)","Definitive (congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay[MONDO:0060549]-AD)",P:24; LP:20; VUS:15,OMIM:617641 (cakut: 0.395 | cyst_cilio: 0.181 | cancer: 0.17 | tubulopathy: 0.112 | nephrocalcinosis: 0.111 | glomerulopathy: 0.095 | complement: 0.071),NULL,OMIM:617641 (syndromic: 0.071 | growth: 0.091 | neurologic: 0.088),hm (true); ht (false),0.5,3304,0.5974842767295597,"9606.ENSP00000368632:332, 9606.ENSP00000262367:300, 9606.ENSP00000484803:800, 9606.ENSP00000347684:595, 9606.ENSP00000231509:486, 9606.ENSP00000370421:791",0.5,8.07294,7.1546,980.086926789872,cur_303
PCBD1,8646,3,1.690494668177743,3.32e-4,1.0531,-0.10717,0.71581,"Hyperphenylalaninemia, BH4-deficient, D[OMIM:264070]-Autosomal recessive inheritance","Definitive, Definitive, Strong, Strong, Moderate, Supportive (pterin-4 alpha-carbinolamine dehydratase 1 deficiency[MONDO:0009908]-Autosomal recessive)",Definitive (pterin-4 alpha-carbinolamine dehydratase 1 deficiency[MONDO:0009908]-AR),P:4; LP:5; VUS:23,NULL,NULL,OMIM:264070 (syndromic: 0.012 | neurologic: 0.024),hm (true); ht (false),0.5,670,0.16981132075471697,9606.ENSP00000480291:670,0.5,73.0743,81.5819,22.9903939783395,cur_304
PDE6D,8788,3,1.975208574151117,0.006423,0.48426,1.5357,1.6012,Joubert syndrome 22[OMIM:615665]-Autosomal recessive inheritance,"Supportive (orofaciodigital syndrome type 6[MONDO:0010176]-Autosomal recessive) | Limited (Joubert syndrome 17[MONDO:0013824]-Autosomal recessive) | Strong, Moderate (Joubert syndrome 22[MONDO:0014297]-Autosomal recessive)",NULL,P:7; LP:2; VUS:19,OMIM:615665 (cakut: 0.089 | cyst_cilio: 0.037 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:615665 (antenatal_or_congenital: 0.821),OMIM:615665 (syndromic: 0.042 | growth: 0.102 | skeletal: 0.011 | neurologic: 0.067),hm (false); ht (false),0.5,3913,0.660377358490566,"9606.ENSP00000278935:153, 9606.ENSP00000360777:955, 9606.ENSP00000269601:165, 9606.ENSP00000236850:161, 9606.ENSP00000357283:237, 9606.ENSP00000256078:695, 9606.ENSP00000260746:660, 9606.ENSP00000377769:887",0.5,12.2367,8.7423,33.7769747664835,cur_305
PDSS2,23041,4,2.865750106829686,0,0.72448,1.1224,0.47425,"Coenzyme Q10 deficiency, primary, 3[OMIM:614652]-Autosomal recessive inheritance","Moderate (Leigh syndrome[MONDO:0009723]-Autosomal recessive) | Definitive, Strong (coenzyme Q10 deficiency, primary, 3[MONDO:0013838]-Autosomal recessive) | Supportive (Leigh syndrome with nephrotic syndrome[MONDO:0016816]-Autosomal recessive)",Moderate (Leigh syndrome[MONDO:0009723]-AR),P:2; LP:2; VUS:85,OMIM:614652 (glomerulopathy: 0.109 | complement: 0.036 | cancer: 0.03 | cakut: 0.008),OMIM:614652 (neonatal_or_pediatric: 0.134),OMIM:614652 (syndromic: 0.001 | neurologic: 0.001),hm (true); ht (false),0.5,1292,0.3039832285115304,"9606.ENSP00000297185:327, 9606.ENSP00000365388:965",0.5,8.90258,8.36978,221.404511124981,cur_306
PHEX,8918,5,3.411818842101696,0.99996,0.03008,5.1822,1.7091,"Hypophosphatemic rickets, X-linked dominant[OMIM:307800]-X-linked dominant inheritance","Definitive, Strong, Supportive (X-linked dominant hypophosphatemic rickets[MONDO:0010619]-X-linked)",NULL,P:586; LP:145; VUS:123,OMIM:307800 (nephrocalcinosis: 0.014 | tubulopathy: 0.007),OMIM:307800 (neonatal_or_pediatric: 0.402),OMIM:307800 (syndromic: 0.024 | growth: 0.25 | skeletal: 0.039 | neurologic: 0),hm (false); ht (true),0,NULL,NULL,NULL,0,0.163055,0.10903800000000001,5.70550966821151,cur_307
PKD1,9008,5,4.1629809470321435,1,0.12051,9.9605,-4.3234,Polycystic kidney disease 1[OMIM:173900]-Autosomal dominant inheritance,"Definitive, Supportive (autosomal dominant polycystic kidney disease[MONDO:0004691]-Autosomal dominant) | Definitive, Strong, Strong (polycystic kidney disease 1[MONDO:0008263]-Autosomal dominant) | Definitive (autosomal recessive polycystic kidney disease[MONDO:0009889]-Autosomal recessive) | Strong (Caroli disease[MONDO:0010913]-Autosomal dominant)",Definitive (autosomal dominant polycystic kidney disease[MONDO:0004691]-AD) | Definitive (autosomal recessive polycystic kidney disease[MONDO:0009889]-AR),P:737; LP:305; VUS:1182,OMIM:173900 (cyst_cilio: 0.131 | nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cakut: 0.052 | cancer: 0.03),NULL,OMIM:173900 (syndromic: 0 | neurologic: 0),hm (true); ht (true),0.5,5436,0.7631027253668763,"9606.ENSP00000219476:795, 9606.ENSP00000362680:292, 9606.ENSP00000237596:999, 9606.ENSP00000360158:735, 9606.ENSP00000298552:191, 9606.ENSP00000346839:447, 9606.ENSP00000317469:378, 9606.ENSP00000451828:292, 9606.ENSP00000313169:599, 9606.ENSP00000324856:422, 9606.ENSP00000445306:286",0.5,12.0618,8.34398,85.3475340076503,cur_308
PKD2,9009,5,4.274442241194955,1.73e-4,0.32696,4.3628,0.27238,Polycystic kidney disease 2[OMIM:613095]-Autosomal dominant inheritance,"Definitive, Supportive (autosomal dominant polycystic kidney disease[MONDO:0004691]-Autosomal dominant) | Strong, Strong (polycystic kidney disease 2[MONDO:0013131]-Autosomal dominant)",Definitive (autosomal dominant polycystic kidney disease[MONDO:0004691]-AD),P:165; LP:61; VUS:345,OMIM:613095 (cyst_cilio: 0.262 | glomerulopathy: 0.211 | tubulopathy: 0.147 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.089 | cancer: 0.03),OMIM:613095 (adult: 0.575 | neonatal_or_pediatric: 0.2),OMIM:613095 (syndromic: 0.005),hm (true); ht (true),0.5,3731,0.6477987421383647,"9606.ENSP00000360158:839, 9606.ENSP00000239891:323, 9606.ENSP00000466134:594, 9606.ENSP00000445306:286, 9606.ENSP00000451828:292, 9606.ENSP00000363435:398, 9606.ENSP00000262304:999",0.5,27.1696,15.2634,252.263924008751,cur_309
PKHD1,9016,5,4.365417926231374,0,0.58027,5.2816,-0.98178,"Polycystic kidney disease 4, with or without hepatic disease[OMIM:263200]-Autosomal recessive inheritance","Definitive, Definitive, Supportive (autosomal recessive polycystic kidney disease[MONDO:0009889]-Autosomal recessive) | Supportive (Caroli disease[MONDO:0010913]-Autosomal recessive) | Definitive, Definitive, Strong, Strong (polycystic kidney disease 4[MONDO:0033004]-Autosomal recessive)",Definitive (autosomal recessive polycystic kidney disease[MONDO:0009889]-AR),P:429; LP:512; VUS:975,OMIM:263200 (cyst_cilio: 0.304 | tubulopathy: 0.126 | cakut: 0.125 | nephrocalcinosis: 0.125 | glomerulopathy: 0.091 | complement: 0.071 | cancer: 0.06),OMIM:263200 (antenatal_or_congenital: 0.86 | neonatal_or_pediatric: 0.799 | adult: 0.575),OMIM:263200 (syndromic: 0),hm (true); ht (true),0.5,1574,0.350104821802935,"9606.ENSP00000237596:839, 9606.ENSP00000262304:735",0.5,12.9427,8.80413,196.173973986495,cur_310
PLCE1,17175,5,4.084276218417588,0,0.35315,6.299,1.381,"Nephrotic syndrome, type 3[OMIM:610725]-Autosomal recessive inheritance","Definitive, Strong, Strong (nephrotic syndrome, type 3[MONDO:0012546]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:27; LP:16; VUS:248,OMIM:610725 (glomerulopathy: 0.368 | cyst_cilio: 0.134 | cakut: 0.056 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:610725 (neonatal_or_pediatric: 0.865),NULL,hm (false); ht (false),0.5,1129,0.26834381551362685,"9606.ENSP00000368190:331, 9606.ENSP00000256078:506, 9606.ENSP00000269305:292",0.5,1.81282,5.29528,78.0172624266363,cur_311
PLVAP,13635,2,0.9277426292329076,2e-6,0.59994,1.658,0.54901,"Diarrhea 10, protein-losing enteropathy type[OMIM:618183]-Autosomal recessive inheritance","Supportive (congenital diarrhea 7 with exudative enteropathy[MONDO:0014375]-Autosomal recessive) | Strong, Strong, Moderate (diarrhea 10, protein-losing enteropathy type[MONDO:0032586]-Autosomal recessive)",NULL,P:4; LP:2; VUS:59,OMIM:618183 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cakut: 0.06 | cyst_cilio: 0.042 | glomerulopathy: 0.007),OMIM:618183 (neonatal_or_pediatric: 0.134),OMIM:618183 (syndromic: 0.009 | skeletal: 0.027),hm (true); ht (false),0,165,0.018867924528301886,9606.ENSP00000231509:165,0.5,181.764,103.74,90.8502331363242,cur_312
PMM2,9115,5,3.7652220598155486,0,1.4139,-1.5128,-1.3872,"Congenital disorder of glycosylation, type Ia[OMIM:212065]-Autosomal recessive inheritance","Definitive (congenital disorder of glycosylation type I[MONDO:0005500]-Autosomal recessive) | Definitive, Strong, Supportive (PMM2-congenital disorder of glycosylation[MONDO:0008907]-Autosomal recessive) | Definitive (SRD5A3-congenital disorder of glycosylation[MONDO:0012885]-Autosomal recessive)",NULL,P:98; LP:97; VUS:190,OMIM:212065 (glomerulopathy: 0.129 | cyst_cilio: 0.092 | cakut: 0.052 | tubulopathy: 0.049 | nephrocalcinosis: 0.042 | complement: 0.036 | cancer: 0.03),OMIM:212065 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.799),OMIM:212065 (syndromic: 0.148 | growth: 0.171 | skeletal: 0.083 | neurologic: 0.241),hm (false); ht (true),0,163,0.008385744234800839,9606.ENSP00000357283:163,0.5,5.99731,5.37999,32.610488867261,cur_313
PODXL,9171,4,2.692557370152453,0.001033,0.39369,2.6863,0.67246,NULL,Supportive (young-onset Parkinson disease[MONDO:0017279]-Autosomal recessive) | Supportive (atypical juvenile parkinsonism[MONDO:0018321]-Autosomal recessive),NULL,P:2; LP:1; VUS:57,NULL,NULL,NULL,hm (true); ht (false),0.5,2393,0.4716981132075472,"9606.ENSP00000256078:195, 9606.ENSP00000228606:292, 9606.ENSP00000368190:303, 9606.ENSP00000356587:286, 9606.ENSP00000377789:165, 9606.ENSP00000262613:858, 9606.ENSP00000264634:294",0.5,73.7343,161.507,89.1918777085063,cur_314
PRKCSH,9411,5,3.4468203087207274,NULL,NULL,NULL,NULL,Polycystic liver disease 1[OMIM:174050]-Autosomal dominant inheritance,"Definitive, Definitive, Strong, Strong, Supportive (polycystic liver disease 1[MONDO:0008265]-Autosomal dominant)",Definitive (polycystic liver disease 1[MONDO:0008265]-AD),P:17; LP:12; VUS:103,OMIM:174050 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:174050 (adult: 0.218),OMIM:174050 (syndromic: 0.001 | skeletal: 0.001 | neurologic: 0.001),hm (false); ht (false),0.5,4409,0.70020964360587,"9606.ENSP00000317469:169, 9606.ENSP00000370719:165, 9606.ENSP00000414398:231, 9606.ENSP00000264382:397, 9606.ENSP00000269305:163, 9606.ENSP00000216911:306, 9606.ENSP00000340466:999, 9606.ENSP00000219476:341, 9606.ENSP00000445175:224, 9606.ENSP00000322323:499, 9606.ENSP00000362413:321, 9606.ENSP00000237596:594",0.5,64.1168,61.5681,154.445672015271,cur_315
PTEN,9588,2,1.2668352405768404,0.25651,0.24093,3.2044,3.4883,"{Glioma susceptibility 2}[OMIM:613028]-Autosomal dominant inheritance | {Meningioma}[OMIM:607174]-Autosomal dominant inheritance | Cowden syndrome 1[OMIM:158350]-Autosomal dominant inheritance | Lhermitte-Duclos disease[OMIM:158350]-Autosomal dominant inheritance | Prostate cancer, somatic[OMIM:176807]-NA | Macrocephaly/autism syndrome[OMIM:605309]-Autosomal dominant inheritance","Moderate (leiomyosarcoma[MONDO:0005058]-Autosomal recessive) | Moderate (renal cell carcinoma[MONDO:0005086]-Autosomal dominant) | Supportive (Bannayan-Riley-Ruvalcaba syndrome[MONDO:0007924]-Autosomal dominant) | Definitive, Definitive, Strong, Strong, Moderate, Moderate (Cowden syndrome 1[MONDO:0008021]-Autosomal dominant) | Definitive (Proteus syndrome[MONDO:0008318]-Autosomal dominant) | Definitive (Proteus syndrome[MONDO:0008318]-Somatic mosaicism) | Definitive, Strong, Strong, Supportive (macrocephaly-autism syndrome[MONDO:0011537]-Autosomal dominant) | Limited (glioma susceptibility 2[MONDO:0013092]-Autosomal dominant) | Supportive (Cowden disease[MONDO:0016063]-Autosomal dominant) | Supportive (Proteus-like syndrome[MONDO:0017571]-Autosomal dominant) | Definitive (PTEN hamartoma tumor syndrome[MONDO:0017623]-Autosomal dominant) | Supportive (activated PI3K-delta syndrome[MONDO:0018338]-Autosomal dominant) | Supportive (Lhermitte-Duclos disease[MONDO:0019002]-Autosomal dominant)",Definitive (PTEN hamartoma tumor syndrome[MONDO:0017623]-AD),P:643; LP:231; VUS:1295,NULL,OMIM:158350 (adult: 0.218); OMIM:605309 (neonatal_or_pediatric: 0.402); OMIM:607174 (adult: 0.218); OMIM:613028 (adult: 0.035),OMIM:158350 (syndromic: 0.103 | skeletal: 0.089 | neurologic: 0.141); OMIM:605309 (syndromic: 0.102 | growth: 0.061 | skeletal: 0.026 | neurologic: 0.115); OMIM:607174 (syndromic: 0 | neurologic: 0.001); OMIM:613028 (syndromic: 0 | neurologic: 0.001),hm (false); ht (false),1,9509,0.8909853249475891,"9606.ENSP00000362680:226, 9606.ENSP00000346151:958, 9606.ENSP00000276297:292, 9606.ENSP00000324856:807, 9606.ENSP00000478927:292, 9606.ENSP00000262613:920, 9606.ENSP00000340913:307, 9606.ENSP00000384092:414, 9606.ENSP00000357283:292, 9606.ENSP00000401678:387, 9606.ENSP00000330875:167, 9606.ENSP00000380432:292, 9606.ENSP00000417132:457, 9606.ENSP00000269305:615, 9606.ENSP00000290167:173, 9606.ENSP00000363435:292, 9606.ENSP00000451828:560, 9606.ENSP00000364979:269, 9606.ENSP00000362413:329, 9606.ENSP00000339191:838, 9606.ENSP00000297261:313, 9606.ENSP00000287820:309",0.5,14.5515,9.7955,214.210421741742,cur_316
PTH,9606,4,2.678276804468202,0.012093,0.73523,0.49561,0.54862,"Hypoparathyroidism, familial isolated 1[OMIM:146200]-Autosomal dominant inheritance | Hypoparathyroidism, familial isolated 1[OMIM:146200]-Autosomal recessive inheritance","Strong (hypoparathyroidism, familial isolated 1[MONDO:0007796]-Autosomal recessive) | Supportive (familial isolated hypoparathyroidism due to impaired PTH secretion[MONDO:0016000]-Autosomal dominant)",NULL,P:3; LP:3; VUS:14,OMIM:146200 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),OMIM:146200 (neonatal_or_pediatric: 0.402),OMIM:146200 (syndromic: 0.003 | skeletal: 0.003 | neurologic: 0.006),hm (false); ht (false),0,NULL,NULL,NULL,0,0,0,0.547891903613714,cur_317
PTH1R,9608,4,2.3856004761315095,NULL,NULL,NULL,NULL,"Metaphyseal chondrodysplasia, Murk Jansen type[OMIM:156400]-Autosomal dominant inheritance | Eiken syndrome[OMIM:600002]-Autosomal recessive inheritance | Failure of tooth eruption, primary[OMIM:125350]-Autosomal dominant inheritance | Chondrodysplasia, Blomstrand type[OMIM:215045]-Autosomal recessive inheritance","Definitive, Supportive (primary failure of tooth eruption[MONDO:0007434]-Autosomal dominant) | Definitive, Supportive (metaphyseal chondrodysplasia, Jansen type[MONDO:0007982]-Autosomal dominant) | Definitive, Strong, Supportive (chondrodysplasia Blomstrand type[MONDO:0008970]-Autosomal recessive) | Limited, Supportive (Eiken syndrome[MONDO:0010803]-Autosomal recessive)",NULL,P:16; LP:4; VUS:131,OMIM:156400 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),OMIM:215045 (antenatal_or_congenital: 0.038),OMIM:125350 (syndromic: 0.002); OMIM:156400 (syndromic: 0.025 | growth: 0.017 | skeletal: 0.075 | neurologic: 0.003); OMIM:215045 (syndromic: 0.022 | skeletal: 0.055); OMIM:600002 (syndromic: 0.063 | growth: 0.276 | skeletal: 0.027 | neurologic: 0.061),hm (false); ht (false),0,NULL,NULL,NULL,0.5,59.9768,244.669,55.0684735351941,cur_318
PTPRO,9678,5,3.684297739245931,1.2e-5,0.32903,4.9672,1.3043,"Nephrotic syndrome, type 6[OMIM:614196]-Autosomal recessive inheritance","Limited (nephrotic syndrome, type 6[MONDO:0013619]-Autosomal recessive) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",NULL,P:4; LP:2; VUS:65,OMIM:614196 (glomerulopathy: 0.361 | cyst_cilio: 0.155 | tubulopathy: 0.063 | cakut: 0.056 | cancer: 0.05 | nephrocalcinosis: 0.042 | complement: 0.036),OMIM:614196 (neonatal_or_pediatric: 0.2),NULL,hm (true); ht (false),0,584,0.14675052410901468,"9606.ENSP00000365891:161, 9606.ENSP00000414398:199, 9606.ENSP00000317272:224",0.5,1.8649,15.6367,209.41839996899,cur_319
RCAN1,3040,2,0.9898192597529272,0.016675,0.4686,1.4387,1.0171,NULL,NULL,NULL,P:0; LP:0; VUS:6,NULL,NULL,NULL,hm (false); ht (false),0,NULL,NULL,NULL,0.5,31.0163,22.2527,11.0967468201632,cur_320
REN,9958,5,4.763291060860141,0,0.61362,1.7102,0.79714,"Renal tubular dysgenesis[OMIM:267430]-Autosomal recessive inheritance | Tubulointerstitial kidney disease, autosomal dominant, 4[OMIM:613092]-Autosomal dominant inheritance","Definitive, Supportive (renal tubular dysgenesis of genetic origin[MONDO:0009970]-Autosomal recessive) | Definitive, Definitive, Supportive (familial juvenile hyperuricemic nephropathy type 2[MONDO:0013128]-Autosomal dominant)",Definitive (renal tubular dysgenesis of genetic origin[MONDO:0009970]-AR) | Definitive (familial juvenile hyperuricemic nephropathy type 2[MONDO:0013128]-AD),P:9; LP:8; VUS:53,OMIM:267430 (complement: 0.143 | cakut: 0.016 | glomerulopathy: 0.007 | cyst_cilio: 0.003); OMIM:613092 (glomerulopathy: 0.149 | cyst_cilio: 0.136 | cakut: 0.125 | nephrocalcinosis: 0.083 | tubulopathy: 0.063 | complement: 0.036 | cancer: 0.03),NULL,OMIM:267430 (syndromic: 0.014 | skeletal: 0.05 | neurologic: 0.029),hm (true); ht (true),0.5,1806,0.3836477987421384,"9606.ENSP00000369442:297, 9606.ENSP00000355627:961, 9606.ENSP00000264414:381, 9606.ENSP00000406229:167",0.5,7.603269999999999,48.2006,20.6028902340384,cur_321
RET,9967,5,4.003664882199977,1,0.039068,6.3712,0.95512,"{Hirschsprung disease, susceptibility to, 1}[OMIM:142623]-Autosomal dominant inheritance | Multiple endocrine neoplasia IIA[OMIM:171400]-Autosomal dominant inheritance | {Hirschsprung disease, protection against}[OMIM:142623]-Autosomal dominant inheritance | Medullary thyroid carcinoma[OMIM:155240]-Autosomal dominant inheritance | Pheochromocytoma[OMIM:171300]-Autosomal dominant inheritance | Multiple endocrine neoplasia IIB[OMIM:162300]-Autosomal dominant inheritance","Supportive (familial medullary thyroid carcinoma[MONDO:0007958]-Autosomal dominant) | Definitive, Definitive, Supportive (multiple endocrine neoplasia type 2B[MONDO:0008082]-Autosomal dominant) | Definitive, Definitive, Supportive (multiple endocrine neoplasia type 2A[MONDO:0008234]-Autosomal dominant) | Supportive (bilateral renal agenesis[MONDO:0015986]-Autosomal recessive) | Supportive (Hirschsprung disease[MONDO:0018309]-Autosomal dominant) | Supportive (renal agenesis, unilateral[MONDO:0019636]-Autosomal dominant) | Supportive (Haddad syndrome[MONDO:0020493]-Autosomal dominant) | Limited (renal hypodysplasia/aplasia 1[MONDO:0024519]-Autosomal recessive)",Definitive (multiple endocrine neoplasia type 2B[MONDO:0008082]-AD) | Definitive (multiple endocrine neoplasia type 2A[MONDO:0008234]-AD),P:99; LP:43; VUS:1492,OMIM:171300 (cancer: 0.04 | cakut: 0.008 | cyst_cilio: 0.005),NULL,OMIM:142623 (syndromic: 0.001 | neurologic: 0.001); OMIM:162300 (syndromic: 0.058 | growth: 0.018 | skeletal: 0.072 | neurologic: 0.053); OMIM:171300 (syndromic: 0.001 | neurologic: 0.001); OMIM:171400 (syndromic: 0.002 | neurologic: 0.003),hm (true); ht (true),0.5,6296,0.7966457023060797,"9606.ENSP00000362680:820, 9606.ENSP00000409007:999, 9606.ENSP00000245907:398, 9606.ENSP00000347591:999, 9606.ENSP00000265171:260, 9606.ENSP00000215832:386, 9606.ENSP00000380321:311, 9606.ENSP00000393312:210, 9606.ENSP00000355396:183, 9606.ENSP00000366563:499, 9606.ENSP00000180166:319, 9606.ENSP00000264170:189, 9606.ENSP00000269601:329, 9606.ENSP00000264664:231, 9606.ENSP00000369497:163",0,0.652675,0.576294,7.91366451623509,cur_322
RMND1,21176,5,2.999736393682547,NULL,NULL,NULL,NULL,Combined oxidative phosphorylation deficiency 11[OMIM:614922]-Autosomal recessive inheritance,"Strong, Moderate, Supportive (combined oxidative phosphorylation defect type 11[MONDO:0013969]-Autosomal recessive) | Definitive (mitochondrial disease[MONDO:0044970]-Autosomal recessive)",Definitive (mitochondrial disease[MONDO:0044970]-AR),P:24; LP:9; VUS:73,OMIM:614922 (cakut: 0.234 | cyst_cilio: 0.22 | nephrocalcinosis: 0.132 | tubulopathy: 0.112 | glomerulopathy: 0.095 | complement: 0.071 | cancer: 0.05),OMIM:614922 (antenatal_or_congenital: 0.821),OMIM:614922 (syndromic: 0.075 | neurologic: 0.157),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,12.4487,13.1674,46.0082287596545,cur_323
ROBO1,10249,4,2.2004048867915813,0,0.46,4.7242,1.0722,"Pituitary hormone deficiency, combined or isolated, 8[OMIM:620303]-Autosomal dominant inheritance | Neurooculorenal syndrome[OMIM:620305]-Autosomal recessive inheritance | ?Nystagmus 8, congenital, autosomal recessive[OMIM:257400]-Autosomal recessive inheritance",Supportive (pituitary stalk interruption syndrome[MONDO:0019828]-Autosomal dominant),NULL,P:8; LP:14; VUS:137,OMIM:620305 (cyst_cilio: 0.163 | glomerulopathy: 0.135 | cakut: 0.105 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),OMIM:620305 (antenatal_or_congenital: 0.851),OMIM:620303 (syndromic: 0.014 | growth: 0.25 | neurologic: 0.001); OMIM:620305 (syndromic: 0.076 | growth: 0.034 | skeletal: 0.029 | neurologic: 0.13),hm (true); ht (false),0.5,2948,0.5534591194968553,"9606.ENSP00000390436:190, 9606.ENSP00000256078:163, 9606.ENSP00000347198:968, 9606.ENSP00000417335:628, 9606.ENSP00000422591:999",0.5,2.76123,2.07368,680.329262738732,cur_324
ROBO2,10250,5,3.5616229997767537,NULL,NULL,NULL,NULL,Vesicoureteral reflux 2[OMIM:610878]-Autosomal dominant inheritance,Strong (vesicoureteral reflux 2[MONDO:0012573]-Autosomal dominant) | Supportive (familial vesicoureteral reflux[MONDO:0017329]-Autosomal dominant),NULL,P:0; LP:0; VUS:163,OMIM:610878 (cakut: 0.153 | cancer: 0.05 | cyst_cilio: 0.045 | glomerulopathy: 0.007 | tubulopathy: 0.007),NULL,NULL,hm (true); ht (false),0.5,3062,0.5681341719077568,"9606.ENSP00000368190:388, 9606.ENSP00000422591:998, 9606.ENSP00000352138:349, 9606.ENSP00000420321:628, 9606.ENSP00000347198:388, 9606.ENSP00000406229:311",1,0.176421,0.5142100000000001,2024.01449669115,cur_325
ROR2,10257,4,2.2134745568393575,1.24e-4,0.35686,3.7328,0.14325,"Brachydactyly, type B1[OMIM:113000]-Autosomal dominant inheritance | Robinow syndrome, autosomal recessive[OMIM:268310]-Autosomal recessive inheritance","Definitive (brachydactyly type B1[MONDO:0007220]-Autosomal dominant) | Definitive, Supportive (autosomal recessive Robinow syndrome[MONDO:0009999]-Autosomal recessive) | Definitive (autosomal dominant Robinow syndrome 1[MONDO:0024455]-Autosomal dominant)",NULL,P:31; LP:20; VUS:229,OMIM:268310 (nephrocalcinosis: 0.306 | tubulopathy: 0.259 | cakut: 0.097 | glomerulopathy: 0.031 | cancer: 0.03 | cyst_cilio: 0.021),OMIM:268310 (antenatal_or_congenital: 0.821),OMIM:113000 (syndromic: 0.01 | skeletal: 0.036); OMIM:268310 (syndromic: 0.169 | growth: 0.25 | skeletal: 0.216 | neurologic: 0.091),hm (false); ht (false),0.5,1790,0.37735849056603776,"9606.ENSP00000264634:995, 9606.ENSP00000360154:163, 9606.ENSP00000290167:284, 9606.ENSP00000256646:163, 9606.ENSP00000256078:185",0.5,1.52013,0.877391,450.709664166103,cur_326
RPGRIP1L,29168,5,4.796232323552032,NULL,NULL,NULL,NULL,Joubert syndrome 7[OMIM:611560]-Autosomal recessive inheritance | Meckel syndrome 5[OMIM:611561]-Autosomal recessive inheritance | ?COACH syndrome 3[OMIM:619113]-Autosomal recessive inheritance,"Supportive (COACH syndrome 1[MONDO:0008996]-Autosomal recessive) | Supportive (Joubert syndrome with renal defect[MONDO:0012308]-Autosomal recessive) | Definitive (Meckel syndrome, type 5[MONDO:0012695]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",NULL,P:152; LP:68; VUS:570,OMIM:611560 (cyst_cilio: 0.315 | glomerulopathy: 0.135 | cakut: 0.085 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.021); OMIM:611561 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007); OMIM:619113 (cyst_cilio: 0.333 | glomerulopathy: 0.239 | tubulopathy: 0.161 | nephrocalcinosis: 0.132 | complement: 0.107 | cakut: 0.089 | cancer: 0.02),OMIM:611561 (antenatal_or_congenital: 0.821); OMIM:619113 (neonatal_or_pediatric: 0.402),OMIM:611560 (syndromic: 0.07 | skeletal: 0.052 | neurologic: 0.116); OMIM:611561 (syndromic: 0.01 | skeletal: 0.011 | neurologic: 0.001); OMIM:619113 (syndromic: 0.038 | neurologic: 0.08),hm (true); ht (false),0,NULL,NULL,NULL,0.5,1.1672,0.7283350000000001,42.5329652430518,cur_327
RRAGD,19903,2,1.6815963123916773,0.81991,0.13865,3.0315,2.1976,"Hypomagnesemia 7, renal, with or without dilated cardiomyopathy[OMIM:620152]-Autosomal dominant inheritance",Moderate (NA[NA]-Autosomal dominant),NULL,P:5; LP:0; VUS:10,OMIM:620152 (nephrocalcinosis: 0.25 | tubulopathy: 0.238 | cyst_cilio: 0.026 | glomerulopathy: 0.022 | cancer: 0.01 | cakut: 0.008),OMIM:620152 (neonatal_or_pediatric: 0.865 | adult: 0.049),OMIM:620152 (syndromic: 0.02 | neurologic: 0.041),hm (NA); ht (NA),0.5,1466,0.3312368972746331,"9606.ENSP00000234396:499, 9606.ENSP00000219476:458, 9606.ENSP00000285071:292, 9606.ENSP00000451828:217",0.5,19.7675,13.8791,22.2527698090269,cur_328
RRM2B,17296,4,3.079135514125027,0.002357,0.38717,2.5814,1.2056,"Mitochondrial DNA depletion syndrome 8B (MNGIE type)[OMIM:612075]-Autosomal recessive inheritance | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)[OMIM:612075]-Autosomal recessive inheritance | Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction[OMIM:268315]-Autosomal recessive inheritance | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5[OMIM:613077]-Autosomal dominant inheritance",Supportive (autosomal dominant progressive external ophthalmoplegia[MONDO:0008003]-Autosomal dominant) | Supportive (Kearns-Sayre syndrome[MONDO:0010787]-Autosomal recessive) | Supportive (mitochondrial DNA depletion syndrome 8a[MONDO:0012792]-Autosomal recessive) | Supportive (mitochondrial neurogastrointestinal encephalomyopathy[MONDO:0017575]-Autosomal recessive) | Supportive (adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy[MONDO:0018002]-Autosomal dominant),NULL,P:18; LP:16; VUS:117,OMIM:268315 (glomerulopathy: 0.131 | cyst_cilio: 0.126 | tubulopathy: 0.056 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.028 | cancer: 0.02); OMIM:612075 (nephrocalcinosis: 0.042 | tubulopathy: 0.042 | glomerulopathy: 0.013),OMIM:268315 (neonatal_or_pediatric: 0.262); OMIM:612075 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.134); OMIM:613077 (adult: 0.575),OMIM:268315 (syndromic: 0.025 | growth: 0.25 | skeletal: 0.005 | neurologic: 0.02); OMIM:612075 (syndromic: 0.054 | growth: 0.184 | neurologic: 0.093); OMIM:613077 (syndromic: 0.03 | neurologic: 0.064),hm (true); ht (false),0.5,1085,0.25157232704402516,"9606.ENSP00000269305:888, 9606.ENSP00000216911:197",0.5,11.4111,7.07331,17.4032231879819,cur_329
SALL1,10524,5,4.528473335105979,0.99971,0.062296,4.9235,0.72174,Townes-Brocks syndrome 1[OMIM:107480]-Autosomal dominant inheritance | Townes-Brocks branchiootorenal-like syndrome[OMIM:107480]-Autosomal dominant inheritance,"Supportive (Townes-Brocks syndrome[MONDO:0007142]-Autosomal dominant) | Definitive, Definitive, Strong (Townes-Brocks syndrome 1[MONDO:0054581]-Autosomal dominant)",NULL,P:55; LP:13; VUS:162,OMIM:107480 (cakut: 0.262 | cyst_cilio: 0.131 | tubulopathy: 0.112 | nephrocalcinosis: 0.111 | glomerulopathy: 0.089 | complement: 0.071 | cancer: 0.06),OMIM:107480 (antenatal_or_congenital: 0.821),OMIM:107480 (syndromic: 0.07 | growth: 0.046 | skeletal: 0.064 | neurologic: 0.128),hm (true); ht (true),0.5,1524,0.34591194968553457,"9606.ENSP00000326649:394, 9606.ENSP00000231509:165, 9606.ENSP00000217086:610, 9606.ENSP00000482245:190, 9606.ENSP00000484803:165",0.5,50.7803,15.8897,114.39216349363,cur_330
SALL4,15924,4,2.4201943137339605,0.99997,0,5.0361,1.075,?IVIC syndrome[OMIM:147750]-Autosomal dominant inheritance | Duane-radial ray syndrome[OMIM:607323]-Autosomal dominant inheritance,"Supportive (Duane retraction syndrome[MONDO:0007473]-Autosomal dominant) | Supportive (IVIC syndrome[MONDO:0007836]-Autosomal dominant) | Definitive, Definitive, Strong (Duane-radial ray syndrome[MONDO:0011812]-Autosomal dominant)",NULL,P:32; LP:7; VUS:107,OMIM:607323 (cakut: 0.31 | cancer: 0.17 | cyst_cilio: 0.068 | glomerulopathy: 0.013 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:147750 (antenatal_or_congenital: 0.821); OMIM:607323 (antenatal_or_congenital: 0.821),OMIM:147750 (syndromic: 0.02 | skeletal: 0.072); OMIM:607323 (syndromic: 0.028 | skeletal: 0.06 | neurologic: 0.006),hm (false); ht (true),0.5,2493,0.48846960167714887,"9606.ENSP00000484803:800, 9606.ENSP00000368253:781, 9606.ENSP00000227507:302, 9606.ENSP00000251020:610",0,1.08797,0.24968200000000002,7.10238554686583,cur_331
SARS2,17697,4,2.52803624489665,NULL,NULL,NULL,NULL,"Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis[OMIM:613845]-Autosomal recessive inheritance","Strong, Limited, Supportive (hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome[MONDO:0013458]-Autosomal recessive) | Moderate (mitochondrial disease[MONDO:0044970]-Autosomal recessive)",Moderate (mitochondrial disease[MONDO:0044970]-AR),P:4; LP:3; VUS:103,OMIM:613845 (tubulopathy: 0.154 | nephrocalcinosis: 0.118 | cyst_cilio: 0.068 | complement: 0.036 | glomerulopathy: 0.031 | cakut: 0.024),OMIM:613845 (neonatal_or_pediatric: 0.402),OMIM:613845 (syndromic: 0.033 | growth: 0.171 | neurologic: 0.051),hm (NA); ht (NA),0.5,1424,0.3249475890985325,"9606.ENSP00000356319:292, 9606.ENSP00000380321:292, 9606.ENSP00000269305:305, 9606.ENSP00000261584:343, 9606.ENSP00000246868:192",0.5,22.3487,17.5368,26.1506623046936,cur_332
SCARB2,1665,5,3.7492626579182344,8.9e-5,0.43758,2.613,1.3237,"Epilepsy, progressive myoclonic 4, with or without renal failure[OMIM:254900]-Autosomal recessive inheritance","Supportive (Unverricht-Lundborg syndrome[MONDO:0009698]-Autosomal recessive) | Strong, Supportive (action myoclonus-renal failure syndrome[MONDO:0009699]-Autosomal recessive) | Definitive (progressive myoclonus epilepsy[MONDO:0020074]-Autosomal recessive)",Definitive (progressive myoclonus epilepsy[MONDO:0020074]-AR),P:21; LP:8; VUS:188,OMIM:254900 (glomerulopathy: 0.31 | nephrocalcinosis: 0.132 | tubulopathy: 0.112 | complement: 0.107 | cyst_cilio: 0.076 | cakut: 0.06 | cancer: 0.05),OMIM:254900 (neonatal_or_pediatric: 0.2 | adult: 0.049),OMIM:254900 (syndromic: 0.028 | neurologic: 0.059),hm (true); ht (false),0.5,4771,0.7274633123689728,"9606.ENSP00000234396:163, 9606.ENSP00000260010:982, 9606.ENSP00000376410:163, 9606.ENSP00000362680:454, 9606.ENSP00000358866:163, 9606.ENSP00000363435:163, 9606.ENSP00000339191:897, 9606.ENSP00000294304:228, 9606.ENSP00000003084:400, 9606.ENSP00000346839:327, 9606.ENSP00000296387:183, 9606.ENSP00000236850:349, 9606.ENSP00000317674:299",0.5,35.6769,28.1663,113.768578334592,cur_333
SCLT1,26406,3,2.2343042007295733,0,0.66138,2.1827,-0.26924,NULL,Limited (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Limited (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive),NULL,P:22; LP:10; VUS:197,NULL,NULL,NULL,hm (true); ht (false),0.5,2518,0.49056603773584906,"9606.ENSP00000355922:540, 9606.ENSP00000278935:985, 9606.ENSP00000380911:993",0.5,2.26307,1.1888299999999998,168.684868908111,cur_334
SCN4A,10591,3,1.2879252660116278,0.01294,0.25767,5.907,1.5606,"Paramyotonia congenita[OMIM:168300]-Autosomal dominant inheritance | Hyperkalemic periodic paralysis[OMIM:170500]-Autosomal dominant inheritance | Congenital myopathy 22B, severe fetal[OMIM:620369]-Autosomal recessive inheritance | Hypokalemic periodic paralysis, type 2[OMIM:613345]-Autosomal dominant inheritance | Myotonia congenita, atypical, acetazolamide-responsive[OMIM:608390]-Autosomal dominant inheritance | Myasthenic syndrome, congenital, 16[OMIM:614198]-Autosomal recessive inheritance | Congenital myopathy 22A, classic[OMIM:620351]-Autosomal recessive inheritance","Definitive, Definitive, Strong, Supportive (paramyotonia congenita of Von Eulenburg[MONDO:0008195]-Autosomal dominant) | Supportive (hypokalemic periodic paralysis[MONDO:0008223]-Autosomal dominant) | Definitive, Strong, Supportive (hyperkalemic periodic paralysis[MONDO:0008224]-Autosomal dominant) | Strong (hypokalemic periodic paralysis, type 2[MONDO:0013234]-Autosomal dominant) | Strong, Strong, Strong (congenital myasthenic syndrome 16[MONDO:0013620]-Autosomal recessive) | Strong (congenital myopathy[MONDO:0019952]-Autosomal recessive) | Supportive (postsynaptic congenital myasthenic syndrome[MONDO:0020344]-Autosomal recessive) | Supportive (myotonia fluctuans[MONDO:0020481]-Autosomal dominant) | Supportive (myotonia permanens[MONDO:0020482]-Autosomal dominant) | Supportive (acetazolamide-responsive myotonia[MONDO:0020483]-Autosomal dominant) | Definitive (hypokalemic periodic paralysis, type 1[MONDO:0042979]-Autosomal dominant) | Definitive, Definitive (SCN4A-related myopathy, autosomal recessive[MONDO:0100121]-Autosomal recessive)","Definitive (SCN4A-related myopathy, autosomal recessive[MONDO:0100121]-AR)",P:87; LP:50; VUS:854,NULL,OMIM:168300 (neonatal_or_pediatric: 0.402); OMIM:170500 (neonatal_or_pediatric: 0.402); OMIM:608390 (adult: 0.372 | neonatal_or_pediatric: 0.134); OMIM:614198 (neonatal_or_pediatric: 0.603); OMIM:620351 (antenatal_or_congenital: 0.849); OMIM:620369 (antenatal_or_congenital: 0.89),OMIM:170500 (syndromic: 0 | neurologic: 0); OMIM:613345 (syndromic: 0 | neurologic: 0); OMIM:614198 (syndromic: 0.021 | skeletal: 0.004 | neurologic: 0.024); OMIM:620351 (syndromic: 0.072 | skeletal: 0.121 | neurologic: 0.023); OMIM:620369 (syndromic: 0.087 | skeletal: 0.15 | neurologic: 0.025),hm (false); ht (false),0.5,4147,0.6792452830188679,"9606.ENSP00000353292:900, 9606.ENSP00000382717:214, 9606.ENSP00000406012:239, 9606.ENSP00000300061:900, 9606.ENSP00000314444:253, 9606.ENSP00000296266:183, 9606.ENSP00000345751:900, 9606.ENSP00000334198:558",0,1.42739,0.380994,1.77635143578422,cur_335
SCNN1A,10599,4,2.8581846255497276,NULL,NULL,NULL,NULL,"Pseudohypoaldosteronism, type IB1, autosomal recessive[OMIM:264350]-Autosomal recessive inheritance | ?Liddle syndrome 3[OMIM:618126]-Autosomal dominant inheritance | Bronchiectasis with or without elevated sweat chloride 2[OMIM:613021]-Autosomal dominant inheritance","Supportive (Liddle syndrome[MONDO:0008323]-Autosomal dominant) | Definitive, Strong, Strong, Supportive (autosomal recessive pseudohypoaldosteronism type 1[MONDO:0009917]-Autosomal recessive) | Strong, Moderate (bronchiectasis with or without elevated sweat chloride 2[MONDO:0013087]-Autosomal dominant) | Supportive (Brugada syndrome[MONDO:0015263]-Autosomal dominant) | Strong (pseudohypoaldosteronism type 1[MONDO:0019161]-Autosomal recessive) | Limited (Liddle syndrome 3[MONDO:0029132]-Autosomal dominant)",Strong (autosomal recessive pseudohypoaldosteronism type 1[MONDO:0009917]-AR),P:16; LP:10; VUS:86,NULL,OMIM:264350 (neonatal_or_pediatric: 0.134),OMIM:264350 (syndromic: 0.009 | growth: 0.171),hm (false); ht (false),0.5,3438,0.6163522012578616,"9606.ENSP00000300061:999, 9606.ENSP00000396320:900, 9606.ENSP00000334198:540, 9606.ENSP00000345751:999",0.5,137.437,73.7548,6.46001272337745,cur_336
SCNN1B,10600,4,3.020684882913959,0,0.53199,2.4516,0.21217,"Bronchiectasis with or without elevated sweat chloride 1[OMIM:211400]-Autosomal dominant inheritance | Pseudohypoaldosteronism, type IB2, autosomal recessive[OMIM:620125]-Autosomal recessive inheritance | Liddle syndrome 1[OMIM:177200]-Autosomal dominant inheritance",Supportive (Liddle syndrome[MONDO:0008323]-Autosomal dominant) | Strong (bronchiectasis with or without elevated sweat chloride 1[MONDO:0008887]-Autosomal dominant) | Supportive (autosomal recessive pseudohypoaldosteronism type 1[MONDO:0009917]-Autosomal recessive) | Strong (pseudohypoaldosteronism type 1[MONDO:0019161]-Autosomal recessive) | Strong (Liddle syndrome 1[MONDO:0020607]-Autosomal dominant),NULL,P:20; LP:8; VUS:94,OMIM:177200 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:177200 (neonatal_or_pediatric: 0.463); OMIM:620125 (neonatal_or_pediatric: 0.134),NULL,hm (true); ht (true),0.5,4095,0.6729559748427673,"9606.ENSP00000353292:999, 9606.ENSP00000334198:540, 9606.ENSP00000396320:900, 9606.ENSP00000300061:999, 9606.ENSP00000339191:365, 9606.ENSP00000356319:292",0.5,24.378,13.3734,12.6316030215646,cur_337
SCNN1G,10602,3,2.8416319440238587,0.48199,0.21723,4.1175,0.56139,"Bronchiectasis with or without elevated sweat chloride 3[OMIM:613071]-Autosomal dominant inheritance | Pseudohypoaldosteronism, type IB3, autosomal recessive[OMIM:620126]-Autosomal recessive inheritance | Liddle syndrome 2[OMIM:618114]-Autosomal dominant inheritance","Definitive, Supportive (Liddle syndrome[MONDO:0008323]-Autosomal dominant) | Supportive (autosomal recessive pseudohypoaldosteronism type 1[MONDO:0009917]-Autosomal recessive) | Strong (bronchiectasis with or without elevated sweat chloride 3[MONDO:0013112]-Autosomal dominant) | Strong (pseudohypoaldosteronism type 1[MONDO:0019161]-Autosomal recessive) | Strong, Strong, Moderate (Liddle syndrome 2[MONDO:0020854]-Autosomal dominant)",Definitive (Liddle syndrome[MONDO:0008323]-AD),P:8; LP:4; VUS:63,NULL,OMIM:618114 (adult: 0.372 | neonatal_or_pediatric: 0.2); OMIM:620126 (neonatal_or_pediatric: 0.134),NULL,hm (true); ht (false),0.5,3666,0.639412997903564,"9606.ENSP00000003084:228, 9606.ENSP00000353292:999, 9606.ENSP00000345751:999, 9606.ENSP00000396320:900, 9606.ENSP00000334198:540",0.5,47.0689,25.7038,12.4730818755097,cur_338
SDCCAG8,10671,4,3.599801319700168,0,0.56158,2.7106,-0.098609,Senior-Loken syndrome 7[OMIM:613615]-Autosomal recessive inheritance | Bardet-Biedl syndrome 16[OMIM:615993]-Autosomal recessive inheritance,"Definitive, Moderate (Senior-Loken syndrome 7[MONDO:0013326]-Autosomal recessive) | Strong, Moderate (Bardet-Biedl syndrome 16[MONDO:0014444]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive)",NULL,P:34; LP:26; VUS:268,OMIM:613615 (cyst_cilio: 0.097 | glomerulopathy: 0.007 | cakut: 0.004); OMIM:615993 (cyst_cilio: 0.312 | glomerulopathy: 0.22 | cakut: 0.173 | tubulopathy: 0.154 | nephrocalcinosis: 0.132 | complement: 0.107 | cancer: 0.1),NULL,OMIM:613615 (syndromic: 0.003 | neurologic: 0.006); OMIM:615993 (syndromic: 0.061 | growth: 0.293 | skeletal: 0.003 | neurologic: 0.094),hm (true); ht (false),0.5,2532,0.4947589098532495,"9606.ENSP00000311505:381, 9606.ENSP00000216181:500, 9606.ENSP00000278935:186, 9606.ENSP00000298552:229, 9606.ENSP00000344314:863, 9606.ENSP00000319756:187, 9606.ENSP00000455426:186",0.5,5.8478699999999995,5.022819999999999,179.783215807748,cur_339
SDHB,10681,3,1.499869962164291,2.44e-4,0.47277,2.1317,-0.10185,"Pheochromocytoma/paraganglioma syndrome 4[OMIM:115310]-Autosomal dominant inheritance | Mitochondrial complex II deficiency, nuclear type 4[OMIM:619224]-Autosomal recessive inheritance | Gastrointestinal stromal tumor[OMIM:606764]-Autosomal dominant inheritance | Gastrointestinal stromal tumor[OMIM:606764]-Sporadic | Paraganglioma and gastric stromal sarcoma[OMIM:606864]-NA","Strong (renal cell carcinoma[MONDO:0005086]-Autosomal dominant) | Definitive, Strong (paragangliomas 4[MONDO:0007273]-Autosomal dominant) | Supportive (mitochondrial complex II deficiency[MONDO:0009641]-Autosomal recessive) | Definitive, Strong (gastrointestinal stromal tumor[MONDO:0011719]-Autosomal dominant) | Strong, Supportive (Carney-Stratakis syndrome[MONDO:0011740]-Autosomal dominant) | Definitive (Carney-Stratakis syndrome[MONDO:0011740]-Mitochondrial) | Supportive (Cowden disease[MONDO:0016063]-Autosomal dominant) | Definitive, Supportive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-Autosomal dominant) | Strong (mitochondrial complex 2 deficiency, nuclear type 4[MONDO:0030974]-Autosomal recessive) | Definitive (mitochondrial disease[MONDO:0044970]-Autosomal recessive)",Definitive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-AD) | Definitive (mitochondrial disease[MONDO:0044970]-AR),P:171; LP:86; VUS:516,OMIM:115310 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:115310 (adult: 0.218); OMIM:619224 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.665),OMIM:115310 (syndromic: 0.001 | neurologic: 0.002); OMIM:606764 (syndromic: 0.005 | neurologic: 0.01); OMIM:606864 (syndromic: 0 | neurologic: 0); OMIM:619224 (syndromic: 0.066 | skeletal: 0.061 | neurologic: 0.131),hm (false); ht (false),0.5,4317,0.6918238993710691,"9606.ENSP00000297185:570, 9606.ENSP00000362924:207, 9606.ENSP00000246957:900, 9606.ENSP00000380321:292, 9606.ENSP00000356953:999, 9606.ENSP00000281043:161, 9606.ENSP00000364699:999, 9606.ENSP00000445175:189",0.5,104.51899999999999,95.1223,49.7602858585475,cur_340
SDHC,10682,2,0.7968164794007491,2.01e-4,0.66948,0.99036,0.82502,Pheochromocytoma/paraganglioma syndrome 3[OMIM:605373]-Autosomal dominant inheritance | Paraganglioma and gastric stromal sarcoma[OMIM:606864]-NA | Gastrointestinal stromal tumor[OMIM:606764]-Autosomal dominant inheritance | Gastrointestinal stromal tumor[OMIM:606764]-Sporadic,"Moderate (renal cell carcinoma[MONDO:0005086]-Autosomal dominant) | Definitive, Strong (paragangliomas 3[MONDO:0011544]-Autosomal dominant) | Strong (gastrointestinal stromal tumor[MONDO:0011719]-Autosomal dominant) | Strong, Supportive (Carney-Stratakis syndrome[MONDO:0011740]-Autosomal dominant) | Supportive (Cowden disease[MONDO:0016063]-Autosomal dominant) | Definitive, Supportive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-Autosomal dominant) | No Known Disease Relationship (mitochondrial disease[MONDO:0044970]-Unknown)",Definitive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-AD) | No Known Disease Relationship (mitochondrial disease[MONDO:0044970]-Undetermined),P:44; LP:28; VUS:347,NULL,OMIM:605373 (adult: 0.218),OMIM:605373 (syndromic: 0.001 | neurologic: 0.002); OMIM:606764 (syndromic: 0.005 | neurologic: 0.01); OMIM:606864 (syndromic: 0 | neurologic: 0),hm (false); ht (false),0.5,2243,0.44654088050314467,"9606.ENSP00000364699:999, 9606.ENSP00000364649:999, 9606.ENSP00000273986:245",0.5,16.2057,14.0161,26.4986696297116,cur_341
SDHD,10683,2,0.9823395937559802,0.33697,0.23221,2.088,-0.16607,"Pheochromocytoma/paraganglioma syndrome 1[OMIM:168000]-Autosomal dominant inheritance | Paraganglioma and gastric stromal sarcoma[OMIM:606864]-NA | Mitochondrial complex II deficiency, nuclear type 3[OMIM:619167]-Autosomal recessive inheritance","Moderate (renal cell carcinoma[MONDO:0005086]-Autosomal dominant) | Definitive (paragangliomas 1[MONDO:0008192]-Autosomal dominant) | Moderate, Supportive (mitochondrial complex II deficiency[MONDO:0009641]-Autosomal recessive) | Strong, Supportive (Carney-Stratakis syndrome[MONDO:0011740]-Autosomal dominant) | Supportive (Cowden disease[MONDO:0016063]-Autosomal dominant) | Definitive, Supportive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-Autosomal dominant) | Limited (mitochondrial disease[MONDO:0044970]-Autosomal recessive) | Limited (mitochondrial complex II deficiency, nuclear type 1[MONDO:0100294]-Autosomal recessive)",Definitive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-AD) | Limited (mitochondrial disease[MONDO:0044970]-AR),P:87; LP:53; VUS:302,NULL,OMIM:168000 (adult: 0.683 | neonatal_or_pediatric: 0.2); OMIM:619167 (neonatal_or_pediatric: 0.402 | antenatal_or_congenital: 0.077),OMIM:168000 (syndromic: 0.001 | neurologic: 0.002); OMIM:606864 (syndromic: 0 | neurologic: 0); OMIM:619167 (syndromic: 0.065 | skeletal: 0.006 | neurologic: 0.135),hm (false); ht (false),0.5,2720,0.519916142557652,"9606.ENSP00000273986:409, 9606.ENSP00000364649:999, 9606.ENSP00000356953:999, 9606.ENSP00000245907:313",0.5,91.3687,69.8611,31.9091419264788,cur_342
SEC61A1,18276,5,3.839212588022336,0.98675,0.11405,4.2105,4.0608,"Tubulointerstitial kidney disease, autosomal dominant, 5[OMIM:617056]-Autosomal dominant inheritance","Strong, Moderate (hyperuricemic nephropathy, familial juvenile type 4[MONDO:0014891]-Autosomal dominant) | Moderate (SEC61A1 deficiency[MONDO:0100337]-Autosomal dominant)",Moderate (SEC61A1 deficiency[MONDO:0100337]-AD),P:3; LP:4; VUS:53,OMIM:617056 (glomerulopathy: 0.122 | cyst_cilio: 0.113 | cakut: 0.073 | nephrocalcinosis: 0.062 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036),OMIM:617056 (neonatal_or_pediatric: 0.463 | adult: 0.372),OMIM:617056 (syndromic: 0.019 | growth: 0.352 | skeletal: 0.001),hm (false); ht (false),1,8341,0.8490566037735849,"9606.ENSP00000269305:163, 9606.ENSP00000341292:154, 9606.ENSP00000348849:800, 9606.ENSP00000481646:800, 9606.ENSP00000322323:292, 9606.ENSP00000256078:163, 9606.ENSP00000336655:357, 9606.ENSP00000414398:382, 9606.ENSP00000317272:165, 9606.ENSP00000357998:994, 9606.ENSP00000229179:163, 9606.ENSP00000229769:345, 9606.ENSP00000359345:908, 9606.ENSP00000246914:154, 9606.ENSP00000463784:901, 9606.ENSP00000470972:800, 9606.ENSP00000414321:800",0.5,98.2853,70.0167,52.8776885415627,cur_343
SEC63,21082,4,3.009754408383491,0,0.39615,4.0741,2.1992,Polycystic liver disease 2[OMIM:617004]-Autosomal dominant inheritance,"Strong, Supportive (polycystic liver disease 1[MONDO:0008265]-Autosomal dominant) | Definitive, Definitive, Strong (polycystic liver disease 2[MONDO:0014860]-Autosomal dominant)",Definitive (polycystic liver disease 2[MONDO:0014860]-AD),P:29; LP:16; VUS:147,NULL,OMIM:617004 (adult: 0.218),NULL,hm (false); ht (false),0.5,3646,0.6373165618448637,"9606.ENSP00000273986:165, 9606.ENSP00000414398:165, 9606.ENSP00000231509:165, 9606.ENSP00000307235:235, 9606.ENSP00000363435:165, 9606.ENSP00000481646:313, 9606.ENSP00000243253:994, 9606.ENSP00000226760:238, 9606.ENSP00000357283:188, 9606.ENSP00000297185:153, 9606.ENSP00000336655:552, 9606.ENSP00000258173:313",0.5,18.7641,11.8907,156.217742290717,cur_344
SGPL1,10817,4,2.77584625226192,0.003626,0.32649,3.454,1.8214,RENI syndrome[OMIM:617575]-Autosomal recessive inheritance,"Strong, Moderate (nephrotic syndrome 14[MONDO:0033203]-Autosomal recessive)",NULL,P:14; LP:5; VUS:87,OMIM:617575 (glomerulopathy: 0.397 | cyst_cilio: 0.136 | cakut: 0.056 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:617575 (neonatal_or_pediatric: 0.865),OMIM:617575 (syndromic: 0.072 | skeletal: 0.049 | neurologic: 0.15),hm (true); ht (true),0.5,749,0.18448637316561844,"9606.ENSP00000311505:292, 9606.ENSP00000351157:165, 9606.ENSP00000322323:292",0.5,17.0948,10.374,56.2830001416331,cur_345
SHH,10848,2,1.6301280884622644,0.98258,0,3.2544,2.9479,Microphthalmia with coloboma 5[OMIM:611638]-Autosomal dominant inheritance | Schizencephaly[OMIM:269160]-NA | Single median maxillary central incisor[OMIM:147250]-Autosomal dominant inheritance | Holoprosencephaly 3[OMIM:142945]-Autosomal dominant inheritance,"Supportive (microphthalmia, isolated, with coloboma[MONDO:0000170]-Autosomal dominant) | Moderate (skeletal system disorder[MONDO:0005172]-Autosomal dominant) | Definitive, Definitive (holoprosencephaly 3[MONDO:0007733]-Autosomal dominant) | Definitive, Moderate (solitary median maxillary central incisor syndrome[MONDO:0007819]-Autosomal dominant) | Definitive, Supportive (polydactyly of a triphalangeal thumb[MONDO:0008270]-Autosomal dominant) | Supportive (syndactyly type 4[MONDO:0008515]-Autosomal dominant) | Definitive, Strong (microphthalmia, isolated, with coloboma 5[MONDO:0012709]-Autosomal dominant) | Supportive (holoprosencephaly[MONDO:0016296]-Autosomal recessive) | Supportive (triphalangeal thumb-polysyndactyly syndrome[MONDO:0017454]-Autosomal dominant) | Supportive (hypoplastic tibiae-postaxial polydactyly syndrome[MONDO:0018052]-Autosomal dominant) | Supportive (autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome[MONDO:0018777]-Autosomal dominant)",NULL,P:44; LP:20; VUS:126,OMIM:142945 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,OMIM:142945 (syndromic: 0.084 | skeletal: 0.059 | neurologic: 0.132); OMIM:147250 (syndromic: 0.035 | growth: 0.25 | skeletal: 0.049 | neurologic: 0.04); OMIM:269160 (syndromic: 0.005 | neurologic: 0.011); OMIM:611638 (syndromic: 0.001 | neurologic: 0.001),hm (false); ht (true),0.5,1942,0.39832285115303984,"9606.ENSP00000396688:405, 9606.ENSP00000346839:372, 9606.ENSP00000379204:373, 9606.ENSP00000361021:313, 9606.ENSP00000264664:223, 9606.ENSP00000265171:256",0,3.4576599999999997,1.5733700000000002,1.17058454931188,cur_346
SIX1,10887,3,2.9642524760843827,NULL,NULL,NULL,NULL,"Deafness, autosomal dominant 23[OMIM:605192]-Autosomal dominant inheritance | Branchiootic syndrome 3[OMIM:608389]-Autosomal dominant inheritance","Definitive, Supportive (branchio-oto-renal syndrome[MONDO:0007029]-Autosomal dominant) | Definitive, Strong (autosomal dominant nonsyndromic hearing loss 23[MONDO:0011519]-Autosomal dominant) | Definitive, Strong (branchiootic syndrome 3[MONDO:0012025]-Autosomal dominant) | Supportive (branchiootic syndrome[MONDO:0018878]-Autosomal dominant) | Supportive (autosomal dominant nonsyndromic hearing loss[MONDO:0019587]-Autosomal dominant)",Definitive (branchio-oto-renal syndrome[MONDO:0007029]-AD),P:6; LP:10; VUS:77,OMIM:605192 (cakut: 0.065 | cancer: 0.02 | cyst_cilio: 0.008 | glomerulopathy: 0.002),NULL,OMIM:605192 (syndromic: 0.001); OMIM:608389 (syndromic: 0.001),hm (true); ht (false),0,NULL,NULL,NULL,0.5,0.06387319999999999,0.0603659,26.144708895347,cur_347
SIX2,10888,3,2.3797935553654543,0.93869,0,2.7577,0.51896,NULL,NULL,NULL,P:0; LP:1; VUS:13,NULL,NULL,NULL,hm (true); ht (false),0,NULL,NULL,NULL,0.5,0.649506,0.46592799999999995,35.2957752567577,cur_348
SIX5,10891,5,3.757341992941496,0.006924,0.40618,2.1149,-0.563,Branchiootorenal syndrome 2[OMIM:610896]-NA,"Supportive, Disputed Evidence (branchio-oto-renal syndrome[MONDO:0007029]-Autosomal dominant) | Definitive, Limited (branchiootorenal syndrome 2[MONDO:0012575]-Autosomal dominant)",Disputed (branchio-oto-renal syndrome[MONDO:0007029]-AD),P:1; LP:0; VUS:124,OMIM:610896 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | cakut: 0.093 | cyst_cilio: 0.087 | glomerulopathy: 0.084 | complement: 0.071 | cancer: 0.02),NULL,OMIM:610896 (syndromic: 0.001),hm (false); ht (false),0,163,0.008385744234800839,9606.ENSP00000437256:163,0.5,10.9425,7.77245,29.033255359593,cur_349
SLC12A1,10910,5,3.910427107817595,NULL,NULL,NULL,NULL,"Bartter syndrome, type 1[OMIM:601678]-Autosomal recessive inheritance",Strong (Bartter syndrome[MONDO:0015231]-Autosomal recessive) | Supportive (antenatal Bartter syndrome[MONDO:0100343]-Autosomal recessive),NULL,P:30; LP:22; VUS:223,OMIM:601678 (nephrocalcinosis: 0.264 | tubulopathy: 0.252 | cyst_cilio: 0.026 | glomerulopathy: 0.022 | cancer: 0.01 | cakut: 0.008),OMIM:601678 (antenatal_or_congenital: 0.077),OMIM:601678 (syndromic: 0.091 | growth: 0.467 | skeletal: 0.01 | neurologic: 0.133),hm (true); ht (false),0,NULL,NULL,NULL,0.5,374.901,28.8841,44.2564397303799,cur_350
SLC12A3,10912,5,3.729467313584483,NULL,NULL,NULL,NULL,Gitelman syndrome[OMIM:263800]-Autosomal recessive inheritance,"Strong, Supportive (Gitelman syndrome[MONDO:0009904]-Autosomal recessive)",NULL,P:195; LP:132; VUS:242,OMIM:263800 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:263800 (neonatal_or_pediatric: 0.2),OMIM:263800 (syndromic: 0.044 | growth: 0.282 | skeletal: 0.001 | neurologic: 0.06),hm (true); ht (true),0.5,848,0.20335429769392033,"9606.ENSP00000376432:187, 9606.ENSP00000365256:161, 9606.ENSP00000420194:208, 9606.ENSP00000312397:292",0,24.9413,67.6717,3.62520903276312,cur_351
SLC1A1,10939,3,1.6132657435881388,9e-6,0.51399,2.1761,-1.3329,Dicarboxylic aminoaciduria[OMIM:222730]-Autosomal recessive inheritance | {?Schizophrenia susceptibility 18}[OMIM:615232]-NA,"Strong, Limited (dicarboxylic aminoaciduria[MONDO:0009110]-Autosomal recessive) | Supportive (hot water reflex epilepsy[MONDO:0013229]-Autosomal dominant)",Limited (dicarboxylic aminoaciduria[MONDO:0009110]-AR),P:2; LP:1; VUS:110,OMIM:222730 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),NULL,OMIM:222730 (syndromic: 0.019 | neurologic: 0.04),hm (true); ht (false),0,165,0.018867924528301886,9606.ENSP00000393312:165,0.5,9.90783,10.9764,13.8262296740308,cur_352
SLC22A12,17989,5,3.8615318710215063,0,0.90219,0.43728,0.37234,"Hypouricemia, renal[OMIM:220150]-Autosomal recessive inheritance","Supportive (hereditary renal hypouricemia[MONDO:0009071]-Autosomal recessive) | Strong (hypouricemia, renal 1[MONDO:0020728]-Autosomal recessive)",NULL,P:12; LP:5; VUS:109,OMIM:220150 (complement: 0.143 | nephrocalcinosis: 0.021 | glomerulopathy: 0.011 | tubulopathy: 0.007 | cyst_cilio: 0.003),OMIM:220150 (adult: 0.05),NULL,hm (true); ht (false),0,NULL,NULL,NULL,0,12.4287,53.3548,NULL,cur_353
SLC26A1,10993,4,2.5912956849079984,NULL,NULL,NULL,NULL,"?Hypersulfaturia[OMIM:620372]-Autosomal recessive inheritance | ?Nephrolithiasis, calcium oxalate, 1[OMIM:167030]-Autosomal recessive inheritance","Moderate, Limited (nephrolithiasis susceptibility caused by SLC26A1[MONDO:0020722]-Autosomal recessive)",NULL,P:31; LP:15; VUS:211,OMIM:167030 (complement: 0.143 | tubulopathy: 0.049 | cakut: 0.028 | nephrocalcinosis: 0.028 | glomerulopathy: 0.009 | cyst_cilio: 0.003); OMIM:620372 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),OMIM:167030 (neonatal_or_pediatric: 0.262); OMIM:620372 (adult: 0.372),OMIM:620372 (syndromic: 0 | skeletal: 0),hm (true); ht (false),0,179,0.033542976939203356,9606.ENSP00000261584:179,0,2.50631,3.9980599999999997,4.61471200364999,cur_354
SLC2A2,11006,5,3.409829186864442,0,0.60768,1.8654,0.93553,"Fanconi-Bickel syndrome[OMIM:227810]-Autosomal recessive inheritance | {Diabetes mellitus, noninsulin-dependent}[OMIM:125853]-Autosomal dominant inheritance","Definitive, Strong, Strong, Strong, Supportive (glycogen storage disease due to GLUT2 deficiency[MONDO:0009216]-Autosomal recessive) | Strong (neonatal diabetes mellitus[MONDO:0016391]-Autosomal recessive) | Strong (transient neonatal diabetes mellitus[MONDO:0020525]-Autosomal recessive) | Strong (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal recessive)",NULL,P:30; LP:9; VUS:111,OMIM:227810 (nephrocalcinosis: 0.014 | tubulopathy: 0.007),OMIM:125853 (adult: 0.108); OMIM:227810 (neonatal_or_pediatric: 0.537),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:227810 (syndromic: 0.036 | growth: 0.205 | skeletal: 0.002 | neurologic: 0.051),hm (false); ht (false),0.5,1107,0.259958071278826,"9606.ENSP00000327943:197, 9606.ENSP00000223366:447, 9606.ENSP00000312652:171, 9606.ENSP00000322323:292",0,2.24994,6.25856,1.30074718386613,cur_355
SLC2A9,13446,5,4.38176636265872,0,0.76051,1.0492,-0.1243,"{Uric acid concentration, serum, QTL 2}[OMIM:612076]-Autosomal dominant inheritance | {Uric acid concentration, serum, QTL 2}[OMIM:612076]-Autosomal recessive inheritance | Hypouricemia, renal, 2[OMIM:612076]-Autosomal dominant inheritance | Hypouricemia, renal, 2[OMIM:612076]-Autosomal recessive inheritance",Supportive (hereditary renal hypouricemia[MONDO:0009071]-Autosomal recessive),NULL,P:3; LP:4; VUS:106,OMIM:612076 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),NULL,NULL,hm (true); ht (true),0,472,0.11740041928721175,9606.ENSP00000262613:472,0.5,2.65512,5.29737,18.1374651969141,cur_356
SLC34A1,11019,5,4.0902641574826655,0,1.4064,-1.8515,-0.47512,"?Fanconi renotubular syndrome 2[OMIM:613388]-Autosomal recessive inheritance | Hypercalcemia, infantile, 2[OMIM:616963]-Autosomal recessive inheritance | Nephrolithiasis/osteoporosis, hypophosphatemic, 1[OMIM:612286]-Autosomal dominant inheritance","Supportive (primary Fanconi syndrome[MONDO:0007600]-Autosomal dominant) | Limited (primary Fanconi syndrome[MONDO:0007600]-Autosomal recessive) | Supportive (autosomal recessive infantile hypercalcemia[MONDO:0007749]-Autosomal recessive) | Limited (hypophosphatemic nephrolithiasis/osteoporosis 1[MONDO:0012850]-Autosomal dominant) | Moderate (hypercalcemia, infantile, 2[MONDO:0014851]-Autosomal recessive) | Supportive (dominant hypophosphatemia with nephrolithiasis or osteoporosis[MONDO:0016579]-Autosomal dominant)",NULL,P:15; LP:14; VUS:171,OMIM:612286 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005); OMIM:613388 (nephrocalcinosis: 0.181 | tubulopathy: 0.168 | glomerulopathy: 0.098 | cyst_cilio: 0.076 | complement: 0.071 | cakut: 0.04 | cancer: 0.02); OMIM:616963 (tubulopathy: 0.266 | nephrocalcinosis: 0.264 | cyst_cilio: 0.026 | glomerulopathy: 0.022 | cancer: 0.01 | cakut: 0.008),OMIM:613388 (neonatal_or_pediatric: 0.262),OMIM:612286 (syndromic: 0.005 | skeletal: 0.017); OMIM:613388 (syndromic: 0.018 | growth: 0.25 | skeletal: 0.017); OMIM:616963 (syndromic: 0.009 | growth: 0.171),hm (true); ht (false),0.5,1806,0.3836477987421384,"9606.ENSP00000442397:906, 9606.ENSP00000262613:900",0,19.9177,35.5047,7.24557198263416,cur_357
SLC34A3,20305,5,3.397217630690231,NULL,NULL,NULL,NULL,Hypophosphatemic rickets with hypercalciuria[OMIM:241530]-Autosomal recessive inheritance,"Strong, Supportive (hereditary hypophosphatemic rickets with hypercalciuria[MONDO:0009431]-Autosomal recessive)",NULL,P:37; LP:25; VUS:225,OMIM:241530 (nephrocalcinosis: 0.021 | tubulopathy: 0.007),OMIM:241530 (neonatal_or_pediatric: 0.402),OMIM:241530 (syndromic: 0.027 | growth: 0.262 | skeletal: 0.04 | neurologic: 0.004),hm (true); ht (false),0.5,1806,0.3836477987421384,"9606.ENSP00000321424:906, 9606.ENSP00000262613:900",0,2.79412,9.07987,0.284770853604805,cur_358
SLC36A2,18762,4,1.9328224916500691,0,0.83176,0.68375,0.078412,[Iminoglycinuria][OMIM:242600]-Autosomal recessive inheritance | [Iminoglycinuria][OMIM:242600]-Digenic inheritance | [Hyperglycinuria][OMIM:138500]-Autosomal dominant inheritance,"Limited (hyperglycinuria[MONDO:0007677]-Autosomal dominant) | Limited (hyperglycinuria[MONDO:0007677]-Semidominant) | Limited, Supportive (iminoglycinuria[MONDO:0009448]-Autosomal recessive)",Limited (iminoglycinuria[MONDO:0009448]-AR),P:0; LP:0; VUS:26,OMIM:138500 (tubulopathy: 0.028 | nephrocalcinosis: 0.021),NULL,OMIM:242600 (syndromic: 0.019 | neurologic: 0.04),hm (NA); ht (NA),0,NULL,NULL,NULL,0,5.73822,30.4297,0.987237084258073,cur_359
SLC3A1,11025,5,4.0498670576321185,0,1.2306,-1.1555,-3.1434,Cystinuria[OMIM:220100]-Autosomal dominant inheritance | Cystinuria[OMIM:220100]-Autosomal recessive inheritance,"Definitive, Definitive (cystinuria[MONDO:0009067]-Autosomal recessive) | Strong, Supportive (cystinuria type A[MONDO:0019745]-Autosomal recessive)",Definitive (cystinuria[MONDO:0009067]-AR),P:41; LP:36; VUS:170,OMIM:220100 (tubulopathy: 0.238 | nephrocalcinosis: 0.236 | glomerulopathy: 0.093 | cyst_cilio: 0.073 | complement: 0.071 | cakut: 0.052 | cancer: 0.03),NULL,NULL,hm (true); ht (false),0.5,2553,0.5010482180293501,"9606.ENSP00000369647:298, 9606.ENSP00000023064:999, 9606.ENSP00000355627:910, 9606.ENSP00000380666:346",0.5,18.2637,29.4032,16.1299582671737,cur_360
SLC41A1,19429,3,2.1999537085348058,0.65493,0.19137,3.4258,1.4798,?Nephronophthisis-like nephropathy 2[OMIM:619468]-Autosomal recessive inheritance,Limited (kidney disorder[MONDO:0005240]-Autosomal recessive),Limited (kidney disorder[MONDO:0005240]-AR),P:1; LP:0; VUS:24,OMIM:619468 (tubulopathy: 0.259 | cyst_cilio: 0.22 | glomerulopathy: 0.217 | nephrocalcinosis: 0.208 | complement: 0.107 | cakut: 0.085 | cancer: 0.02),OMIM:619468 (neonatal_or_pediatric: 0.402),OMIM:619468 (syndromic: 0 | neurologic: 0.001),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,13.2187,12.4561,19.455128598744,cur_361
SLC4A1,11027,5,4.3956000311576355,0.84602,0.19333,4.8086,1.6611,"[Blood group, Swann][OMIM:601550]-NA | [Blood group, Wright][OMIM:112050]-NA | Distal renal tubular acidosis 1[OMIM:179800]-Autosomal dominant inheritance | [Blood group, Waldner][OMIM:112010]-NA | Spherocytosis, type 4[OMIM:612653]-Autosomal dominant inheritance | [Blood group, Froese][OMIM:601551]-NA | Distal renal tubular acidosis 4 with hemolytic anemia[OMIM:611590]-Autosomal recessive inheritance | {Malaria, resistance to}[OMIM:611162]-NA | Cryohydrocytosis[OMIM:185020]-Autosomal dominant inheritance | Ovalocytosis, SA type[OMIM:166900]-Autosomal dominant inheritance | [Blood group, Diego][OMIM:110500]-NA","Supportive (southeast Asian ovalocytosis[MONDO:0008165]-Autosomal dominant) | Strong, Supportive (autosomal dominant distal renal tubular acidosis[MONDO:0008368]-Autosomal dominant) | Supportive (cryohydrocytosis[MONDO:0008494]-Autosomal dominant) | Supportive (renal tubular acidosis, distal, 4, with hemolytic anemia[MONDO:0012700]-Autosomal dominant) | Strong (renal tubular acidosis, distal, 4, with hemolytic anemia[MONDO:0012700]-Autosomal recessive) | Strong (distal renal tubular acidosis[MONDO:0015827]-Autosomal recessive) | Supportive (dehydrated hereditary stomatocytosis[MONDO:0017910]-Autosomal dominant) | Supportive (hereditary spherocytosis[MONDO:0019350]-Autosomal dominant)",NULL,P:64; LP:55; VUS:216,OMIM:179800 (nephrocalcinosis: 0.34 | tubulopathy: 0.294 | glomerulopathy: 0.029 | cakut: 0.024 | cancer: 0.01 | cyst_cilio: 0.008); OMIM:611590 (nephrocalcinosis: 0.215 | tubulopathy: 0.161 | glomerulopathy: 0.018 | cakut: 0.012 | cancer: 0.01 | cyst_cilio: 0.003),OMIM:179800 (neonatal_or_pediatric: 0.2); OMIM:612653 (adult: 0.372),OMIM:179800 (syndromic: 0.001 | skeletal: 0.002); OMIM:611590 (syndromic: 0.025 | growth: 0.421 | skeletal: 0.002 | neurologic: 0.003),hm (true); ht (false),0.5,2193,0.4360587002096436,"9606.ENSP00000385675:349, 9606.ENSP00000445306:292, 9606.ENSP00000256785:192, 9606.ENSP00000362413:282, 9606.ENSP00000285379:479, 9606.ENSP00000368190:286, 9606.ENSP00000379438:313",0,27.8147,26.1723,2.9281673983292,cur_362
SLC4A4,11030,5,3.475060726825474,NULL,NULL,NULL,NULL,"Renal tubular acidosis, proximal, with ocular abnormalities[OMIM:604278]-Autosomal recessive inheritance","Definitive, Strong, Strong, Supportive (autosomal recessive proximal renal tubular acidosis[MONDO:0011422]-Autosomal recessive)",NULL,P:4; LP:2; VUS:127,OMIM:604278 (nephrocalcinosis: 0.007 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:604278 (neonatal_or_pediatric: 0.262 | adult: 0.049),OMIM:604278 (syndromic: 0.038 | growth: 0.341 | skeletal: 0.003 | neurologic: 0.042),hm (true); ht (true),0.5,774,0.18867924528301888,"9606.ENSP00000285379:613, 9606.ENSP00000256078:161",0.5,6.17282,13.2889,76.8844149931303,cur_363
SLC5A2,11037,5,3.837744576030517,0,0.79885,1.0217,-1.1569,Renal glucosuria[OMIM:233100]-Autosomal dominant inheritance | Renal glucosuria[OMIM:233100]-Autosomal recessive inheritance,Supportive (familial renal glucosuria[MONDO:0009297]-Autosomal dominant),NULL,P:10; LP:8; VUS:107,OMIM:233100 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),NULL,OMIM:233100 (syndromic: 0.001 | neurologic: 0.002),hm (true); ht (false),0.5,1150,0.27044025157232704,"9606.ENSP00000199280:229, 9606.ENSP00000265748:292, 9606.ENSP00000266088:432, 9606.ENSP00000323568:197",0,25.3299,36.0052,1.94353850806066,cur_364
SLC6A19,27960,4,2.1587523141462324,0,1.0724,-0.3832,-0.040124,Hartnup disorder[OMIM:234500]-Autosomal recessive inheritance,"Definitive, Strong, Supportive (Hartnup disease[MONDO:0009324]-Autosomal recessive)",Definitive (Hartnup disease[MONDO:0009324]-AR),P:10; LP:12; VUS:155,NULL,OMIM:234500 (neonatal_or_pediatric: 0.262),OMIM:234500 (syndromic: 0.099 | growth: 0.25 | neurologic: 0.18),hm (true); ht (false),0,442,0.1069182389937107,9606.ENSP00000290866:442,0,5.55319,20.2439,1.72795507939413,cur_365
SLC6A20,30927,2,1.007590537978155,0,0.91356,0.43547,0.49651,NULL,Limited (hyperglycinuria[MONDO:0007677]-Autosomal recessive) | No Known Disease Relationship (hyperglycinuria[MONDO:0007677]-Unknown),NULL,P:0; LP:0; VUS:152,NULL,NULL,NULL,hm (NA); ht (NA),0,NULL,NULL,NULL,0,1.1199,1.25385,0.551691733449349,cur_366
SLC7A7,11065,5,3.1048203661766087,NULL,NULL,NULL,NULL,Lysinuric protein intolerance[OMIM:222700]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Strong, Supportive (lysinuric protein intolerance[MONDO:0009109]-Autosomal recessive)",Definitive (lysinuric protein intolerance[MONDO:0009109]-AR),P:62; LP:38; VUS:211,OMIM:222700 (glomerulopathy: 0.129 | cyst_cilio: 0.126 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),OMIM:222700 (neonatal_or_pediatric: 0.402),OMIM:222700 (syndromic: 0.073 | growth: 0.429 | skeletal: 0.02 | neurologic: 0.093),hm (true); ht (false),0.5,845,0.20125786163522014,"9606.ENSP00000260649:346, 9606.ENSP00000023064:499",0,0.19617,0.297732,5.75188123064544,cur_367
SLC7A9,11067,5,4.18674697483039,0,0.74709,1.1179,0.80513,Cystinuria[OMIM:220100]-Autosomal dominant inheritance | Cystinuria[OMIM:220100]-Autosomal recessive inheritance,"Definitive, Definitive (cystinuria[MONDO:0009067]-Autosomal recessive) | Strong (cystinuria type A[MONDO:0019745]-Autosomal dominant) | Strong (cystinuria type A[MONDO:0019745]-Autosomal recessive) | Supportive (cystinuria type B[MONDO:0019746]-Semidominant)",Definitive (cystinuria[MONDO:0009067]-AR),P:33; LP:22; VUS:81,OMIM:220100 (tubulopathy: 0.238 | nephrocalcinosis: 0.236 | glomerulopathy: 0.093 | cyst_cilio: 0.073 | complement: 0.071 | cakut: 0.052 | cancer: 0.03),NULL,NULL,hm (true); ht (true),0.5,1498,0.3417190775681342,"9606.ENSP00000260649:999, 9606.ENSP00000380666:499",0,9.26799,37.9492,4.28490557433346,cur_368
NHERF1,11075,5,3.148206707027968,8.8e-5,0.6411,1.1748,-0.47173,"Nephrolithiasis/osteoporosis, hypophosphatemic, 2[OMIM:612287]-Autosomal dominant inheritance","Moderate (hypophosphatemic nephrolithiasis/osteoporosis 2[MONDO:0012851]-Autosomal dominant) | Limited (hypophosphatemic nephrolithiasis/osteoporosis 2[MONDO:0012851]-Unknown) | Limited, Supportive (dominant hypophosphatemia with nephrolithiasis or osteoporosis[MONDO:0016579]-Autosomal dominant)",NULL,P:0; LP:0; VUS:25,OMIM:612287 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),NULL,OMIM:612287 (syndromic: 0.005 | skeletal: 0.017),hm (false); ht (false),1,9351,0.8846960167714885,"9606.ENSP00000234396:404, 9606.ENSP00000078429:292, 9606.ENSP00000322323:292, 9606.ENSP00000215832:286, 9606.ENSP00000451828:292, 9606.ENSP00000367817:858, 9606.ENSP00000376432:292, 9606.ENSP00000321424:900, 9606.ENSP00000339191:234, 9606.ENSP00000442397:900, 9606.ENSP00000260570:233, 9606.ENSP00000361021:920, 9606.ENSP00000362121:164, 9606.ENSP00000381098:319, 9606.ENSP00000312778:201, 9606.ENSP00000358866:220, 9606.ENSP00000264784:472, 9606.ENSP00000478927:530, 9606.ENSP00000003084:999, 9606.ENSP00000228872:329, 9606.ENSP00000362424:214",0,NULL,NULL,NULL,cur_369
SLIT2,11086,3,2.41084421011018,1,0.085237,7.6818,2.0993,NULL,NULL,NULL,P:2; LP:0; VUS:72,NULL,NULL,NULL,hm (true); ht (false),0.5,2853,0.5429769392033543,"9606.ENSP00000420321:999, 9606.ENSP00000417335:998, 9606.ENSP00000347198:687, 9606.ENSP00000451828:169",0.5,1.8129099999999998,4.8929599999999995,461.070009601963,cur_370
SMARCAL1,11102,5,4.102382895547218,2e-6,0.40724,3.5489,0.8448,Schimke immunoosseous dysplasia[OMIM:242900]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Supportive (Schimke immuno-osseous dysplasia[MONDO:0009458]-Autosomal recessive)",Definitive (Schimke immuno-osseous dysplasia[MONDO:0009458]-AR),P:77; LP:27; VUS:280,OMIM:242900 (glomerulopathy: 0.415 | cyst_cilio: 0.202 | tubulopathy: 0.154 | nephrocalcinosis: 0.139 | complement: 0.107 | cakut: 0.097 | cancer: 0.05),OMIM:242900 (antenatal_or_congenital: 0.821),OMIM:242900 (syndromic: 0.096 | growth: 0.245 | skeletal: 0.039 | neurologic: 0.115),hm (true); ht (false),0.5,694,0.1740041928721174,"9606.ENSP00000231509:165, 9606.ENSP00000269305:305, 9606.ENSP00000357048:224",0.5,6.856269999999999,5.55299,38.4132901707992,cur_371
SON,11183,2,0.8143468478090599,1,0.051624,7.7358,1.541,ZTTK syndrome[OMIM:617140]-Autosomal dominant inheritance,"Definitive, Definitive, Strong, Supportive (ZTTK syndrome[MONDO:0014936]-Autosomal dominant)",Definitive (ZTTK syndrome[MONDO:0014936]-AD),P:80; LP:31; VUS:398,OMIM:617140 (tubulopathy: 0.119 | cancer: 0.09 | cakut: 0.085 | nephrocalcinosis: 0.076 | cyst_cilio: 0.039 | glomerulopathy: 0.011),OMIM:617140 (neonatal_or_pediatric: 0.402),OMIM:617140 (syndromic: 0.228 | growth: 0.614 | skeletal: 0.119 | neurologic: 0.217),hm (true); ht (false),0.5,1794,0.37945492662473795,"9606.ENSP00000337088:454, 9606.ENSP00000359345:185, 9606.ENSP00000281043:161, 9606.ENSP00000256474:292, 9606.ENSP00000356319:292, 9606.ENSP00000360231:205, 9606.ENSP00000360532:205",0.5,35.4364,22.1065,212.623221751546,cur_372
SOX11,11191,3,1.6156657047657632,0.85844,0.092703,2.7614,2.2591,Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism[OMIM:615866]-Autosomal dominant inheritance,"Definitive, Strong, Strong (intellectual disability, autosomal dominant 27[MONDO:0014376]-Autosomal dominant) | Supportive (Coffin-Siris syndrome[MONDO:0015452]-Autosomal dominant)",NULL,P:15; LP:44; VUS:87,OMIM:615866 (cakut: 0.012 | glomerulopathy: 0.002),OMIM:615866 (neonatal_or_pediatric: 0.397),OMIM:615866 (syndromic: 0.09 | growth: 0.463 | skeletal: 0.06 | neurologic: 0.037),hm (false); ht (false),0,313,0.07337526205450734,9606.ENSP00000312987:313,0.5,13.3828,9.97524,141.011945457174,cur_373
SOX17,18122,4,2.8991920221269094,0.88495,0.087561,2.8574,0.7745,Vesicoureteral reflux 3[OMIM:613674]-Autosomal dominant inheritance,"Definitive, Strong (vesicoureteral reflux 3[MONDO:0013356]-Autosomal dominant) | Definitive (pulmonary arterial hypertension[MONDO:0015924]-Autosomal dominant) | Supportive (familial vesicoureteral reflux[MONDO:0017329]-Autosomal dominant)",Definitive (pulmonary arterial hypertension[MONDO:0015924]-AD),P:2; LP:2; VUS:48,OMIM:613674 (cakut: 0.129 | cyst_cilio: 0.021 | cancer: 0.02 | tubulopathy: 0.014 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,NULL,hm (false); ht (false),0.5,1592,0.35429769392033544,"9606.ENSP00000360231:292, 9606.ENSP00000362680:265, 9606.ENSP00000480291:292, 9606.ENSP00000312987:538, 9606.ENSP00000269305:205",0,7.73453,2.15312,1.80190475851191,cur_374
SRGAP1,17382,3,1.514865586960806,0.99845,0.14781,5.8097,2.2072,"{Thyroid cancer, nonmedullary, 2}[OMIM:188470]-Autosomal dominant inheritance | {Thyroid cancer, nonmedullary, 2}[OMIM:188470]-Somatic mutation","No Known Disease Relationship (thyroid cancer, nonmedullary, 2[MONDO:0008566]-Autosomal dominant)",NULL,P:2; LP:0; VUS:35,NULL,NULL,NULL,hm (false); ht (false),0.5,2214,0.44234800838574423,"9606.ENSP00000417335:388, 9606.ENSP00000365891:171, 9606.ENSP00000422591:687, 9606.ENSP00000420321:968",0.5,1.25676,1.0738299999999998,291.843143846769,cur_375
STRA6,30650,3,2.1000880550872436,NULL,NULL,NULL,NULL,"Microphthalmia, syndromic 9[OMIM:601186]-Autosomal recessive inheritance | Microphthalmia, isolated, with coloboma 8[OMIM:601186]-Autosomal recessive inheritance","Supportive (microphthalmia, isolated, with coloboma[MONDO:0000170]-Autosomal dominant) | Supportive (Matthew-Wood syndrome[MONDO:0011010]-Autosomal dominant) | Definitive, Strong, Strong (Matthew-Wood syndrome[MONDO:0011010]-Autosomal recessive)",NULL,P:26; LP:8; VUS:92,OMIM:601186 (cakut: 0.202 | cancer: 0.12 | cyst_cilio: 0.06 | glomerulopathy: 0.013 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:601186 (antenatal_or_congenital: 0.851),OMIM:601186 (syndromic: 0.035 | growth: 0.369 | skeletal: 0.027 | neurologic: 0.004),hm (false); ht (false),0,499,0.12578616352201258,9606.ENSP00000237014:499,0.5,0.807906,2.1748,11.1674292749572,cur_376
STRADA,30172,2,1.3412995881437582,4e-6,0.50062,2.3581,1.4895,"Polyhydramnios, megalencephaly, and symptomatic epilepsy[OMIM:611087]-Autosomal recessive inheritance","Definitive, Strong, Strong, Supportive (polyhydramnios, megalencephaly, and symptomatic epilepsy[MONDO:0012611]-Autosomal recessive)",NULL,P:9; LP:4; VUS:178,OMIM:611087 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),NULL,OMIM:611087 (syndromic: 0.1 | growth: 0.006 | skeletal: 0.025 | neurologic: 0.165),hm (false); ht (false),0.5,2330,0.4612159329140461,"9606.ENSP00000324856:999, 9606.ENSP00000313169:422, 9606.ENSP00000243253:357, 9606.ENSP00000357998:552",0.5,16.1386,10.1822,61.2309970643099,cur_377
STX16,11431,3,1.5126704003953164,0.48261,0.21049,3.1892,0.95215,Pseudohypoparathyroidism Ib[OMIM:603233]-Autosomal dominant inheritance,"Strong, Strong, Supportive (pseudohypoparathyroidism type 1B[MONDO:0011301]-Autosomal dominant)",NULL,P:2; LP:0; VUS:84,NULL,NULL,OMIM:603233 (syndromic: 0.007 | growth: 0.043 | skeletal: 0.018),hm (false); ht (false),0,379,0.09643605870020965,9606.ENSP00000003084:379,0.5,57.8483,36.1164,63.6304319019184,cur_378
SYNPO,30672,2,1.7199137204209318,NULL,NULL,NULL,NULL,NULL,NULL,NULL,P:0; LP:1; VUS:95,NULL,NULL,NULL,hm (true); ht (false),0.5,5010,0.7421383647798742,"9606.ENSP00000468002:179, 9606.ENSP00000216181:201, 9606.ENSP00000477725:303, 9606.ENSP00000360532:239, 9606.ENSP00000265748:420, 9606.ENSP00000363435:165, 9606.ENSP00000367817:165, 9606.ENSP00000341292:161, 9606.ENSP00000362924:161, 9606.ENSP00000288235:207, 9606.ENSP00000252699:728, 9606.ENSP00000368190:278, 9606.ENSP00000376410:163, 9606.ENSP00000356319:292, 9606.ENSP00000356587:159, 9606.ENSP00000352264:865, 9606.ENSP00000358866:161, 9606.ENSP00000265970:163",0.5,28.7264,33.3899,23.2410620844392,cur_379
TBC1D1,11578,3,1.7933224655846045,NULL,NULL,NULL,NULL,NULL,NULL,NULL,P:0; LP:0; VUS:59,NULL,NULL,NULL,hm (false); ht (false),0,NULL,NULL,NULL,0.5,48.8269,37.271,135.766657092463,cur_380
TBC1D8B,24715,3,2.08891566950649,0,0.51149,2.8307,0.05699,"Nephrotic syndrome, type 20[OMIM:301028]-X-linked inheritance","Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant) | Limited (nephrotic syndrome, type 20[MONDO:0026726]-X-linked)",NULL,P:3; LP:2; VUS:59,OMIM:301028 (glomerulopathy: 0.259 | cyst_cilio: 0.136 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:301028 (neonatal_or_pediatric: 0.865 | antenatal_or_congenital: 0.821 | adult: 0.218),NULL,hm (NA); ht (NA),0.5,1290,0.3018867924528302,"9606.ENSP00000356319:292, 9606.ENSP00000265970:499, 9606.ENSP00000360154:499",0,1.69997,1.80865,6.55482739138441,cur_381
TBX18,11595,4,3.3405411839318218,0.99905,0.040708,4.4058,0.099027,Congenital anomalies of kidney and urinary tract 2[OMIM:143400]-Autosomal dominant inheritance,"Strong, Moderate (congenital anomalies of kidney and urinary tract 2[MONDO:0027676]-Autosomal dominant) | Limited (congenital anomalies of kidney and urinary tract 2[MONDO:0027676]-Unknown)",NULL,P:5; LP:2; VUS:46,OMIM:143400 (cakut: 0.327 | cyst_cilio: 0.176 | tubulopathy: 0.126 | nephrocalcinosis: 0.118 | glomerulopathy: 0.095 | complement: 0.071 | cancer: 0.05),OMIM:143400 (adult: 0.575 | neonatal_or_pediatric: 0.463 | antenatal_or_congenital: 0.077),OMIM:143400 (syndromic: 0 | skeletal: 0.001),hm (false); ht (false),0,NULL,NULL,NULL,0.5,0.24296399999999999,0.07689349999999999,15.3345676872552,cur_382
TBX6,11605,2,1.6197049071697134,0.006813,0.36642,2.5662,0.53549,Spondylocostal dysostosis 5[OMIM:122600]-Autosomal dominant inheritance | Spondylocostal dysostosis 5[OMIM:122600]-Autosomal recessive inheritance,Moderate (spondylocostal dysostosis 5[MONDO:0007389]-Semidominant) | Supportive (autosomal dominant spondylocostal dysostosis[MONDO:0015826]-Autosomal dominant) | Limited (congenital anomaly of kidney and urinary tract[MONDO:0019719]-Autosomal dominant),NULL,P:14; LP:4; VUS:88,NULL,OMIM:122600 (antenatal_or_congenital: 0.821),OMIM:122600 (syndromic: 0.019 | growth: 0.023 | skeletal: 0.064 | neurologic: 0.001),hm (true); ht (false),0,439,0.10482180293501048,9606.ENSP00000245451:439,0,2.55937,1.29893,1.57918022417611,cur_383
TCTN1,26113,3,2.7148656631902965,0,0.88263,0.57882,0.60556,Joubert syndrome 13[OMIM:614173]-Autosomal recessive inheritance,Strong (Joubert syndrome 13[MONDO:0013608]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive),NULL,P:19; LP:14; VUS:158,NULL,NULL,OMIM:614173 (syndromic: 0.004 | neurologic: 0.008),hm (false); ht (false),1,9771,0.8951781970649895,"9606.ENSP00000386264:154, 9606.ENSP00000314116:777, 9606.ENSP00000243578:986, 9606.ENSP00000389998:973, 9606.ENSP00000304941:995, 9606.ENSP00000261499:995, 9606.ENSP00000403465:993, 9606.ENSP00000448012:946, 9606.ENSP00000258173:967, 9606.ENSP00000376827:992, 9606.ENSP00000483364:993",0.5,12.1771,10.5603,37.7335250357185,cur_384
TCTN2,25774,4,3.604220952635565,0,0.71799,1.6025,0.23716,Joubert syndrome 24[OMIM:616654]-Autosomal recessive inheritance | ?Meckel syndrome 8[OMIM:613885]-Autosomal recessive inheritance,"Definitive, Strong, Moderate (Joubert syndrome 24[MONDO:0014724]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",Definitive (Joubert syndrome 24[MONDO:0014724]-AR),P:29; LP:23; VUS:255,OMIM:613885 (cyst_cilio: 0.118 | cancer: 0.04 | cakut: 0.028 | glomerulopathy: 0.007),OMIM:613885 (antenatal_or_congenital: 0.821); OMIM:616654 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402),OMIM:613885 (syndromic: 0.033 | skeletal: 0.074 | neurologic: 0.031); OMIM:616654 (syndromic: 0.063 | skeletal: 0.007 | neurologic: 0.128),hm (false); ht (false),1,10873,0.9245283018867925,"9606.ENSP00000482396:191, 9606.ENSP00000258173:955, 9606.ENSP00000483364:988, 9606.ENSP00000261499:988, 9606.ENSP00000380779:995, 9606.ENSP00000260570:233, 9606.ENSP00000312778:201, 9606.ENSP00000448012:922, 9606.ENSP00000243578:974, 9606.ENSP00000386264:170, 9606.ENSP00000362121:164, 9606.ENSP00000403465:985, 9606.ENSP00000264634:175, 9606.ENSP00000376827:956, 9606.ENSP00000362424:214, 9606.ENSP00000314116:789, 9606.ENSP00000389998:973",0.5,10.8432,7.737660000000001,17.8204769976352,cur_385
TCTN3,24519,4,2.8005398254429563,0,0.72839,1.3832,0.83564,Joubert syndrome 18[OMIM:614815]-Autosomal recessive inheritance | Orofaciodigital syndrome IV[OMIM:258860]-Autosomal recessive inheritance,"Definitive (ciliopathy[MONDO:0005308]-Autosomal recessive) | Definitive, Strong, Supportive (orofaciodigital syndrome IV[MONDO:0009794]-Autosomal recessive) | Supportive (orofaciodigital syndrome type 6[MONDO:0010176]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",Definitive (ciliopathy[MONDO:0005308]-AR),P:31; LP:12; VUS:206,OMIM:614815 (cyst_cilio: 0.102 | cancer: 0.1 | cakut: 0.073 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:614815 (antenatal_or_congenital: 0.851),OMIM:258860 (syndromic: 0.058 | growth: 0.25 | skeletal: 0.07 | neurologic: 0.01); OMIM:614815 (syndromic: 0.046 | growth: 0.102 | skeletal: 0.041 | neurologic: 0.05),hm (false); ht (false),1,8860,0.8658280922431866,"9606.ENSP00000386264:214, 9606.ENSP00000243578:936, 9606.ENSP00000380911:329, 9606.ENSP00000448012:745, 9606.ENSP00000304941:988, 9606.ENSP00000389998:946, 9606.ENSP00000380779:993, 9606.ENSP00000261499:972, 9606.ENSP00000314116:341, 9606.ENSP00000376827:933, 9606.ENSP00000403465:978, 9606.ENSP00000258173:485",0.5,29.2617,20.2754,58.9295153152694,cur_386
TFAP2A,11742,4,2.644939448117649,NULL,NULL,NULL,NULL,Branchiooculofacial syndrome[OMIM:113620]-Autosomal dominant inheritance,"Definitive, Strong, Supportive (branchiooculofacial syndrome[MONDO:0007235]-Autosomal dominant)",NULL,P:19; LP:25; VUS:59,OMIM:113620 (cyst_cilio: 0.1 | cancer: 0.08 | cakut: 0.044 | glomerulopathy: 0.007 | tubulopathy: 0.007),NULL,OMIM:113620 (syndromic: 0.094 | growth: 0.135 | skeletal: 0.14 | neurologic: 0.08),hm (false); ht (false),0,NULL,NULL,NULL,0.5,4.84875,4.6279,32.6640488962351,cur_387
THBD,11784,5,3.0316743605819534,0.053769,0.34569,2.0625,0.60196,"Thrombophilia 12 due to thrombomodulin defect[OMIM:614486]-Autosomal dominant inheritance | {Hemolytic uremic syndrome, atypical, susceptibility to, 6}[OMIM:612926]-Autosomal dominant inheritance","Strong (atypical hemolytic-uremic syndrome with thrombomodulin anomaly[MONDO:0013044]-Autosomal dominant) | Strong, Moderate, Supportive (thrombomodulin-related bleeding disorder[MONDO:0013775]-Autosomal dominant) | Limited (thrombomodulin-related bleeding disorder[MONDO:0013775]-Autosomal recessive)",Moderate (thrombomodulin-related bleeding disorder[MONDO:0013775]-AD) | Limited (thrombomodulin-related bleeding disorder[MONDO:0013775]-AR),P:3; LP:4; VUS:195,OMIM:612926 (complement: 0.143 | glomerulopathy: 0.071 | tubulopathy: 0.042 | nephrocalcinosis: 0.035 | cakut: 0.016 | cyst_cilio: 0.013),OMIM:614486 (adult: 0.218),NULL,hm (true); ht (false),0.5,2642,0.5115303983228512,"9606.ENSP00000396688:227, 9606.ENSP00000245907:737, 9606.ENSP00000296280:542, 9606.ENSP00000356399:540, 9606.ENSP00000308938:411, 9606.ENSP00000363773:185",0,16.7689,10.2439,6.4636609184993,cur_388
TMEM107,28128,4,3.6511117111630025,NULL,NULL,NULL,NULL,Orofaciodigital syndrome XVI[OMIM:617563]-Autosomal recessive inheritance | Meckel syndrome 13[OMIM:617562]-Autosomal recessive inheritance | ?Joubert syndrome 29[OMIM:617562]-Autosomal recessive inheritance,Moderate (ciliopathy[MONDO:0005308]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive),NULL,P:29; LP:6; VUS:145,OMIM:617562 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:617563 (antenatal_or_congenital: 0.821),OMIM:617562 (syndromic: 0.069 | skeletal: 0.041 | neurologic: 0.12); OMIM:617563 (syndromic: 0.067 | skeletal: 0.017 | neurologic: 0.115),hm (true); ht (false),1,8627,0.8574423480083857,"9606.ENSP00000403465:826, 9606.ENSP00000367398:256, 9606.ENSP00000386264:576, 9606.ENSP00000258173:856, 9606.ENSP00000243578:816, 9606.ENSP00000448012:749, 9606.ENSP00000389998:720, 9606.ENSP00000304941:789, 9606.ENSP00000376827:793, 9606.ENSP00000380779:777, 9606.ENSP00000261499:826, 9606.ENSP00000313169:302, 9606.ENSP00000483364:341",0,6.27876,5.06837,8.41132729518374,cur_389
TMEM127,26038,2,0.6467438515543782,0.012865,0.50485,1.2915,0.44804,"{Pheochromocytoma, susceptibility to}[OMIM:171300]-Autosomal dominant inheritance","Moderate (renal cell carcinoma[MONDO:0005086]-Autosomal dominant) | Definitive, Definitive, Strong (pheochromocytoma[MONDO:0008233]-Autosomal dominant) | Definitive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-Autosomal dominant)",Definitive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-AD),P:48; LP:26; VUS:456,OMIM:171300 (cancer: 0.04 | cakut: 0.008 | cyst_cilio: 0.005),NULL,OMIM:171300 (syndromic: 0.001 | neurologic: 0.001),hm (false); ht (false),0,292,0.0649895178197065,9606.ENSP00000265748:292,0.5,30.4456,20.9024,22.9830307828272,cur_390
TMEM138,26944,5,3.654980419475412,0.047034,0.42876,1.4002,0.47268,Joubert syndrome 16[OMIM:614465]-Autosomal recessive inheritance,"Moderate (ciliopathy[MONDO:0005308]-Autosomal recessive) | Supportive (Joubert syndrome with oculorenal defect[MONDO:0009480]-Autosomal recessive) | Strong, Moderate, Limited (Joubert syndrome 16[MONDO:0013764]-Autosomal recessive)",Moderate (ciliopathy[MONDO:0005308]-AR),P:10; LP:6; VUS:76,OMIM:614465 (cyst_cilio: 0.189 | cakut: 0.048 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),NULL,OMIM:614465 (syndromic: 0.004 | skeletal: 0.008 | neurologic: 0.007),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,14.5056,9.83816,10.9672065638443,cur_391
TMEM216,25018,4,4.162530182286601,0.001886,0.65616,0.87953,0.49118,Joubert syndrome 2[OMIM:608091]-Autosomal recessive inheritance | Meckel syndrome 2[OMIM:603194]-Autosomal recessive inheritance,Supportive (Joubert syndrome with oculorenal defect[MONDO:0009480]-Autosomal recessive) | Supportive (orofaciodigital syndrome type 6[MONDO:0010176]-Autosomal recessive) | Strong (Joubert syndrome 2[MONDO:0011963]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive),NULL,P:17; LP:20; VUS:81,OMIM:603194 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007); OMIM:608091 (cyst_cilio: 0.257 | tubulopathy: 0.112 | nephrocalcinosis: 0.111 | cakut: 0.089 | glomerulopathy: 0.089 | complement: 0.071 | cancer: 0.05),OMIM:603194 (antenatal_or_congenital: 0.899),OMIM:603194 (syndromic: 0.016 | growth: 0.102 | skeletal: 0.015 | neurologic: 0.004); OMIM:608091 (syndromic: 0.115 | growth: 0.171 | skeletal: 0.046 | neurologic: 0.164),hm (NA); ht (NA),0,NULL,NULL,NULL,0,12.2947,6.841139999999999,9.79256640724162,cur_392
TMEM231,37234,5,4.157771449616652,NULL,NULL,NULL,NULL,Joubert syndrome 20[OMIM:614970]-Autosomal recessive inheritance | Meckel syndrome 11[OMIM:615397]-Autosomal recessive inheritance,Definitive (ciliopathy[MONDO:0005308]-Autosomal recessive) | Supportive (Joubert syndrome with oculorenal defect[MONDO:0009480]-Autosomal recessive) | Supportive (orofaciodigital syndrome III[MONDO:0009793]-Autosomal recessive) | Definitive (Joubert syndrome 20[MONDO:0013994]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive),Definitive (ciliopathy[MONDO:0005308]-AR),P:22; LP:12; VUS:177,OMIM:614970 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007); OMIM:615397 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:614970 (antenatal_or_congenital: 0.821); OMIM:615397 (antenatal_or_congenital: 0.821),OMIM:614970 (syndromic: 0.039 | skeletal: 0.005 | neurologic: 0.08); OMIM:615397 (syndromic: 0.001 | skeletal: 0.004 | neurologic: 0.001),hm (false); ht (false),1,11898,0.9580712788259959,"9606.ENSP00000389998:962, 9606.ENSP00000376827:926, 9606.ENSP00000304941:955, 9606.ENSP00000380779:967, 9606.ENSP00000414398:422, 9606.ENSP00000339824:290, 9606.ENSP00000483364:485, 9606.ENSP00000313169:327, 9606.ENSP00000261499:984, 9606.ENSP00000315602:227, 9606.ENSP00000357998:313, 9606.ENSP00000314116:856, 9606.ENSP00000367398:295, 9606.ENSP00000386264:556, 9606.ENSP00000403465:966, 9606.ENSP00000243578:966, 9606.ENSP00000448012:927, 9606.ENSP00000436596:226, 9606.ENSP00000311505:248",0.5,5.18739,2.75921,23.4538971188196,cur_393
TMEM237,14432,4,3.0643392125893185,0,0.85719,0.63921,0.094482,Joubert syndrome 14[OMIM:614424]-Autosomal recessive inheritance,"Supportive (Joubert syndrome with oculorenal defect[MONDO:0009480]-Autosomal recessive) | Supportive (Joubert syndrome with renal defect[MONDO:0012308]-Autosomal recessive) | Definitive, Definitive, Strong, Moderate (Joubert syndrome 14[MONDO:0013745]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",Definitive (Joubert syndrome 14[MONDO:0013745]-AR),P:24; LP:13; VUS:210,OMIM:614424 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),NULL,OMIM:614424 (syndromic: 0.089 | growth: 0.091 | skeletal: 0.019 | neurologic: 0.109),hm (NA); ht (NA),0.5,4344,0.6960167714884696,"9606.ENSP00000258173:556, 9606.ENSP00000311505:293, 9606.ENSP00000483364:214, 9606.ENSP00000313169:420, 9606.ENSP00000314116:576, 9606.ENSP00000261499:263, 9606.ENSP00000304941:170, 9606.ENSP00000389998:716, 9606.ENSP00000380779:154, 9606.ENSP00000448012:271, 9606.ENSP00000367398:266, 9606.ENSP00000243578:208, 9606.ENSP00000256078:237",0.5,5.0681400000000005,2.99689,26.9351337683812,cur_394
TMEM260,20185,2,1.1393531161242934,0,0.83258,0.9618,-0.74092,Structural heart defects and renal anomalies syndrome[OMIM:617478]-Autosomal recessive inheritance,Strong (structural heart defects and renal anomalies syndrome[MONDO:0044321]-Autosomal recessive),NULL,P:12; LP:9; VUS:44,OMIM:617478 (cyst_cilio: 0.16 | tubulopathy: 0.112 | nephrocalcinosis: 0.111 | glomerulopathy: 0.089 | cakut: 0.085 | complement: 0.071 | cancer: 0.05),NULL,OMIM:617478 (syndromic: 0.018 | skeletal: 0.052 | neurologic: 0.03),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,6.96157,4.01978,60.9604277298978,cur_395
TMEM67,28396,5,4.925462726667397,0,0.73805,1.9164,0.4925,"Nephronophthisis 11[OMIM:613550]-Autosomal recessive inheritance | {Bardet-Biedl syndrome 14, modifier of}[OMIM:615991]-Autosomal recessive inheritance | Joubert syndrome 6[OMIM:610688]-Autosomal recessive inheritance | Meckel syndrome 3[OMIM:607361]-Autosomal recessive inheritance | ?RHYNS syndrome[OMIM:602152]-Autosomal recessive inheritance | COACH syndrome 1[OMIM:216360]-Autosomal recessive inheritance","Definitive (ciliopathy[MONDO:0005308]-Autosomal recessive) | Strong, Supportive (COACH syndrome 1[MONDO:0008996]-Autosomal recessive) | Definitive (Meckel syndrome, type 3[MONDO:0011821]-Autosomal recessive) | Strong (Joubert syndrome 6[MONDO:0012539]-Autosomal recessive) | Definitive, Moderate (nephronophthisis 11[MONDO:0013302]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive) | Supportive (Senior-Boichis syndrome[MONDO:0019394]-Autosomal recessive) | Definitive (COACH syndrome 1[MONDO:0800103]-Autosomal recessive)",Definitive (ciliopathy[MONDO:0005308]-AR),P:99; LP:77; VUS:372,OMIM:216360 (cyst_cilio: 0.328 | glomerulopathy: 0.135 | cakut: 0.133 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.021); OMIM:602152 (cyst_cilio: 0.178 | nephrocalcinosis: 0.153 | tubulopathy: 0.147 | glomerulopathy: 0.109 | complement: 0.107 | cakut: 0.06 | cancer: 0.02); OMIM:607361 (cakut: 0.016 | cancer: 0.01 | cyst_cilio: 0.008 | glomerulopathy: 0.002); OMIM:610688 (cyst_cilio: 0.223 | glomerulopathy: 0.135 | tubulopathy: 0.042 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02); OMIM:613550 (cyst_cilio: 0.302 | tubulopathy: 0.168 | glomerulopathy: 0.162 | nephrocalcinosis: 0.097 | cakut: 0.048 | complement: 0.036 | cancer: 0.02); OMIM:615991 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:216360 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402); OMIM:602152 (antenatal_or_congenital: 0.821),OMIM:216360 (syndromic: 0.09 | growth: 0.091 | skeletal: 0.007 | neurologic: 0.157); OMIM:602152 (syndromic: 0.028 | growth: 0.25 | skeletal: 0.047 | neurologic: 0.002); OMIM:607361 (syndromic: 0.013 | skeletal: 0.016 | neurologic: 0.01); OMIM:610688 (syndromic: 0.059 | neurologic: 0.124); OMIM:613550 (syndromic: 0.03 | growth: 0.091 | neurologic: 0.052); OMIM:615991 (syndromic: 0.047 | growth: 0.043 | skeletal: 0.003 | neurologic: 0.091),hm (true); ht (false),1,13049,0.9727463312368972,"9606.ENSP00000264634:270, 9606.ENSP00000313169:806, 9606.ENSP00000483364:946, 9606.ENSP00000376827:894, 9606.ENSP00000448012:920, 9606.ENSP00000358866:557, 9606.ENSP00000258173:962, 9606.ENSP00000403465:887, 9606.ENSP00000367398:696, 9606.ENSP00000261499:985, 9606.ENSP00000380779:973, 9606.ENSP00000304941:973, 9606.ENSP00000243578:976, 9606.ENSP00000380911:380, 9606.ENSP00000484824:190, 9606.ENSP00000386264:716, 9606.ENSP00000314116:720, 9606.ENSP00000379430:198",0.5,4.109380000000001,2.37262,73.3264828813766,cur_396
TNS2,19737,3,2.599884158151795,NULL,NULL,NULL,NULL,NULL,NULL,NULL,P:0; LP:0; VUS:126,NULL,NULL,NULL,hm (true); ht (false),0.5,2407,0.47379454926624737,"9606.ENSP00000355499:187, 9606.ENSP00000339191:292, 9606.ENSP00000393312:229, 9606.ENSP00000317272:151, 9606.ENSP00000298552:187, 9606.ENSP00000362680:376, 9606.ENSP00000276297:985",0.5,107.825,82.4978,NULL,cur_397
TNXB,11976,3,2.71075133861943,NULL,NULL,NULL,NULL,"Ehlers-Danlos syndrome, classic-like, 1[OMIM:606408]-Autosomal recessive inheritance | Vesicoureteral reflux 8[OMIM:615963]-Autosomal dominant inheritance","Definitive, Strong, Strong, Strong, Supportive (Ehlers-Danlos syndrome due to tenascin-X deficiency[MONDO:0011670]-Autosomal recessive) | Supportive (familial vesicoureteral reflux[MONDO:0017329]-Autosomal dominant)",NULL,P:23; LP:27; VUS:1115,OMIM:606408 (cakut: 0.113 | cancer: 0.02 | cyst_cilio: 0.013 | tubulopathy: 0.007 | glomerulopathy: 0.002); OMIM:615963 (cakut: 0.073 | cancer: 0.06 | cyst_cilio: 0.01 | glomerulopathy: 0.002),NULL,OMIM:606408 (syndromic: 0.002 | skeletal: 0.008); OMIM:615963 (syndromic: 0.002 | skeletal: 0.008),hm (false); ht (false),0,NULL,NULL,NULL,0,4.260280000000001,3.10566,3.89460207001997,cur_398
TP53RK,16197,4,2.472075174337039,7.75e-4,0.82897,0.38924,0.19783,Galloway-Mowat syndrome 4[OMIM:617730]-Autosomal recessive inheritance,"Supportive (Galloway-Mowat syndrome[MONDO:0009627]-Autosomal recessive) | Strong, Strong, Limited (Galloway-Mowat syndrome 4[MONDO:0033008]-Autosomal recessive)",NULL,P:4; LP:2; VUS:28,OMIM:617730 (glomerulopathy: 0.373 | cyst_cilio: 0.134 | cakut: 0.056 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:617730 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402),OMIM:617730 (syndromic: 0.107 | growth: 0.25 | skeletal: 0.014 | neurologic: 0.188),hm (NA); ht (NA),0.5,4292,0.689727463312369,"9606.ENSP00000306320:998, 9606.ENSP00000206542:999, 9606.ENSP00000349923:999, 9606.ENSP00000381266:234, 9606.ENSP00000269305:827, 9606.ENSP00000361512:235",0,7.30733,4.87003,8.98124220195605,cur_399
TPRKB,24259,4,2.3750815141063084,0.00821,0.57749,1.0304,0.10089,Galloway-Mowat syndrome 5[OMIM:617731]-Autosomal recessive inheritance,Supportive (Galloway-Mowat syndrome[MONDO:0009627]-Autosomal recessive) | Limited (Galloway-Mowat syndrome 5[MONDO:0033009]-Autosomal recessive),NULL,P:1; LP:0; VUS:19,OMIM:617731 (glomerulopathy: 0.259 | cyst_cilio: 0.136 | cancer: 0.05 | tubulopathy: 0.049 | cakut: 0.048 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:617731 (neonatal_or_pediatric: 0.262),OMIM:617731 (syndromic: 0.078 | skeletal: 0.012 | neurologic: 0.141),hm (false); ht (false),0,NULL,NULL,NULL,0.5,22.7807,14.1818,21.9258893227976,cur_400
TRAF3IP1,17861,4,2.713719741760948,0,0.50255,2.8344,0.32801,Senior-Loken syndrome 9[OMIM:616629]-Autosomal recessive inheritance,"Definitive (Senior-Loken syndrome 9[MONDO:0014712]-Autosomal recessive) | Strong, Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive) | Supportive (short rib-polydactyly syndrome, Majewski type[MONDO:0019662]-Autosomal recessive)",NULL,P:22; LP:10; VUS:276,OMIM:616629 (cyst_cilio: 0.236 | glomerulopathy: 0.137 | tubulopathy: 0.042 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,OMIM:616629 (syndromic: 0.03 | growth: 0.043 | skeletal: 0.012 | neurologic: 0.051),hm (false); ht (false),1,11878,0.9559748427672956,"9606.ENSP00000406012:540, 9606.ENSP00000242591:977, 9606.ENSP00000362413:292, 9606.ENSP00000404122:984, 9606.ENSP00000260570:994, 9606.ENSP00000304941:214, 9606.ENSP00000297185:292, 9606.ENSP00000382717:540, 9606.ENSP00000246957:292, 9606.ENSP00000393541:995, 9606.ENSP00000262613:214, 9606.ENSP00000216181:292, 9606.ENSP00000238628:540, 9606.ENSP00000360532:342, 9606.ENSP00000380911:436, 9606.ENSP00000362121:983, 9606.ENSP00000312778:996, 9606.ENSP00000296266:583, 9606.ENSP00000314444:540, 9606.ENSP00000243344:540, 9606.ENSP00000252699:292",0.5,5.69056,5.1413400000000005,45.1924847981947,cur_401
TRAP1,16264,3,2.713278667039019,0,1.0916,-0.52632,-2.7246,NULL,NULL,NULL,P:1; LP:0; VUS:115,NULL,NULL,NULL,hm (false); ht (false),0.5,4455,0.7044025157232704,"9606.ENSP00000215832:292, 9606.ENSP00000231509:316, 9606.ENSP00000219476:369, 9606.ENSP00000333946:197, 9606.ENSP00000364649:900, 9606.ENSP00000265748:292, 9606.ENSP00000297185:428, 9606.ENSP00000216181:190, 9606.ENSP00000367203:403, 9606.ENSP00000356319:292, 9606.ENSP00000470972:286, 9606.ENSP00000362424:292, 9606.ENSP00000354497:198",0.5,17.6989,19.4309,95.1358901501138,cur_402
TRIM32,16380,3,2.8048825344174615,0.001668,0.45499,1.9809,0.82684,"?Bardet-Biedl syndrome 11[OMIM:615988]-Autosomal recessive inheritance | Muscular dystrophy, limb-girdle, autosomal recessive 8[OMIM:254110]-Autosomal recessive inheritance","Definitive, Supportive (autosomal recessive limb-girdle muscular dystrophy type 2H[MONDO:0009683]-Autosomal recessive) | Definitive (Bardet-Biedl syndrome 11[MONDO:0014439]-Autosomal recessive) | Definitive (autosomal recessive limb-girdle muscular dystrophy[MONDO:0015152]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",Definitive (autosomal recessive limb-girdle muscular dystrophy[MONDO:0015152]-AR),P:26; LP:17; VUS:343,OMIM:615988 (cyst_cilio: 0.018 | cancer: 0.01 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:254110 (adult: 0.372); OMIM:615988 (antenatal_or_congenital: 0.821),OMIM:254110 (syndromic: 0.012 | neurologic: 0.025); OMIM:615988 (syndromic: 0.003 | growth: 0.043 | skeletal: 0.003),hm (false); ht (false),0.5,2419,0.4758909853249476,"9606.ENSP00000281043:292, 9606.ENSP00000262366:292, 9606.ENSP00000356319:292, 9606.ENSP00000311505:457, 9606.ENSP00000381266:407, 9606.ENSP00000269305:387, 9606.ENSP00000264414:292",0,4.48623,3.02831,7.89472011678815,cur_403
TRIM8,15579,4,2.523388679765143,NULL,NULL,NULL,NULL,Focal segmental glomerulosclerosis and neurodevelopmental syndrome[OMIM:619428]-Autosomal dominant inheritance,Supportive (developmental and epileptic encephalopathy[MONDO:0100062]-Autosomal dominant) | Definitive (focal segmental glomerulosclerosis and neurodevelopmental syndrome[MONDO:0100111]-Autosomal dominant),Definitive (focal segmental glomerulosclerosis and neurodevelopmental syndrome[MONDO:0100111]-AD),P:11; LP:9; VUS:80,OMIM:619428 (glomerulopathy: 0.124 | complement: 0.036 | cancer: 0.03 | cakut: 0.008 | cyst_cilio: 0.008 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),NULL,OMIM:619428 (syndromic: 0.123 | growth: 0.091 | skeletal: 0.064 | neurologic: 0.218),hm (false); ht (false),0,NULL,NULL,NULL,0.5,89.1211,78.1007,44.5188933170635,cur_404
TRPC6,12338,5,4.142929698142213,0,0.44134,3.3061,2.1227,"Glomerulosclerosis, focal segmental, 2[OMIM:603965]-Autosomal dominant inheritance",Strong (focal segmental glomerulosclerosis 2[MONDO:0011390]-Autosomal dominant) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant),NULL,P:7; LP:13; VUS:150,OMIM:603965 (glomerulopathy: 0.353 | cyst_cilio: 0.147 | cakut: 0.073 | nephrocalcinosis: 0.069 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036),OMIM:603965 (adult: 0.372),NULL,hm (false); ht (false),0.5,4500,0.7085953878406709,"9606.ENSP00000368190:919, 9606.ENSP00000362680:543, 9606.ENSP00000352138:220, 9606.ENSP00000445306:292, 9606.ENSP00000252699:454, 9606.ENSP00000356587:977, 9606.ENSP00000363435:457, 9606.ENSP00000361021:307, 9606.ENSP00000406229:331",0.5,1.3459,1.17262,25.6398552541435,cur_405
TRPM6,17995,3,2.5060324946290087,0,0.34479,6.3741,1.6105,"Hypomagnesemia 1, intestinal[OMIM:602014]-Autosomal recessive inheritance",Supportive (intestinal hypomagnesemia 1[MONDO:0011176]-Autosomal recessive),NULL,P:28; LP:4; VUS:234,NULL,OMIM:602014 (neonatal_or_pediatric: 0.402),OMIM:602014 (syndromic: 0.02 | neurologic: 0.041),hm (false); ht (false),0.5,866,0.20545073375262055,"9606.ENSP00000265171:376, 9606.ENSP00000484803:198, 9606.ENSP00000216181:292",0,0.420387,0.8684850000000001,3.23724864730488,cur_406
TSC1,12362,5,3.9955703878759743,1,0.037521,6.5116,2.3217,"Focal cortical dysplasia, type II, somatic[OMIM:607341]-NA | Tuberous sclerosis-1[OMIM:191100]-Autosomal dominant inheritance | Lymphangioleiomyomatosis[OMIM:606690]-NA","Definitive (tuberous sclerosis[MONDO:0001734]-Autosomal dominant) | Strong (lung lymphangioleiomyomatosis[MONDO:0006277]-Autosomal dominant) | Definitive, Definitive, Strong, Strong, Strong (tuberous sclerosis 1[MONDO:0008612]-Autosomal dominant) | Definitive (lymphangioleiomyomatosis[MONDO:0011705]-Autosomal dominant) | Supportive (tuberous sclerosis complex[MONDO:0019341]-Autosomal dominant)",Definitive (tuberous sclerosis[MONDO:0001734]-AD),P:443; LP:95; VUS:1686,OMIM:191100 (cancer: 0.17 | cyst_cilio: 0.11 | cakut: 0.048 | glomerulopathy: 0.009 | tubulopathy: 0.007),OMIM:607341 (neonatal_or_pediatric: 0.402 | adult: 0.218),OMIM:191100 (syndromic: 0.047 | skeletal: 0.003 | neurologic: 0.098); OMIM:607341 (syndromic: 0.023 | neurologic: 0.049),hm (false); ht (true),0.5,4160,0.6813417190775681,"9606.ENSP00000297185:345, 9606.ENSP00000319756:187, 9606.ENSP00000451828:426, 9606.ENSP00000256078:165, 9606.ENSP00000228872:292, 9606.ENSP00000367203:403, 9606.ENSP00000355499:229, 9606.ENSP00000219476:999, 9606.ENSP00000216911:186, 9606.ENSP00000262304:191, 9606.ENSP00000414398:737",0.5,11.6185,11.7621,50.5864901877951,cur_407
TSC2,12363,5,4.001594484261517,1,0.023406,8.3653,-0.33027,"Lymphangioleiomyomatosis, somatic[OMIM:606690]-NA | ?Focal cortical dysplasia, type II, somatic[OMIM:607341]-NA | Tuberous sclerosis-2[OMIM:613254]-Autosomal dominant inheritance","Definitive (tuberous sclerosis[MONDO:0001734]-Autosomal dominant) | Definitive (lung lymphangioleiomyomatosis[MONDO:0006277]-Autosomal dominant) | Strong (lymphangioleiomyomatosis[MONDO:0011705]-Autosomal dominant) | Definitive, Definitive, Strong, Strong, Strong (tuberous sclerosis 2[MONDO:0013199]-Autosomal dominant) | Supportive (tuberous sclerosis complex[MONDO:0019341]-Autosomal dominant)",Definitive (tuberous sclerosis[MONDO:0001734]-AD),P:867; LP:202; VUS:3345,OMIM:613254 (cancer: 0.17 | cyst_cilio: 0.118 | cakut: 0.056 | glomerulopathy: 0.009 | tubulopathy: 0.007),OMIM:607341 (neonatal_or_pediatric: 0.402 | adult: 0.218); OMIM:613254 (neonatal_or_pediatric: 0.402),OMIM:607341 (syndromic: 0.023 | neurologic: 0.049); OMIM:613254 (syndromic: 0.047 | skeletal: 0.003 | neurologic: 0.098),hm (true); ht (true),0.5,5457,0.7672955974842768,"9606.ENSP00000451828:292, 9606.ENSP00000215832:292, 9606.ENSP00000466134:341, 9606.ENSP00000298552:999, 9606.ENSP00000362680:351, 9606.ENSP00000227507:457, 9606.ENSP00000246957:369, 9606.ENSP00000262304:795, 9606.ENSP00000358423:458, 9606.ENSP00000228872:588, 9606.ENSP00000339191:286, 9606.ENSP00000424757:229",0.5,28.4143,23.7701,90.4729658803666,cur_408
TTC21B,25660,4,3.9046060046380338,0,0.67797,2.6384,-0.40884,Short-rib thoracic dysplasia 4 with or without polydactyly[OMIM:613819]-Autosomal recessive inheritance | Nephronophthisis 12[OMIM:613820]-Autosomal dominant inheritance | Nephronophthisis 12[OMIM:613820]-Autosomal recessive inheritance,Supportive (nephronophthisis 2[MONDO:0011190]-Autosomal recessive) | Definitive (asphyxiating thoracic dystrophy 4[MONDO:0013441]-Autosomal recessive) | Definitive (nephronophthisis 12[MONDO:0013442]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive),Definitive (nephronophthisis 12[MONDO:0013442]-AR),P:63; LP:36; VUS:525,OMIM:613819 (glomerulopathy: 0.129 | cyst_cilio: 0.126 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02); OMIM:613820 (cyst_cilio: 0.223 | glomerulopathy: 0.135 | tubulopathy: 0.042 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,OMIM:613819 (syndromic: 0.031 | growth: 0.25 | skeletal: 0.062),hm (true); ht (false),1,10187,0.9056603773584906,"9606.ENSP00000296266:999, 9606.ENSP00000393541:900, 9606.ENSP00000382717:999, 9606.ENSP00000380321:825, 9606.ENSP00000314444:999, 9606.ENSP00000312778:543, 9606.ENSP00000362424:540, 9606.ENSP00000238628:999, 9606.ENSP00000242591:562, 9606.ENSP00000406012:999, 9606.ENSP00000260570:540, 9606.ENSP00000362121:540, 9606.ENSP00000404122:742",0.5,4.84964,4.1637,95.5383601637807,cur_409
TTC8,20087,5,4.408177566883946,1e-6,0.48061,2.6888,-0.079034,Bardet-Biedl syndrome 8[OMIM:615985]-Autosomal recessive inheritance | ?Retinitis pigmentosa 51[OMIM:613464]-Autosomal recessive inheritance,"Definitive (retinitis pigmentosa 51[MONDO:0013274]-Autosomal recessive) | Definitive, Strong, Moderate (Bardet-Biedl syndrome 8[MONDO:0014436]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive) | Supportive (retinitis pigmentosa[MONDO:0019200]-Autosomal dominant)",NULL,P:25; LP:13; VUS:221,OMIM:613464 (cyst_cilio: 0.018 | cancer: 0.01 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:615985 (cakut: 0.052 | cyst_cilio: 0.018 | glomerulopathy: 0.002),OMIM:613464 (neonatal_or_pediatric: 0.262); OMIM:615985 (antenatal_or_congenital: 0.821),OMIM:613464 (syndromic: 0.029 | growth: 0.043 | skeletal: 0.003 | neurologic: 0.055); OMIM:615985 (syndromic: 0.05 | growth: 0.043 | skeletal: 0.013 | neurologic: 0.091),hm (true); ht (false),1,10082,0.89937106918239,"9606.ENSP00000242591:153, 9606.ENSP00000296135:822, 9606.ENSP00000356405:244, 9606.ENSP00000334379:303, 9606.ENSP00000264499:987, 9606.ENSP00000433157:972, 9606.ENSP00000245157:997, 9606.ENSP00000317469:999, 9606.ENSP00000295240:996, 9606.ENSP00000338766:374, 9606.ENSP00000413017:551, 9606.ENSP00000242067:998, 9606.ENSP00000311505:292, 9606.ENSP00000362121:194, 9606.ENSP00000448012:201, 9606.ENSP00000268057:999",0.5,4.505719999999999,3.10348,44.4172382732001,cur_410
TTR,12405,4,2.3985344392872205,0.51566,0.16087,1.9387,1.0149,"Amyloidosis, hereditary, transthyretin-related[OMIM:105210]-Autosomal dominant inheritance | Carpal tunnel syndrome, familial[OMIM:115430]-Autosomal dominant inheritance | [Dystransthyretinemic hyperthyroxinemia][OMIM:145680]-Autosomal dominant inheritance","Strong (heart conduction disease[MONDO:0000992]-Autosomal dominant) | Definitive, Strong, Supportive (familial amyloid neuropathy[MONDO:0007100]-Autosomal dominant) | Definitive (hereditary ATTR amyloidosis[MONDO:0017132]-Autosomal dominant) | Supportive (ATTRV122I amyloidosis[MONDO:0019441]-Autosomal dominant)",Definitive (hereditary ATTR amyloidosis[MONDO:0017132]-AD),P:79; LP:53; VUS:107,NULL,OMIM:105210 (adult: 0.218),OMIM:105210 (syndromic: 0.071 | neurologic: 0.149); OMIM:115430 (syndromic: 0.002 | skeletal: 0 | neurologic: 0.004),hm (false); ht (false),0.5,4078,0.6708595387840671,"9606.ENSP00000356399:347, 9606.ENSP00000252486:766, 9606.ENSP00000346839:200, 9606.ENSP00000245907:465, 9606.ENSP00000456609:499, 9606.ENSP00000355627:163, 9606.ENSP00000236850:892, 9606.ENSP00000362924:364, 9606.ENSP00000381448:382",0,1.1456,1.36871,3.5394477862271,cur_411
TULP3,12425,2,1.3031369260129733,NULL,NULL,NULL,NULL,Hepatorenocardiac degenerative fibrosis[OMIM:619902]-Autosomal recessive inheritance,Strong (ciliopathy[MONDO:0005308]-Autosomal recessive) | Moderate (NA[NA]-Autosomal recessive),Strong (ciliopathy[MONDO:0005308]-AR),P:6; LP:0; VUS:24,OMIM:619902 (cyst_cilio: 0.168 | cakut: 0.065 | cancer: 0.03 | nephrocalcinosis: 0.014 | glomerulopathy: 0.013 | tubulopathy: 0.007),OMIM:619902 (neonatal_or_pediatric: 0.865 | adult: 0.372),OMIM:619902 (syndromic: 0 | neurologic: 0),hm (true); ht (true),1,8151,0.8469601677148847,"9606.ENSP00000347942:311, 9606.ENSP00000256078:235, 9606.ENSP00000472847:292, 9606.ENSP00000296266:892, 9606.ENSP00000314444:776, 9606.ENSP00000215832:359, 9606.ENSP00000377836:292, 9606.ENSP00000264414:292, 9606.ENSP00000437256:292, 9606.ENSP00000243344:825, 9606.ENSP00000242591:292, 9606.ENSP00000406012:799, 9606.ENSP00000404122:292, 9606.ENSP00000387982:292, 9606.ENSP00000382717:776, 9606.ENSP00000364649:292, 9606.ENSP00000238628:571, 9606.ENSP00000367888:271",0.5,20.7095,15.9413,74.459904895486,cur_412
TXNDC15,20652,3,1.8303858994129651,0.009648,0.38338,2.2604,0.56315,Meckel syndrome 14[OMIM:619879]-Autosomal recessive inheritance,"Moderate, Supportive (Meckel syndrome[MONDO:0018921]-Autosomal recessive)",NULL,P:7; LP:2; VUS:16,OMIM:619879 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:619879 (antenatal_or_congenital: 0.857),OMIM:619879 (syndromic: 0.027 | skeletal: 0.074 | neurologic: 0.002),hm (NA); ht (NA),0,165,0.018867924528301886,9606.ENSP00000362298:165,0.5,20.5261,13.3808,39.822562089366,cur_413
UMOD,12559,5,4.350787924478848,NULL,NULL,NULL,NULL,"Tubulointerstitial kidney disease, autosomal dominant, 1[OMIM:162000]-Autosomal dominant inheritance",Definitive (autosomal dominant medullary cystic kidney disease with or without hyperuricemia[MONDO:0008264]-Autosomal dominant) | Definitive (glomerulocystic kidney disease with hyperuricemia and isosthenuria[MONDO:0012356]-Autosomal dominant) | Supportive (autosomal dominant medullary cystic kidney disease with hyperuricemia[MONDO:0019511]-Autosomal dominant),Definitive (autosomal dominant medullary cystic kidney disease with or without hyperuricemia[MONDO:0008264]-AD),P:34; LP:35; VUS:130,OMIM:162000 (nephrocalcinosis: 0.174 | glomerulopathy: 0.142 | tubulopathy: 0.14 | cyst_cilio: 0.108 | complement: 0.071 | cakut: 0.048 | cancer: 0.02),OMIM:162000 (neonatal_or_pediatric: 0.2),OMIM:162000 (syndromic: 0 | skeletal: 0.001),hm (true); ht (true),0,313,0.07337526205450734,9606.ENSP00000262418:313,1,2116.02,190.47799999999998,9.90678307333827,cur_414
UPK3A,12580,2,2.159682341278337,0,1.1921,-0.61011,-0.41056,NULL,"Supportive (renal agenesis, unilateral[MONDO:0019636]-Autosomal dominant) | Limited (renal dysplasia[MONDO:0019638]-Autosomal dominant) | Disputed Evidence (congenital anomaly of kidney and urinary tract[MONDO:0019719]-Autosomal dominant)",Disputed (congenital anomaly of kidney and urinary tract[MONDO:0019719]-AD),P:0; LP:1; VUS:37,NULL,NULL,NULL,hm (true); ht (false),0,NULL,NULL,NULL,0,0.154798,0,9.9054123279114,cur_415
VDR,12679,4,2.7181940188590317,NULL,NULL,NULL,NULL,"Rickets, vitamin D-resistant, type IIA[OMIM:277440]-Autosomal recessive inheritance","Definitive (vitamin D-dependent rickets, type 2A[MONDO:0010186]-Autosomal recessive) | Supportive (vitamin D-dependent rickets, type 2[MONDO:0019642]-Autosomal recessive)",NULL,P:20; LP:7; VUS:167,NULL,OMIM:277440 (neonatal_or_pediatric: 0.537),OMIM:277440 (syndromic: 0.051 | growth: 0.262 | skeletal: 0.043 | neurologic: 0.025),hm (true); ht (false),0,NULL,NULL,NULL,0,3.30652,9.82517,5.45094165239832,cur_416
VHL,12687,5,4.553102546475109,0.079515,0.35884,1.7179,-0.39499,"Erythrocytosis, familial, 2[OMIM:263400]-Autosomal recessive inheritance | von Hippel-Lindau syndrome[OMIM:193300]-Autosomal dominant inheritance | Renal cell carcinoma, somatic[OMIM:144700]-NA | Pheochromocytoma[OMIM:171300]-Autosomal dominant inheritance","Strong (renal cell carcinoma[MONDO:0005086]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (von Hippel-Lindau disease[MONDO:0008667]-Autosomal dominant) | Strong, Supportive (Chuvash polycythemia[MONDO:0009892]-Autosomal recessive) | Supportive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-Autosomal dominant)",Definitive (von Hippel-Lindau disease[MONDO:0008667]-AD),P:288; LP:120; VUS:826,OMIM:144700 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:171300 (cancer: 0.04 | cakut: 0.008 | cyst_cilio: 0.005); OMIM:193300 (cancer: 0.14 | cyst_cilio: 0.018 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:193300 (adult: 0.372); OMIM:263400 (neonatal_or_pediatric: 0.865),OMIM:171300 (syndromic: 0.001 | neurologic: 0.001); OMIM:193300 (syndromic: 0 | neurologic: 0.001); OMIM:263400 (syndromic: 0.011 | growth: 0.171 | neurologic: 0.004),hm (false); ht (true),0.5,6793,0.8176100628930818,"9606.ENSP00000359345:292, 9606.ENSP00000228872:414, 9606.ENSP00000346839:666, 9606.ENSP00000358866:647, 9606.ENSP00000348984:292, 9606.ENSP00000413720:292, 9606.ENSP00000268766:292, 9606.ENSP00000313967:321, 9606.ENSP00000287820:292, 9606.ENSP00000369647:296, 9606.ENSP00000420194:292, 9606.ENSP00000379823:309, 9606.ENSP00000337439:292, 9606.ENSP00000364979:457, 9606.ENSP00000451828:292, 9606.ENSP00000231509:165, 9606.ENSP00000269305:560, 9606.ENSP00000262367:165, 9606.ENSP00000216911:457",0.5,10.7547,6.89641,74.4322785253836,cur_417
VIPAS39,20347,4,2.789003151395005,NULL,NULL,NULL,NULL,"Arthrogryposis, renal dysfunction, and cholestasis 2[OMIM:613404]-Autosomal recessive inheritance","Definitive, Definitive, Strong (arthrogryposis, renal dysfunction, and cholestasis 2[MONDO:0013255]-Autosomal recessive) | Supportive (arthrogryposis-renal dysfunction-cholestasis syndrome[MONDO:0017123]-Autosomal recessive)","Definitive (arthrogryposis, renal dysfunction, and cholestasis 2[MONDO:0013255]-AR)",P:16; LP:5; VUS:70,OMIM:613404 (nephrocalcinosis: 0.208 | tubulopathy: 0.133 | glomerulopathy: 0.042 | cancer: 0.03 | cyst_cilio: 0.016 | cakut: 0.008),OMIM:613404 (neonatal_or_pediatric: 0.134),OMIM:613404 (syndromic: 0.052 | growth: 0.171 | skeletal: 0.058 | neurologic: 0.081),hm (false); ht (false),0.5,959,0.2222222222222222,9606.ENSP00000327650:959,0.5,11.1608,8.8863,15.7229413547744,cur_418
VPS33B,12712,4,3.0137482857786937,0,0.71213,1.76,0.3636,"Keratoderma-ichthyosis-deafness syndrome, autosomal recessive[OMIM:620009]-Autosomal recessive inheritance | Cholestasis, progressive familial intrahepatic, 12[OMIM:620010]-Autosomal recessive inheritance | Arthrogryposis, renal dysfunction, and cholestasis 1[OMIM:208085]-Autosomal recessive inheritance","Definitive, Definitive (arthrogryposis, renal dysfunction, and cholestasis 1[MONDO:0008822]-Autosomal recessive) | Supportive (arthrogryposis-renal dysfunction-cholestasis syndrome[MONDO:0017123]-Autosomal recessive)","Definitive (arthrogryposis, renal dysfunction, and cholestasis 1[MONDO:0008822]-AR)",P:27; LP:11; VUS:132,OMIM:208085 (nephrocalcinosis: 0.208 | tubulopathy: 0.147 | glomerulopathy: 0.064 | cyst_cilio: 0.045 | cancer: 0.03 | cakut: 0.012),OMIM:208085 (antenatal_or_congenital: 0.821); OMIM:620009 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402); OMIM:620010 (neonatal_or_pediatric: 0.402),OMIM:208085 (syndromic: 0.062 | growth: 0.217 | skeletal: 0.084 | neurologic: 0.081); OMIM:620009 (syndromic: 0.024 | neurologic: 0.051); OMIM:620010 (syndromic: 0.013 | growth: 0.25),hm (false); ht (false),0.5,1347,0.3165618448637317,"9606.ENSP00000326649:165, 9606.ENSP00000452181:959, 9606.ENSP00000234396:223",0.5,12.7127,8.79547,10.5151159799314,cur_419
WBP11,16461,2,1.1393531161242934,0.99994,0.031137,5.088,2.9803,"Vertebral, cardiac, tracheoesophageal, renal, and limb defects[OMIM:619227]-Autosomal dominant inheritance","Strong (vertebral, cardiac, tracheoesophageal, renal, and limb defects[MONDO:0030987]-Autosomal dominant)",NULL,P:4; LP:3; VUS:25,OMIM:619227 (cakut: 0.093 | cancer: 0.07 | cyst_cilio: 0.013 | tubulopathy: 0.007),NULL,OMIM:619227 (syndromic: 0.07 | growth: 0.25 | skeletal: 0.078 | neurologic: 0.087),hm (false); ht (true),0.5,2247,0.45073375262054505,"9606.ENSP00000269601:800, 9606.ENSP00000360532:958, 9606.ENSP00000281043:161, 9606.ENSP00000231887:163, 9606.ENSP00000445122:165",0.5,26.5193,17.4222,59.8797823661387,cur_420
WDPCP,28027,3,2.538538585769712,0,0.55232,2.6771,0.89768,"?Bardet-Biedl syndrome 15[OMIM:615992]-Autosomal recessive inheritance | Congenital heart defects, hamartomas of tongue, and polysyndactyly[OMIM:217085]-Autosomal recessive inheritance","Limited (heart defect - tongue hamartoma - polysyndactyly syndrome[MONDO:0009008]-Autosomal recessive) | Definitive, Limited (Bardet-Biedl syndrome 15[MONDO:0014443]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:24; LP:14; VUS:301,NULL,OMIM:217085 (antenatal_or_congenital: 0.821),OMIM:217085 (syndromic: 0.028 | skeletal: 0.013 | neurologic: 0.051),hm (true); ht (false),0.5,963,0.22431865828092243,9606.ENSP00000334003:963,0.5,0.8628530000000001,0.739322,226.476719914866,cur_421
WDR19,18340,5,4.794965702019201,0,0.41546,4.679,1.5033,Nephronophthisis 13[OMIM:614377]-Autosomal recessive inheritance | Cranioectodermal dysplasia 4[OMIM:614378]-Autosomal recessive inheritance | Senior-Loken syndrome 8[OMIM:616307]-Autosomal recessive inheritance | Short-rib thoracic dysplasia 5 with or without polydactyly[OMIM:614376]-Autosomal recessive inheritance | ?Spermatogenic failure 72[OMIM:619867]-Autosomal recessive inheritance,Definitive (ciliopathy[MONDO:0005308]-Autosomal recessive) | Supportive (cranioectodermal dysplasia[MONDO:0009032]-Autosomal recessive) | Supportive (nephronophthisis 1[MONDO:0009728]-Autosomal recessive) | Definitive (asphyxiating thoracic dystrophy 5[MONDO:0013717]-Autosomal recessive) | Definitive (cranioectodermal dysplasia 4[MONDO:0013719]-Autosomal recessive) | Supportive (Senior-Loken syndrome[MONDO:0017842]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive),Definitive (ciliopathy[MONDO:0005308]-AR),P:53; LP:43; VUS:484,OMIM:614376 (cyst_cilio: 0.171 | glomerulopathy: 0.149 | cakut: 0.125 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.021); OMIM:614377 (cyst_cilio: 0.278 | glomerulopathy: 0.155 | cakut: 0.129 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028); OMIM:614378 (glomerulopathy: 0.129 | cyst_cilio: 0.126 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02); OMIM:616307 (cyst_cilio: 0.228 | glomerulopathy: 0.135 | tubulopathy: 0.049 | cakut: 0.04 | complement: 0.036 | nephrocalcinosis: 0.028 | cancer: 0.02),OMIM:614376 (antenatal_or_congenital: 0.821); OMIM:614377 (neonatal_or_pediatric: 0.463 | antenatal_or_congenital: 0.077); OMIM:614378 (antenatal_or_congenital: 0.821); OMIM:616307 (neonatal_or_pediatric: 0.463); OMIM:619867 (adult: 0.372),OMIM:614376 (syndromic: 0.031 | growth: 0.267 | skeletal: 0.03); OMIM:614377 (syndromic: 0.005 | growth: 0.091); OMIM:614378 (syndromic: 0.044 | growth: 0.25 | skeletal: 0.052); OMIM:616307 (syndromic: 0.001 | skeletal: 0.003),hm (false); ht (false),1,11676,0.949685534591195,"9606.ENSP00000404122:540, 9606.ENSP00000334003:252, 9606.ENSP00000231509:165, 9606.ENSP00000243344:999, 9606.ENSP00000260570:540, 9606.ENSP00000362424:540, 9606.ENSP00000288139:214, 9606.ENSP00000362121:540, 9606.ENSP00000396320:214, 9606.ENSP00000238628:999, 9606.ENSP00000406012:999, 9606.ENSP00000312778:721, 9606.ENSP00000242591:540, 9606.ENSP00000393541:900, 9606.ENSP00000296266:999, 9606.ENSP00000231749:214, 9606.ENSP00000317469:525, 9606.ENSP00000314444:999, 9606.ENSP00000380321:776",0.5,11.1886,8.77248,63.9051834302753,cur_422
DYNC2I2,28296,3,1.8804135034489824,0,0.63528,1.5866,-0.12221,Short-rib thoracic dysplasia 11 with or without polydactyly[OMIM:615633]-Autosomal recessive inheritance,"Moderate (short-rib thoracic dysplasia 11 with or without polydactyly[MONDO:0014287]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive) | Supportive (short rib-polydactyly syndrome, Verma-Naumoff type[MONDO:0019664]-Autosomal recessive)",NULL,P:25; LP:10; VUS:199,OMIM:615633 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),NULL,OMIM:615633 (syndromic: 0.02 | growth: 0.043 | skeletal: 0.03 | neurologic: 0.02),hm (false); ht (false),0.5,1983,0.40461215932914046,"9606.ENSP00000384290:997, 9606.ENSP00000474032:986",0,NULL,NULL,NULL,cur_423
WDR35,29250,5,4.2785679427198895,NULL,NULL,NULL,NULL,Short-rib thoracic dysplasia 7 with or without polydactyly[OMIM:614091]-Autosomal recessive inheritance | Cranioectodermal dysplasia 2[OMIM:613610]-Autosomal recessive inheritance,"Supportive (cranioectodermal dysplasia[MONDO:0009032]-Autosomal recessive) | Definitive, Definitive, Strong (cranioectodermal dysplasia 2[MONDO:0013323]-Autosomal recessive) | Definitive, Supportive (short-rib thoracic dysplasia 7 with or without polydactyly[MONDO:0013569]-Autosomal recessive) | Supportive (short rib-polydactyly syndrome, Verma-Naumoff type[MONDO:0019664]-Autosomal recessive)",Definitive (cranioectodermal dysplasia 2[MONDO:0013323]-AR) | Definitive (short-rib thoracic dysplasia 7 with or without polydactyly[MONDO:0013569]-AR),P:31; LP:21; VUS:284,OMIM:613610 (cyst_cilio: 0.16 | tubulopathy: 0.112 | nephrocalcinosis: 0.111 | glomerulopathy: 0.089 | cakut: 0.085 | complement: 0.071 | cancer: 0.05); OMIM:614091 (cyst_cilio: 0.192 | cakut: 0.145 | cancer: 0.04 | glomerulopathy: 0.011 | tubulopathy: 0.007),OMIM:613610 (antenatal_or_congenital: 0.821),OMIM:613610 (syndromic: 0.161 | growth: 0.267 | skeletal: 0.167 | neurologic: 0.091); OMIM:614091 (syndromic: 0.05 | growth: 0.25 | skeletal: 0.056),hm (false); ht (false),1,11411,0.9412997903563941,"9606.ENSP00000362121:540, 9606.ENSP00000238628:999, 9606.ENSP00000396320:253, 9606.ENSP00000288139:253, 9606.ENSP00000362424:540, 9606.ENSP00000260570:540, 9606.ENSP00000243344:999, 9606.ENSP00000264414:292, 9606.ENSP00000404122:540, 9606.ENSP00000334003:189, 9606.ENSP00000216911:190, 9606.ENSP00000380321:776, 9606.ENSP00000231749:253, 9606.ENSP00000382717:999, 9606.ENSP00000242591:540, 9606.ENSP00000393541:900, 9606.ENSP00000296266:999, 9606.ENSP00000312778:610, 9606.ENSP00000406012:999",0.5,7.1106,3.4687300000000003,57.6762426485565,cur_424
DYNC2I1,21862,3,2.1653175919695102,0,0.48777,3.66,0.42237,Short-rib thoracic dysplasia 8 with or without polydactyly[OMIM:615503]-Autosomal recessive inheritance,"Strong (short-rib thoracic dysplasia 8 with or without polydactyly[MONDO:0014214]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive) | Supportive (short rib-polydactyly syndrome, Verma-Naumoff type[MONDO:0019664]-Autosomal recessive)",NULL,P:13; LP:6; VUS:150,NULL,NULL,OMIM:615503 (syndromic: 0.045 | growth: 0.421 | skeletal: 0.056),hm (NA); ht (NA),0.5,1995,0.4109014675052411,"9606.ENSP00000474032:998, 9606.ENSP00000361800:997",0,NULL,NULL,NULL,cur_425
WDR72,26790,4,2.51738155269683,NULL,NULL,NULL,NULL,"Amelogenesis imperfecta, type IIA3[OMIM:613211]-Autosomal recessive inheritance",Limited (renal tubular acidosis[MONDO:0001909]-Autosomal recessive) | Moderate (amelogenesis imperfecta hypomaturation type 2A3[MONDO:0013181]-Autosomal recessive) | Supportive (amelogenesis imperfecta type 2[MONDO:0015048]-Autosomal recessive) | Definitive (amelogenesis imperfecta[MONDO:0019507]-Autosomal recessive),Definitive (amelogenesis imperfecta[MONDO:0019507]-AR),P:12; LP:9; VUS:195,NULL,NULL,OMIM:613211 (syndromic: 0.001 | skeletal: 0.002),hm (true); ht (false),0,329,0.08176100628930817,"9606.ENSP00000356405:157, 9606.ENSP00000299339:172",0.5,11.1161,20.9719,34.6379337360677,cur_426
WDR73,25928,4,3.33802406359584,0,0.81803,0.72208,-0.46135,Galloway-Mowat syndrome 1[OMIM:251300]-Autosomal recessive inheritance,Supportive (Galloway-Mowat syndrome[MONDO:0009627]-Autosomal recessive) | Supportive (CAMOS syndrome[MONDO:0019374]-Autosomal recessive) | Strong (Galloway-Mowat syndrome 1[MONDO:0033005]-Autosomal recessive),NULL,P:17; LP:16; VUS:66,OMIM:251300 (glomerulopathy: 0.322 | nephrocalcinosis: 0.118 | tubulopathy: 0.112 | complement: 0.107 | cyst_cilio: 0.076 | cakut: 0.06 | cancer: 0.05),OMIM:251300 (neonatal_or_pediatric: 0.402),OMIM:251300 (syndromic: 0.198 | growth: 0.398 | skeletal: 0.098 | neurologic: 0.297),hm (NA); ht (NA),0,446,0.1090146750524109,"9606.ENSP00000358262:154, 9606.ENSP00000380321:292",0.5,9.465539999999999,6.00378,45.7220406858424,cur_427
WFS1,12762,4,2.414700454263571,0,1.6193,-3.0919,-4.7128,"Deafness, autosomal dominant 6/14/38[OMIM:600965]-Autosomal dominant inheritance | ?Cataract 41[OMIM:116400]-Autosomal dominant inheritance | Wolfram-like syndrome, autosomal dominant[OMIM:614296]-Autosomal dominant inheritance | {Diabetes mellitus, noninsulin-dependent, association with}[OMIM:125853]-Autosomal dominant inheritance | Wolfram syndrome 1[OMIM:222300]-Autosomal recessive inheritance","Limited (cataract 41[MONDO:0007287]-Autosomal dominant) | Definitive, Strong, Strong (Wolfram syndrome 1[MONDO:0009101]-Autosomal recessive) | Definitive, Definitive, Definitive, Strong, Strong, Supportive (Wolfram-like syndrome[MONDO:0013673]-Autosomal dominant) | Definitive, Supportive (Wolfram syndrome[MONDO:0018105]-Autosomal recessive) | Supportive (autosomal dominant nonsyndromic hearing loss[MONDO:0019587]-Autosomal dominant) | Supportive (early-onset nuclear cataract[MONDO:0020376]-Autosomal dominant)",Definitive (Wolfram-like syndrome[MONDO:0013673]-AD) | Definitive (Wolfram syndrome[MONDO:0018105]-AR),P:114; LP:81; VUS:611,OMIM:222300 (cakut: 0.097 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:125853 (adult: 0.108); OMIM:222300 (neonatal_or_pediatric: 0.463); OMIM:600965 (neonatal_or_pediatric: 0.2); OMIM:614296 (neonatal_or_pediatric: 0.463),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:222300 (syndromic: 0.072 | growth: 0.091 | skeletal: 0 | neurologic: 0.141); OMIM:614296 (syndromic: 0.007 | neurologic: 0.015),hm (false); ht (false),0.5,1882,0.3920335429769392,"9606.ENSP00000468308:323, 9606.ENSP00000363435:367, 9606.ENSP00000451828:292, 9606.ENSP00000269305:163, 9606.ENSP00000322323:499, 9606.ENSP00000357998:238",0.5,16.4233,16.4077,17.6090338005472,cur_428
WLS,30238,2,0.8143468478090599,NULL,NULL,NULL,NULL,Zaki syndrome[OMIM:619648]-Autosomal recessive inheritance,NULL,NULL,P:2; LP:2; VUS:25,OMIM:619648 (cakut: 0.117 | cancer: 0.07 | cyst_cilio: 0.021 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:619648 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402),OMIM:619648 (syndromic: 0.149 | growth: 0.25 | skeletal: 0.122 | neurologic: 0.175),hm (true); ht (false),0.5,3356,0.6079664570230608,"9606.ENSP00000256078:163, 9606.ENSP00000264634:829, 9606.ENSP00000417052:457, 9606.ENSP00000290167:800, 9606.ENSP00000245479:420, 9606.ENSP00000290015:687",0.5,30.2108,20.6457,92.4443381855509,cur_429
WNK1,14540,4,3.175505901391792,1,0.067205,8.8217,2.1626,"Neuropathy, hereditary sensory and autonomic, type II[OMIM:201300]-Autosomal recessive inheritance | Pseudohypoaldosteronism, type IIC[OMIM:614492]-Autosomal dominant inheritance","Moderate (pseudohypoaldosteronism type 2C[MONDO:0013778]-Autosomal dominant) | Strong (pseudohypoaldosteronism type 2[MONDO:0019162]-Autosomal dominant) | Strong, Supportive (hereditary sensory and autonomic neuropathy type 2[MONDO:0019941]-Autosomal recessive) | Definitive, Strong (neuropathy, hereditary sensory and autonomic, type 2A[MONDO:0024309]-Autosomal recessive)","Definitive (neuropathy, hereditary sensory and autonomic, type 2A[MONDO:0024309]-AR)",P:47; LP:8; VUS:860,NULL,OMIM:201300 (neonatal_or_pediatric: 0.402),OMIM:201300 (syndromic: 0.011 | skeletal: 0.001 | neurologic: 0.022),hm (true); ht (false),0.5,2150,0.429769392033543,"9606.ENSP00000377789:161, 9606.ENSP00000312397:457, 9606.ENSP00000262366:403, 9606.ENSP00000243253:154, 9606.ENSP00000264414:199, 9606.ENSP00000451828:225, 9606.ENSP00000344314:234, 9606.ENSP00000310842:317",0.5,18.2015,31.1437,234.287182857107,cur_430
WNK4,14544,4,3.188577277294054,0,0.81334,1.2576,0.8137,"Pseudohypoaldosteronism, type IIB[OMIM:614491]-Autosomal dominant inheritance",Strong (pseudohypoaldosteronism type 2[MONDO:0019162]-Autosomal dominant),NULL,P:4; LP:1; VUS:128,NULL,NULL,NULL,hm (true); ht (true),0.5,2004,0.4129979035639413,"9606.ENSP00000243253:154, 9606.ENSP00000312397:802, 9606.ENSP00000451828:292, 9606.ENSP00000376432:299, 9606.ENSP00000264414:457",0,52.4793,16.2105,5.06761074281948,cur_431
WNT4,12783,4,3.4687759545678767,0.12766,0.28443,2.4866,1.6116,?SERKAL syndrome[OMIM:611812]-Autosomal recessive inheritance | Mullerian aplasia and hyperandrogenism[OMIM:158330]-Autosomal dominant inheritance,"Strong, Strong, Moderate, Supportive (mullerian aplasia and hyperandrogenism[MONDO:0008019]-Autosomal dominant) | Strong, Limited, Supportive (SERKAL syndrome[MONDO:0012734]-Autosomal recessive)",NULL,P:4; LP:0; VUS:26,OMIM:158330 (cakut: 0.048 | cancer: 0.02 | tubulopathy: 0.007 | cyst_cilio: 0.005); OMIM:611812 (cancer: 0.05 | cakut: 0.044 | cyst_cilio: 0.008),OMIM:158330 (adult: 0.049); OMIM:611812 (antenatal_or_congenital: 0.038),OMIM:611812 (syndromic: 0.011 | growth: 0.102),hm (true); ht (false),0.5,4038,0.6666666666666666,"9606.ENSP00000336701:165, 9606.ENSP00000268053:191, 9606.ENSP00000294304:527, 9606.ENSP00000361021:173, 9606.ENSP00000362410:394, 9606.ENSP00000265171:171, 9606.ENSP00000346829:800, 9606.ENSP00000369442:663, 9606.ENSP00000364860:284, 9606.ENSP00000264634:670",0.5,0.8528680000000001,0.527844,21.201153225378,cur_432
WNT5A,12784,4,2.645473187009702,NULL,NULL,NULL,NULL,"Robinow syndrome, autosomal dominant 1[OMIM:180700]-Autosomal dominant inheritance","Moderate, Supportive (autosomal dominant Robinow syndrome[MONDO:0008389]-Autosomal dominant) | Definitive, Strong, Moderate, Moderate (autosomal dominant Robinow syndrome 1[MONDO:0024455]-Autosomal dominant)",Moderate (autosomal dominant Robinow syndrome[MONDO:0008389]-AD),P:4; LP:4; VUS:83,OMIM:180700 (cakut: 0.077 | cancer: 0.03 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:180700 (antenatal_or_congenital: 0.821),OMIM:180700 (syndromic: 0.168 | growth: 0.267 | skeletal: 0.164 | neurologic: 0.091),hm (true); ht (false),0.5,6549,0.8050314465408805,"9606.ENSP00000364860:995, 9606.ENSP00000369442:414, 9606.ENSP00000369647:400, 9606.ENSP00000294304:933, 9606.ENSP00000389998:270, 9606.ENSP00000304941:175, 9606.ENSP00000290167:670, 9606.ENSP00000367817:294, 9606.ENSP00000451828:168, 9606.ENSP00000370719:499, 9606.ENSP00000346829:829, 9606.ENSP00000377836:403, 9606.ENSP00000347244:499",0.5,4.1959,0.638764,50.1839675767785,cur_433
WNT9B,12779,2,0.8941947565543071,0.54137,0.18468,2.4862,0.80337,NULL,NULL,NULL,P:0; LP:2; VUS:17,NULL,NULL,NULL,hm (true); ht (true),0.5,966,0.23060796645702306,"9606.ENSP00000346829:687, 9606.ENSP00000294304:279",0,2.75294,0.319479,4.05826587469968,cur_434
WT1,12796,5,4.7364476717623445,NULL,NULL,NULL,NULL,"Mesothelioma, somatic[OMIM:156240]-NA | Meacham syndrome[OMIM:608978]-Autosomal dominant inheritance | Frasier syndrome[OMIM:136680]-Autosomal dominant inheritance | Frasier syndrome[OMIM:136680]-Somatic mutation | Nephrotic syndrome, type 4[OMIM:256370]-Autosomal dominant inheritance | Denys-Drash syndrome[OMIM:194080]-Autosomal dominant inheritance | Denys-Drash syndrome[OMIM:194080]-Somatic mutation | Wilms tumor, type 1[OMIM:194070]-Autosomal dominant inheritance | Wilms tumor, type 1[OMIM:194070]-Somatic mutation","Definitive, Supportive (Frasier syndrome[MONDO:0007635]-Autosomal dominant) | Definitive, Strong (Wilms tumor 1[MONDO:0008679]-Autosomal dominant) | Definitive, Definitive (Denys-Drash syndrome[MONDO:0008682]-Autosomal dominant) | Supportive (familial idiopathic steroid-resistant nephrotic syndrome[MONDO:0019006]-Autosomal dominant)",Definitive (Wilms tumor 1[MONDO:0008679]-AD) | Definitive (Denys-Drash syndrome[MONDO:0008682]-AD),P:61; LP:39; VUS:667,OMIM:136680 (glomerulopathy: 0.333 | cyst_cilio: 0.134 | cakut: 0.056 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028); OMIM:194070 (cancer: 0.12 | complement: 0.036 | cakut: 0.008 | glomerulopathy: 0.007); OMIM:194080 (glomerulopathy: 0.395 | cancer: 0.17 | cyst_cilio: 0.157 | cakut: 0.073 | tubulopathy: 0.049 | nephrocalcinosis: 0.042 | complement: 0.036); OMIM:256370 (glomerulopathy: 0.328 | cancer: 0.17 | nephrocalcinosis: 0.118 | tubulopathy: 0.112 | complement: 0.107 | cyst_cilio: 0.076 | cakut: 0.06); OMIM:608978 (cancer: 0.1 | cakut: 0.044 | cyst_cilio: 0.034 | glomerulopathy: 0.007),OMIM:194080 (antenatal_or_congenital: 0.03); OMIM:256370 (neonatal_or_pediatric: 0.262); OMIM:608978 (antenatal_or_congenital: 0.821),OMIM:194080 (syndromic: 0.007 | skeletal: 0.004),hm (true); ht (true),0,NULL,NULL,NULL,0.5,3.6598900000000003,10.1536,378.837152089663,cur_435
XDH,12805,5,3.3724988792634263,0,0.66847,2.5207,-1.4541,"Xanthinuria, type I[OMIM:278300]-Autosomal recessive inheritance","Moderate, Supportive (xanthinuria type I[MONDO:0010209]-Autosomal recessive) | Strong (hereditary xanthinuria[MONDO:0018106]-Autosomal recessive)",NULL,P:15; LP:9; VUS:298,OMIM:278300 (cakut: 0.077 | complement: 0.036 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,NULL,hm (true); ht (false),0.5,1430,0.3270440251572327,"9606.ENSP00000484824:248, 9606.ENSP00000356319:292, 9606.ENSP00000264382:256, 9606.ENSP00000381098:323, 9606.ENSP00000290866:311",0,0.200846,0.137871,1.21728417150355,cur_436
XPNPEP3,28052,5,4.05991291911701,0,0.5861,2.0656,-0.099488,Nephronophthisis-like nephropathy 1[OMIM:613159]-Autosomal recessive inheritance,"Strong, Moderate, Limited (nephronophthisis-like nephropathy 1[MONDO:0013163]-Autosomal recessive) | Supportive (late-onset nephronophthisis[MONDO:0019742]-Autosomal recessive)",Moderate (nephronophthisis-like nephropathy 1[MONDO:0013163]-AR),P:5; LP:5; VUS:187,OMIM:613159 (cyst_cilio: 0.31 | glomerulopathy: 0.162 | cakut: 0.065 | tubulopathy: 0.056 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,OMIM:613159 (syndromic: 0.039 | neurologic: 0.082),hm (NA); ht (NA),0.5,1110,0.2620545073375262,"9606.ENSP00000367815:165, 9606.ENSP00000265748:292, 9606.ENSP00000297185:196, 9606.ENSP00000231509:292, 9606.ENSP00000269305:165",0.5,4.53837,3.86597,88.5625786460168,cur_437
XPO5,17675,3,2.325875299995192,0.99971,0.15314,6.651,3.1112,NULL,NULL,NULL,P:0; LP:0; VUS:60,NULL,NULL,NULL,hm (NA); ht (NA),0.5,1467,0.3333333333333333,"9606.ENSP00000459943:161, 9606.ENSP00000227507:163, 9606.ENSP00000437256:900, 9606.ENSP00000310668:243",0.5,13.2194,7.19728,66.6023002015067,cur_438
YRDC,28905,3,1.527951442484126,0.002175,0.63258,0.95721,0.098365,Galloway-Mowat syndrome 10[OMIM:619609]-Autosomal recessive inheritance,Strong (Galloway-Mowat syndrome 10[MONDO:0030476]-Autosomal recessive),NULL,P:4; LP:0; VUS:21,OMIM:619609 (glomerulopathy: 0.182 | cyst_cilio: 0.126 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),OMIM:619609 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402),OMIM:619609 (syndromic: 0.035 | skeletal: 0.062 | neurologic: 0.07),hm (NA); ht (NA),0,254,0.05241090146750524,9606.ENSP00000206542:254,0,15.7339,11.6478,8.80671675497395,cur_439
ZIC3,12874,3,2.3514230960002154,0.92495,0,2.6665,2.5168,"Congenital heart defects, nonsyndromic, 1, X-linked[OMIM:306955]-X-linked recessive inheritance | Heterotaxy, visceral, 1, X-linked[OMIM:306955]-X-linked recessive inheritance | VACTERL association, X-linked[OMIM:314390]-X-linked recessive inheritance","Moderate (heterotaxy, visceral, 1, X-linked[MONDO:0010607]-X-linked) | Definitive (heterotaxy, visceral, 1, X-linked[MONDO:0010607]-X-linked recessive) | Definitive, Strong, Moderate (VACTERL association, X-linked, with or without hydrocephalus[MONDO:0010752]-X-linked) | Definitive (VACTERL association, X-linked, with or without hydrocephalus[MONDO:0010752]-X-linked recessive)",NULL,P:25; LP:5; VUS:51,OMIM:306955 (cancer: 0.15 | cakut: 0.089 | cyst_cilio: 0.042 | glomerulopathy: 0.007); OMIM:314390 (cakut: 0.089 | cancer: 0.05 | cyst_cilio: 0.037 | glomerulopathy: 0.009 | nephrocalcinosis: 0.007),OMIM:306955 (antenatal_or_congenital: 0.821); OMIM:314390 (antenatal_or_congenital: 0.028),OMIM:306955 (syndromic: 0.018 | growth: 0.175 | skeletal: 0.007 | neurologic: 0.014); OMIM:314390 (syndromic: 0.006 | growth: 0.001 | skeletal: 0.009 | neurologic: 0.006),hm (false); ht (false),0.5,1988,0.40670859538784065,"9606.ENSP00000379258:773, 9606.ENSP00000368253:190, 9606.ENSP00000269305:292, 9606.ENSP00000262426:347, 9606.ENSP00000390436:386",0,0,0,0.261317494861369,cur_440
ZMPSTE24,12877,2,2.263146207257373,0,0.94343,0.26439,0.37201,Mandibuloacral dysplasia with type B lipodystrophy[OMIM:608612]-Autosomal recessive inheritance | Restrictive dermopathy 1[OMIM:275210]-Autosomal recessive inheritance,"Supportive (Hutchinson-Gilford progeria syndrome[MONDO:0008310]-Autosomal dominant) | Supportive (lethal restrictive dermopathy[MONDO:0010143]-Autosomal dominant) | Definitive, Definitive, Strong (lethal restrictive dermopathy[MONDO:0010143]-Autosomal recessive) | Definitive, Strong, Moderate, Supportive (mandibuloacral dysplasia with type B lipodystrophy[MONDO:0012074]-Autosomal recessive)",Definitive (obsolete lethal restrictive dermopathy[MONDO:0010143]-AR) | Definitive (mandibuloacral dysplasia with type B lipodystrophy[MONDO:0012074]-AR),P:28; LP:4; VUS:73,OMIM:275210 (glomerulopathy: 0.004 | cyst_cilio: 0.003); OMIM:608612 (glomerulopathy: 0.129 | cyst_cilio: 0.126 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),OMIM:275210 (antenatal_or_congenital: 0.926); OMIM:608612 (neonatal_or_pediatric: 0.402),OMIM:275210 (syndromic: 0.04 | growth: 0.102 | skeletal: 0.061); OMIM:608612 (syndromic: 0.035 | growth: 0.091 | skeletal: 0.05),hm (true); ht (false),0.5,1234,0.2893081761006289,"9606.ENSP00000269305:163, 9606.ENSP00000231509:292, 9606.ENSP00000357283:487, 9606.ENSP00000322323:292",0.5,22.3812,20.5483,32.0956234577297,cur_441
ZMYM2,12989,3,1.6444329785414549,NULL,NULL,NULL,NULL,Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities[OMIM:619522]-Autosomal dominant inheritance,"Strong, Moderate (congenital anomaly of kidney and urinary tract[MONDO:0019719]-Autosomal dominant)",NULL,P:30; LP:35; VUS:76,OMIM:619522 (cakut: 0.161 | cancer: 0.07 | cyst_cilio: 0.024 | tubulopathy: 0.014 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:619522 (neonatal_or_pediatric: 0.402),OMIM:619522 (syndromic: 0.195 | growth: 0.443 | skeletal: 0.122 | neurologic: 0.22),hm (false); ht (false),0.5,1309,0.31027253668763105,"9606.ENSP00000261396:239, 9606.ENSP00000262367:229, 9606.ENSP00000231509:165, 9606.ENSP00000269305:190, 9606.ENSP00000393312:486",0.5,12.2901,8.94432,370.516166013787,cur_442
ZNF423,16762,4,4.261888500494075,NULL,NULL,NULL,NULL,Nephronophthisis 14[OMIM:614844]-Autosomal dominant inheritance | Nephronophthisis 14[OMIM:614844]-Autosomal recessive inheritance | Joubert syndrome 19[OMIM:614844]-Autosomal dominant inheritance | Joubert syndrome 19[OMIM:614844]-Autosomal recessive inheritance,"Supportive (Joubert syndrome with oculorenal defect[MONDO:0009480]-Autosomal recessive) | Supportive (nephronophthisis 2[MONDO:0011190]-Autosomal recessive) | Strong (Joubert syndrome 17[MONDO:0013824]-Autosomal dominant) | Limited (nephronophthisis 14[MONDO:0013916]-Autosomal dominant) | Strong, Limited (nephronophthisis 14[MONDO:0013916]-Autosomal recessive) | Limited (nephronophthisis 14[MONDO:0013916]-Unknown) | Limited (nephronophthisis[MONDO:0019005]-Autosomal recessive)",Limited (nephronophthisis[MONDO:0019005]-AR),P:3; LP:1; VUS:409,OMIM:614844 (cyst_cilio: 0.16 | cakut: 0.016 | cancer: 0.01 | glomerulopathy: 0.007),NULL,OMIM:614844 (syndromic: 0.002 | neurologic: 0.004),hm (NA); ht (NA),0.5,727,0.18029350104821804,"9606.ENSP00000355499:186, 9606.ENSP00000448012:541",0.5,1.1535799999999998,0.7895989999999999,365.122108477516,cur_443
ABCC6,57,4,2.8107678351205396,0,0.82767,1.3596,-1.0878,"Pseudoxanthoma elasticum[OMIM:264800]-Autosomal recessive inheritance | Arterial calcification, generalized, of infancy, 2[OMIM:614473]-Autosomal recessive inheritance | Pseudoxanthoma elasticum, forme fruste[OMIM:177850]-Autosomal dominant inheritance","Definitive, Definitive, Strong, Supportive (autosomal recessive inherited pseudoxanthoma elasticum[MONDO:0009925]-Autosomal recessive) | Definitive (arterial calcification, generalized, of infancy, 2[MONDO:0013768]-Autosomal recessive) | Supportive (arterial calcification of infancy[MONDO:0018870]-Autosomal dominant)",NULL,P:128; LP:138; VUS:554,OMIM:614473 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),OMIM:614473 (neonatal_or_pediatric: 0.402),OMIM:177850 (syndromic: 0.023 | skeletal: 0.048 | neurologic: 0.001); OMIM:264800 (syndromic: 0.001 | neurologic: 0.001); OMIM:614473 (syndromic: 0 | skeletal: 0.001),hm (true); ht (false),0.5,749,0.18448637316561844,"9606.ENSP00000231509:165, 9606.ENSP00000357048:292, 9606.ENSP00000362413:292",0,3.71901,6.4682,7.62586646490335,cur_444
ABCC8,59,2,1.5058448786488792,0,0.60559,3.3541,1.914,"Diabetes mellitus, permanent neonatal 3, with or without neurologic features[OMIM:618857]-Autosomal dominant inheritance | Diabetes mellitus, permanent neonatal 3, with or without neurologic features[OMIM:618857]-Autosomal recessive inheritance | Diabetes mellitus, transient neonatal 2[OMIM:610374]-NA | Diabetes mellitus, noninsulin-dependent[OMIM:125853]-Autosomal dominant inheritance | Hypoglycemia of infancy, leucine-sensitive[OMIM:240800]-Autosomal dominant inheritance | Hyperinsulinemic hypoglycemia, familial, 1[OMIM:256450]-Autosomal dominant inheritance | Hyperinsulinemic hypoglycemia, familial, 1[OMIM:256450]-Autosomal recessive inheritance","Strong (diabetes mellitus, noninsulin-dependent[MONDO:0007455]-Autosomal dominant) | Strong (hypoglycemia, leucine-induced[MONDO:0009415]-Autosomal dominant) | Definitive, Strong (hyperinsulinemic hypoglycemia, familial, 1[MONDO:0009734]-Autosomal dominant) | Strong (hyperinsulinemic hypoglycemia, familial, 1[MONDO:0009734]-Autosomal recessive) | Definitive (hyperinsulinemic hypoglycemia, familial, 1[MONDO:0009734]-Semidominant) | Strong (diabetes mellitus, transient neonatal, 2[MONDO:0012480]-Unknown) | Moderate (pulmonary arterial hypertension[MONDO:0015924]-Autosomal dominant) | Definitive (monogenic diabetes[MONDO:0015967]-Semidominant) | Definitive (familial hyperinsulinism[MONDO:0017182]-Autosomal recessive) | Supportive (autosomal dominant hyperinsulinism due to SUR1 deficiency[MONDO:0017184]-Autosomal dominant) | Supportive (diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency[MONDO:0017187]-Autosomal dominant) | Supportive (maturity-onset diabetes of the young[MONDO:0018911]-Autosomal dominant) | Supportive (DEND syndrome[MONDO:0019207]-Autosomal dominant) | Supportive (autosomal recessive hyperinsulinism due to SUR1 deficiency[MONDO:0019333]-Autosomal recessive) | Strong, Supportive (transient neonatal diabetes mellitus[MONDO:0020525]-Autosomal dominant) | Strong (diabetes mellitus, permanent neonatal 3[MONDO:0030088]-Autosomal dominant) | Strong (diabetes mellitus, permanent neonatal 3[MONDO:0030088]-Autosomal recessive) | Definitive (diabetes mellitus, permanent neonatal 3[MONDO:0030088]-Semidominant) | Supportive (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal dominant) | Strong (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal recessive)",Moderate (pulmonary arterial hypertension[MONDO:0015924]-AD) | Definitive (monogenic diabetes[MONDO:0015967]-SD),P:155; LP:163; VUS:379,NULL,OMIM:125853 (adult: 0.108); OMIM:240800 (neonatal_or_pediatric: 0.134),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:240800 (syndromic: 0.062 | neurologic: 0.13); OMIM:256450 (syndromic: 0.02 | growth: 0.008 | neurologic: 0.041); OMIM:618857 (syndromic: 0.012 | growth: 0.046 | neurologic: 0.019),hm (false); ht (false),0,NULL,NULL,NULL,0.5,0.0599048,0.0220264,10.190789689893,cur_445
ACTB,132,2,1.3241175193209271,NULL,NULL,NULL,NULL,"Baraitser-Winter syndrome 1[OMIM:243310]-Autosomal dominant inheritance | Becker nevus, syndromic or isolated, somatic mosaic[OMIM:604919]-NA | Thrombocytopenia 8, with dysmorphic features and developmental delay[OMIM:620475]-Autosomal dominant inheritance | Dystonia-deafness syndrome 1[OMIM:607371]-Autosomal dominant inheritance | Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic[OMIM:620479]-NA","Definitive, Strong, Strong (Baraitser-Winter syndrome 1[MONDO:0009470]-Autosomal dominant) | Strong, Strong, Limited, Supportive (developmental malformations-deafness-dystonia syndrome[MONDO:0011823]-Autosomal dominant) | Definitive, Supportive (Baraitser-Winter cerebrofrontofacial syndrome[MONDO:0017579]-Autosomal dominant) | Moderate (ACTB-associated syndromic thrombocytopenia[MONDO:0100433]-Autosomal dominant)",Definitive (Baraitser-Winter cerebrofrontofacial syndrome[MONDO:0017579]-AD) | Moderate (ACTB-associated syndromic thrombocytopenia[MONDO:0100433]-AD),P:48; LP:72; VUS:95,NULL,OMIM:607371 (antenatal_or_congenital: 0.821),OMIM:243310 (syndromic: 0.158 | growth: 0.455 | skeletal: 0.075 | neurologic: 0.183); OMIM:604919 (syndromic: 0.014 | skeletal: 0.051); OMIM:607371 (syndromic: 0.039 | growth: 0.046 | skeletal: 0.009 | neurologic: 0.053),hm (true); ht (false),0,NULL,NULL,NULL,0.5,1490.7,1065.64,537.414728217346,cur_446
ADA2,1839,3,1.95922195293514,NULL,NULL,NULL,NULL,"Sneddon syndrome[OMIM:182410]-Autosomal recessive inheritance | Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome[OMIM:615688]-Autosomal recessive inheritance","Supportive (Sneddon syndrome[MONDO:0008436]-Autosomal dominant) | Moderate (Sneddon syndrome[MONDO:0008436]-Autosomal recessive) | Strong, Supportive (vasculitis due to ADA2 deficiency[MONDO:0014306]-Autosomal recessive) | Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant) | Moderate (polyarteritis nodosa[MONDO:0019170]-Autosomal recessive) | Definitive (deficiency of adenosine deaminase 2[MONDO:0100317]-Autosomal recessive)",Definitive (deficiency of adenosine deaminase 2[MONDO:0100317]-AR),P:39; LP:25; VUS:220,OMIM:615688 (glomerulopathy: 0.002),OMIM:182410 (neonatal_or_pediatric: 0.402); OMIM:615688 (neonatal_or_pediatric: 0.999),OMIM:182410 (syndromic: 0.035 | neurologic: 0.073); OMIM:615688 (syndromic: 0.015 | skeletal: 0.006 | neurologic: 0.026),hm (NA); ht (NA),0,NULL,NULL,NULL,0,NULL,NULL,NULL,cur_447
AGPAT2,325,3,1.63600601224932,0,0.93721,0.19935,-0.72172,"Lipodystrophy, congenital generalized, type 1[OMIM:608594]-Autosomal recessive inheritance","Limited (neonatal diabetes mellitus[MONDO:0016391]-Autosomal recessive) | Strong, Supportive (Berardinelli-Seip congenital lipodystrophy[MONDO:0018883]-Autosomal recessive)",NULL,P:23; LP:6; VUS:86,OMIM:608594 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),OMIM:608594 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.397),OMIM:608594 (syndromic: 0.025 | growth: 0.011 | skeletal: 0.011 | neurologic: 0.041),hm (true); ht (false),0,507,0.129979035639413,"9606.ENSP00000397908:338, 9606.ENSP00000334003:169",0.5,104.71799999999999,57.0291,19.3514720939169,cur_448
ARL3,694,2,1.291031617667523,0.001407,0.5559,1.352,1.1563,Retinitis pigmentosa 83[OMIM:618173]-Autosomal dominant inheritance | Joubert syndrome 35[OMIM:618161]-Autosomal recessive inheritance,"Strong (Joubert syndrome 17[MONDO:0013824]-Autosomal recessive) | Supportive (Joubert syndrome[MONDO:0018772]-Autosomal recessive) | Limited, Supportive (retinitis pigmentosa[MONDO:0019200]-Autosomal dominant) | Limited (retinitis pigmentosa 83[MONDO:0032577]-Autosomal dominant)",NULL,P:2; LP:0; VUS:65,OMIM:618161 (cakut: 0.089 | cancer: 0.03 | cyst_cilio: 0.021 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:618173 (neonatal_or_pediatric: 0.2),OMIM:618161 (syndromic: 0.056 | skeletal: 0.007 | neurologic: 0.077),hm (true); ht (false),0.5,2993,0.5555555555555556,"9606.ENSP00000476176:218, 9606.ENSP00000347244:369, 9606.ENSP00000287600:660, 9606.ENSP00000338766:565, 9606.ENSP00000377769:467, 9606.ENSP00000340466:345, 9606.ENSP00000370719:369",0.5,18.9199,14.2689,65.8445974330618,cur_449
ATP7B,870,3,2.052177662169405,0,0.93189,0.44824,-0.88091,Wilson disease[OMIM:277900]-Autosomal recessive inheritance,"Definitive, Strong, Strong, Supportive (Wilson disease[MONDO:0010200]-Autosomal recessive)",Definitive (Wilson disease[MONDO:0010200]-AR),P:357; LP:341; VUS:670,OMIM:277900 (tubulopathy: 0.14 | nephrocalcinosis: 0.139 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),OMIM:277900 (neonatal_or_pediatric: 0.463 | adult: 0.422),OMIM:277900 (syndromic: 0.053 | skeletal: 0.017 | neurologic: 0.101),hm (false); ht (false),0,NULL,NULL,NULL,0.5,2.4062799999999998,2.1850400000000003,17.0691670120705,cur_450
AVIL,14188,3,1.898998438988785,NULL,NULL,NULL,NULL,"Nephrotic syndrome, type 21[OMIM:618594]-Autosomal recessive inheritance",NULL,NULL,P:3; LP:1; VUS:44,OMIM:618594 (glomerulopathy: 0.182 | cyst_cilio: 0.129 | tubulopathy: 0.042 | cakut: 0.036 | complement: 0.036 | nephrocalcinosis: 0.021 | cancer: 0.02),NULL,NULL,hm (false); ht (false),0,629,0.15723270440251572,"9606.ENSP00000482968:407, 9606.ENSP00000317469:222",0.5,4.34746,3.59124,14.455112852939,cur_451
BRAF,1097,4,2.755099232160259,NULL,NULL,NULL,NULL,"Melanoma, malignant, somatic[OMIM:155600]-NA | LEOPARD syndrome 3[OMIM:613707]-Autosomal dominant inheritance | Cardiofaciocutaneous syndrome[OMIM:115150]-Autosomal dominant inheritance | Adenocarcinoma of lung, somatic[OMIM:211980]-NA | Noonan syndrome 7[OMIM:613706]-Autosomal dominant inheritance | Colorectal cancer, somatic[OMIM:114500]-NA | Nonsmall cell lung cancer, somatic[OMIM:211980]-NA","Definitive, Definitive, Definitive, Strong (cardiofaciocutaneous syndrome 1[MONDO:0007265]-Autosomal dominant) | Limited, Supportive (Noonan syndrome with multiple lentigines[MONDO:0007893]-Autosomal dominant) | Disputed Evidence (Costello syndrome[MONDO:0009026]-Autosomal dominant) | Definitive, Definitive, Strong, Moderate (Noonan syndrome 7[MONDO:0013379]-Autosomal dominant) | Definitive, Strong, Limited (LEOPARD syndrome 3[MONDO:0013380]-Autosomal dominant) | Definitive, Supportive (cardiofaciocutaneous syndrome[MONDO:0015280]-Autosomal dominant) | Limited (anaplastic astrocytoma[MONDO:0016684]-Autosomal dominant) | Moderate (Noonan syndrome[MONDO:0018997]-Autosomal dominant)",Limited (Noonan syndrome with multiple lentigines[MONDO:0007893]-AD) | Disputed (Costello syndrome[MONDO:0009026]-AD) | Definitive (cardiofaciocutaneous syndrome[MONDO:0015280]-AD) | Moderate (Noonan syndrome[MONDO:0018997]-AD),P:94; LP:91; VUS:437,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:115150 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:115150 (antenatal_or_congenital: 0.821); OMIM:613707 (neonatal_or_pediatric: 0.134),OMIM:115150 (syndromic: 0.166 | growth: 0.421 | skeletal: 0.153 | neurologic: 0.097); OMIM:613706 (syndromic: 0.119 | growth: 0.349 | skeletal: 0.101 | neurologic: 0.094); OMIM:613707 (syndromic: 0.09 | growth: 0.341 | skeletal: 0.047 | neurologic: 0.081),hm (false); ht (true),0,NULL,NULL,NULL,0.5,9.11994,5.39542,468.865476500813,cur_452
BSCL2,15832,2,1.3556712842158471,NULL,NULL,NULL,NULL,"Lipodystrophy, congenital generalized, type 2[OMIM:269700]-Autosomal recessive inheritance | Neuronopathy, distal hereditary motor, autosomal dominant 13[OMIM:619112]-Autosomal dominant inheritance | Silver spastic paraplegia syndrome[OMIM:270685]-Autosomal dominant inheritance | Encephalopathy, progressive, with or without lipodystrophy[OMIM:615924]-Autosomal recessive inheritance","Strong (congenital generalized lipodystrophy type 2[MONDO:0010020]-Autosomal recessive) | Supportive (hereditary spastic paraplegia 17[MONDO:0010043]-Autosomal dominant) | Supportive (severe neurodegenerative syndrome with lipodystrophy[MONDO:0014402]-Autosomal recessive) | Supportive (neuronopathy, distal hereditary motor, type 5A[MONDO:0015353]-Autosomal dominant) | Strong (neonatal diabetes mellitus[MONDO:0016391]-Autosomal recessive) | Supportive (Berardinelli-Seip congenital lipodystrophy[MONDO:0018883]-Autosomal recessive) | Definitive (distal hereditary motor neuropathy[MONDO:0018894]-Autosomal dominant) | Strong (generalized lipodystrophy[MONDO:0027766]-Autosomal recessive)",Definitive (distal hereditary motor neuropathy[MONDO:0018894]-AD),P:30; LP:16; VUS:234,OMIM:269700 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),OMIM:269700 (antenatal_or_congenital: 0.821); OMIM:270685 (neonatal_or_pediatric: 0.2); OMIM:619112 (adult: 0.218 | neonatal_or_pediatric: 0.2),OMIM:269700 (syndromic: 0.009 | growth: 0.011 | skeletal: 0.011 | neurologic: 0.008); OMIM:270685 (syndromic: 0.016 | skeletal: 0.002 | neurologic: 0.033); OMIM:615924 (syndromic: 0.076 | neurologic: 0.159); OMIM:619112 (syndromic: 0.007 | neurologic: 0.014),hm (false); ht (false),0,546,0.14046121593291405,"9606.ENSP00000417052:197, 9606.ENSP00000397908:349",0.5,44.7818,31.2085,20.2644054911018,cur_453
C1QA,1241,3,2.1258728090123946,0.00382,0.54902,1.2611,1.2949,C1q deficiency 1[OMIM:613652]-Autosomal recessive inheritance,Moderate (C1Q deficiency[MONDO:0013343]-Autosomal recessive),NULL,P:4; LP:3; VUS:65,OMIM:613652 (complement: 0.071 | glomerulopathy: 0.011),NULL,NULL,hm (true); ht (false),0.5,1889,0.3941299790356394,"9606.ENSP00000313967:999, 9606.ENSP00000396688:163, 9606.ENSP00000366307:185, 9606.ENSP00000346839:292, 9606.ENSP00000385675:250",0.5,14.7666,8.38556,14.7089672398992,cur_454
C1QB,1242,2,1.1206708304064992,NULL,NULL,NULL,NULL,C1q deficiency 2[OMIM:620321]-NA,Definitive (C1Q deficiency[MONDO:0013343]-Autosomal recessive),Definitive (C1Q deficiency[MONDO:0013343]-AR),P:3; LP:1; VUS:39,NULL,OMIM:620321 (neonatal_or_pediatric: 0.262),OMIM:620321 (syndromic: 0.001 | skeletal: 0.003),hm (false); ht (false),0.5,2556,0.5052410901467506,"9606.ENSP00000256474:321, 9606.ENSP00000346839:315, 9606.ENSP00000363773:999, 9606.ENSP00000252486:416, 9606.ENSP00000314299:236, 9606.ENSP00000396688:269",0,NULL,NULL,7.23415834573947,cur_455
C4A,1323,2,1.3151013436263954,0,0.96525,0.13512,1.9202,"[Blood group, Rodgers][OMIM:614374]-NA | C4a deficiency[OMIM:614380]-Autosomal recessive inheritance",Moderate (complement component 4a deficiency[MONDO:0013721]-Autosomal recessive),NULL,P:1; LP:0; VUS:18,OMIM:614380 (complement: 0.036 | glomerulopathy: 0.016 | cyst_cilio: 0.003),NULL,NULL,hm (true); ht (true),0.5,7329,0.8280922431865828,"9606.ENSP00000368632:363, 9606.ENSP00000308938:267, 9606.ENSP00000356399:749, 9606.ENSP00000366307:227, 9606.ENSP00000313875:994, 9606.ENSP00000363773:163, 9606.ENSP00000297261:405, 9606.ENSP00000384092:185, 9606.ENSP00000236850:414, 9606.ENSP00000416561:681, 9606.ENSP00000296280:345, 9606.ENSP00000313967:269, 9606.ENSP00000314299:243, 9606.ENSP00000322323:499, 9606.ENSP00000245907:988, 9606.ENSP00000356386:243, 9606.ENSP00000381448:294",0,2.69424,8.200560000000001,NULL,cur_456
CCND1,1582,2,2.020077678364819,0.89057,0.086423,2.8797,1.4216,"{von Hippel-Lindau syndrome, modifier of}[OMIM:193300]-Autosomal dominant inheritance | {Colorectal cancer, susceptibility to}[OMIM:114500]-Autosomal dominant inheritance | {Colorectal cancer, susceptibility to}[OMIM:114500]-Somatic mutation | {Multiple myeloma, susceptibility to}[OMIM:254500]-Somatic mutation",NULL,NULL,P:0; LP:0; VUS:8,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:193300 (cancer: 0.14 | cyst_cilio: 0.018 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:193300 (adult: 0.372); OMIM:254500 (adult: 0.218),OMIM:193300 (syndromic: 0 | neurologic: 0.001),hm (false); ht (false),1,8788,0.859538784067086,"9606.ENSP00000368632:410, 9606.ENSP00000219476:457, 9606.ENSP00000287647:163, 9606.ENSP00000295108:292, 9606.ENSP00000217086:302, 9606.ENSP00000297185:163, 9606.ENSP00000289081:154, 9606.ENSP00000369497:511, 9606.ENSP00000357283:204, 9606.ENSP00000228872:999, 9606.ENSP00000317674:158, 9606.ENSP00000413720:965, 9606.ENSP00000262367:963, 9606.ENSP00000254958:340, 9606.ENSP00000256078:262, 9606.ENSP00000367203:169, 9606.ENSP00000310842:163, 9606.ENSP00000362680:286, 9606.ENSP00000265351:163, 9606.ENSP00000358866:396, 9606.ENSP00000215832:320, 9606.ENSP00000437256:330, 9606.ENSP00000269305:292, 9606.ENSP00000252934:163, 9606.ENSP00000347717:163",0.5,30.299,17.8658,179.583765531219,cur_457
CDKN1C,1786,4,2.282087926000236,NULL,NULL,NULL,NULL,IMAGE syndrome[OMIM:614732]-Autosomal dominant inheritance | Beckwith-Wiedemann syndrome[OMIM:130650]-Autosomal dominant inheritance,"Moderate (rhabdomyosarcoma[MONDO:0005212]-Autosomal dominant) | Definitive, Definitive, Strong (Beckwith-Wiedemann syndrome[MONDO:0007534]-Autosomal dominant) | Definitive (Beckwith-Wiedemann syndrome[MONDO:0007534]-Autosomal dominant inheritance with paternal imprinting) | Limited (Silver-Russell syndrome[MONDO:0008394]-Autosomal dominant) | Definitive, Moderate, Moderate, Supportive (IMAGe syndrome[MONDO:0013873]-Autosomal dominant) | Definitive (IMAGe syndrome[MONDO:0013873]-Autosomal dominant inheritance with paternal imprinting) | Supportive (Beckwith-Wiedemann syndrome due to CDKN1C mutation[MONDO:0016476]-Autosomal dominant) | Supportive (intrauterine growth restriction-short stature-early adult-onset diabetes syndrome[MONDO:0018573]-Autosomal dominant)",NULL,P:84; LP:14; VUS:458,OMIM:130650 (nephrocalcinosis: 0.299 | tubulopathy: 0.259 | cancer: 0.18 | cakut: 0.101 | cyst_cilio: 0.039 | glomerulopathy: 0.038 | complement: 0.036),NULL,OMIM:130650 (syndromic: 0.011 | growth: 0.014 | skeletal: 0.012 | neurologic: 0.002); OMIM:614732 (syndromic: 0.057 | growth: 0.135 | skeletal: 0.04 | neurologic: 0.053),hm (true); ht (true),0.5,3310,0.6037735849056604,"9606.ENSP00000227507:965, 9606.ENSP00000451828:292, 9606.ENSP00000269305:292, 9606.ENSP00000228872:905, 9606.ENSP00000256474:292, 9606.ENSP00000295108:564",0.5,41.3427,89.5923,105.023016046129,cur_458
CEP19,28209,2,1.1689330543933054,0.015687,0.47679,1.4043,-0.13605,Morbid obesity and spermatogenic failure[OMIM:615703]-Autosomal recessive inheritance,"Strong, Supportive (obesity due to CEP19 deficiency[MONDO:0014309]-Autosomal recessive) | Supportive (Bardet-Biedl syndrome[MONDO:0015229]-Autosomal recessive)",NULL,P:1; LP:0; VUS:73,NULL,NULL,OMIM:615703 (syndromic: 0.021 | growth: 0.043 | neurologic: 0.04),hm (false); ht (false),0,NULL,NULL,NULL,0,2.55039,1.96105,4.67735586548285,cur_459
CFTR,1884,2,1.776063991340392,0,1.0903,-0.73413,-3.1397,"Cystic fibrosis[OMIM:219700]-Autosomal recessive inheritance | Congenital bilateral absence of vas deferens[OMIM:277180]-Autosomal recessive inheritance | {Pancreatitis, hereditary}[OMIM:167800]-Autosomal dominant inheritance | {Bronchiectasis with or without elevated sweat chloride 1, modifier of}[OMIM:211400]-Autosomal dominant inheritance","Limited (hereditary chronic pancreatitis[MONDO:0008185]-Autosomal dominant) | Definitive, Definitive, Supportive (cystic fibrosis[MONDO:0009061]-Autosomal recessive) | Supportive (congenital bilateral absence of vas deferens[MONDO:0018801]-Autosomal recessive)",NULL,P:865; LP:333; VUS:1592,NULL,OMIM:219700 (neonatal_or_pediatric: 0.665),OMIM:167800 (syndromic: 0 | skeletal: 0); OMIM:219700 (syndromic: 0.01 | growth: 0.171 | skeletal: 0.003),hm (false); ht (false),0.5,4614,0.71698113207547165,"9606.ENSP00000216181:315, 9606.ENSP00000360183:379, 9606.ENSP00000256078:165, 9606.ENSP00000358866:944, 9606.ENSP00000285379:449, 9606.ENSP00000376432:735, 9606.ENSP00000262613:999, 9606.ENSP00000300061:228, 9606.ENSP00000264896:400",0,0.324831,0.959175,3.02231860219801,cur_460
CISD2,24212,2,0.9911087866108786,0.41583,0.19223,1.7073,1.2696,Wolfram syndrome 2[OMIM:604928]-Autosomal recessive inheritance,"Strong, Strong, Strong, Strong, Moderate (Wolfram syndrome 2[MONDO:0011502]-Autosomal recessive) | Strong, Supportive (Wolfram syndrome[MONDO:0018105]-Autosomal recessive)",Strong (Wolfram syndrome[MONDO:0018105]-AR),P:2; LP:0; VUS:20,NULL,NULL,OMIM:604928 (syndromic: 0.002 | neurologic: 0.004),hm (true); ht (false),0.5,1012,0.24109014675052412,"9606.ENSP00000357998:165, 9606.ENSP00000364699:409, 9606.ENSP00000357048:193, 9606.ENSP00000356953:245",0.5,13.2098,12.4182,20.0016396053531,cur_461
COPA,2230,2,1.4636184891314927,NULL,NULL,NULL,NULL,"{Autoimmune interstitial lung, joint, and kidney disease}[OMIM:616414]-Autosomal dominant inheritance","Strong, Supportive (autoimmune interstitial lung disease-arthritis syndrome[MONDO:0014629]-Autosomal dominant)",NULL,P:4; LP:2; VUS:215,OMIM:616414 (glomerulopathy: 0.013),OMIM:616414 (neonatal_or_pediatric: 0.262),OMIM:616414 (syndromic: 0.001 | skeletal: 0.003),hm (false); ht (false),0.5,2115,0.4276729559748428,"9606.ENSP00000362413:156, 9606.ENSP00000205557:292, 9606.ENSP00000359297:181, 9606.ENSP00000340466:193, 9606.ENSP00000322323:292, 9606.ENSP00000417132:292, 9606.ENSP00000273986:193, 9606.ENSP00000349823:224, 9606.ENSP00000356319:292",0.5,52.9094,33.8606,130.891228414305,cur_462
COX14,28216,2,1.1309261498321586,0.3573,0,0.76924,-0.059703,"?Mitochondrial complex IV deficiency, nuclear type 10[OMIM:619053]-Autosomal recessive inheritance","Limited, Supportive (cytochrome-c oxidase deficiency disease[MONDO:0009068]-Autosomal recessive) | Limited (mitochondrial disease[MONDO:0044970]-Autosomal recessive)",Limited (mitochondrial disease[MONDO:0044970]-AR),P:1; LP:1; VUS:12,OMIM:619053 (cakut: 0.089 | cyst_cilio: 0.037 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),NULL,OMIM:619053 (syndromic: 0.009 | neurologic: 0.003),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,97.1587,74.1072,12.2771781512994,cur_463
CREBBP,2348,3,2.0674855512615,1,0.025349,9.8253,3.8991,Menke-Hennekam syndrome 1[OMIM:618332]-Autosomal dominant inheritance | Rubinstein-Taybi syndrome 1[OMIM:180849]-Autosomal dominant inheritance,"Definitive, Definitive, Strong (Rubinstein-Taybi syndrome due to CREBBP mutations[MONDO:0008393]-Autosomal dominant) | Definitive, Definitive (Rubinstein-Taybi syndrome[MONDO:0019188]-Autosomal dominant) | Strong (Menke-Hennekam syndrome 1[MONDO:0020763]-Autosomal dominant)",Definitive (Rubinstein-Taybi syndrome[MONDO:0019188]-AD),P:285; LP:128; VUS:551,OMIM:180849 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:180849 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402),OMIM:180849 (syndromic: 0.251 | growth: 0.6 | skeletal: 0.242 | neurologic: 0.222); OMIM:618332 (syndromic: 0.149 | skeletal: 0.11 | neurologic: 0.098),hm (false); ht (false),1,14514,0.9811320754716981,"9606.ENSP00000379258:457, 9606.ENSP00000381098:292, 9606.ENSP00000367203:357, 9606.ENSP00000362680:888, 9606.ENSP00000260010:292, 9606.ENSP00000362410:348, 9606.ENSP00000480291:581, 9606.ENSP00000245479:536, 9606.ENSP00000228606:457, 9606.ENSP00000295108:328, 9606.ENSP00000304286:158, 9606.ENSP00000291582:578, 9606.ENSP00000256646:563, 9606.ENSP00000231509:630, 9606.ENSP00000301067:150, 9606.ENSP00000269305:999, 9606.ENSP00000350815:292, 9606.ENSP00000393312:753, 9606.ENSP00000451828:523, 9606.ENSP00000405890:300, 9606.ENSP00000215832:653, 9606.ENSP00000368632:457, 9606.ENSP00000256474:165, 9606.ENSP00000312987:823, 9606.ENSP00000262518:750, 9606.ENSP00000287820:992, 9606.ENSP00000227507:963, 9606.ENSP00000479904:229",0.5,10.4085,8.516760000000001,377.985006402678,cur_464
CYP11A1,2590,2,0.9911087866108786,1e-6,0.56386,2.0138,0.76894,"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete[OMIM:613743]-NA","Supportive (Congenital adrenal insuffiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency[MONDO:0013400]-Autosomal dominant) | Strong (Congenital adrenal insuffiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency[MONDO:0013400]-Autosomal recessive) | Supportive (inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency[MONDO:0017337]-Autosomal recessive)",NULL,P:15; LP:5; VUS:42,NULL,NULL,OMIM:613743 (syndromic: 0 | neurologic: 0),hm (false); ht (false),0,191,0.03773584905660377,9606.ENSP00000290167:191,0,0.645841,0.438187,1.64582001548279,cur_465
DACH1,2663,3,1.832628712468154,NULL,NULL,NULL,NULL,NULL,NULL,NULL,P:0; LP:0; VUS:23,NULL,NULL,NULL,hm (false); ht (false),0.5,1095,0.2557651991614256,"9606.ENSP00000324856:191, 9606.ENSP00000269305:515, 9606.ENSP00000216911:199, 9606.ENSP00000251020:190",1,3.9576300000000004,6.30138,2127.42697587239,cur_466
DIS3L2,28648,2,1.3304203399936725,0.944,0.18027,5.0603,0.94426,Perlman syndrome[OMIM:267000]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Supportive (Perlman syndrome[MONDO:0009965]-Autosomal recessive)",Definitive (Perlman syndrome[MONDO:0009965]-AR),P:46; LP:21; VUS:1076,OMIM:267000 (cancer: 0.13 | complement: 0.036 | cakut: 0.008 | glomerulopathy: 0.007),NULL,OMIM:267000 (syndromic: 0.051 | growth: 0.016 | skeletal: 0.027 | neurologic: 0.057),hm (true); ht (false),0,324,0.07966457023060797,"9606.ENSP00000269305:163, 9606.ENSP00000281043:161",0.5,5.25536,4.27599,153.51120820152,cur_467
DNAAF1,30539,2,1.4943216373088812,0,0.70022,1.5571,-1.9871,"Ciliary dyskinesia, primary, 13[OMIM:613193]-Autosomal recessive inheritance","Definitive, Strong (primary ciliary dyskinesia 13[MONDO:0013174]-Autosomal recessive) | Supportive (primary ciliary dyskinesia[MONDO:0016575]-Autosomal dominant)",Definitive (primary ciliary dyskinesia 13[MONDO:0013174]-AR),P:33; LP:5; VUS:246,NULL,NULL,OMIM:613193 (syndromic: 0.001 | skeletal: 0.004),hm (false); ht (false),0,330,0.08385744234800839,"9606.ENSP00000231509:165, 9606.ENSP00000349658:165",0,2.73191,1.1759899999999999,4.4605727498667,cur_468
DNASE1L3,2959,3,1.540822921661252,NULL,NULL,NULL,NULL,Systemic lupus erythematosus 16[OMIM:614420]-Autosomal recessive inheritance,"Supportive (autosomal systemic lupus erythematosus type 16[MONDO:0013743]-Autosomal dominant) | Strong, Moderate (autosomal systemic lupus erythematosus type 16[MONDO:0013743]-Autosomal recessive) | Supportive (hypocomplementemic urticarial vasculitis[MONDO:0018227]-Autosomal recessive)",NULL,P:6; LP:3; VUS:96,OMIM:614420 (glomerulopathy: 0.004),OMIM:614420 (neonatal_or_pediatric: 0.463),NULL,hm (false); ht (false),0,NULL,NULL,NULL,0,29.0846,14.6321,1.51536898731858,cur_469
EBP,3133,3,1.997978215102004,0.93645,0,2.7419,1.4942,"MEND syndrome[OMIM:300960]-X-linked recessive inheritance | Chondrodysplasia punctata, X-linked dominant[OMIM:302960]-X-linked dominant inheritance","Definitive, Strong, Moderate, Supportive (MEND syndrome[MONDO:0010498]-X-linked) | Definitive, Strong, Supportive (X-linked chondrodysplasia punctata 2[MONDO:0020603]-X-linked) | Definitive (chondrodysplasia punctata 2, X-linked dominant[MONDO:0026782]-X-linked) | Definitive (chondrodysplasia punctata 2, X-linked dominant[MONDO:0026782]-X-linked dominant)",Definitive (MEND syndrome[MONDO:0010498]-XL),P:46; LP:25; VUS:29,OMIM:300960 (cakut: 0.012); OMIM:302960 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:302960 (antenatal_or_congenital: 0.821),OMIM:300960 (syndromic: 0.137 | growth: 0.421 | skeletal: 0.065 | neurologic: 0.156); OMIM:302960 (syndromic: 0.056 | growth: 0.222 | skeletal: 0.101 | neurologic: 0.016),hm (true); ht (true),0.5,1702,0.3689727463312369,"9606.ENSP00000347717:292, 9606.ENSP00000346829:457, 9606.ENSP00000315011:323, 9606.ENSP00000354032:197, 9606.ENSP00000308122:243, 9606.ENSP00000296387:190",0.5,22.8874,20.51,14.4198445660662,cur_470
EDNRA,3179,3,1.761672017112028,NULL,NULL,NULL,NULL,"{Migraine, resistance to}[OMIM:157300]-Autosomal dominant inheritance | Mandibulofacial dysostosis with alopecia[OMIM:616367]-Autosomal dominant inheritance","Definitive, Strong, Moderate, Supportive (mandibulofacial dysostosis with alopecia[MONDO:0014608]-Autosomal dominant)",NULL,P:2; LP:0; VUS:26,OMIM:616367 (cakut: 0.024 | cyst_cilio: 0.005),OMIM:616367 (antenatal_or_congenital: 0.821),OMIM:157300 (syndromic: 0.002 | neurologic: 0.005); OMIM:616367 (syndromic: 0.025 | skeletal: 0.032),hm (false); ht (false),0.5,1600,0.3584905660377358,"9606.ENSP00000417052:323, 9606.ENSP00000355627:693, 9606.ENSP00000362680:292, 9606.ENSP00000078429:292",0.5,6.51635,2.6903599999999996,193.848308025583,cur_471
EIF2AK3,3255,4,2.212527256544169,0.00276,0.28878,4.75,2.0329,Wolcott-Rallison syndrome[OMIM:226980]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Strong, Supportive (Wolcott-Rallison syndrome[MONDO:0009192]-Autosomal recessive)",NULL,P:25; LP:8; VUS:290,OMIM:226980 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:226980 (neonatal_or_pediatric: 0.402),OMIM:226980 (syndromic: 0.082 | growth: 0.25 | skeletal: 0.092 | neurologic: 0.08),hm (false); ht (false),0.5,1258,0.29979035639413,"9606.ENSP00000357998:235, 9606.ENSP00000346839:400, 9606.ENSP00000287820:331, 9606.ENSP00000451828:292",0.5,6.32066,4.56876,125.507731133187,cur_472
ELP1,5959,4,2.1042636582178096,0,0.57662,3.5421,-0.07981,"{Medulloblastoma}[OMIM:155255]-Autosomal dominant inheritance | {Medulloblastoma}[OMIM:155255]-Autosomal recessive inheritance | {Medulloblastoma}[OMIM:155255]-Somatic mutation | Dysautonomia, familial[OMIM:223900]-Autosomal recessive inheritance",Limited (medulloblastoma[MONDO:0007959]-Autosomal dominant) | Supportive (Riley-Day syndrome[MONDO:0009131]-Autosomal recessive) | Definitive (primary dysautonomia[MONDO:0021809]-Autosomal recessive),NULL,P:100; LP:133; VUS:638,OMIM:223900 (glomerulopathy: 0.018 | nephrocalcinosis: 0.007 | tubulopathy: 0.007 | cyst_cilio: 0.005),OMIM:223900 (antenatal_or_congenital: 0.821),OMIM:155255 (syndromic: 0 | neurologic: 0.001); OMIM:223900 (syndromic: 0.021 | growth: 0.091 | skeletal: 0.037 | neurologic: 0.012),hm (false); ht (false),0.5,1386,0.32075471698113206,"9606.ENSP00000356319:292, 9606.ENSP00000358866:292, 9606.ENSP00000288235:345, 9606.ENSP00000414398:292, 9606.ENSP00000231509:165",0,NULL,NULL,NULL,cur_473
ESCO2,27230,2,1.5916610887951088,0,0.54121,2.2382,0.40775,Juberg-Hayward syndrome[OMIM:216100]-Autosomal recessive inheritance | Roberts-SC phocomelia syndrome[OMIM:268300]-Autosomal recessive inheritance,"Strong, Supportive (Roberts syndrome[MONDO:0009997]-Autosomal recessive) | Definitive, Definitive, Strong (Roberts-SC phocomelia syndrome[MONDO:0100253]-Autosomal recessive)",Definitive (Roberts-SC phocomelia syndrome[MONDO:0100253]-AR),P:73; LP:21; VUS:120,OMIM:216100 (cancer: 0.07 | cakut: 0.028 | cyst_cilio: 0.01 | glomerulopathy: 0.007); OMIM:268300 (cancer: 0.08 | cyst_cilio: 0.073 | cakut: 0.04 | glomerulopathy: 0.007),OMIM:268300 (antenatal_or_congenital: 0.821),OMIM:216100 (syndromic: 0.051 | growth: 0.25 | skeletal: 0.052 | neurologic: 0.071); OMIM:268300 (syndromic: 0.096 | growth: 0.035 | skeletal: 0.161 | neurologic: 0.076),hm (false); ht (false),0,622,0.15513626834381553,"9606.ENSP00000282516:161, 9606.ENSP00000356319:292, 9606.ENSP00000323421:169",0.5,0.0415435,0.0314624,13.3203640852454,cur_474
ETFA,3481,2,1.4852333280114676,0.002922,0.37671,2.6616,1.0633,Glutaric acidemia IIA[OMIM:231680]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Strong (multiple acyl-CoA dehydrogenase deficiency[MONDO:0009282]-Autosomal recessive)",Definitive (multiple acyl-CoA dehydrogenase deficiency[MONDO:0009282]-AR),P:22; LP:11; VUS:111,OMIM:231680 (cyst_cilio: 0.066 | nephrocalcinosis: 0.042 | tubulopathy: 0.042 | glomerulopathy: 0.013 | cakut: 0.012 | cancer: 0.01),NULL,OMIM:231680 (syndromic: 0.019 | skeletal: 0.019 | neurologic: 0.005),hm (NA); ht (NA),0.5,3828,0.6540880503144654,"9606.ENSP00000333946:210, 9606.ENSP00000265748:292, 9606.ENSP00000231509:165, 9606.ENSP00000356319:292, 9606.ENSP00000362924:366, 9606.ENSP00000445175:258, 9606.ENSP00000426638:483, 9606.ENSP00000346173:999, 9606.ENSP00000264170:175, 9606.ENSP00000322316:185, 9606.ENSP00000313432:238, 9606.ENSP00000297185:165",0.5,48.1325,47.7969,112.435917520368,cur_475
ETFB,3482,2,1.0497141350503731,NULL,NULL,NULL,NULL,Glutaric acidemia IIB[OMIM:231680]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Strong (multiple acyl-CoA dehydrogenase deficiency[MONDO:0009282]-Autosomal recessive)",Definitive (multiple acyl-CoA dehydrogenase deficiency[MONDO:0009282]-AR),P:6; LP:8; VUS:86,OMIM:231680 (cyst_cilio: 0.066 | nephrocalcinosis: 0.042 | tubulopathy: 0.042 | glomerulopathy: 0.013 | cakut: 0.012 | cancer: 0.01),NULL,OMIM:231680 (syndromic: 0.019 | skeletal: 0.019 | neurologic: 0.005),hm (false); ht (false),0.5,2369,0.46331236897274636,"9606.ENSP00000313432:257, 9606.ENSP00000297185:165, 9606.ENSP00000356319:292, 9606.ENSP00000333946:163, 9606.ENSP00000426638:493, 9606.ENSP00000452762:999",0.5,24.9541,20.97,35.6170976537525,cur_476
ETFDH,3483,2,1.597675210119882,0,0.74211,1.359,0.39306,Glutaric acidemia IIC[OMIM:231680]-Autosomal recessive inheritance,"Definitive, Definitive, Definitive, Strong, Strong (multiple acyl-CoA dehydrogenase deficiency[MONDO:0009282]-Autosomal recessive)",Definitive (multiple acyl-CoA dehydrogenase deficiency[MONDO:0009282]-AR),P:111; LP:85; VUS:217,OMIM:231680 (cyst_cilio: 0.066 | nephrocalcinosis: 0.042 | tubulopathy: 0.042 | glomerulopathy: 0.013 | cakut: 0.012 | cancer: 0.01),NULL,OMIM:231680 (syndromic: 0.019 | skeletal: 0.019 | neurologic: 0.005),hm (NA); ht (NA),0.5,976,0.23270440251572327,"9606.ENSP00000452762:483, 9606.ENSP00000346173:493",0.5,17.1766,14.4384,28.7864423404687,cur_477
FANCA,3582,3,1.540822921661252,0,1.1525,-1.2899,-5.4138,"Fanconi anemia, complementation group A[OMIM:227650]-Autosomal recessive inheritance","Definitive, Definitive, Definitive, Definitive, Strong (Fanconi anemia complementation group A[MONDO:0009215]-Autosomal recessive) | Strong, Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group A[MONDO:0009215]-AR),P:513; LP:264; VUS:1336,OMIM:227650 (cancer: 0.18 | cakut: 0.097 | cyst_cilio: 0.021 | glomerulopathy: 0.007 | tubulopathy: 0.007),NULL,OMIM:227650 (syndromic: 0.051 | growth: 0.296 | skeletal: 0.055 | neurologic: 0.069),hm (false); ht (false),1,8585,0.8553459119496856,"9606.ENSP00000294008:578, 9606.ENSP00000310842:895, 9606.ENSP00000330875:999, 9606.ENSP00000216911:292, 9606.ENSP00000287647:969, 9606.ENSP00000229769:999, 9606.ENSP00000354497:499, 9606.ENSP00000337088:161, 9606.ENSP00000289081:999, 9606.ENSP00000369497:637, 9606.ENSP00000451828:558, 9606.ENSP00000385021:999",0.5,0.996165,0.586968,88.5793606067667,cur_478
FANCB,3583,3,1.4112608778656317,NULL,NULL,NULL,NULL,"Fanconi anemia, complementation group B[OMIM:300514]-X-linked recessive inheritance","Supportive (VACTERL with hydrocephalus[MONDO:0010172]-Autosomal recessive) | Definitive, Strong (Fanconi anemia complementation group B[MONDO:0010351]-X-linked) | Definitive (Fanconi anemia complementation group B[MONDO:0010351]-X-linked recessive) | Strong (VACTERL association, X-linked, with or without hydrocephalus[MONDO:0010752]-X-linked) | Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group B[MONDO:0010351]-XL),P:21; LP:6; VUS:214,OMIM:300514 (cancer: 0.05 | cakut: 0.044 | cyst_cilio: 0.008),OMIM:300514 (neonatal_or_pediatric: 0.665),OMIM:300514 (syndromic: 0.055 | growth: 0.193 | skeletal: 0.016 | neurologic: 0.084),hm (false); ht (false),0,NULL,NULL,NULL,0.5,0.178181,0.105887,11.7765582248911,cur_479
FANCC,3584,2,1.1309261498321586,0,0.74194,1.3601,-0.19398,"Fanconi anemia, complementation group C[OMIM:227645]-Autosomal recessive inheritance","Limited (colorectal cancer[MONDO:0005575]-Autosomal dominant) | Limited (breast cancer[MONDO:0007254]-Autosomal dominant) | Limited (ovarian cancer[MONDO:0008170]-Autosomal dominant) | Definitive, Definitive, Definitive (Fanconi anemia complementation group C[MONDO:0009213]-Autosomal recessive) | Limited (malignant pancreatic neoplasm[MONDO:0009831]-Autosomal dominant) | Strong, Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group C[MONDO:0009213]-AR),P:133; LP:123; VUS:768,OMIM:227645 (cancer: 0.16 | cakut: 0.097 | cyst_cilio: 0.021 | glomerulopathy: 0.007),NULL,OMIM:227645 (syndromic: 0.067 | growth: 0.398 | skeletal: 0.068 | neurologic: 0.069),hm (false); ht (false),0.5,7375,0.8322851153039832,"9606.ENSP00000373952:999, 9606.ENSP00000287647:946, 9606.ENSP00000310842:932, 9606.ENSP00000330875:999, 9606.ENSP00000294008:499, 9606.ENSP00000385021:999, 9606.ENSP00000369497:349, 9606.ENSP00000227507:154, 9606.ENSP00000354497:499, 9606.ENSP00000229769:999",0.5,3.82295,2.96685,141.348002049277,cur_480
FANCD2,3585,2,1.6788872249016673,NULL,NULL,NULL,NULL,"Fanconi anemia, complementation group D2[OMIM:227646]-Autosomal recessive inheritance","Definitive, Definitive, Definitive, Strong (Fanconi anemia complementation group D2[MONDO:0009214]-Autosomal recessive) | Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group D2[MONDO:0009214]-AR),P:69; LP:50; VUS:521,OMIM:227646 (cancer: 0.19 | cakut: 0.113 | cyst_cilio: 0.021 | glomerulopathy: 0.007),NULL,OMIM:227646 (syndromic: 0.067 | growth: 0.296 | skeletal: 0.057 | neurologic: 0.1),hm (false); ht (false),1,12333,0.9664570230607966,"9606.ENSP00000373952:969, 9606.ENSP00000336701:222, 9606.ENSP00000261584:906, 9606.ENSP00000354497:966, 9606.ENSP00000229769:972, 9606.ENSP00000369497:995, 9606.ENSP00000227507:163, 9606.ENSP00000337088:870, 9606.ENSP00000289081:946, 9606.ENSP00000310842:999, 9606.ENSP00000330875:898, 9606.ENSP00000294008:939, 9606.ENSP00000265748:292, 9606.ENSP00000264414:390, 9606.ENSP00000385021:974, 9606.ENSP00000451828:292, 9606.ENSP00000421491:540",0.5,1.39739,0.6059720000000001,34.4053147025056,cur_481
FANCE,3586,2,1.1309261498321586,2e-6,0.56115,1.9574,0.12875,"Fanconi anemia, complementation group E[OMIM:600901]-Autosomal recessive inheritance","Definitive, Definitive, Strong (Fanconi anemia complementation group E[MONDO:0010953]-Autosomal recessive) | Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group E[MONDO:0010953]-AR),P:18; LP:13; VUS:281,OMIM:600901 (cancer: 0.16 | cakut: 0.097 | cyst_cilio: 0.021 | glomerulopathy: 0.007),NULL,OMIM:600901 (syndromic: 0.075 | growth: 0.296 | skeletal: 0.055 | neurologic: 0.12),hm (false); ht (false),1,10294,0.909853249475891,"9606.ENSP00000243253:345, 9606.ENSP00000369497:292, 9606.ENSP00000294008:499, 9606.ENSP00000310842:949, 9606.ENSP00000330875:999, 9606.ENSP00000348849:495, 9606.ENSP00000481646:378, 9606.ENSP00000385021:999, 9606.ENSP00000463784:378, 9606.ENSP00000470972:495, 9606.ENSP00000287647:972, 9606.ENSP00000373952:999, 9606.ENSP00000414321:499, 9606.ENSP00000354497:499, 9606.ENSP00000289081:999, 9606.ENSP00000359345:497",0,2.91215,1.5154100000000001,3.76169941281285,cur_482
FANCF,3587,2,1.1309261498321586,0.45886,0,1.1618,-1.826,"Fanconi anemia, complementation group F[OMIM:603467]-Autosomal recessive inheritance","Definitive, Definitive, Strong (Fanconi anemia complementation group F[MONDO:0011325]-Autosomal recessive) | Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group F[MONDO:0011325]-AR),P:22; LP:7; VUS:239,OMIM:603467 (cakut: 0.165 | cancer: 0.05 | cyst_cilio: 0.045 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:603467 (antenatal_or_congenital: 0.821),OMIM:603467 (syndromic: 0.056 | growth: 0.523 | skeletal: 0.059 | neurologic: 0.053),hm (false); ht (false),1,7541,0.8406708595387841,"9606.ENSP00000310842:925, 9606.ENSP00000256078:208, 9606.ENSP00000354497:499, 9606.ENSP00000294008:499, 9606.ENSP00000229769:999, 9606.ENSP00000385021:999, 9606.ENSP00000361021:167, 9606.ENSP00000373952:999, 9606.ENSP00000369497:349, 9606.ENSP00000289081:999, 9606.ENSP00000287647:898",0,5.05654,3.31702,9.59136225727633,cur_483
FANCI,25568,2,1.1309261498321586,0,0.82993,1.3731,-1.351,"Fanconi anemia, complementation group I[OMIM:609053]-Autosomal recessive inheritance","Definitive, Definitive, Strong (Fanconi anemia complementation group I[MONDO:0012186]-Autosomal recessive) | Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group I[MONDO:0012186]-AR),P:64; LP:41; VUS:739,OMIM:609053 (cakut: 0.19 | cancer: 0.12 | cyst_cilio: 0.055 | glomerulopathy: 0.013 | tubulopathy: 0.007),NULL,OMIM:609053 (syndromic: 0.072 | growth: 0.378 | skeletal: 0.071 | neurologic: 0.092),hm (false); ht (false),1,10978,0.9287211740041929,"9606.ENSP00000330875:925, 9606.ENSP00000294008:745, 9606.ENSP00000385021:979, 9606.ENSP00000341292:317, 9606.ENSP00000421491:540, 9606.ENSP00000451828:292, 9606.ENSP00000373952:895, 9606.ENSP00000336701:446, 9606.ENSP00000287647:999, 9606.ENSP00000369497:955, 9606.ENSP00000227507:163, 9606.ENSP00000289081:932, 9606.ENSP00000261584:879, 9606.ENSP00000354497:962, 9606.ENSP00000229769:949",0.5,1.38132,0.87059,63.5748064133746,cur_484
FANCL,20748,2,1.1309261498321586,NULL,NULL,NULL,NULL,"Fanconi anemia, complementation group L[OMIM:614083]-Autosomal recessive inheritance","Definitive, Strong, Strong, Strong (Fanconi anemia complementation group L[MONDO:0013566]-Autosomal recessive) | Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group L[MONDO:0013566]-AR),P:25; LP:24; VUS:244,OMIM:614083 (cakut: 0.137 | cancer: 0.05 | cyst_cilio: 0.042 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:614083 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.402),OMIM:614083 (syndromic: 0.074 | growth: 0.193 | skeletal: 0.044 | neurologic: 0.077),hm (false); ht (false),0.5,7471,0.8364779874213837,"9606.ENSP00000369497:353, 9606.ENSP00000289081:999, 9606.ENSP00000354497:499, 9606.ENSP00000229769:999, 9606.ENSP00000373952:999, 9606.ENSP00000336701:171, 9606.ENSP00000287647:974, 9606.ENSP00000330875:999, 9606.ENSP00000310842:979, 9606.ENSP00000294008:499",0.5,8.723239999999999,6.02323,79.8106852873782,cur_485
FAT4,23109,3,1.999353394386978,1,0.12097,9.368,0.62191,Van Maldergem syndrome 2[OMIM:615546]-Autosomal recessive inheritance | Hennekam lymphangiectasia-lymphedema syndrome 2[OMIM:616006]-Autosomal recessive inheritance,Definitive (van Maldergem syndrome 2[MONDO:0014242]-Autosomal recessive) | Definitive (Hennekam lymphangiectasia-lymphedema syndrome 2[MONDO:0014454]-Autosomal recessive) | Supportive (Hennekam syndrome[MONDO:0016256]-Autosomal recessive) | Supportive (van Maldergem syndrome[MONDO:0017813]-Autosomal recessive),NULL,P:25; LP:6; VUS:1192,OMIM:615546 (cakut: 0.089 | cyst_cilio: 0.037 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:615546 (antenatal_or_congenital: 0.821),OMIM:615546 (syndromic: 0.134 | growth: 0.091 | skeletal: 0.123 | neurologic: 0.105); OMIM:616006 (syndromic: 0.032 | growth: 0.091 | skeletal: 0.019 | neurologic: 0.006),hm (true); ht (false),0.5,740,0.18238993710691823,"9606.ENSP00000406229:418, 9606.ENSP00000269305:157, 9606.ENSP00000231509:165",0.5,1.6130000000000002,1.10804,161.860500778156,cur_486
FLNA,3754,2,2.040297830069389,1,0.02614,7.8936,3.7802,"Otopalatodigital syndrome, type II[OMIM:304120]-X-linked dominant inheritance | Intestinal pseudoobstruction, neuronal[OMIM:300048]-X-linked recessive inheritance | Cardiac valvular dysplasia, X-linked[OMIM:314400]-X-linked inheritance | ?FG syndrome 2[OMIM:300321]-X-linked inheritance | Melnick-Needles syndrome[OMIM:309350]-X-linked dominant inheritance | Terminal osseous dysplasia[OMIM:300244]-X-linked dominant inheritance | Congenital short bowel syndrome[OMIM:300048]-X-linked recessive inheritance | Otopalatodigital syndrome, type I[OMIM:311300]-X-linked dominant inheritance | Heterotopia, periventricular, 1[OMIM:300049]-X-linked dominant inheritance | Frontometaphyseal dysplasia 1[OMIM:305620]-X-linked recessive inheritance","Definitive (intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked[MONDO:0010232]-X-linked) | Definitive (intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked[MONDO:0010232]-X-linked recessive) | Definitive, Definitive, Definitive (heterotopia, periventricular, X-linked dominant[MONDO:0010233]-X-linked) | Definitive (heterotopia, periventricular, X-linked dominant[MONDO:0010233]-X-linked dominant) | Definitive, Supportive (terminal osseous dysplasia-pigmentary defects syndrome[MONDO:0010279]-X-linked) | Definitive (terminal osseous dysplasia-pigmentary defects syndrome[MONDO:0010279]-X-linked recessive) | Definitive (FG syndrome 2[MONDO:0010297]-X-linked recessive) | Definitive, Moderate, Supportive (otopalatodigital syndrome type 2[MONDO:0010571]-X-linked) | Definitive (otopalatodigital syndrome type 2[MONDO:0010571]-X-linked recessive) | Supportive (X-linked Ehlers-Danlos syndrome[MONDO:0010586]-X-linked) | Definitive, Supportive (Melnick-Needles syndrome[MONDO:0010650]-X-linked) | Definitive (Melnick-Needles syndrome[MONDO:0010650]-X-linked dominant) | Supportive (otopalatodigital syndrome type 1[MONDO:0010704]-X-linked) | Definitive (otopalatodigital syndrome type 1[MONDO:0010704]-X-linked recessive) | Moderate, Supportive (cardiac valvular dysplasia, X-linked[MONDO:0010753]-X-linked) | Supportive (congenital short bowel syndrome[MONDO:0014097]-Autosomal recessive) | Supportive (frontometaphyseal dysplasia[MONDO:0015942]-Autosomal dominant) | Limited (familial thoracic aortic aneurysm and aortic dissection[MONDO:0019625]-X-linked) | Supportive (periventricular nodular heterotopia[MONDO:0020341]-Autosomal dominant) | Definitive (periventricular nodular heterotopia[MONDO:0020341]-X-linked) | Definitive (frontometaphyseal dysplasia 1[MONDO:0024550]-X-linked) | Definitive (frontometaphyseal dysplasia 1[MONDO:0024550]-X-linked recessive)",Limited (familial thoracic aortic aneurysm and aortic dissection[MONDO:0019625]-XL) | Definitive (periventricular nodular heterotopia[MONDO:0020341]-XL),P:161; LP:85; VUS:919,OMIM:300048 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002); OMIM:304120 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002); OMIM:305620 (cakut: 0.097 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002); OMIM:309350 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:300048 (neonatal_or_pediatric: 0.402); OMIM:304120 (antenatal_or_congenital: 0.821),OMIM:300048 (syndromic: 0.029 | skeletal: 0 | neurologic: 0.042); OMIM:300049 (syndromic: 0.039 | skeletal: 0.015 | neurologic: 0.073); OMIM:300244 (syndromic: 0.03 | skeletal: 0.042); OMIM:300321 (syndromic: 0.016 | growth: 0.026 | skeletal: 0.004 | neurologic: 0.02); OMIM:304120 (syndromic: 0.108 | growth: 0.284 | skeletal: 0.154 | neurologic: 0.047); OMIM:305620 (syndromic: 0.073 | skeletal: 0.079 | neurologic: 0.04); OMIM:309350 (syndromic: 0.051 | growth: 0.171 | skeletal: 0.085 | neurologic: 0.022); OMIM:311300 (syndromic: 0.071 | growth: 0.25 | skeletal: 0.111 | neurologic: 0.006); OMIM:314400 (syndromic: 0.006 | skeletal: 0.012),hm (false); ht (false),1,16609,0.9916142557651991,"9606.ENSP00000362413:343, 9606.ENSP00000356405:292, 9606.ENSP00000420194:784, 9606.ENSP00000339191:814, 9606.ENSP00000256474:647, 9606.ENSP00000379616:161, 9606.ENSP00000313169:328, 9606.ENSP00000216181:366, 9606.ENSP00000200181:855, 9606.ENSP00000363779:292, 9606.ENSP00000369497:972, 9606.ENSP00000227507:396, 9606.ENSP00000256078:354, 9606.ENSP00000265748:394, 9606.ENSP00000367316:650, 9606.ENSP00000269305:165, 9606.ENSP00000252699:187, 9606.ENSP00000362924:595, 9606.ENSP00000288235:189, 9606.ENSP00000215832:476, 9606.ENSP00000451828:624, 9606.ENSP00000363435:159, 9606.ENSP00000378611:965, 9606.ENSP00000003084:944, 9606.ENSP00000346839:551, 9606.ENSP00000389998:557, 9606.ENSP00000281043:161, 9606.ENSP00000262613:220, 9606.ENSP00000311505:292, 9606.ENSP00000357283:238, 9606.ENSP00000377789:161, 9606.ENSP00000362680:590, 9606.ENSP00000376410:201, 9606.ENSP00000346151:420, 9606.ENSP00000264896:163, 9606.ENSP00000265970:161, 9606.ENSP00000386896:650, 9606.ENSP00000356319:292",0.5,128.804,85.4026,181.828630759569,cur_487
FOXF1,3809,2,1.144897225638441,0.95792,0,2.9175,1.089,Alveolar capillary dysplasia with misalignment of pulmonary veins[OMIM:265380]-Autosomal dominant inheritance,"Definitive, Supportive (alveolar capillary dysplasia with misalignment of pulmonary veins[MONDO:0009934]-Autosomal dominant)",NULL,P:37; LP:15; VUS:36,OMIM:265380 (cakut: 0.097 | cyst_cilio: 0.021 | cancer: 0.02 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,OMIM:265380 (syndromic: 0.05 | skeletal: 0.047 | neurologic: 0.064),hm (false); ht (false),0.5,2489,0.48427672955974843,"9606.ENSP00000370421:455, 9606.ENSP00000401678:476, 9606.ENSP00000484803:165, 9606.ENSP00000287538:347, 9606.ENSP00000379258:407, 9606.ENSP00000216911:292, 9606.ENSP00000368253:347",0,2.87437,1.96497,0.212852822895007,cur_488
FOXP3,6106,3,2.12369522995381,0.99424,0,3.6276,1.6724,"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked[OMIM:304790]-X-linked recessive inheritance","Definitive, Strong, Supportive (immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome[MONDO:0010580]-X-linked) | Definitive (immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome[MONDO:0010580]-X-linked recessive)",NULL,P:30; LP:20; VUS:94,OMIM:304790 (complement: 0.036 | glomerulopathy: 0.016 | cyst_cilio: 0.003),OMIM:304790 (neonatal_or_pediatric: 0.402),OMIM:304790 (syndromic: 0.059 | growth: 0.171 | skeletal: 0.003 | neurologic: 0.103),hm (false); ht (false),0.5,2726,0.5220125786163522,"9606.ENSP00000216117:241, 9606.ENSP00000287820:739, 9606.ENSP00000484803:667, 9606.ENSP00000367721:165, 9606.ENSP00000261396:165, 9606.ENSP00000229179:165, 9606.ENSP00000229135:292, 9606.ENSP00000368632:292",0,0.378422,0.23587600000000003,1.3642785508974,cur_489
G6PC1,4056,4,2.4525467400115764,1.8e-5,0.5956,1.5355,0.2658,Glycogen storage disease Ia[OMIM:232200]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Strong (glycogen storage disease due to glucose-6-phosphatase deficiency type IA[MONDO:0009287]-Autosomal recessive)",NULL,P:80; LP:66; VUS:145,OMIM:232200 (tubulopathy: 0.161 | nephrocalcinosis: 0.16 | glomerulopathy: 0.115 | cancer: 0.04 | cyst_cilio: 0.037 | cakut: 0.028),OMIM:232200 (neonatal_or_pediatric: 0.665),OMIM:232200 (syndromic: 0.022 | growth: 0.361 | skeletal: 0.007),hm (true); ht (false),0.5,900,0.21174004192872117,9606.ENSP00000223366:900,0,NULL,NULL,NULL,cur_490
GCK,4195,2,1.6337410788342357,NULL,NULL,NULL,NULL,"MODY, type II[OMIM:125851]-Autosomal dominant inheritance | Diabetes mellitus, permanent neonatal 1[OMIM:606176]-Autosomal recessive inheritance | Hyperinsulinemic hypoglycemia, familial, 3[OMIM:602485]-Autosomal dominant inheritance | Diabetes mellitus, noninsulin-dependent, late onset[OMIM:125853]-Autosomal dominant inheritance","Definitive, Strong (maturity-onset diabetes of the young type 2[MONDO:0007453]-Autosomal dominant) | Strong (diabetes mellitus, noninsulin-dependent[MONDO:0007455]-Autosomal dominant) | Definitive, Strong, Supportive (hyperinsulinism due to glucokinase deficiency[MONDO:0011236]-Autosomal dominant) | Definitive (monogenic diabetes[MONDO:0015967]-Autosomal dominant) | Supportive (maturity-onset diabetes of the young[MONDO:0018911]-Autosomal dominant) | Strong (transient neonatal diabetes mellitus[MONDO:0020525]-Autosomal recessive) | Supportive (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal dominant) | Strong, Moderate (permanent neonatal diabetes mellitus 1[MONDO:0100165]-Autosomal recessive)",Definitive (monogenic diabetes[MONDO:0015967]-AD),P:214; LP:219; VUS:210,NULL,OMIM:125851 (neonatal_or_pediatric: 0.2); OMIM:125853 (adult: 0.108); OMIM:602485 (adult: 0.372 | neonatal_or_pediatric: 0.2),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:602485 (syndromic: 0.02 | neurologic: 0.041); OMIM:606176 (syndromic: 0.008 | growth: 0.148),hm (true); ht (true),0.5,1347,0.3165618448637317,"9606.ENSP00000323568:447, 9606.ENSP00000253801:900",0,0.591947,0.153421,2.86549826662077,cur_491
GLIS3,28510,4,2.482453113819424,0,0.49621,2.8117,-3.1361,"Diabetes mellitus, neonatal, with congenital hypothyroidism[OMIM:610199]-Autosomal recessive inheritance","Limited (Tourette syndrome[MONDO:0007661]-Unknown) | Definitive, Strong, Moderate, Supportive (neonatal diabetes mellitus with congenital hypothyroidism[MONDO:0012436]-Autosomal recessive)",NULL,P:5; LP:3; VUS:272,OMIM:610199 (cyst_cilio: 0.155 | cakut: 0.056 | cancer: 0.04 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:610199 (neonatal_or_pediatric: 0.134),OMIM:610199 (syndromic: 0.058 | growth: 0.102 | skeletal: 0.015 | neurologic: 0.057),hm (true); ht (false),0.5,698,0.17819706498951782,"9606.ENSP00000297185:288, 9606.ENSP00000295108:410",0.5,6.36414,4.48461,160.246356546333,cur_492
HBB,4827,3,2.0331504315745126,0,2.6505,-2.9707,-0.2113,"Methemoglobinemia, beta type[OMIM:617971]-Autosomal dominant inheritance | Thalassemia-beta, dominant inclusion-body[OMIM:603902]-Autosomal dominant inheritance | Sickle cell disease[OMIM:603903]-Autosomal recessive inheritance | Thalassemia, beta[OMIM:613985]-NA | Delta-beta thalassemia[OMIM:141749]-Autosomal dominant inheritance | {Malaria, resistance to}[OMIM:611162]-NA | Hereditary persistence of fetal hemoglobin[OMIM:141749]-Autosomal dominant inheritance | Erythrocytosis, familial, 6[OMIM:617980]-Autosomal dominant inheritance | Heinz body anemia[OMIM:140700]-Autosomal dominant inheritance","Strong (Heinz body anemia[MONDO:0007705]-Autosomal dominant) | Definitive, Supportive (dominant beta-thalassemia[MONDO:0011381]-Autosomal dominant) | Supportive (sickle cell anemia[MONDO:0011382]-Autosomal recessive) | Definitive (beta-thalassemia HBB/LCRB[MONDO:0013517]-Autosomal recessive) | Definitive (beta-thalassemia HBB/LCRB[MONDO:0013517]-Semidominant) | Supportive (hemoglobin C disease[MONDO:0016242]-Autosomal recessive) | Supportive (hemoglobin E disease[MONDO:0016243]-Autosomal recessive) | Supportive (beta-thalassemia major[MONDO:0016486]-Autosomal recessive) | Supportive (beta-thalassemia intermedia[MONDO:0016487]-Autosomal recessive) | Supportive (delta-beta-thalassemia[MONDO:0016489]-Autosomal recessive) | Supportive (hemoglobin C-beta-thalassemia syndrome[MONDO:0016490]-Autosomal recessive) | Supportive (hemoglobin E-beta-thalassemia syndrome[MONDO:0016491]-Autosomal recessive) | Supportive (sickle cell-beta-thalassemia disease syndrome[MONDO:0016668]-Autosomal recessive) | Supportive (sickle cell-hemoglobin c disease syndrome[MONDO:0016669]-Autosomal recessive) | Supportive (sickle cell-hemoglobin d disease syndrome[MONDO:0016670]-Autosomal recessive) | Supportive (sickle cell-hemoglobin E disease syndrome[MONDO:0016671]-Autosomal recessive) | Supportive (hereditary persistence of fetal hemoglobin-sickle cell disease syndrome[MONDO:0016672]-Autosomal recessive) | Definitive (sickle cell disease and related diseases[MONDO:0017146]-Autosomal recessive) | Moderate, Supportive (hemoglobin M disease[MONDO:0018023]-Autosomal dominant) | Supportive (hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome[MONDO:0018749]-Autosomal dominant) | Definitive, Strong (beta thalassemia[MONDO:0019402]-Autosomal recessive) | Strong (erythrocytosis, familial, 6[MONDO:0054801]-Autosomal dominant)",Definitive (dominant beta-thalassemia[MONDO:0011381]-AD) | Definitive (beta-thalassemia HBB/LCRB[MONDO:0013517]-AR) | Definitive (sickle cell disease and related diseases[MONDO:0017146]-AR),P:315; LP:82; VUS:179,OMIM:603903 (complement: 0.214 | tubulopathy: 0.14 | nephrocalcinosis: 0.139 | glomerulopathy: 0.126 | cyst_cilio: 0.079 | cakut: 0.056 | cancer: 0.02),NULL,OMIM:603903 (syndromic: 0.001 | neurologic: 0.001),hm (false); ht (true),0,NULL,NULL,NULL,0.5,605.695,512.7280000000001,17.6032804560983,cur_493
HGD,4892,3,1.4112608778656317,0,0.61603,1.8133,0.28979,Alkaptonuria[OMIM:203500]-Autosomal recessive inheritance,"Definitive, Strong, Supportive (alkaptonuria[MONDO:0008753]-Autosomal recessive)",Definitive (alkaptonuria[MONDO:0008753]-AR),P:136; LP:66; VUS:72,OMIM:203500 (tubulopathy: 0.154 | nephrocalcinosis: 0.153 | cyst_cilio: 0.013 | glomerulopathy: 0.013 | cakut: 0.012 | cancer: 0.01),OMIM:203500 (neonatal_or_pediatric: 0.402 | adult: 0.218),OMIM:203500 (syndromic: 0.005 | growth: 0.008 | skeletal: 0.017),hm (true); ht (false),0,NULL,NULL,NULL,0,26.1435,44.2492,8.90385946315121,cur_494
HNF1A,11621,4,3.058271043964929,0.96115,0.14406,4.1795,1.1354,"Hepatic adenoma, somatic[OMIM:142330]-NA | Diabetes mellitus, insulin-dependent, 20[OMIM:612520]-NA | {Diabetes mellitus, noninsulin-dependent, 2}[OMIM:125853]-Autosomal dominant inheritance | MODY, type III[OMIM:600496]-Autosomal dominant inheritance | {Diabetes mellitus, insulin-dependent}[OMIM:222100]-Autosomal recessive inheritance | Renal cell carcinoma[OMIM:144700]-NA","Strong (diabetes mellitus, noninsulin-dependent[MONDO:0007455]-Autosomal dominant) | No Known Disease Relationship (nonpapillary renal cell carcinoma[MONDO:0007763]-Unknown) | Strong (maturity-onset diabetes of the young type 3[MONDO:0010894]-Autosomal dominant) | Definitive, Strong (type 1 diabetes mellitus 20[MONDO:0012919]-Autosomal dominant) | Definitive (monogenic diabetes[MONDO:0015967]-Autosomal dominant) | Supportive (hyperinsulinism due to HNF1A deficiency[MONDO:0017935]-Autosomal dominant) | Supportive (maturity-onset diabetes of the young[MONDO:0018911]-Autosomal dominant)",Definitive (monogenic diabetes[MONDO:0015967]-AD),P:143; LP:126; VUS:275,OMIM:144700 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:222100 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:125853 (adult: 0.108); OMIM:600496 (neonatal_or_pediatric: 0.402),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:222100 (syndromic: 0.001 | neurologic: 0.002),hm (true); ht (false),0,NULL,NULL,NULL,0,1.9411200000000002,5.28446,3.17921207800619,cur_495
HPS1,5163,3,1.63600601224932,NULL,NULL,NULL,NULL,Hermansky-Pudlak syndrome 1[OMIM:203300]-Autosomal recessive inheritance,"Definitive, Definitive, Strong (Hermansky-Pudlak syndrome 1[MONDO:0008748]-Autosomal recessive) | Supportive (Hermansky-Pudlak syndrome with pulmonary fibrosis[MONDO:0016501]-Autosomal recessive)",Definitive (Hermansky-Pudlak syndrome 1[MONDO:0008748]-AR),P:68; LP:45; VUS:254,OMIM:203300 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),NULL,OMIM:203300 (syndromic: 0.003 | neurologic: 0.004),hm (true); ht (false),0,559,0.14465408805031446,"9606.ENSP00000251020:394, 9606.ENSP00000327650:165",0.5,20.4395,17.1801,19.213247690852,cur_496
IFNG,5438,3,1.863618263636588,0.47156,0.17338,1.8396,1.609,"{Hepatitis C virus, response to therapy of}[OMIM:609532]-NA | {TSC2 angiomyolipomas, renal, modifier of}[OMIM:613254]-Autosomal dominant inheritance | {Aplastic anemia}[OMIM:609135]-NA | ?Immunodeficiency 69, mycobacteriosis[OMIM:618963]-Autosomal recessive inheritance | {Tuberculosis, protection against}[OMIM:607948]-NA | {AIDS, rapid progression to}[OMIM:609423]-NA",NULL,NULL,P:2; LP:0; VUS:17,OMIM:613254 (cancer: 0.17 | cyst_cilio: 0.118 | cakut: 0.056 | glomerulopathy: 0.009 | tubulopathy: 0.007),OMIM:613254 (neonatal_or_pediatric: 0.402),OMIM:613254 (syndromic: 0.047 | skeletal: 0.003 | neurologic: 0.098); OMIM:618963 (syndromic: 0.009 | growth: 0.171),hm (true); ht (false),0,489,0.12159329140461216,"9606.ENSP00000365380:292, 9606.ENSP00000339191:197",0,0.286671,0.0743764,0.14749210084686,cur_497
IFT80,29262,2,1.3936833827077542,0,0.75019,1.6036,1.5119,Short-rib thoracic dysplasia 2 with or without polydactyly[OMIM:611263]-Autosomal recessive inheritance,"Supportive (Beemer-Langer syndrome[MONDO:0010024]-Autosomal recessive) | Definitive, Moderate (asphyxiating thoracic dystrophy 2[MONDO:0012644]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive) | Supportive (short rib-polydactyly syndrome, Verma-Naumoff type[MONDO:0019664]-Autosomal recessive)",NULL,P:30; LP:15; VUS:300,NULL,NULL,OMIM:611263 (syndromic: 0.011 | growth: 0.017 | skeletal: 0.037),hm (true); ht (false),1,10105,0.9014675052410901,"9606.ENSP00000242591:990, 9606.ENSP00000260570:998, 9606.ENSP00000404122:984, 9606.ENSP00000382717:721, 9606.ENSP00000393541:981, 9606.ENSP00000238628:542, 9606.ENSP00000362424:996, 9606.ENSP00000262613:201, 9606.ENSP00000406012:804, 9606.ENSP00000304941:201, 9606.ENSP00000314444:610, 9606.ENSP00000296266:540, 9606.ENSP00000243344:543, 9606.ENSP00000362121:994",0.5,18.2875,7.97337,88.1399177069978,cur_498
INS,6081,2,1.6847142020965158,NULL,NULL,NULL,NULL,"Diabetes mellitus, insulin-dependent, 2[OMIM:125852]-Autosomal dominant inheritance | Maturity-onset diabetes of the young, type 10[OMIM:613370]-Autosomal dominant inheritance | Hyperproinsulinemia[OMIM:616214]-Autosomal dominant inheritance | Diabetes mellitus, permanent neonatal 4[OMIM:618858]-Autosomal dominant inheritance | Diabetes mellitus, permanent neonatal 4[OMIM:618858]-Autosomal recessive inheritance","Strong (type 1 diabetes mellitus 2[MONDO:0007454]-Autosomal dominant) | Strong (maturity-onset diabetes of the young type 10[MONDO:0013240]-Autosomal dominant) | Strong, Limited (hyperproinsulinemia[MONDO:0014535]-Autosomal dominant) | Definitive (monogenic diabetes[MONDO:0015967]-Autosomal dominant) | Definitive (monogenic diabetes[MONDO:0015967]-Autosomal recessive) | Supportive (maturity-onset diabetes of the young[MONDO:0018911]-Autosomal dominant) | Strong (transient neonatal diabetes mellitus[MONDO:0020525]-Autosomal dominant) | Strong (transient neonatal diabetes mellitus[MONDO:0020525]-Autosomal recessive) | Strong (diabetes mellitus, permanent neonatal 4[MONDO:0030089]-Autosomal dominant) | Strong (diabetes mellitus, permanent neonatal 4[MONDO:0030089]-Autosomal recessive) | Strong, Supportive (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal dominant)",Definitive (monogenic diabetes[MONDO:0015967]-AD) | Definitive (monogenic diabetes[MONDO:0015967]-AR),P:20; LP:24; VUS:26,NULL,OMIM:125852 (adult: 0.049),OMIM:613370 (syndromic: 0.005 | growth: 0.102); OMIM:618858 (syndromic: 0.002 | growth: 0.046),hm (true); ht (true),0.5,2532,0.4947589098532495,"9606.ENSP00000379204:295, 9606.ENSP00000393312:307, 9606.ENSP00000265171:900, 9606.ENSP00000269305:173, 9606.ENSP00000339191:565, 9606.ENSP00000361021:292",0.5,0.104458,0.13133699999999998,25.1648538574982,cur_499
ITGA6,6142,2,1.6473334600067473,NULL,NULL,NULL,NULL,"Epidermolysis bullosa, junctional 6, with pyloric atresia[OMIM:619817]-Autosomal recessive inheritance","Limited (junctional epidermolysis bullosa with pyloric atresia[MONDO:0009183]-Autosomal dominant) | Strong, Strong, Strong, Supportive (junctional epidermolysis bullosa with pyloric atresia[MONDO:0009183]-Autosomal recessive)",NULL,P:9; LP:4; VUS:123,NULL,OMIM:619817 (antenatal_or_congenital: 0.821),OMIM:619817 (syndromic: 0),hm (false); ht (false),0.5,5025,0.7463312368972747,"9606.ENSP00000331902:323, 9606.ENSP00000264664:181, 9606.ENSP00000200181:999, 9606.ENSP00000256646:238, 9606.ENSP00000360997:244, 9606.ENSP00000367316:540, 9606.ENSP00000252999:972, 9606.ENSP00000256078:228, 9606.ENSP00000358866:650, 9606.ENSP00000252699:650",0.5,22.215999999999998,27.3145,89.5564494155436,cur_500
KANSL1,24565,3,1.4112608778656317,NULL,NULL,NULL,NULL,Koolen-De Vries syndrome[OMIM:610443]-Autosomal dominant inheritance,"Definitive, Definitive, Strong (Koolen-de Vries syndrome[MONDO:0012496]-Autosomal dominant) | Supportive (Koolen-de Vries syndrome due to a point mutation[MONDO:0018217]-Autosomal dominant)",Definitive (Koolen-de Vries syndrome[MONDO:0012496]-AD),P:61; LP:27; VUS:326,OMIM:610443 (cakut: 0.137 | cyst_cilio: 0.021 | cancer: 0.02 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,OMIM:610443 (syndromic: 0.2 | growth: 0.569 | skeletal: 0.134 | neurologic: 0.219),hm (false); ht (false),0,NULL,NULL,NULL,0.5,7.8574600000000006,5.514390000000001,505.562932424256,cur_501
KAT6B,17582,3,1.589085145648058,1,0.060836,7.8898,2.8874,SBBYSS syndrome[OMIM:603736]-Autosomal dominant inheritance | Genitopatellar syndrome[OMIM:606170]-Autosomal dominant inheritance,"Definitive, Strong, Supportive (blepharophimosis - intellectual disability syndrome, SBBYS type[MONDO:0011365]-Autosomal dominant) | Definitive, Strong, Supportive (genitopatellar syndrome[MONDO:0011640]-Autosomal dominant) | Disputed Evidence (RASopathy[MONDO:0021060]-Autosomal dominant) | Definitive (KAT6B-related multiple congenital anomalies syndrome[MONDO:0036042]-Autosomal dominant)",Disputed (RASopathy[MONDO:0021060]-AD) | Definitive (KAT6B-related multiple congenital anomalies syndrome[MONDO:0036042]-AD),P:93; LP:39; VUS:375,OMIM:606170 (cakut: 0.089 | cancer: 0.03 | cyst_cilio: 0.021 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:603736 (neonatal_or_pediatric: 0.402),OMIM:603736 (syndromic: 0.054 | skeletal: 0.08 | neurologic: 0.053); OMIM:606170 (syndromic: 0.095 | skeletal: 0.141 | neurologic: 0.104),hm (false); ht (false),0,156,0,9606.ENSP00000362734:156,0.5,2.50224,2.64177,595.164422066634,cur_502
KCNJ11,6257,2,1.4611275477869698,0.010894,0.53021,1.1957,1.647,"Diabetes, permanent neonatal 2, with or without neurologic features[OMIM:618856]-Autosomal dominant inheritance | {Diabetes mellitus, type 2, susceptibility to}[OMIM:125853]-Autosomal dominant inheritance | Maturity-onset diabetes of the young, type 13[OMIM:616329]-Autosomal dominant inheritance | Diabetes mellitus, transient neonatal 3[OMIM:610582]-Autosomal dominant inheritance | Hyperinsulinemic hypoglycemia, familial, 2[OMIM:601820]-Autosomal dominant inheritance | Hyperinsulinemic hypoglycemia, familial, 2[OMIM:601820]-Autosomal recessive inheritance","Strong (hyperinsulinemic hypoglycemia[MONDO:0005803]-Autosomal recessive) | Strong (diabetes mellitus, noninsulin-dependent[MONDO:0007455]-Autosomal dominant) | Strong (hyperinsulinemic hypoglycemia, familial, 2[MONDO:0011153]-Autosomal dominant) | Definitive, Definitive, Strong (hyperinsulinemic hypoglycemia, familial, 2[MONDO:0011153]-Autosomal recessive) | Definitive, Strong (diabetes mellitus, transient neonatal, 3[MONDO:0012522]-Autosomal dominant) | Strong (maturity-onset diabetes of the young type 13[MONDO:0014589]-Autosomal dominant) | Definitive (monogenic diabetes[MONDO:0015967]-Autosomal dominant) | Supportive (autosomal dominant hyperinsulinism due to Kir6.2 deficiency[MONDO:0017185]-Autosomal dominant) | Supportive (diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency[MONDO:0017188]-Autosomal recessive) | Supportive (maturity-onset diabetes of the young[MONDO:0018911]-Autosomal dominant) | Supportive (DEND syndrome[MONDO:0019207]-Autosomal dominant) | Supportive (autosomal recessive hyperinsulinism due to Kir6.2 deficiency[MONDO:0019334]-Autosomal recessive) | Supportive (transient neonatal diabetes mellitus[MONDO:0020525]-Autosomal dominant) | Supportive (intermediate DEND syndrome[MONDO:0020569]-Autosomal dominant) | Strong (diabetes mellitus, permanent neonatal 2[MONDO:0030087]-Autosomal dominant) | Supportive (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal dominant)",Definitive (monogenic diabetes[MONDO:0015967]-AD),P:16; LP:23; VUS:150,NULL,OMIM:125853 (adult: 0.108); OMIM:601820 (neonatal_or_pediatric: 0.134); OMIM:610582 (neonatal_or_pediatric: 0.799 | adult: 0.016); OMIM:616329 (neonatal_or_pediatric: 0.665 | adult: 0.05),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:601820 (syndromic: 0 | growth: 0.008); OMIM:616329 (syndromic: 0 | growth: 0); OMIM:618856 (syndromic: 0.038 | skeletal: 0.014 | neurologic: 0.067),hm (false); ht (false),0.5,977,0.2348008385744235,"9606.ENSP00000287820:265, 9606.ENSP00000445175:712",0,3.5234199999999998,1.7699,0.980283100897185,cur_503
KCTD1,18249,3,1.5195244761919913,NULL,NULL,NULL,NULL,Scalp-ear-nipple syndrome[OMIM:181270]-Autosomal dominant inheritance,"Definitive, Strong, Supportive (scalp-ear-nipple syndrome[MONDO:0008404]-Autosomal dominant)",NULL,P:10; LP:1; VUS:43,OMIM:181270 (cakut: 0.181 | nephrocalcinosis: 0.118 | tubulopathy: 0.112 | cyst_cilio: 0.11 | complement: 0.107 | glomerulopathy: 0.089 | cancer: 0.05),NULL,OMIM:181270 (syndromic: 0.05 | growth: 0.25 | skeletal: 0.044 | neurologic: 0.002),hm (true); ht (true),0,317,0.07756813417190776,9606.ENSP00000264414:317,0.5,19.0295,11.2108,179.03619872138,cur_504
KRAS,6407,3,1.95922195293514,NULL,NULL,NULL,NULL,"Gastric cancer, somatic[OMIM:613659]-NA | Oculoectodermal syndrome, somatic[OMIM:600268]-NA | Breast cancer, somatic[OMIM:114480]-NA | Noonan syndrome 3[OMIM:609942]-Autosomal dominant inheritance | RAS-associated autoimmune leukoproliferative disorder[OMIM:614470]-Autosomal dominant inheritance | Arteriovenous malformation of the brain, somatic[OMIM:108010]-NA | Lung cancer, somatic[OMIM:211980]-NA | Pancreatic carcinoma, somatic[OMIM:260350]-NA | Leukemia, acute myeloid, somatic[OMIM:601626]-NA | Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic[OMIM:163200]-NA | Cardiofaciocutaneous syndrome 2[OMIM:615278]-Autosomal dominant inheritance | Bladder cancer, somatic[OMIM:109800]-NA","Definitive (cardiofaciocutaneous syndrome 1[MONDO:0007265]-Autosomal dominant) | Disputed Evidence (Costello syndrome[MONDO:0009026]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong (Noonan syndrome 3[MONDO:0012371]-Autosomal dominant) | Definitive, Strong, Moderate (cardiofaciocutaneous syndrome 2[MONDO:0014112]-Autosomal dominant) | Strong, Supportive (cardiofaciocutaneous syndrome[MONDO:0015280]-Autosomal dominant) | Definitive, Supportive (Noonan syndrome[MONDO:0018997]-Autosomal dominant)",Disputed (Costello syndrome[MONDO:0009026]-AD) | Strong (cardiofaciocutaneous syndrome[MONDO:0015280]-AD) | Definitive (Noonan syndrome[MONDO:0018997]-AD),P:54; LP:47; VUS:189,OMIM:163200 (cancer: 0.07 | cakut: 0.028 | cyst_cilio: 0.01 | glomerulopathy: 0.007),OMIM:260350 (adult: 0.218); OMIM:600268 (antenatal_or_congenital: 0.821); OMIM:609942 (antenatal_or_congenital: 0.821),OMIM:108010 (syndromic: 0 | neurologic: 0); OMIM:163200 (syndromic: 0.064 | growth: 0.355 | skeletal: 0.022 | neurologic: 0.081); OMIM:600268 (syndromic: 0.079 | growth: 0.093 | skeletal: 0.03 | neurologic: 0.097); OMIM:609942 (syndromic: 0.082 | growth: 0.25 | skeletal: 0.053 | neurologic: 0.052); OMIM:615278 (syndromic: 0.043 | neurologic: 0.053),hm (true); ht (false),1,11998,0.960167714884696,"9606.ENSP00000358866:354, 9606.ENSP00000386896:228, 9606.ENSP00000346829:163, 9606.ENSP00000393557:161, 9606.ENSP00000229179:163, 9606.ENSP00000362680:687, 9606.ENSP00000385675:579, 9606.ENSP00000463784:165, 9606.ENSP00000288235:165, 9606.ENSP00000264414:333, 9606.ENSP00000360532:161, 9606.ENSP00000297185:171, 9606.ENSP00000227507:262, 9606.ENSP00000420321:163, 9606.ENSP00000364860:185, 9606.ENSP00000352138:231, 9606.ENSP00000243253:163, 9606.ENSP00000317272:216, 9606.ENSP00000406229:323, 9606.ENSP00000380321:235, 9606.ENSP00000370719:390, 9606.ENSP00000445306:212, 9606.ENSP00000386264:237, 9606.ENSP00000269601:163, 9606.ENSP00000377769:233, 9606.ENSP00000003084:165, 9606.ENSP00000346839:499, 9606.ENSP00000366563:458, 9606.ENSP00000351015:840, 9606.ENSP00000215832:837, 9606.ENSP00000393312:152, 9606.ENSP00000367817:195, 9606.ENSP00000287600:695, 9606.ENSP00000360431:506, 9606.ENSP00000347244:369, 9606.ENSP00000256646:163, 9606.ENSP00000078429:161, 9606.ENSP00000330875:208, 9606.ENSP00000298552:165, 9606.ENSP00000287820:242",0.5,9.44171,6.95241,75.4241160618325,cur_505
LDHA,6535,3,1.5195244761919913,NULL,NULL,NULL,NULL,Glycogen storage disease XI[OMIM:612933]-Autosomal recessive inheritance,"Strong, Strong, Strong, Supportive (glycogen storage disease due to lactate dehydrogenase M-subunit deficiency[MONDO:0013047]-Autosomal recessive)",NULL,P:2; LP:2; VUS:87,OMIM:612933 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:612933 (neonatal_or_pediatric: 0.2),NULL,hm (false); ht (false),0.5,4216,0.6876310272536688,"9606.ENSP00000364649:189, 9606.ENSP00000297185:189, 9606.ENSP00000385080:221, 9606.ENSP00000264170:192, 9606.ENSP00000362413:188, 9606.ENSP00000355518:326, 9606.ENSP00000356405:292, 9606.ENSP00000448012:292, 9606.ENSP00000451828:206, 9606.ENSP00000393312:748, 9606.ENSP00000466134:224, 9606.ENSP00000367615:179, 9606.ENSP00000452762:258, 9606.ENSP00000345708:712",0.5,245.082,163.164,41.1235789568159,cur_506
LHX1,6593,2,1.2680722891566265,NULL,NULL,NULL,NULL,NULL,NULL,NULL,P:0; LP:0; VUS:9,NULL,NULL,NULL,hm (true); ht (true),0,336,0.0880503144654088,9606.ENSP00000357283:336,0.5,8.880889999999999,8.92517,132.825112110027,cur_507
LPIN1,13345,3,1.7050475905472224,NULL,NULL,NULL,NULL,"Myoglobinuria, acute recurrent, autosomal recessive[OMIM:268200]-Autosomal recessive inheritance","Definitive, Definitive, Strong, Strong (myoglobinuria, acute recurrent, autosomal recessive[MONDO:0009992]-Autosomal recessive) | Supportive (hereditary recurrent myoglobinuria[MONDO:0020504]-Autosomal dominant)","Definitive (myoglobinuria, acute recurrent, autosomal recessive[MONDO:0009992]-AR)",P:23; LP:7; VUS:238,OMIM:268200 (complement: 0.143 | glomerulopathy: 0.009 | nephrocalcinosis: 0.007 | tubulopathy: 0.007 | cyst_cilio: 0.003),OMIM:268200 (neonatal_or_pediatric: 0.463),OMIM:268200 (syndromic: 0.008 | neurologic: 0.016),hm (false); ht (false),0.5,3031,0.5618448637316562,"9606.ENSP00000312987:667, 9606.ENSP00000231509:408, 9606.ENSP00000360761:338, 9606.ENSP00000354032:349, 9606.ENSP00000347244:208, 9606.ENSP00000287820:769, 9606.ENSP00000356319:292",0.5,14.1999,7.7907,61.1686300545022,cur_508
MASP1,6901,3,1.6131548716069308,0,0.68479,1.6556,-0.16024,3MC syndrome 1[OMIM:257920]-Autosomal recessive inheritance,"Definitive, Strong (3MC syndrome 1[MONDO:0009770]-Autosomal recessive) | Supportive (3MC syndrome[MONDO:0017398]-Autosomal recessive)",NULL,P:12; LP:6; VUS:89,OMIM:257920 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),NULL,OMIM:257920 (syndromic: 0.073 | growth: 0.125 | skeletal: 0.078 | neurologic: 0.076),hm (false); ht (false),0.5,2103,0.42557651991614254,"9606.ENSP00000366307:542, 9606.ENSP00000245907:676, 9606.ENSP00000396688:345, 9606.ENSP00000356399:540",0,0.634608,0.8419469999999999,3.50449129259723,cur_509
MNX1,4979,3,1.4112608778656317,0.78819,0.10538,2.5537,0.73106,Currarino syndrome[OMIM:176450]-Autosomal dominant inheritance,"Definitive, Strong, Supportive (Currarino triad[MONDO:0008305]-Autosomal dominant) | Strong (Currarino triad[MONDO:0008305]-Autosomal recessive) | Strong (neonatal diabetes mellitus[MONDO:0016391]-Autosomal recessive) | Strong (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal recessive)",NULL,P:26; LP:4; VUS:111,OMIM:176450 (cakut: 0.093 | cancer: 0.09 | cyst_cilio: 0.018 | glomerulopathy: 0.009),OMIM:176450 (antenatal_or_congenital: 0.821),OMIM:176450 (syndromic: 0.025 | skeletal: 0.001 | neurologic: 0.051),hm (false); ht (false),0,NULL,NULL,NULL,0,0.0989348,0.039473,0.58725942234751,cur_510
MT-TL1,7490,2,1.5235636785959414,NULL,NULL,NULL,NULL,NULL,Limited (Leigh syndrome[MONDO:0009723]-Mitochondrial) | Strong (maternally-inherited diabetes and deafness[MONDO:0010785]-Mitochondrial) | Definitive (mitochondrial disease[MONDO:0044970]-Mitochondrial),Limited (Leigh syndrome[MONDO:0009723]-MT) | Definitive (mitochondrial disease[MONDO:0044970]-MT),P:6; LP:10; VUS:12,NULL,NULL,NULL,hm (NA); ht (NA),0,NULL,NULL,NULL,0,6.54041,19.2624,NULL,cur_511
MVK,7530,3,1.63600601224932,0.16679,0.25909,3.0161,0.94087,"Hyper-IgD syndrome[OMIM:260920]-Autosomal recessive inheritance | Porokeratosis 3, multiple types[OMIM:175900]-Autosomal dominant inheritance | Mevalonic aciduria[OMIM:610377]-Autosomal recessive inheritance","Definitive, Supportive (hyperimmunoglobulinemia D with periodic fever[MONDO:0009849]-Autosomal recessive) | Supportive (mevalonic aciduria[MONDO:0012481]-Autosomal recessive) | Definitive (mevalonic aciduria[MONDO:0012481]-Mitochondrial) | Strong, Supportive (porokeratosis of Mibelli[MONDO:0019141]-Autosomal dominant) | Supportive (disseminated superficial actinic porokeratosis[MONDO:0019212]-Autosomal dominant)",NULL,P:49; LP:38; VUS:182,OMIM:260920 (cancer: 0.01 | cyst_cilio: 0.005),OMIM:175900 (neonatal_or_pediatric: 0.2); OMIM:260920 (neonatal_or_pediatric: 0.402); OMIM:610377 (neonatal_or_pediatric: 0.402),OMIM:260920 (syndromic: 0.003 | skeletal: 0.003 | neurologic: 0.004); OMIM:610377 (syndromic: 0.1 | growth: 0.432 | skeletal: 0.065 | neurologic: 0.134),hm (NA); ht (NA),0,NULL,NULL,NULL,0,33.4165,17.654,6.61516910693293,cur_512
MYCN,7559,2,1.2158539209945671,0.88897,0.086748,2.8733,1.4064,Feingold syndrome 1[OMIM:164280]-Autosomal dominant inheritance,"Definitive, Definitive, Strong, Supportive (Feingold syndrome type 1[MONDO:0008115]-Autosomal dominant)",NULL,P:36; LP:27; VUS:58,NULL,OMIM:164280 (antenatal_or_congenital: 0.821),OMIM:164280 (syndromic: 0.084 | skeletal: 0.088 | neurologic: 0.077),hm (true); ht (true),0.5,6679,0.8155136268343816,"9606.ENSP00000408292:292, 9606.ENSP00000216911:990, 9606.ENSP00000481646:161, 9606.ENSP00000368632:161, 9606.ENSP00000410294:268, 9606.ENSP00000245907:161, 9606.ENSP00000348984:161, 9606.ENSP00000414398:161, 9606.ENSP00000261167:161, 9606.ENSP00000424757:161, 9606.ENSP00000364649:161, 9606.ENSP00000360532:161, 9606.ENSP00000392028:368, 9606.ENSP00000264414:161, 9606.ENSP00000306320:161, 9606.ENSP00000451828:499, 9606.ENSP00000348849:161, 9606.ENSP00000315569:161, 9606.ENSP00000308938:161, 9606.ENSP00000261267:161, 9606.ENSP00000216181:161, 9606.ENSP00000297185:161, 9606.ENSP00000361512:161, 9606.ENSP00000358866:161, 9606.ENSP00000298556:161, 9606.ENSP00000470972:161, 9606.ENSP00000463784:161, 9606.ENSP00000414321:161, 9606.ENSP00000246062:161, 9606.ENSP00000359345:161, 9606.ENSP00000357283:237",0.5,1.41141,1.02029,31.0895463052084,cur_513
NEUROD1,7762,2,1.5345751844876188,0.77109,0.1084,2.5095,0.23293,"{Type 2 diabetes mellitus, susceptibility to}[OMIM:125853]-Autosomal dominant inheritance | Maturity-onset diabetes of the young 6[OMIM:606394]-NA",Strong (maturity-onset diabetes of the young type 6[MONDO:0011668]-Autosomal dominant) | Strong (maturity-onset diabetes of the young type 6[MONDO:0011668]-Autosomal recessive) | Strong (permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome[MONDO:0012192]-Autosomal recessive) | Limited (monogenic diabetes[MONDO:0015967]-Autosomal dominant) | Moderate (monogenic diabetes[MONDO:0015967]-Autosomal recessive) | Supportive (maturity-onset diabetes of the young[MONDO:0018911]-Autosomal dominant) | Limited (retinitis pigmentosa[MONDO:0019200]-Autosomal recessive),Limited (monogenic diabetes[MONDO:0015967]-AD) | Moderate (monogenic diabetes[MONDO:0015967]-AR),P:2; LP:0; VUS:154,NULL,OMIM:125853 (adult: 0.108),OMIM:125853 (syndromic: 0.001 | growth: 0.011),hm (true); ht (false),0.5,1594,0.35639412997903563,"9606.ENSP00000227507:292, 9606.ENSP00000413720:564, 9606.ENSP00000371398:410, 9606.ENSP00000262367:328",0,0.00841603,0,0.15968243677851,cur_514
NF1,7765,4,2.3454592096543245,0.90175,0.21503,8.7339,6.5427,"Watson syndrome[OMIM:193520]-Autosomal dominant inheritance | Leukemia, juvenile myelomonocytic[OMIM:607785]-Autosomal dominant inheritance | Leukemia, juvenile myelomonocytic[OMIM:607785]-Somatic mutation | Neurofibromatosis, familial spinal[OMIM:162210]-Autosomal dominant inheritance | Neurofibromatosis, type 1[OMIM:162200]-Autosomal dominant inheritance | Neurofibromatosis-Noonan syndrome[OMIM:601321]-Autosomal dominant inheritance","Definitive (neurofibromatosis, familial spinal[MONDO:0008078]-Autosomal dominant) | Definitive (Watson syndrome[MONDO:0008672]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (neurofibromatosis-Noonan syndrome[MONDO:0011035]-Autosomal dominant) | No Known Disease Relationship (familial ovarian cancer[MONDO:0016248]-Autosomal dominant) | Moderate (Moyamoya disease[MONDO:0016820]-Autosomal dominant) | Supportive (hereditary pheochromocytoma-paraganglioma[MONDO:0017366]-Autosomal dominant) | Definitive, Definitive, Definitive, Strong (neurofibromatosis type 1[MONDO:0018975]-Autosomal dominant)",No Known Disease Relationship (familial ovarian cancer[MONDO:0016248]-AD) | Definitive (neurofibromatosis type 1[MONDO:0018975]-AD),P:3242; LP:761; VUS:4606,OMIM:162200 (cancer: 0.04 | cakut: 0.008 | cyst_cilio: 0.005),OMIM:162200 (neonatal_or_pediatric: 0.665); OMIM:162210 (adult: 0.575); OMIM:193520 (antenatal_or_congenital: 0.821),OMIM:162200 (syndromic: 0.063 | growth: 0.26 | skeletal: 0.069 | neurologic: 0.062); OMIM:162210 (syndromic: 0.001 | neurologic: 0.001); OMIM:193520 (syndromic: 0.022 | growth: 0.25 | skeletal: 0.009 | neurologic: 0.001); OMIM:601321 (syndromic: 0.118 | growth: 0.25 | skeletal: 0.09 | neurologic: 0.114),hm (true); ht (false),0.5,1900,0.39622641509433965,"9606.ENSP00000256078:840, 9606.ENSP00000231509:165, 9606.ENSP00000451828:311, 9606.ENSP00000356319:292, 9606.ENSP00000339191:292",0.5,4.4294199999999995,3.42215,501.676370723154,cur_515
NR0B1,7960,2,1.1689330543933054,0.97025,0,3.0554,1.0824,"Adrenal hypoplasia, congenital[OMIM:300200]-X-linked recessive inheritance | 46XY sex reversal 2, dosage-sensitive[OMIM:300018]-X-linked inheritance","Moderate (46,XY sex reversal 2[MONDO:0010226]-X-linked) | Definitive, Definitive, Definitive, Strong, Supportive (X-linked adrenal hypoplasia congenita[MONDO:0010264]-X-linked)",NULL,P:91; LP:17; VUS:35,NULL,OMIM:300200 (neonatal_or_pediatric: 0.999 | adult: 0.372),OMIM:300200 (syndromic: 0.01 | growth: 0.191),hm (false); ht (false),0.5,3988,0.6645702306079665,"9606.ENSP00000245479:382, 9606.ENSP00000262426:347, 9606.ENSP00000348849:720, 9606.ENSP00000287820:638, 9606.ENSP00000231509:229, 9606.ENSP00000308938:319, 9606.ENSP00000379258:382, 9606.ENSP00000287538:190, 9606.ENSP00000217086:781",0,15.2233,11.7231,0.102040572811228,cur_516
NRIP1,8001,2,1.221470948211456,NULL,NULL,NULL,NULL,?Congenital anomalies of kidney and urinary tract 3[OMIM:618270]-Autosomal dominant inheritance,Limited (congenital anomalies of kidney and urinary tract 3[MONDO:0032646]-Autosomal dominant),NULL,P:1; LP:0; VUS:76,OMIM:618270 (cakut: 0.242 | cancer: 0.11 | cyst_cilio: 0.058 | glomerulopathy: 0.007 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:618270 (antenatal_or_congenital: 0.86 | neonatal_or_pediatric: 0.463 | adult: 0.108),NULL,hm (false); ht (false),0,NULL,NULL,NULL,0.5,4.41461,3.9266099999999997,275.997144402545,cur_517
NSD1,14234,3,1.63600601224932,1,0.045197,9.306,3.4113,Sotos syndrome[OMIM:117550]-Autosomal dominant inheritance,"Definitive, Definitive, Strong, Strong (Sotos syndrome 1[MONDO:0007299]-Autosomal dominant) | Definitive (Beckwith-Wiedemann syndrome[MONDO:0007534]-Autosomal dominant) | Definitive (Weaver syndrome[MONDO:0010193]-Autosomal dominant) | Definitive, Supportive (Sotos syndrome[MONDO:0019349]-Autosomal dominant)",Definitive (Sotos syndrome[MONDO:0019349]-AD),P:409; LP:153; VUS:485,OMIM:117550 (cyst_cilio: 0.018 | cancer: 0.01 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:117550 (neonatal_or_pediatric: 0.397 | antenatal_or_congenital: 0.077),OMIM:117550 (syndromic: 0.181 | growth: 0.024 | skeletal: 0.102 | neurologic: 0.223),hm (false); ht (false),0,NULL,NULL,NULL,0.5,7.82755,5.624630000000001,280.876583387707,cur_518
NSDHL,13398,3,1.589085145648058,0.96393,0,2.9798,0.86892,CK syndrome[OMIM:300831]-X-linked recessive inheritance | CHILD syndrome[OMIM:308050]-X-linked dominant inheritance,"Definitive, Strong, Moderate, Supportive (CK syndrome[MONDO:0010441]-X-linked) | Definitive (CK syndrome[MONDO:0010441]-X-linked recessive) | Definitive, Strong, Strong, Supportive (CHILD syndrome[MONDO:0010621]-X-linked) | Definitive (CHILD syndrome[MONDO:0010621]-X-linked dominant)",Moderate (CK syndrome[MONDO:0010441]-XL),P:12; LP:8; VUS:52,OMIM:308050 (cakut: 0.121 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | tubulopathy: 0.007 | glomerulopathy: 0.002),OMIM:308050 (antenatal_or_congenital: 0.821),OMIM:300831 (syndromic: 0.15 | growth: 0.006 | skeletal: 0.153 | neurologic: 0.201); OMIM:308050 (syndromic: 0.051 | growth: 0.251 | skeletal: 0.095 | neurologic: 0.006),hm (false); ht (false),0.5,2383,0.469601677148847,"9606.ENSP00000357048:181, 9606.ENSP00000437256:179, 9606.ENSP00000359345:343, 9606.ENSP00000463784:238, 9606.ENSP00000470972:335, 9606.ENSP00000414321:343, 9606.ENSP00000231509:165, 9606.ENSP00000348849:345, 9606.ENSP00000481646:254",0.5,15.1785,10.0261,11.4373111669534,cur_519
OPLAH,8149,3,1.889714616775644,NULL,NULL,NULL,NULL,5-oxoprolinase deficiency[OMIM:260005]-Autosomal dominant inheritance | 5-oxoprolinase deficiency[OMIM:260005]-Autosomal recessive inheritance,"Strong, Supportive (5-oxoprolinase deficiency[MONDO:0009825]-Autosomal recessive)",NULL,P:12; LP:5; VUS:183,OMIM:260005 (tubulopathy: 0.028 | nephrocalcinosis: 0.021),NULL,NULL,hm (NA); ht (NA),0,NULL,NULL,NULL,0,21.6194,16.384,3.47188231371209,cur_520
PALB2,26144,2,1.144897225638441,0,0.75888,1.5174,0.27604,"{Breast-ovarian cancer, familial, susceptibility to, 5}[OMIM:620442]-Autosomal dominant inheritance | {Pancreatic cancer, susceptibility to, 3}[OMIM:613348]-NA | Fanconi anemia, complementation group N[OMIM:610832]-NA","Definitive, Definitive, Strong (Fanconi anemia complementation group N[MONDO:0012565]-Autosomal recessive) | Strong (pancreatic cancer, susceptibility to, 3[MONDO:0013236]-Autosomal dominant) | Moderate (familial ovarian cancer[MONDO:0016248]-Autosomal dominant) | Definitive, Definitive (hereditary breast carcinoma[MONDO:0016419]-Autosomal dominant) | Limited (hereditary nonpolyposis colon cancer[MONDO:0018630]-Autosomal dominant) | Strong, Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (Fanconi anemia complementation group N[MONDO:0012565]-AR) | Moderate (familial ovarian cancer[MONDO:0016248]-AD) | Definitive (hereditary breast carcinoma[MONDO:0016419]-AD) | Limited (hereditary nonpolyposis colon cancer[MONDO:0018630]-AD),P:860; LP:257; VUS:2547,OMIM:610832 (cancer: 0.12 | complement: 0.036 | cakut: 0.008 | glomerulopathy: 0.007),NULL,OMIM:610832 (syndromic: 0.027 | growth: 0.034 | skeletal: 0.066 | neurologic: 0.03),hm (false); ht (false),0.5,5965,0.7819706498951782,"9606.ENSP00000414398:171, 9606.ENSP00000287647:906, 9606.ENSP00000337088:169, 9606.ENSP00000310842:879, 9606.ENSP00000336701:969, 9606.ENSP00000369497:999, 9606.ENSP00000354721:179, 9606.ENSP00000472847:343, 9606.ENSP00000262210:179, 9606.ENSP00000421491:540, 9606.ENSP00000463784:339, 9606.ENSP00000264414:292",0.5,4.1814599999999995,2.58032,21.1767485839565,cur_521
PDSS1,17759,2,1.2158539209945671,0,0.61088,1.8454,1.3191,"Coenzyme Q10 deficiency, primary, 2[OMIM:614651]-Autosomal recessive inheritance","Strong, Strong, Moderate, Supportive (deafness-encephaloneuropathy-obesity-valvulopathy syndrome[MONDO:0013837]-Autosomal recessive)",NULL,P:7; LP:3; VUS:113,NULL,OMIM:614651 (neonatal_or_pediatric: 0.262),OMIM:614651 (syndromic: 0.015 | growth: 0.047 | skeletal: 0.015 | neurologic: 0.017),hm (NA); ht (NA),0.5,965,0.22641509433962265,9606.ENSP00000358033:965,0.5,4.22905,3.9843900000000003,33.5290845390505,cur_522
PDX1,6107,2,1.58531661173507,0.017775,0.46026,1.4745,-0.26592,"{Diabetes mellitus, type II, susceptibility to}[OMIM:125853]-Autosomal dominant inheritance | Pancreatic agenesis 1[OMIM:260370]-Autosomal recessive inheritance | MODY, type IV[OMIM:606392]-NA","Supportive (pancreatic agenesis[MONDO:0009832]-Autosomal recessive) | Definitive, Strong (maturity-onset diabetes of the young type 4[MONDO:0011667]-Autosomal dominant) | Strong (maturity-onset diabetes of the young type 4[MONDO:0011667]-Autosomal recessive) | Moderate (monogenic diabetes[MONDO:0015967]-Autosomal dominant) | Supportive (maturity-onset diabetes of the young[MONDO:0018911]-Autosomal dominant) | Definitive, Strong, Moderate (pancreatic agenesis 1[MONDO:0024547]-Autosomal recessive) | Supportive (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal dominant) | Strong (permanent neonatal diabetes mellitus[MONDO:0100164]-Autosomal recessive)",Moderate (monogenic diabetes[MONDO:0015967]-AD) | Definitive (pancreatic agenesis 1[MONDO:0024547]-AR),P:3; LP:8; VUS:56,NULL,OMIM:125853 (adult: 0.108); OMIM:260370 (antenatal_or_congenital: 0.899),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:260370 (syndromic: 0.015 | growth: 0.273),hm (false); ht (false),0.5,1246,0.29559748427672955,"9606.ENSP00000405890:791, 9606.ENSP00000262426:455",0,0.013296200000000001,0,0.156502242313872,cur_523
PEX6,8859,2,1.6651718619256537,6e-6,0.42072,3.2052,1.442,Peroxisome biogenesis disorder 4B[OMIM:614863]-Autosomal dominant inheritance | Peroxisome biogenesis disorder 4B[OMIM:614863]-Autosomal recessive inheritance | Peroxisome biogenesis disorder 4A (Zellweger)[OMIM:614862]-Autosomal recessive inheritance | Heimler syndrome 2[OMIM:616617]-Autosomal recessive inheritance,"Supportive (autosomal recessive cerebellar ataxia-blindness-deafness syndrome[MONDO:0010061]-Autosomal recessive) | Definitive, Definitive (peroxisome biogenesis disorder 4A (Zellweger)[MONDO:0013930]-Autosomal recessive) | Definitive (peroxisome biogenesis disorder 4B[MONDO:0013931]-Autosomal recessive) | Definitive (peroxisome biogenesis disorder[MONDO:0019234]-Autosomal recessive) | Supportive (Zellweger spectrum disorders[MONDO:0019609]-Autosomal recessive)",Definitive (peroxisome biogenesis disorder[MONDO:0019234]-AR),P:117; LP:89; VUS:532,OMIM:614862 (cyst_cilio: 0.092 | cakut: 0.044 | cancer: 0.03 | glomerulopathy: 0.007 | tubulopathy: 0.007),OMIM:614862 (neonatal_or_pediatric: 0.134),OMIM:614862 (syndromic: 0.03 | skeletal: 0.001 | neurologic: 0.041); OMIM:614863 (syndromic: 0.081 | skeletal: 0.015 | neurologic: 0.154); OMIM:616617 (syndromic: 0.026 | skeletal: 0.002 | neurologic: 0.051),hm (NA); ht (NA),0,525,0.1320754716981132,"9606.ENSP00000368632:364, 9606.ENSP00000359583:161",0.5,5.4084699999999994,5.30134,28.4950885889238,cur_524
PGK1,8896,2,1.1309261498321586,0.76537,0.14777,2.9054,0.33828,Phosphoglycerate kinase 1 deficiency[OMIM:300653]-X-linked recessive inheritance,"Definitive, Strong, Strong, Supportive (glycogen storage disease due to phosphoglycerate kinase 1 deficiency[MONDO:0010392]-X-linked) | Definitive (glycogen storage disease due to phosphoglycerate kinase 1 deficiency[MONDO:0010392]-X-linked recessive)",NULL,P:13; LP:5; VUS:79,OMIM:300653 (nephrocalcinosis: 0.111 | tubulopathy: 0.105 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:300653 (neonatal_or_pediatric: 0.2),OMIM:300653 (syndromic: 0.082 | neurologic: 0.172),hm (false); ht (false),0.5,3784,0.6519916142557652,"9606.ENSP00000466134:321, 9606.ENSP00000357048:156, 9606.ENSP00000358866:343, 9606.ENSP00000262418:282, 9606.ENSP00000216181:224, 9606.ENSP00000362424:292, 9606.ENSP00000357283:221, 9606.ENSP00000361021:329, 9606.ENSP00000311505:292, 9606.ENSP00000205557:292, 9606.ENSP00000445175:188, 9606.ENSP00000355518:186, 9606.ENSP00000308938:658",0.5,112.883,90.1344,65.7036569603965,cur_525
PHGDH,8923,2,1.3151013436263954,NULL,NULL,NULL,NULL,Neu-Laxova syndrome 1[OMIM:256520]-Autosomal recessive inheritance | Phosphoglycerate dehydrogenase deficiency[OMIM:601815]-Autosomal recessive inheritance,"Supportive (Neu-Laxova syndrome[MONDO:0000179]-Autosomal recessive) | Definitive, Strong, Supportive (PHGDH deficiency[MONDO:0011152]-Autosomal recessive) | Definitive (neurometabolic disorder due to serine deficiency[MONDO:0018162]-Autosomal recessive)",Definitive (neurometabolic disorder due to serine deficiency[MONDO:0018162]-AR),P:48; LP:22; VUS:248,OMIM:256520 (cancer: 0.05 | cakut: 0.044 | cyst_cilio: 0.008),OMIM:256520 (antenatal_or_congenital: 0.821),OMIM:256520 (syndromic: 0.054 | growth: 0.102 | skeletal: 0.08 | neurologic: 0.034); OMIM:601815 (syndromic: 0.049 | growth: 0.091 | skeletal: 0.006 | neurologic: 0.09),hm (false); ht (false),0,NULL,NULL,NULL,0.5,17.6418,11.0479,57.7252968924288,cur_526
PKHD1L1,20313,2,1.193002780352178,0,0.93233,0.85665,-0.7193,NULL,NULL,NULL,P:0; LP:0; VUS:156,NULL,NULL,NULL,hm (false); ht (false),0,NULL,NULL,NULL,0,0.204294,0.660917,1.76059578612734,cur_527
PLG,9071,3,2.067538884558071,0.010345,0.27851,4.5678,0.21339,"Dysplasminogenemia[OMIM:217090]-Autosomal recessive inheritance | Angioedema, hereditary, 4[OMIM:619360]-Autosomal dominant inheritance | Plasminogen deficiency, type I[OMIM:217090]-Autosomal recessive inheritance","Definitive, Strong, Supportive (hypoplasminogenemia[MONDO:0009009]-Autosomal recessive)",Definitive (hypoplasminogenemia[MONDO:0009009]-AR),P:11; LP:1; VUS:101,OMIM:217090 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | glomerulopathy: 0.027 | cakut: 0.012 | cancer: 0.01 | cyst_cilio: 0.008),OMIM:217090 (neonatal_or_pediatric: 0.402 | antenatal_or_congenital: 0.028); OMIM:619360 (adult: 0.372),OMIM:217090 (syndromic: 0.021 | skeletal: 0.019 | neurologic: 0.028); OMIM:619360 (syndromic: 0),hm (true); ht (false),0.5,3690,0.6415094339622641,"9606.ENSP00000281043:161, 9606.ENSP00000356405:292, 9606.ENSP00000346839:986, 9606.ENSP00000366307:411, 9606.ENSP00000362413:658, 9606.ENSP00000294304:186, 9606.ENSP00000368253:319, 9606.ENSP00000245907:410, 9606.ENSP00000396688:267",0,3.6377900000000003,19.1513,0.285255118863967,cur_528
POMC,9201,2,1.4611275477869698,NULL,NULL,NULL,NULL,"{Obesity, early-onset, susceptibility to}[OMIM:601665]-Autosomal dominant inheritance | {Obesity, early-onset, susceptibility to}[OMIM:601665]-Autosomal recessive inheritance | {Obesity, early-onset, susceptibility to}[OMIM:601665]-Multifactorial inheritance | Obesity, adrenal insufficiency, and red hair due to POMC deficiency[OMIM:609734]-Autosomal recessive inheritance","Strong, Strong, Moderate, Supportive (obesity due to pro-opiomelanocortin deficiency[MONDO:0012335]-Autosomal recessive) | Limited (inherited obesity[MONDO:0019182]-Autosomal dominant) | Strong (inherited obesity[MONDO:0019182]-Semidominant)",NULL,P:13; LP:2; VUS:57,NULL,OMIM:609734 (neonatal_or_pediatric: 0.537),OMIM:601665 (syndromic: 0.003 | growth: 0.054); OMIM:609734 (syndromic: 0.004 | growth: 0.043 | neurologic: 0.004),hm (true); ht (false),0.5,3078,0.570230607966457,"9606.ENSP00000078429:499, 9606.ENSP00000312652:813, 9606.ENSP00000245907:185, 9606.ENSP00000360141:356, 9606.ENSP00000396688:185, 9606.ENSP00000420194:218, 9606.ENSP00000330393:183, 9606.ENSP00000269305:225, 9606.ENSP00000361021:414",0,4.61684,2.01574,3.63868088629211,cur_529
PRODH,9453,2,0.9911087866108786,0,0.76372,1.1481,0.064942,"{Schizophrenia, susceptibility to, 4}[OMIM:600850]-Autosomal dominant inheritance | Hyperprolinemia, type I[OMIM:239500]-Autosomal recessive inheritance","Definitive, Definitive, Strong, Supportive (hyperprolinemia type 1[MONDO:0009400]-Autosomal recessive)",Definitive (hyperprolinemia type 1[MONDO:0009400]-AR),P:10; LP:1; VUS:118,NULL,NULL,OMIM:239500 (syndromic: 0.095 | neurologic: 0.2); OMIM:600850 (syndromic: 0 | neurologic: 0.001),hm (true); ht (false),0,NULL,NULL,NULL,0,24.1727,8.12697,2.50419816082543,cur_530
PROKR2,15836,3,1.6490865199876117,NULL,NULL,NULL,NULL,Hypogonadotropic hypogonadism 3 with or without anosmia[OMIM:244200]-Autosomal dominant inheritance,"Supportive (septooptic dysplasia[MONDO:0008428]-Autosomal dominant) | Definitive, Definitive, Strong (hypogonadotropic hypogonadism 3 with or without anosmia[MONDO:0009482]-Autosomal dominant) | Supportive (hypogonadotropic hypogonadism[MONDO:0018555]-Autosomal dominant) | Limited, Supportive (Kallmann syndrome[MONDO:0018800]-Autosomal dominant)",Definitive (hypogonadotropic hypogonadism 3 with or without anosmia[MONDO:0009482]-AD),P:4; LP:5; VUS:43,OMIM:244200 (cakut: 0.048 | cancer: 0.02 | tubulopathy: 0.007 | cyst_cilio: 0.005),NULL,OMIM:244200 (syndromic: 0.031 | skeletal: 0.012 | neurologic: 0.044),hm (false); ht (false),0,276,0.06079664570230608,9606.ENSP00000262648:276,0,0,0,0.0188260321984597,cur_531
PRPS1,9462,3,2.801023073982811,0.91542,0,2.6104,3.7321,"Arts syndrome[OMIM:301835]-X-linked recessive inheritance | Phosphoribosylpyrophosphate synthetase superactivity[OMIM:300661]-X-linked recessive inheritance | Charcot-Marie-Tooth disease, X-linked recessive, 5[OMIM:311070]-X-linked recessive inheritance | Deafness, X-linked 1[OMIM:304500]-X-linked inheritance | Gout, PRPS-related[OMIM:300661]-X-linked recessive inheritance","Definitive, Limited (phosphoribosylpyrophosphate synthetase superactivity[MONDO:0010395]-X-linked) | Definitive (phosphoribosylpyrophosphate synthetase superactivity[MONDO:0010395]-X-linked recessive) | Definitive, Strong, Supportive (Arts syndrome[MONDO:0010533]-X-linked) | Definitive (Arts syndrome[MONDO:0010533]-X-linked recessive) | Definitive, Strong (hearing loss, X-linked 1[MONDO:0010577]-X-linked) | Definitive (hearing loss, X-linked 1[MONDO:0010577]-X-linked recessive) | Definitive, Strong, Supportive (Charcot-Marie-Tooth disease X-linked recessive 5[MONDO:0010699]-X-linked) | Definitive (Charcot-Marie-Tooth disease X-linked recessive 5[MONDO:0010699]-X-linked recessive) | Supportive (mild phosphoribosylpyrophosphate synthetase superactivity[MONDO:0018463]-X-linked) | Supportive (severe phosphoribosylpyrophosphate synthetase superactivity[MONDO:0018464]-X-linked) | Supportive (X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome[MONDO:0018495]-X-linked) | Supportive (X-linked nonsyndromic hearing loss[MONDO:0019586]-X-linked) | Definitive, Definitive (PRPS1 deficiency disorder[MONDO:0100061]-X-linked)",Limited (phosphoribosylpyrophosphate synthetase superactivity[MONDO:0010395]-XL) | Definitive (PRPS1 deficiency disorder[MONDO:0100061]-XL),P:22; LP:16; VUS:77,OMIM:300661 (nephrocalcinosis: 0.132 | tubulopathy: 0.112 | glomerulopathy: 0.082 | complement: 0.071 | cyst_cilio: 0.068 | cakut: 0.04 | cancer: 0.02),OMIM:300661 (antenatal_or_congenital: 0.821); OMIM:311070 (neonatal_or_pediatric: 0.262),OMIM:300661 (syndromic: 0.116 | growth: 0.296 | skeletal: 0.001 | neurologic: 0.132); OMIM:301835 (syndromic: 0.101 | growth: 0.091 | neurologic: 0.198); OMIM:311070 (syndromic: 0.014 | neurologic: 0.03),hm (false); ht (false),0,602,0.1509433962264151,"9606.ENSP00000246868:206, 9606.ENSP00000281043:161, 9606.ENSP00000361186:235",0.5,19.2324,14.9899,11.2086226713142,cur_532
PTPN11,9644,3,1.4112608778656317,0.99998,0.028439,5.3387,3.1293,"Noonan syndrome 1[OMIM:163950]-Autosomal dominant inheritance | LEOPARD syndrome 1[OMIM:151100]-Autosomal dominant inheritance | Metachondromatosis[OMIM:156250]-Autosomal dominant inheritance | Leukemia, juvenile myelomonocytic, somatic[OMIM:607785]-NA","Definitive, Supportive (Noonan syndrome with multiple lentigines[MONDO:0007893]-Autosomal dominant) | Strong, Supportive (metachondromatosis[MONDO:0007979]-Autosomal dominant) | Definitive, Definitive, Definitive, Definitive, Strong (Noonan syndrome 1[MONDO:0008104]-Autosomal dominant) | Disputed Evidence (Costello syndrome[MONDO:0009026]-Autosomal dominant) | Disputed Evidence (cardiofaciocutaneous syndrome[MONDO:0015280]-Autosomal dominant) | Definitive, Supportive (Noonan syndrome[MONDO:0018997]-Autosomal dominant) | Definitive (Noonan syndrome and Noonan-related syndrome[MONDO:0020297]-Autosomal dominant) | Definitive, Definitive, Strong (LEOPARD syndrome 1[MONDO:0100082]-Autosomal dominant)",Definitive (Noonan syndrome with multiple lentigines[MONDO:0007893]-AD) | Disputed (Costello syndrome[MONDO:0009026]-AD) | Disputed (cardiofaciocutaneous syndrome[MONDO:0015280]-AD) | Definitive (Noonan syndrome[MONDO:0018997]-AD),P:132; LP:73; VUS:318,OMIM:151100 (cakut: 0.048 | cancer: 0.02 | tubulopathy: 0.007 | cyst_cilio: 0.005),NULL,OMIM:151100 (syndromic: 0.053 | growth: 0.271 | skeletal: 0.071 | neurologic: 0.008); OMIM:156250 (syndromic: 0.001 | skeletal: 0.002); OMIM:163950 (syndromic: 0.089 | growth: 0.294 | skeletal: 0.075 | neurologic: 0.04),hm (false); ht (false),0,NULL,NULL,NULL,0.5,NULL,NULL,92.9667208833833,cur_533
RAD51C,9820,2,1.1309261498321586,0,1.0269,-0.11019,0.12622,"{Breast-ovarian cancer, familial, susceptibility to, 3}[OMIM:613399]-NA | Fanconi anemia, complementation group O[OMIM:613390]-Autosomal recessive inheritance","Supportive (hereditary breast ovarian cancer syndrome[MONDO:0003582]-Autosomal dominant) | Strong, Moderate (Fanconi anemia complementation group O[MONDO:0013248]-Autosomal recessive) | Definitive, Strong, Limited (breast-ovarian cancer, familial, susceptibility to, 3[MONDO:0013253]-Autosomal dominant) | Definitive (familial ovarian cancer[MONDO:0016248]-Autosomal dominant) | Disputed Evidence (hereditary breast carcinoma[MONDO:0016419]-Autosomal dominant) | Moderate, Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",Definitive (familial ovarian cancer[MONDO:0016248]-AD) | Disputed (hereditary breast carcinoma[MONDO:0016419]-AD) | Moderate (Fanconi anemia[MONDO:0019391]-AR),P:170; LP:89; VUS:932,OMIM:613390 (cyst_cilio: 0.231 | cakut: 0.153 | glomerulopathy: 0.137 | cancer: 0.05 | tubulopathy: 0.049 | complement: 0.036 | nephrocalcinosis: 0.028),OMIM:613390 (antenatal_or_congenital: 0.821),OMIM:613390 (syndromic: 0.016 | growth: 0.25 | skeletal: 0.008),hm (false); ht (false),0.5,2840,0.5408805031446541,"9606.ENSP00000287647:222, 9606.ENSP00000310842:446, 9606.ENSP00000369497:867, 9606.ENSP00000385021:171, 9606.ENSP00000290167:165, 9606.ENSP00000261584:969",0.5,3.39235,2.0745,31.6916865772657,cur_534
RPL11,10301,3,1.4112608778656317,NULL,NULL,NULL,NULL,Diamond-Blackfan anemia 7[OMIM:612562]-Autosomal dominant inheritance,Strong (Diamond-Blackfan anemia 7[MONDO:0012938]-Autosomal dominant) | Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant),NULL,P:28; LP:8; VUS:36,OMIM:612562 (cakut: 0.093 | cancer: 0.09 | cyst_cilio: 0.018 | glomerulopathy: 0.009),NULL,OMIM:612562 (syndromic: 0.032 | growth: 0.193 | skeletal: 0.057),hm (false); ht (false),0,NULL,NULL,NULL,0.5,499.51099999999997,316.953,532.353372411126,cur_535
RPL26,10327,2,1.1309261498321586,NULL,NULL,NULL,NULL,?Diamond-Blackfan anemia 11[OMIM:614900]-Autosomal dominant inheritance,"Strong, Strong, Limited, Limited (Diamond-Blackfan anemia 11[MONDO:0013964]-Autosomal dominant) | Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant)",NULL,P:1; LP:0; VUS:23,OMIM:614900 (cakut: 0.048 | cancer: 0.02 | tubulopathy: 0.007 | cyst_cilio: 0.005),OMIM:614900 (antenatal_or_congenital: 0.028),OMIM:614900 (syndromic: 0.016 | growth: 0.25 | skeletal: 0.007),hm (NA); ht (NA),1,8796,0.8616352201257862,"9606.ENSP00000356319:292, 9606.ENSP00000470972:952, 9606.ENSP00000414321:904, 9606.ENSP00000359345:948, 9606.ENSP00000256078:165, 9606.ENSP00000265748:292, 9606.ENSP00000269305:775, 9606.ENSP00000348849:936, 9606.ENSP00000243253:901, 9606.ENSP00000245451:161, 9606.ENSP00000246868:246, 9606.ENSP00000359297:238, 9606.ENSP00000281043:161, 9606.ENSP00000229769:378, 9606.ENSP00000445122:238, 9606.ENSP00000481646:870, 9606.ENSP00000261584:339",0.5,439.967,273.899,206.638268264814,cur_536
RPL35A,10345,2,0.9911087866108786,NULL,NULL,NULL,NULL,Diamond-Blackfan anemia 5[OMIM:612528]-Autosomal dominant inheritance,"Strong, Strong (Diamond-Blackfan anemia 5[MONDO:0012925]-Autosomal dominant) | Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant)",NULL,P:5; LP:4; VUS:30,NULL,OMIM:612528 (neonatal_or_pediatric: 0.402),OMIM:612528 (syndromic: 0.038 | growth: 0.25 | neurologic: 0.051),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,279.17400000000004,172.984,431.95410987175,cur_537
RPL5,10360,2,0.9911087866108786,0.99776,0,3.9155,1.9019,Diamond-Blackfan anemia 6[OMIM:612561]-Autosomal dominant inheritance,"Definitive, Strong (Diamond-Blackfan anemia 6[MONDO:0012937]-Autosomal dominant) | Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant)",Definitive (Diamond-Blackfan anemia 6[MONDO:0012937]-AD),P:52; LP:17; VUS:77,NULL,NULL,OMIM:612561 (syndromic: 0.033 | growth: 0.262 | skeletal: 0.041),hm (false); ht (false),1,10023,0.8972746331236897,"9606.ENSP00000348984:185, 9606.ENSP00000371985:228, 9606.ENSP00000229769:497, 9606.ENSP00000246868:345, 9606.ENSP00000245451:161, 9606.ENSP00000359297:343, 9606.ENSP00000281043:161, 9606.ENSP00000215832:190, 9606.ENSP00000481646:930, 9606.ENSP00000445122:343, 9606.ENSP00000285379:342, 9606.ENSP00000356319:292, 9606.ENSP00000470972:966, 9606.ENSP00000463784:948, 9606.ENSP00000414321:966, 9606.ENSP00000269305:667, 9606.ENSP00000348849:967, 9606.ENSP00000265748:292, 9606.ENSP00000243253:908, 9606.ENSP00000256474:292",0.5,878.562,567.721,756.305712902649,cur_538
RPS10,10383,2,0.9911087866108786,NULL,NULL,NULL,NULL,Diamond-Blackfan anemia 9[OMIM:613308]-Autosomal dominant inheritance,"Strong, Strong, Strong (Diamond-Blackfan anemia 9[MONDO:0013216]-Autosomal dominant) | Definitive, Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant)",Definitive (Diamond-Blackfan anemia[MONDO:0015253]-AD),P:6; LP:2; VUS:37,NULL,OMIM:613308 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.603),OMIM:613308 (syndromic: 0.006 | growth: 0.091),hm (NA); ht (NA),1,8967,0.8679245283018868,"9606.ENSP00000348849:995, 9606.ENSP00000269305:361, 9606.ENSP00000417132:292, 9606.ENSP00000265748:292, 9606.ENSP00000216911:161, 9606.ENSP00000445122:254, 9606.ENSP00000243253:800, 9606.ENSP00000356405:292, 9606.ENSP00000356319:292, 9606.ENSP00000371985:175, 9606.ENSP00000357998:313, 9606.ENSP00000359345:930, 9606.ENSP00000229769:378, 9606.ENSP00000414321:993, 9606.ENSP00000281043:161, 9606.ENSP00000470972:996, 9606.ENSP00000463784:870, 9606.ENSP00000280481:158, 9606.ENSP00000359297:254",0.5,NULL,NULL,287.558314287479,cur_539
RPS19,10402,3,1.4112608778656317,0.92111,0,2.6432,1.4515,Diamond-Blackfan anemia 1[OMIM:105650]-Autosomal dominant inheritance,"Definitive, Definitive (Diamond-Blackfan anemia 1[MONDO:0007110]-Autosomal dominant) | Definitive, Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant)",Definitive (Diamond-Blackfan anemia[MONDO:0015253]-AD),P:44; LP:20; VUS:57,OMIM:105650 (cakut: 0.089 | cyst_cilio: 0.037 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:105650 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.799 | adult: 0.372),OMIM:105650 (syndromic: 0.133 | growth: 0.523 | skeletal: 0.119 | neurologic: 0.121),hm (false); ht (false),1,9144,0.8763102725366876,"9606.ENSP00000246957:286, 9606.ENSP00000216911:161, 9606.ENSP00000445122:335, 9606.ENSP00000215832:154, 9606.ENSP00000481646:996, 9606.ENSP00000281043:161, 9606.ENSP00000246868:345, 9606.ENSP00000359297:335, 9606.ENSP00000280481:190, 9606.ENSP00000229769:495, 9606.ENSP00000371985:228, 9606.ENSP00000243253:800, 9606.ENSP00000265748:292, 9606.ENSP00000348849:997, 9606.ENSP00000269305:163, 9606.ENSP00000414321:996, 9606.ENSP00000463784:952, 9606.ENSP00000359345:966, 9606.ENSP00000356319:292",0.5,203.025,130.452,296.0456613401,cur_540
RPS24,10411,2,0.9911087866108786,NULL,NULL,NULL,NULL,Diamond-blackfan anemia 3[OMIM:610629]-Autosomal dominant inheritance,"Definitive, Strong (Diamond-Blackfan anemia 3[MONDO:0012529]-Autosomal dominant) | Definitive, Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant)",Definitive (Diamond-Blackfan anemia[MONDO:0015253]-AD),P:9; LP:4; VUS:40,NULL,NULL,OMIM:610629 (syndromic: 0.001),hm (false); ht (false),1,8968,0.870020964360587,"9606.ENSP00000445122:343, 9606.ENSP00000360231:205, 9606.ENSP00000481646:993, 9606.ENSP00000280481:188, 9606.ENSP00000359297:343, 9606.ENSP00000246868:345, 9606.ENSP00000281043:161, 9606.ENSP00000229769:499, 9606.ENSP00000371985:228, 9606.ENSP00000243253:800, 9606.ENSP00000264499:161, 9606.ENSP00000265748:292, 9606.ENSP00000269305:256, 9606.ENSP00000348849:996, 9606.ENSP00000463784:904, 9606.ENSP00000470972:996, 9606.ENSP00000359345:966, 9606.ENSP00000356319:292",0.5,310.649,181.11599999999999,687.657343866046,cur_541
RPS26,10414,3,1.4112608778656317,NULL,NULL,NULL,NULL,Diamond-Blackfan anemia 10[OMIM:613309]-Autosomal dominant inheritance,"Definitive, Strong (Diamond-Blackfan anemia 10[MONDO:0013217]-Autosomal dominant) | Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant)",NULL,P:20; LP:9; VUS:27,OMIM:613309 (cancer: 0.06 | cakut: 0.02),OMIM:613309 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.665),OMIM:613309 (syndromic: 0.035 | growth: 0.341 | skeletal: 0.038),hm (false); ht (false),1,9571,0.8930817610062893,"9606.ENSP00000371985:228, 9606.ENSP00000356319:292, 9606.ENSP00000414321:996, 9606.ENSP00000281043:161, 9606.ENSP00000470972:997, 9606.ENSP00000359297:345, 9606.ENSP00000463784:936, 9606.ENSP00000280481:190, 9606.ENSP00000359345:967, 9606.ENSP00000229769:495, 9606.ENSP00000265748:292, 9606.ENSP00000368253:720, 9606.ENSP00000445122:345, 9606.ENSP00000215832:154, 9606.ENSP00000481646:995, 9606.ENSP00000269305:366, 9606.ENSP00000231509:292, 9606.ENSP00000243253:800",0.5,257.572,162.236,52.4861060511172,cur_542
RPS7,10440,2,0.9911087866108786,NULL,NULL,NULL,NULL,Diamond-Blackfan anemia 8[OMIM:612563]-Autosomal dominant inheritance,Strong (Diamond-Blackfan anemia 8[MONDO:0012939]-Autosomal dominant) | Supportive (Diamond-Blackfan anemia[MONDO:0015253]-Autosomal dominant),NULL,P:4; LP:3; VUS:55,NULL,NULL,OMIM:612563 (syndromic: 0.027 | growth: 0.341),hm (false); ht (false),0,NULL,NULL,NULL,0.5,716.528,475.108,121.498125011514,cur_543
SBDS,19440,2,1.113207349885096,6.2e-5,0.67954,1.0189,0.59266,"{Aplastic anemia, susceptibility to}[OMIM:609135]-NA | Shwachman-Diamond syndrome 1[OMIM:260400]-Autosomal recessive inheritance","Definitive, Supportive (Shwachman-Diamond syndrome[MONDO:0009833]-Autosomal recessive) | Definitive, Strong (Shwachman-Diamond syndrome 1[MONDO:0044204]-Autosomal recessive)",Definitive (Shwachman-Diamond syndrome[MONDO:0009833]-AR),P:17; LP:16; VUS:28,OMIM:260400 (nephrocalcinosis: 0.174 | tubulopathy: 0.126 | glomerulopathy: 0.018 | cancer: 0.01 | cakut: 0.008 | cyst_cilio: 0.003),NULL,OMIM:260400 (syndromic: 0.06 | growth: 0.467 | skeletal: 0.024 | neurologic: 0.058),hm (false); ht (false),0.5,2554,0.5031446540880503,"9606.ENSP00000361512:206, 9606.ENSP00000472847:192, 9606.ENSP00000264414:398, 9606.ENSP00000269305:292, 9606.ENSP00000414321:345, 9606.ENSP00000463784:246, 9606.ENSP00000334003:185, 9606.ENSP00000470972:345, 9606.ENSP00000359345:345",0.5,111.69,87.1094,18.3841573256811,cur_544
SEMA3E,10727,2,1.1689330543933054,NULL,NULL,NULL,NULL,NULL,Limited (CHARGE syndrome[MONDO:0008965]-Autosomal dominant) | Limited (Kallmann syndrome[MONDO:0018800]-Autosomal dominant),NULL,P:0; LP:2; VUS:225,NULL,NULL,NULL,hm (false); ht (false),0,NULL,NULL,NULL,0.5,0.0319406,0.0323349,10.4772284601548,cur_545
SETBP1,15573,2,0.9201520912547528,NULL,NULL,NULL,NULL,"Schinzel-Giedion midface retraction syndrome[OMIM:269150]-Autosomal dominant inheritance | Intellectual developmental disorder, autosomal dominant 29[OMIM:616078]-Autosomal dominant inheritance","Definitive, Definitive, Strong, Strong, Supportive (Schinzel-Giedion syndrome[MONDO:0010010]-Autosomal dominant) | Supportive (intellectual disability-expressive aphasia-facial dysmorphism syndrome[MONDO:0018574]-Autosomal dominant) | Definitive (complex neurodevelopmental disorder[MONDO:0100038]-Autosomal dominant)",Definitive (Schinzel-Giedion syndrome[MONDO:0010010]-AD) | Definitive (complex neurodevelopmental disorder[MONDO:0100038]-AD),P:57; LP:27; VUS:427,OMIM:269150 (cakut: 0.097 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:616078 (neonatal_or_pediatric: 0.402),OMIM:269150 (syndromic: 0.111 | growth: 0.205 | skeletal: 0.044 | neurologic: 0.12); OMIM:616078 (syndromic: 0.156 | growth: 0.043 | skeletal: 0.046 | neurologic: 0.217),hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,6.706930000000001,4.6469,618.575835372994,cur_546
SI,10856,3,1.4112608778656317,0,0.8802,1.1773,-1.0804,"Sucrase-isomaltase deficiency, congenital[OMIM:222900]-Autosomal recessive inheritance","Strong, Strong, Strong, Supportive (congenital sucrase-isomaltase deficiency[MONDO:0009114]-Autosomal recessive)",NULL,P:50; LP:25; VUS:497,OMIM:222900 (tubulopathy: 0.133 | nephrocalcinosis: 0.125 | cakut: 0.012 | glomerulopathy: 0.011 | cancer: 0.01 | cyst_cilio: 0.005),OMIM:222900 (neonatal_or_pediatric: 0.402),NULL,hm (true); ht (true),0.5,653,0.16771488469601678,"9606.ENSP00000368727:256, 9606.ENSP00000466134:397",0,0,0,1.20117584317813,cur_547
SLC16A12,23094,2,1.4037768389295835,0.49267,0.20931,3.2031,0.95055,"Cataract 47, juvenile, with microcornea[OMIM:612018]-Autosomal dominant inheritance","Strong, Supportive (juvenile cataract-microcornea-renal glucosuria syndrome[MONDO:0012786]-Autosomal dominant) | Limited (juvenile cataract-microcornea-renal glucosuria syndrome[MONDO:0012786]-Unknown)",NULL,P:1; LP:2; VUS:30,NULL,NULL,NULL,hm (NA); ht (NA),0,NULL,NULL,NULL,0.5,11.9409,10.054,10.7529537230339,cur_548
SLC37A4,4061,4,2.764491768584727,NULL,NULL,NULL,NULL,"Glycogen storage disease Ib[OMIM:232220]-Autosomal recessive inheritance | Congenital disorder of glycosylation, type IIw[OMIM:619525]-Autosomal dominant inheritance | Glycogen storage disease Ic[OMIM:232240]-Autosomal recessive inheritance","Definitive, Strong, Strong, Strong, Strong (glycogen storage disease Ib[MONDO:0009288]-Autosomal recessive) | Definitive (glycogen storage disease type 1 due to SLC37A4 mutation[MONDO:0023258]-Autosomal recessive)",NULL,P:73; LP:52; VUS:371,OMIM:232220 (tubulopathy: 0.161 | nephrocalcinosis: 0.16 | glomerulopathy: 0.115 | cancer: 0.04 | cyst_cilio: 0.037 | cakut: 0.028); OMIM:232240 (glomerulopathy: 0.224 | complement: 0.214 | tubulopathy: 0.168 | nephrocalcinosis: 0.146 | cyst_cilio: 0.087 | cakut: 0.069 | cancer: 0.05); OMIM:619525 (complement: 0.071 | glomerulopathy: 0.04 | tubulopathy: 0.028 | nephrocalcinosis: 0.021),OMIM:232220 (neonatal_or_pediatric: 0.402); OMIM:232240 (neonatal_or_pediatric: 0.134); OMIM:619525 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.603 | adult: 0.575),OMIM:232220 (syndromic: 0.017 | growth: 0.27 | skeletal: 0.007); OMIM:232240 (syndromic: 0.003 | growth: 0.02 | skeletal: 0.001); OMIM:619525 (syndromic: 0.046 | growth: 0.171 | skeletal: 0.094 | neurologic: 0.009),hm (true); ht (false),0,218,0.0440251572327044,9606.ENSP00000260746:218,0.5,25.4136,34.7692,13.066310729344,cur_549
SLC5A1,11036,3,2.1638797135735413,0,0.51412,2.589,1.833,Glucose/galactose malabsorption[OMIM:606824]-Autosomal recessive inheritance,"Definitive, Strong, Strong, Supportive (glucose-galactose malabsorption[MONDO:0011731]-Autosomal recessive)",NULL,P:11; LP:6; VUS:171,NULL,OMIM:606824 (neonatal_or_pediatric: 0.134),OMIM:606824 (syndromic: 0.009 | growth: 0.171),hm (true); ht (false),0,432,0.10062893081761007,9606.ENSP00000327943:432,0,0.44964799999999994,0.208525,0.777939437161439,cur_550
SLX4,23845,3,1.4112608778656317,0,0.68004,2.4119,-1.8817,"Fanconi anemia, complementation group P[OMIM:613951]-Autosomal recessive inheritance","Definitive (Fanconi anemia complementation group P[MONDO:0013499]-Autosomal recessive) | No Known Disease Relationship (familial ovarian cancer[MONDO:0016248]-Autosomal dominant) | Limited (hereditary breast carcinoma[MONDO:0016419]-Autosomal dominant) | Strong, Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive)",No Known Disease Relationship (familial ovarian cancer[MONDO:0016248]-AD) | Limited (hereditary breast carcinoma[MONDO:0016419]-AD),P:72; LP:31; VUS:1088,OMIM:613951 (cancer: 0.09 | cakut: 0.04 | cyst_cilio: 0.01 | glomerulopathy: 0.007),NULL,OMIM:613951 (syndromic: 0.046 | growth: 0.341 | skeletal: 0.082 | neurologic: 0.029),hm (false); ht (false),0.5,5087,0.750524109014675,"9606.ENSP00000287647:939, 9606.ENSP00000289081:499, 9606.ENSP00000379616:165, 9606.ENSP00000373952:578, 9606.ENSP00000385021:499, 9606.ENSP00000229769:499, 9606.ENSP00000330875:499, 9606.ENSP00000310842:745, 9606.ENSP00000312987:165, 9606.ENSP00000354497:499",0.5,1.9090799999999999,1.92698,13.1989425514275,cur_551
SMC1A,11111,2,0.9911087866108786,1,0,6.4253,6.4479,"Cornelia de Lange syndrome 2[OMIM:300590]-X-linked dominant inheritance | Developmental and epileptic encephalopathy 85, with or without midline brain defects[OMIM:301044]-X-linked dominant inheritance",Definitive (Cornelia de Lange syndrome 2[MONDO:0010370]-X-linked) | Definitive (Cornelia de Lange syndrome 2[MONDO:0010370]-X-linked dominant) | Supportive (Cornelia de Lange syndrome[MONDO:0016033]-Autosomal dominant) | Supportive (atypical Rett syndrome[MONDO:0017746]-Autosomal dominant) | Definitive (X-linked complex neurodevelopmental disorder[MONDO:0100148]-X-linked),Definitive (X-linked complex neurodevelopmental disorder[MONDO:0100148]-XL),P:106; LP:73; VUS:242,NULL,OMIM:301044 (antenatal_or_congenital: 0.821),OMIM:300590 (syndromic: 0.168 | growth: 0.385 | skeletal: 0.13 | neurologic: 0.178); OMIM:301044 (syndromic: 0.188 | growth: 0.193 | skeletal: 0.132 | neurologic: 0.214),hm (false); ht (false),0.5,1961,0.40041928721174,"9606.ENSP00000231509:210, 9606.ENSP00000306999:169, 9606.ENSP00000356319:292, 9606.ENSP00000282516:998, 9606.ENSP00000265748:292",0.5,9.48258,6.5620199999999995,76.2008558880273,cur_552
SOX18,11194,3,1.63600601224932,0.15103,0.3352,1.5048,0.85951,Hypotrichosis-lymphedema-telangiectasia syndrome[OMIM:607823]-Autosomal recessive inheritance | Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome[OMIM:137940]-Autosomal dominant inheritance,Supportive (hypotrichosis-lymphedema-telangiectasia syndrome (grouping)[MONDO:0007670]-Autosomal dominant) | Moderate (hypotrichosis-lymphedema-telangiectasia syndrome[MONDO:0011914]-Autosomal dominant) | Strong (hypotrichosis-lymphedema-telangiectasia syndrome[MONDO:0011914]-Autosomal recessive) | Strong (hypotrichosis-lymphedema-telangiectasia-renal defect syndrome[MONDO:0019073]-Autosomal dominant),NULL,P:5; LP:1; VUS:47,OMIM:137940 (nephrocalcinosis: 0.153 | tubulopathy: 0.147 | glomerulopathy: 0.115 | complement: 0.107 | cyst_cilio: 0.081 | cakut: 0.056 | cancer: 0.02),OMIM:137940 (antenatal_or_congenital: 0.899 | neonatal_or_pediatric: 0.402); OMIM:607823 (neonatal_or_pediatric: 0.665 | antenatal_or_congenital: 0.028),OMIM:137940 (syndromic: 0.045 | skeletal: 0.009 | neurologic: 0.051); OMIM:607823 (syndromic: 0.003),hm (false); ht (false),0,292,0.0649895178197065,9606.ENSP00000216911:292,0,33.2383,19.1779,7.07488662884563,cur_553
SOX9,11204,3,1.9632253899061891,0.99772,0,3.911,1.6311,Campomelic dysplasia with autosomal sex reversal[OMIM:114290]-Autosomal dominant inheritance | Acampomelic campomelic dysplasia[OMIM:114290]-Autosomal dominant inheritance | Campomelic dysplasia[OMIM:114290]-Autosomal dominant inheritance,"Limited (Cooks syndrome[MONDO:0007134]-Autosomal dominant) | Definitive, Definitive, Strong, Supportive (campomelic dysplasia[MONDO:0007251]-Autosomal dominant) | Limited, Supportive (isolated Pierre-Robin syndrome[MONDO:0009869]-Autosomal dominant) | Supportive (46,XY complete gonadal dysgenesis[MONDO:0010765]-Autosomal dominant) | Supportive (46,XX sex reversal 1[MONDO:0010766]-Autosomal dominant) | Supportive (46,XX ovotesticular disorder of sex development[MONDO:0016281]-Autosomal dominant) | Supportive (46,XY partial gonadal dysgenesis[MONDO:0016674]-Autosomal dominant)",Limited (Cooks syndrome[MONDO:0007134]-AD) | Definitive (campomelic dysplasia[MONDO:0007251]-AD) | Limited (isolated Pierre-Robin syndrome[MONDO:0009869]-AD),P:66; LP:44; VUS:108,OMIM:114290 (cakut: 0.073 | cancer: 0.02 | cyst_cilio: 0.013 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:114290 (antenatal_or_congenital: 0.86),OMIM:114290 (syndromic: 0.15 | growth: 0.187 | skeletal: 0.165 | neurologic: 0.1),hm (false); ht (false),0.5,3290,0.5953878406708596,"9606.ENSP00000346829:420, 9606.ENSP00000264414:292, 9606.ENSP00000480291:292, 9606.ENSP00000312397:292, 9606.ENSP00000262367:536, 9606.ENSP00000360231:744, 9606.ENSP00000368253:382, 9606.ENSP00000392028:332",0.5,15.6931,12.6364,25.0057050546651,cur_554
SRCAP,16974,3,1.63600601224932,1,0.048453,9.8122,2.1272,"Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities[OMIM:619595]-Autosomal dominant inheritance | Floating-Harbor syndrome[OMIM:136140]-Autosomal dominant inheritance","Definitive, Definitive, Supportive (Floating-Harbor syndrome[MONDO:0007621]-Autosomal dominant) | Definitive (NA[NA]-Autosomal dominant)",NULL,P:36; LP:42; VUS:503,OMIM:136140 (nephrocalcinosis: 0.181 | tubulopathy: 0.126 | cakut: 0.081 | cancer: 0.03 | glomerulopathy: 0.02 | cyst_cilio: 0.016),OMIM:136140 (neonatal_or_pediatric: 0.402); OMIM:619595 (neonatal_or_pediatric: 0.402),OMIM:136140 (syndromic: 0.098 | growth: 0.25 | skeletal: 0.084 | neurologic: 0.076); OMIM:619595 (syndromic: 0.125 | growth: 0.25 | skeletal: 0.099 | neurologic: 0.142),hm (false); ht (false),0.5,1472,0.33752620545073375,"9606.ENSP00000269305:236, 9606.ENSP00000386857:194, 9606.ENSP00000265748:292, 9606.ENSP00000262367:750",0.5,15.9938,12.5812,36.866050985186,cur_555
STAR,11359,2,0.9911087866108786,0,1.0569,-0.19849,-0.089221,Lipoid adrenal hyperplasia[OMIM:201710]-Autosomal recessive inheritance,"Definitive, Definitive, Strong (congenital lipoid adrenal hyperplasia due to STAR deficency[MONDO:0008725]-Autosomal recessive)",NULL,P:48; LP:46; VUS:67,NULL,NULL,NULL,hm (true); ht (false),0,629,0.15723270440251572,9606.ENSP00000325822:629,0,0.259675,0.195298,1.07380912876994,cur_556
STK11,11389,2,1.487483178658833,0.9934,0.051631,3.8676,1.5969,"Melanoma, malignant, somatic[OMIM:155600]-NA | Pancreatic cancer, somatic[OMIM:260350]-NA | Peutz-Jeghers syndrome[OMIM:175200]-Autosomal dominant inheritance | Testicular tumor, somatic[OMIM:273300]-NA","Definitive, Definitive, Strong, Strong, Supportive (Peutz-Jeghers syndrome[MONDO:0008280]-Autosomal dominant) | Definitive (familial pancreatic carcinoma[MONDO:0015278]-Autosomal dominant) | No Known Disease Relationship (familial ovarian cancer[MONDO:0016248]-Autosomal dominant)",Definitive (Peutz-Jeghers syndrome[MONDO:0008280]-AD) | No Known Disease Relationship (familial ovarian cancer[MONDO:0016248]-AD),P:235; LP:73; VUS:952,OMIM:175200 (cyst_cilio: 0.003),OMIM:175200 (neonatal_or_pediatric: 0.262); OMIM:260350 (adult: 0.218),OMIM:175200 (syndromic: 0.001 | skeletal: 0.003),hm (false); ht (false),0.5,6131,0.7882599580712788,"9606.ENSP00000262366:165, 9606.ENSP00000287878:250, 9606.ENSP00000262304:422, 9606.ENSP00000264731:292, 9606.ENSP00000482245:191, 9606.ENSP00000362680:297, 9606.ENSP00000317272:183, 9606.ENSP00000361021:807, 9606.ENSP00000336655:999, 9606.ENSP00000313169:738, 9606.ENSP00000417132:292, 9606.ENSP00000216911:175, 9606.ENSP00000285071:268, 9606.ENSP00000451828:336, 9606.ENSP00000269305:716",0.5,19.1164,16.222,28.4155419056546,cur_557
TP63,15979,4,2.212527256544169,0.99728000000000006,0.12696,5.0769,2.2077,"Premature ovarian failure 21[OMIM:620311]-Autosomal dominant inheritance | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3[OMIM:604292]-Autosomal dominant inheritance | Hay-Wells syndrome[OMIM:106260]-Autosomal dominant inheritance | Split-hand/foot malformation 4[OMIM:605289]-Autosomal dominant inheritance | Orofacial cleft 8[OMIM:618149]-NA | Rapp-Hodgkin syndrome[OMIM:129400]-Autosomal dominant inheritance | ADULT syndrome[OMIM:103285]-Autosomal dominant inheritance | Limb-mammary syndrome[OMIM:603543]-Autosomal dominant inheritance","Definitive, Supportive (ADULT syndrome[MONDO:0007072]-Autosomal dominant) | Definitive, Supportive (ankyloblepharon-ectodermal defects-cleft lip/palate syndrome[MONDO:0007124]-Autosomal dominant) | Definitive (Rapp-Hodgkin syndrome[MONDO:0007508]-Autosomal dominant) | Supportive (EEC syndrome[MONDO:0010004]-Autosomal dominant) | Definitive, Supportive (limb-mammary syndrome[MONDO:0011334]-Autosomal dominant) | Definitive, Definitive (ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3[MONDO:0011428]-Autosomal dominant) | Moderate (split hand-foot malformation 4[MONDO:0011535]-Autosomal dominant) | Supportive (split hand-foot malformation[MONDO:0016576]-Autosomal dominant)",NULL,P:60; LP:46; VUS:196,OMIM:604292 (cakut: 0.266 | cancer: 0.11 | cyst_cilio: 0.047 | nephrocalcinosis: 0.007 | glomerulopathy: 0.002),OMIM:106260 (antenatal_or_congenital: 0.821); OMIM:604292 (antenatal_or_congenital: 0.821 | neonatal_or_pediatric: 0.665); OMIM:620311 (adult: 0.372),OMIM:103285 (syndromic: 0.007 | skeletal: 0.005); OMIM:106260 (syndromic: 0.039 | skeletal: 0.008 | neurologic: 0.041); OMIM:129400 (syndromic: 0.046 | growth: 0.25 | skeletal: 0.014); OMIM:603543 (syndromic: 0.014 | skeletal: 0.02); OMIM:604292 (syndromic: 0.044 | skeletal: 0.02 | neurologic: 0.046); OMIM:605289 (syndromic: 0.003 | skeletal: 0.011); OMIM:620311 (syndromic: 0.001 | neurologic: 0.001),hm (NA); ht (NA),0.5,2381,0.46750524109014674,"9606.ENSP00000478927:673, 9606.ENSP00000324856:292, 9606.ENSP00000301067:349, 9606.ENSP00000269305:839, 9606.ENSP00000254958:228",0,0.0794163,0.152326,9.46248357000133,cur_558
TREX1,12269,2,1.913341922202766,NULL,NULL,NULL,NULL,"Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations[OMIM:192315]-Autosomal dominant inheritance | Aicardi-Goutieres syndrome 1, dominant and recessive[OMIM:225750]-Autosomal dominant inheritance | Aicardi-Goutieres syndrome 1, dominant and recessive[OMIM:225750]-Autosomal recessive inheritance | {Systemic lupus erythematosus, susceptibility to}[OMIM:152700]-Autosomal dominant inheritance | Chilblain lupus[OMIM:610448]-Autosomal dominant inheritance","Strong, Supportive (retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations[MONDO:0008641]-Autosomal dominant) | Strong, Strong (Aicardi-Goutieres syndrome 1[MONDO:0009165]-Autosomal dominant) | Definitive, Strong, Strong (Aicardi-Goutieres syndrome 1[MONDO:0009165]-Autosomal recessive) | Strong (chilblain lupus 1[MONDO:0012500]-Autosomal dominant) | Supportive (familial chilblain lupus[MONDO:0018827]-Autosomal dominant) | Supportive (Aicardi-Goutieres syndrome[MONDO:0018866]-Autosomal dominant)",NULL,P:36; LP:28; VUS:224,OMIM:152700 (glomerulopathy: 0.02 | cyst_cilio: 0.003); OMIM:192315 (complement: 0.143 | glomerulopathy: 0.044 | tubulopathy: 0.035 | nephrocalcinosis: 0.028 | cakut: 0.016 | cyst_cilio: 0.01),OMIM:192315 (adult: 0.218); OMIM:610448 (neonatal_or_pediatric: 0.665),OMIM:152700 (syndromic: 0.021 | skeletal: 0.003 | neurologic: 0.043); OMIM:192315 (syndromic: 0.033 | skeletal: 0 | neurologic: 0.068); OMIM:225750 (syndromic: 0.101 | growth: 0.25 | skeletal: 0.055 | neurologic: 0.184),hm (true); ht (false),0,NULL,NULL,NULL,0,14.4065,11.6554,5.03838076193952,cur_559
TXNL4A,30551,2,1.1309261498321586,7.2e-5,1.069,-0.15142,2.7696,Burn-McKeown syndrome[OMIM:608572]-Autosomal recessive inheritance,"Definitive, Strong, Supportive (choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome[MONDO:0012064]-Autosomal recessive)",NULL,P:5; LP:3; VUS:4,OMIM:608572 (cakut: 0.137 | cancer: 0.05 | cyst_cilio: 0.042 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:608572 (antenatal_or_congenital: 0.821),OMIM:608572 (syndromic: 0.046 | growth: 0.25 | skeletal: 0.039),hm (NA); ht (NA),0.5,1749,0.3731656184486373,"9606.ENSP00000287600:165, 9606.ENSP00000356319:292, 9606.ENSP00000256078:163, 9606.ENSP00000261167:800, 9606.ENSP00000347942:329",0.5,18.6285,12.5985,62.7089610643934,cur_560
UQCC2,21237,3,1.4112608778656317,0.01866,0.45406,1.5016,0.49859,"Mitochondrial complex III deficiency, nuclear type 7[OMIM:615824]-Autosomal recessive inheritance",Supportive (mitochondrial complex III deficiency[MONDO:0015448]-Autosomal recessive),NULL,P:2; LP:0; VUS:13,OMIM:615824 (nephrocalcinosis: 0.007 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:615824 (neonatal_or_pediatric: 0.134),OMIM:615824 (syndromic: 0.086 | growth: 0.273 | skeletal: 0.004 | neurologic: 0.111),hm (NA); ht (NA),0,161,0.0041928721174004195,9606.ENSP00000216911:161,0.5,31.7288,19.0529,36.2260429434042,cur_561
WAS,12731,4,2.1042636582178096,0.99901,0,4.1477,1.9754,"Wiskott-Aldrich syndrome[OMIM:301000]-X-linked recessive inheritance | Neutropenia, severe congenital, X-linked[OMIM:300299]-X-linked recessive inheritance | Thrombocytopenia, X-linked, intermittent[OMIM:313900]-X-linked recessive inheritance | Thrombocytopenia, X-linked[OMIM:313900]-X-linked recessive inheritance","Definitive, Moderate, Supportive (X-linked severe congenital neutropenia[MONDO:0010294]-X-linked) | Supportive (Wiskott-Aldrich syndrome[MONDO:0010518]-Autosomal dominant) | Definitive, Definitive (Wiskott-Aldrich syndrome[MONDO:0010518]-X-linked) | Supportive (thrombocytopenia 1[MONDO:0010743]-X-linked)",Definitive (X-linked severe congenital neutropenia[MONDO:0010294]-XL) | Definitive (Wiskott-Aldrich syndrome[MONDO:0010518]-XL),P:110; LP:42; VUS:131,OMIM:301000 (cancer: 0.02 | glomerulopathy: 0.02 | nephrocalcinosis: 0.014 | cyst_cilio: 0.008),OMIM:300299 (antenatal_or_congenital: 0.821); OMIM:301000 (neonatal_or_pediatric: 0.402),OMIM:301000 (syndromic: 0.003 | skeletal: 0.004 | neurologic: 0); OMIM:313900 (syndromic: 0.001 | skeletal: 0.001),hm (true); ht (false),0.5,5897,0.779874213836478,"9606.ENSP00000347198:171, 9606.ENSP00000362680:945, 9606.ENSP00000347244:457, 9606.ENSP00000269305:194, 9606.ENSP00000370719:726, 9606.ENSP00000451828:936, 9606.ENSP00000362924:610, 9606.ENSP00000215832:262, 9606.ENSP00000288235:340, 9606.ENSP00000219596:304, 9606.ENSP00000368190:339, 9606.ENSP00000281171:161, 9606.ENSP00000216181:452",0,2.58525,3.04695,4.35578617622864,cur_562
WDR4,12756,2,1.221470948211456,0,0.725,1.1591,-1.0205,"Galloway-Mowat syndrome 6[OMIM:618347]-Autosomal recessive inheritance | Microcephaly, growth deficiency, seizures, and brain malformations[OMIM:618346]-Autosomal recessive inheritance","Supportive (Galloway-Mowat syndrome[MONDO:0009627]-Autosomal recessive) | Moderate (microcephaly, growth deficiency, seizures, and brain malformations[MONDO:0032690]-Autosomal recessive) | Limited (Galloway-Mowat syndrome 6[MONDO:0032691]-Autosomal recessive)",NULL,P:7; LP:4; VUS:82,OMIM:618347 (glomerulopathy: 0.204 | complement: 0.036 | cancer: 0.03 | cakut: 0.02 | cyst_cilio: 0.008 | nephrocalcinosis: 0.007 | tubulopathy: 0.007),OMIM:618346 (antenatal_or_congenital: 0.821); OMIM:618347 (neonatal_or_pediatric: 0.402 | antenatal_or_congenital: 0.077),OMIM:618346 (syndromic: 0.099 | growth: 0.595 | skeletal: 0.061 | neurologic: 0.107); OMIM:618347 (syndromic: 0.164 | growth: 0.469 | skeletal: 0.069 | neurologic: 0.226),hm (false); ht (false),0.5,641,0.16561844863731656,"9606.ENSP00000361186:234, 9606.ENSP00000408292:407",0.5,4.8964099999999995,3.49939,26.0941409424125,cur_563
XRCC4,12831,2,1.1309261498321586,NULL,NULL,NULL,NULL,"Short stature, microcephaly, and endocrine dysfunction[OMIM:616541]-Autosomal recessive inheritance","Definitive (Fanconi anemia complementation group Q[MONDO:0014108]-Autosomal recessive) | Strong, Strong (short stature, microcephaly, and endocrine dysfunction[MONDO:0014686]-Autosomal recessive) | Supportive (microcephalic primordial dwarfism-insulin resistance syndrome[MONDO:0018575]-Autosomal recessive) | Limited (hereditary nonpolyposis colon cancer[MONDO:0018630]-Autosomal dominant)",Limited (hereditary nonpolyposis colon cancer[MONDO:0018630]-AD),P:14; LP:6; VUS:43,OMIM:616541 (cakut: 0.153 | cancer: 0.1 | cyst_cilio: 0.042 | tubulopathy: 0.007 | glomerulopathy: 0.004),NULL,OMIM:616541 (syndromic: 0.116 | growth: 0.373 | skeletal: 0.058 | neurologic: 0.167),hm (false); ht (false),0.5,2489,0.48427672955974843,"9606.ENSP00000357283:329, 9606.ENSP00000369497:540, 9606.ENSP00000261584:540, 9606.ENSP00000287647:540, 9606.ENSP00000310842:540",0.5,4.00551,2.55565,50.6999811618963,cur_564
YAP1,16262,2,1.5456388783807975,0.99918,0.04008,4.4432,1.7764,"Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development[OMIM:120433]-Autosomal dominant inheritance","Strong, Strong, Strong, Supportive (uveal coloboma-cleft lip and palate-intellectual disability[MONDO:0007355]-Autosomal dominant)",NULL,P:3; LP:2; VUS:19,OMIM:120433 (complement: 0.143 | glomerulopathy: 0.044 | tubulopathy: 0.035 | nephrocalcinosis: 0.028 | cakut: 0.016 | cyst_cilio: 0.01),OMIM:120433 (antenatal_or_congenital: 0.821),OMIM:120433 (syndromic: 0.026 | neurologic: 0.04),hm (false); ht (false),0.5,2877,0.5450733752620545,"9606.ENSP00000362680:906, 9606.ENSP00000409007:476, 9606.ENSP00000264731:673, 9606.ENSP00000262613:530, 9606.ENSP00000361021:292",0.5,39.4859,22.5593,322.137475335951,cur_565
ZMYND10,19412,2,1.0993723849372383,0,0.55783,2.1247,0.93184,"Ciliary dyskinesia, primary, 22[OMIM:615444]-Autosomal recessive inheritance","Definitive, Strong, Strong, Strong, Strong (primary ciliary dyskinesia 22[MONDO:0014192]-Autosomal recessive) | Supportive (primary ciliary dyskinesia[MONDO:0016575]-Autosomal dominant)",Definitive (primary ciliary dyskinesia 22[MONDO:0014192]-AR),P:13; LP:6; VUS:83,NULL,OMIM:615444 (neonatal_or_pediatric: 0.865),OMIM:615444 (syndromic: 0.002 | skeletal: 0.004),hm (false); ht (false),0.5,1326,0.31446540880503143,"9606.ENSP00000314444:253, 9606.ENSP00000382717:214, 9606.ENSP00000296266:183, 9606.ENSP00000238628:437, 9606.ENSP00000406012:239",0,19.6194,7.280010000000001,1.10213971753131,cur_566
DICER1,17098,3,2.260541664910249,NULL,NULL,NULL,NULL,"Pleuropulmonary blastoma[OMIM:601200]-Autosomal dominant inheritance | Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors[OMIM:138800]-Autosomal dominant inheritance | GLOW syndrome, somatic mosaic[OMIM:618272]-NA | Rhabdomyosarcoma, embryonal, 2[OMIM:180295]-NA","Definitive (goiter, multinodular 1, with or without Sertoli-Leydig cell tumors[MONDO:0007681]-Autosomal dominant) | Definitive, Strong (pleuropulmonary blastoma[MONDO:0011014]-Autosomal dominant) | Supportive (DICER1 syndrome[MONDO:0017288]-Autosomal dominant) | Definitive (DICER1-related tumor predisposition[MONDO:0100216]-Autosomal dominant)",Definitive (DICER1-related tumor predisposition[MONDO:0100216]-AD),P:526; LP:119; VUS:2830,OMIM:180295 (cancer: 0.12 | complement: 0.036 | cakut: 0.008 | glomerulopathy: 0.007); OMIM:618272 (cancer: 0.15 | complement: 0.036 | cakut: 0.024 | cyst_cilio: 0.024 | glomerulopathy: 0.007),OMIM:618272 (antenatal_or_congenital: 0.821),OMIM:601200 (syndromic: 0 | neurologic: 0.001); OMIM:618272 (syndromic: 0.063 | growth: 0.018 | skeletal: 0.087 | neurologic: 0.053),hm (false); ht (false),0.5,3630,0.6331236897274634,"9606.ENSP00000297185:292, 9606.ENSP00000227507:330, 9606.ENSP00000231887:175, 9606.ENSP00000215832:354, 9606.ENSP00000359583:163, 9606.ENSP00000360532:203, 9606.ENSP00000216911:239, 9606.ENSP00000360997:161, 9606.ENSP00000445122:179, 9606.ENSP00000265351:900, 9606.ENSP00000359297:179, 9606.ENSP00000380321:292, 9606.ENSP00000316842:163",0.5,12.8555,7.4075,111.557952110023,cur_567
DYNC2LI1,24595,2,1.089085145648058,0,0.74315,1.1044,-0.32613,Short-rib thoracic dysplasia 15 with polydactyly[OMIM:617088]-Autosomal recessive inheritance,Supportive (Ellis-van Creveld syndrome[MONDO:0009162]-Autosomal recessive) | Definitive (short-rib thoracic dysplasia 15 with polydactyly[MONDO:0014907]-Autosomal recessive) | Supportive (Jeune syndrome[MONDO:0018770]-Autosomal recessive),NULL,P:33; LP:16; VUS:254,OMIM:617088 (cancer: 0.07 | cakut: 0.028 | cyst_cilio: 0.01 | glomerulopathy: 0.007),OMIM:617088 (antenatal_or_congenital: 0.115),OMIM:617088 (syndromic: 0.044 | growth: 0.25 | skeletal: 0.038),hm (false); ht (false),0.5,2224,0.4444444444444444,"9606.ENSP00000367715:240, 9606.ENSP00000361800:986, 9606.ENSP00000384290:998",0.5,17.6252,8.35972,64.2257655560973,cur_568
GLI2,4318,2,1.464757000321854,NULL,NULL,NULL,NULL,Culler-Jones syndrome[OMIM:615849]-Autosomal dominant inheritance | Holoprosencephaly 9[OMIM:610829]-Autosomal dominant inheritance,"Definitive, Moderate (holoprosencephaly 9[MONDO:0012563]-Autosomal dominant) | Supportive (combined pituitary hormone deficiencies, genetic form[MONDO:0013099]-Autosomal dominant) | Definitive, Moderate, Limited, Supportive (postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome[MONDO:0014369]-Autosomal dominant) | Supportive (holoprosencephaly[MONDO:0016296]-Autosomal recessive)",NULL,P:36; LP:22; VUS:367,NULL,NULL,OMIM:610829 (syndromic: 0.103 | growth: 0.25 | skeletal: 0.068 | neurologic: 0.134); OMIM:615849 (syndromic: 0.05 | growth: 0.25 | skeletal: 0.004 | neurologic: 0.052),hm (false); ht (false),0.5,4585,0.7148846960167715,"9606.ENSP00000420321:190, 9606.ENSP00000287538:386, 9606.ENSP00000356405:533, 9606.ENSP00000377934:976, 9606.ENSP00000264414:630, 9606.ENSP00000269305:311, 9606.ENSP00000412940:345, 9606.ENSP00000379258:922, 9606.ENSP00000392028:292",0.5,2.21074,0.7279770000000001,112.726511228161,cur_569
IFT52,15901,2,1.2923751652894166,2e-6,0.54457,2.062,1.444,Short-rib thoracic dysplasia 16 with or without polydactyly[OMIM:617102]-Autosomal recessive inheritance,"Supportive (cranioectodermal dysplasia[MONDO:0009032]-Autosomal recessive) | Strong, Limited (short-rib thoracic dysplasia 16 with or without polydactyly[MONDO:0014915]-Autosomal recessive)",NULL,P:7; LP:2; VUS:60,NULL,OMIM:617102 (antenatal_or_congenital: 0.821),OMIM:617102 (syndromic: 0.067 | growth: 0.25 | skeletal: 0.051 | neurologic: 0.029),hm (false); ht (false),1,11372,0.9371069182389937,"9606.ENSP00000268057:198, 9606.ENSP00000312778:994, 9606.ENSP00000296266:599, 9606.ENSP00000317469:232, 9606.ENSP00000314444:540, 9606.ENSP00000243344:540, 9606.ENSP00000367203:194, 9606.ENSP00000382717:540, 9606.ENSP00000393541:998, 9606.ENSP00000262613:164, 9606.ENSP00000362424:983, 9606.ENSP00000238628:540, 9606.ENSP00000406012:682, 9606.ENSP00000338766:194, 9606.ENSP00000377769:639, 9606.ENSP00000242591:997, 9606.ENSP00000482306:194, 9606.ENSP00000404122:998, 9606.ENSP00000260570:982, 9606.ENSP00000304941:164",0.5,13.5817,10.5944,59.0376270788418,cur_570
INTU,29239,2,1.13600601224932,0,0.51826,2.9085,0.38393,?Orofaciodigital syndrome XVII[OMIM:617926]-Autosomal recessive inheritance | ?Short-rib thoracic dysplasia 20 with polydactyly[OMIM:617925]-Autosomal recessive inheritance,Moderate (orofaciodigital syndrome 17[MONDO:0033375]-Autosomal recessive),NULL,P:2; LP:4; VUS:99,OMIM:617926 (cakut: 0.089 | cyst_cilio: 0.037 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),NULL,OMIM:617925 (syndromic: 0.04 | skeletal: 0.094); OMIM:617926 (syndromic: 0.044 | growth: 0.276 | skeletal: 0.038 | neurologic: 0.034),hm (true); ht (false),0.5,2798,0.5324947589098532,"9606.ENSP00000314444:189, 9606.ENSP00000367398:500, 9606.ENSP00000272321:963, 9606.ENSP00000382717:252, 9606.ENSP00000406012:268, 9606.ENSP00000360761:169, 9606.ENSP00000260570:272, 9606.ENSP00000246868:185",0.5,5.72434,1.7219400000000002,64.7844006205691,cur_571
LEP,6553,2,1.3833701397156053,0.46491,0.17543,1.8243,0.90973,"Obesity, morbid, due to leptin deficiency[OMIM:614962]-Autosomal recessive inheritance","Strong, Strong, Supportive (obesity due to congenital leptin deficiency[MONDO:0013991]-Autosomal recessive)",NULL,P:6; LP:1; VUS:63,NULL,OMIM:614962 (neonatal_or_pediatric: 0.262),OMIM:614962 (syndromic: 0.004 | growth: 0.043 | neurologic: 0.001),hm (true); ht (false),0.5,2424,0.4779874213836478,"9606.ENSP00000323568:171, 9606.ENSP00000237837:157, 9606.ENSP00000384092:813, 9606.ENSP00000330393:995, 9606.ENSP00000381448:288",0,0.0345857,0.018234599999999997,0.450130600058976,cur_572
LEPR,6554,2,1.259181075767505,0.99475,0.16287,5.7664,1.422,"Obesity, morbid, due to leptin receptor deficiency[OMIM:614963]-Autosomal recessive inheritance","Strong, Strong, Supportive (obesity due to leptin receptor gene deficiency[MONDO:0013992]-Autosomal recessive)",NULL,P:7; LP:4; VUS:110,NULL,OMIM:614963 (neonatal_or_pediatric: 0.402),OMIM:614963 (syndromic: 0.042 | growth: 0.312 | neurologic: 0.051),hm (true); ht (false),0.5,2254,0.4528301886792453,"9606.ENSP00000312652:995, 9606.ENSP00000369647:329, 9606.ENSP00000317469:747, 9606.ENSP00000384092:183",0.5,2.98802,1.3840700000000001,23.1995113330424,cur_573
MOCS1,7190,2,1.0195244761919913,NULL,NULL,NULL,NULL,Molybdenum cofactor deficiency A[OMIM:252150]-Autosomal recessive inheritance,"Definitive, Definitive, Definitive, Strong (sulfite oxidase deficiency due to molybdenum cofactor deficiency type A[MONDO:0009643]-Autosomal recessive)",Definitive (sulfite oxidase deficiency due to molybdenum cofactor deficiency type A[MONDO:0009643]-AR),P:24; LP:11; VUS:354,OMIM:252150 (nephrocalcinosis: 0.007),NULL,OMIM:252150 (syndromic: 0.1 | growth: 0.091 | skeletal: 0.08 | neurologic: 0.153),hm (true); ht (false),0,NULL,NULL,NULL,0,15.45,18.9889,4.69165770710027,cur_574
MOCS2,7193,2,1.0195244761919913,4.61e-4,0.7065,0.79258,-0.078768,Molybdenum cofactor deficiency B[OMIM:252160]-Autosomal recessive inheritance,"Definitive, Definitive, Strong, Moderate (sulfite oxidase deficiency due to molybdenum cofactor deficiency type B[MONDO:0009644]-Autosomal recessive)",Definitive (sulfite oxidase deficiency due to molybdenum cofactor deficiency type B[MONDO:0009644]-AR),P:21; LP:11; VUS:123,OMIM:252160 (nephrocalcinosis: 0.007),OMIM:252160 (neonatal_or_pediatric: 0.134),OMIM:252160 (syndromic: 0.112 | growth: 0.091 | skeletal: 0.08 | neurologic: 0.178),hm (true); ht (false),0,NULL,NULL,NULL,0.5,25.3111,20.7483,18.5772818115534,cur_575
NODAL,7865,2,0.9112608778656316,0.97028,0.065441,3.3853,0.97103,"Heterotaxy, visceral, 5[OMIM:270100]-Autosomal dominant inheritance","Definitive, Supportive, Disputed Evidence (situs inversus[MONDO:0010029]-Autosomal dominant) | Strong (visceral heterotaxy[MONDO:0018677]-Autosomal dominant)",NULL,P:6; LP:7; VUS:71,OMIM:270100 (cakut: 0.089 | cyst_cilio: 0.039 | cancer: 0.03 | tubulopathy: 0.007 | glomerulopathy: 0.004),OMIM:270100 (antenatal_or_congenital: 0.821),OMIM:270100 (syndromic: 0.02 | growth: 0.107 | skeletal: 0.001 | neurologic: 0.029),hm (false); ht (false),0,271,0.05450733752620545,9606.ENSP00000265171:271,0,0.0934382,0.142,0.309568281162804,cur_576
PIK3C2A,8971,2,1.3239289301843369,NULL,NULL,NULL,NULL,Oculoskeletodental syndrome[OMIM:618440]-Autosomal recessive inheritance,"Strong, Supportive (oculocerebrodental syndrome[MONDO:0034145]-Autosomal recessive)",NULL,P:6; LP:1; VUS:158,OMIM:618440 (cancer: 0.05 | cakut: 0.044 | cyst_cilio: 0.008),NULL,OMIM:618440 (syndromic: 0.073 | growth: 0.296 | skeletal: 0.056 | neurologic: 0.051),hm (true); ht (false),0.5,2259,0.4549266247379455,"9606.ENSP00000265748:163, 9606.ENSP00000349781:499, 9606.ENSP00000366563:614, 9606.ENSP00000377789:163, 9606.ENSP00000356319:292, 9606.ENSP00000358866:161, 9606.ENSP00000216181:177, 9606.ENSP00000252699:190",0.5,15.6858,10.8299,249.982580592762,cur_577
PIK3CD,8977,2,1.398998438988785,0.99999,0.093265,6.1521,4.2747,"Immunodeficiency 14A, autosomal dominant[OMIM:615513]-Autosomal dominant inheritance | Immunodeficiency 14B, autosomal recessive[OMIM:619281]-Autosomal recessive inheritance | ?Roifman-Chitayat syndrome, digenic[OMIM:613328]-Digenic inheritance","Definitive (immunodeficiency 14[MONDO:0014222]-Autosomal dominant) | Strong, Supportive (activated PI3K-delta syndrome[MONDO:0018338]-Autosomal dominant) | Definitive (immunodeficiency 14b, autosomal recessive[MONDO:0023655]-Autosomal recessive)","Definitive (immunodeficiency 14[MONDO:0014222]-AD) | Definitive (immunodeficiency 14b, autosomal recessive[MONDO:0023655]-AR)",P:10; LP:3; VUS:262,OMIM:613328 (cancer: 0.05 | cakut: 0.016),OMIM:619281 (neonatal_or_pediatric: 0.865),OMIM:613328 (syndromic: 0.054 | skeletal: 0.034 | neurologic: 0.066); OMIM:619281 (syndromic: 0.001 | skeletal: 0.005),hm (false); ht (false),0.5,2882,0.5471698113207547,"9606.ENSP00000347591:499, 9606.ENSP00000265970:614, 9606.ENSP00000409007:499, 9606.ENSP00000256078:458, 9606.ENSP00000362680:313, 9606.ENSP00000347942:499",0.5,8.875869999999999,5.77365,17.6475365408226,cur_578
PPARG,9236,2,1.4426843195117125,NULL,NULL,NULL,NULL,"{Diabetes, type 2}[OMIM:125853]-Autosomal dominant inheritance | Insulin resistance, severe, digenic[OMIM:604367]-Autosomal dominant inheritance | Lipodystrophy, familial partial, type 3[OMIM:604367]-Autosomal dominant inheritance | Obesity, severe[OMIM:601665]-Autosomal dominant inheritance | Obesity, severe[OMIM:601665]-Autosomal recessive inheritance | Obesity, severe[OMIM:601665]-Multifactorial inheritance | Carotid intimal medial thickness 1[OMIM:609338]-NA","Definitive, Strong, Supportive (PPARG-related familial partial lipodystrophy[MONDO:0011448]-Autosomal dominant) | Supportive (Berardinelli-Seip congenital lipodystrophy[MONDO:0018883]-Autosomal recessive)",NULL,P:17; LP:16; VUS:50,NULL,OMIM:125853 (adult: 0.108); OMIM:604367 (adult: 0.372 | neonatal_or_pediatric: 0.2),OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:601665 (syndromic: 0.003 | growth: 0.054),hm (false); ht (true),1,8847,0.8637316561844863,"9606.ENSP00000228606:292, 9606.ENSP00000381098:457, 9606.ENSP00000362680:434, 9606.ENSP00000397908:769, 9606.ENSP00000484824:292, 9606.ENSP00000256474:292, 9606.ENSP00000339191:457, 9606.ENSP00000312987:339, 9606.ENSP00000216117:240, 9606.ENSP00000361021:309, 9606.ENSP00000256078:242, 9606.ENSP00000345708:265, 9606.ENSP00000365380:739, 9606.ENSP00000368253:638, 9606.ENSP00000262367:992, 9606.ENSP00000252699:292, 9606.ENSP00000231509:513, 9606.ENSP00000269305:497, 9606.ENSP00000307235:331, 9606.ENSP00000215832:457",0.5,8.14741,7.85204,101.79949582137,cur_579
SLC17A5,10933,2,1.24426961057568,0,0.70374,1.3884,0.7135,"Salla disease[OMIM:604369]-Autosomal recessive inheritance | Sialic acid storage disorder, infantile[OMIM:269920]-Autosomal recessive inheritance","Strong, Supportive (free sialic acid storage disease, infantile form[MONDO:0010027]-Autosomal recessive) | Definitive, Definitive, Strong, Supportive (Salla disease[MONDO:0011449]-Autosomal recessive) | Supportive (intermediate severe Salla disease[MONDO:0017737]-Autosomal recessive)",NULL,P:51; LP:67; VUS:142,OMIM:269920 (glomerulopathy: 0.109 | complement: 0.036 | cancer: 0.03 | cakut: 0.008),NULL,OMIM:269920 (syndromic: 0.087 | growth: 0.171 | skeletal: 0.012 | neurologic: 0.108); OMIM:604369 (syndromic: 0.103 | growth: 0.091 | skeletal: 0.002 | neurologic: 0.203),hm (false); ht (false),0,NULL,NULL,NULL,0.5,8.93287,11.7161,27.4093690303209,cur_580
TMEM218,27344,2,0.9112608778656316,NULL,NULL,NULL,NULL,Joubert syndrome 39[OMIM:619562]-Autosomal recessive inheritance,NULL,NULL,P:2; LP:2; VUS:6,OMIM:619562 (cyst_cilio: 0.063 | cakut: 0.012 | cancer: 0.01),OMIM:619562 (antenatal_or_congenital: 0.038),OMIM:619562 (syndromic: 0.03 | growth: 0.005 | skeletal: 0.006 | neurologic: 0.06),hm (true); ht (false),0,552,0.14255765199161424,"9606.ENSP00000243578:155, 9606.ENSP00000258173:226, 9606.ENSP00000376827:171",0.5,12.5356,7.42312,15.2879375021018,cur_581
AKT1,391,2,1.3754347603928436,NULL,NULL,NULL,NULL,"Breast cancer, somatic[OMIM:114480]-NA | Cowden syndrome 6[OMIM:615109]-NA | Colorectal cancer, somatic[OMIM:114500]-NA | Proteus syndrome, somatic[OMIM:176920]-NA | Ovarian cancer, somatic[OMIM:167000]-NA",Definitive (Proteus syndrome[MONDO:0008318]-Autosomal dominant) | Definitive (Proteus syndrome[MONDO:0008318]-Somatic mosaicism) | Supportive (Cowden disease[MONDO:0016063]-Autosomal dominant),NULL,P:4; LP:2; VUS:260,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:176920 (neonatal_or_pediatric: 0.402); OMIM:615109 (adult: 0.218),OMIM:176920 (syndromic: 0.025 | growth: 0.004 | skeletal: 0.031 | neurologic: 0.002); OMIM:615109 (syndromic: 0.079 | skeletal: 0.089 | neurologic: 0.09),hm (false); ht (false),1,20158,0.9958071278825996,"9606.ENSP00000337088:371, 9606.ENSP00000262304:292, 9606.ENSP00000262613:292, 9606.ENSP00000358423:217, 9606.ENSP00000287647:292, 9606.ENSP00000281043:499, 9606.ENSP00000262366:165, 9606.ENSP00000312397:292, 9606.ENSP00000351015:311, 9606.ENSP00000352264:292, 9606.ENSP00000445306:206, 9606.ENSP00000413720:292, 9606.ENSP00000276297:536, 9606.ENSP00000344314:199, 9606.ENSP00000379258:613, 9606.ENSP00000361021:560, 9606.ENSP00000365891:936, 9606.ENSP00000219476:292, 9606.ENSP00000339191:606, 9606.ENSP00000262457:410, 9606.ENSP00000422591:169, 9606.ENSP00000215832:798, 9606.ENSP00000393312:292, 9606.ENSP00000341292:225, 9606.ENSP00000307235:292, 9606.ENSP00000363435:934, 9606.ENSP00000231509:450, 9606.ENSP00000301067:292, 9606.ENSP00000417132:292, 9606.ENSP00000216911:526, 9606.ENSP00000310842:292, 9606.ENSP00000298552:426, 9606.ENSP00000246914:292, 9606.ENSP00000264634:168, 9606.ENSP00000228872:657, 9606.ENSP00000373952:558, 9606.ENSP00000445175:206, 9606.ENSP00000358866:624, 9606.ENSP00000360154:456, 9606.ENSP00000324856:336, 9606.ENSP00000237596:292, 9606.ENSP00000260010:165, 9606.ENSP00000362680:981, 9606.ENSP00000297185:359, 9606.ENSP00000477725:292, 9606.ENSP00000226760:292, 9606.ENSP00000216181:342, 9606.ENSP00000293288:292, 9606.ENSP00000256474:292, 9606.ENSP00000269305:205, 9606.ENSP00000252486:165, 9606.ENSP00000262367:523",0.5,37.9332,24.8429,52.8290155139334,cur_582
AURKA,11393,2,1.5916086105169436,NULL,NULL,NULL,NULL,"{Colon cancer, susceptibility to}[OMIM:114500]-Autosomal dominant inheritance | {Colon cancer, susceptibility to}[OMIM:114500]-Somatic mutation",Limited (intellectual disability[MONDO:0001071]-Autosomal dominant) | Limited (breast cancer[MONDO:0007254]-Autosomal dominant),NULL,P:0; LP:1; VUS:4,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),NULL,NULL,hm (false); ht (false),1,9115,0.8742138364779874,"9606.ENSP00000373952:292, 9606.ENSP00000470972:161, 9606.ENSP00000251810:197, 9606.ENSP00000484803:292, 9606.ENSP00000482245:199, 9606.ENSP00000228872:616, 9606.ENSP00000341815:292, 9606.ENSP00000324856:175, 9606.ENSP00000261267:161, 9606.ENSP00000256474:457, 9606.ENSP00000297185:163, 9606.ENSP00000355922:328, 9606.ENSP00000476140:161, 9606.ENSP00000451828:526, 9606.ENSP00000466134:306, 9606.ENSP00000269305:963, 9606.ENSP00000360540:172, 9606.ENSP00000264414:326, 9606.ENSP00000281043:990, 9606.ENSP00000346839:901, 9606.ENSP00000344314:212, 9606.ENSP00000314444:190, 9606.ENSP00000262426:292, 9606.ENSP00000437256:239, 9606.ENSP00000262457:157, 9606.ENSP00000298552:186, 9606.ENSP00000481646:161",0.5,1.63329,1.41744,10.9746268695347,cur_583
BAX,959,2,1.2329417112732886,NULL,NULL,NULL,NULL,"Colorectal cancer, somatic[OMIM:114500]-NA | T-cell acute lymphoblastic leukemia, somatic[OMIM:613065]-NA","Limited (leukemia, acute lymphocytic, susceptibility to, 1[MONDO:0013108]-Unknown)",NULL,P:3; LP:0; VUS:8,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),NULL,NULL,hm (false); ht (false),0.5,1391,0.3228511530398323,"9606.ENSP00000216117:338, 9606.ENSP00000451828:292, 9606.ENSP00000269305:562, 9606.ENSP00000381448:199",0.5,33.9719,27.8881,26.5276333834238,cur_584
BRCA2,1101,2,1.7401888924519369,NULL,NULL,NULL,NULL,"Fanconi anemia, complementation group D1[OMIM:605724]-Autosomal recessive inheritance | {Glioblastoma 3}[OMIM:613029]-Autosomal recessive inheritance | {Medulloblastoma}[OMIM:155255]-Autosomal dominant inheritance | {Medulloblastoma}[OMIM:155255]-Autosomal recessive inheritance | {Medulloblastoma}[OMIM:155255]-Somatic mutation | {Prostate cancer}[OMIM:176807]-Autosomal dominant inheritance | {Prostate cancer}[OMIM:176807]-X-linked inheritance | {Prostate cancer}[OMIM:176807]-Somatic mutation | {Breast-ovarian cancer, familial, 2}[OMIM:612555]-Autosomal dominant inheritance | {Breast cancer, male, susceptibility to}[OMIM:114480]-Autosomal dominant inheritance | {Breast cancer, male, susceptibility to}[OMIM:114480]-Somatic mutation | {Pancreatic cancer 2}[OMIM:613347]-NA | Wilms tumor[OMIM:194070]-Autosomal dominant inheritance | Wilms tumor[OMIM:194070]-Somatic mutation","Supportive (hereditary breast ovarian cancer syndrome[MONDO:0003582]-Autosomal dominant) | Moderate (sarcoma[MONDO:0005089]-Autosomal dominant) | Definitive, Definitive, Definitive (Fanconi anemia complementation group D1[MONDO:0011584]-Autosomal recessive) | Definitive, Definitive, Strong (breast-ovarian cancer, familial, susceptibility to, 2[MONDO:0012933]-Autosomal dominant) | Strong (pancreatic cancer, susceptibility to, 2[MONDO:0013235]-Autosomal dominant) | Supportive (Fanconi anemia[MONDO:0019391]-Autosomal recessive) | Definitive (familial prostate carcinoma[MONDO:0023122]-Autosomal dominant)","Definitive (Fanconi anemia complementation group D1[MONDO:0011584]-AR) | Definitive (breast-ovarian cancer, familial, susceptibility to, 2[MONDO:0012933]-AD)",P:4406; LP:444; VUS:3224,OMIM:194070 (cancer: 0.12 | complement: 0.036 | cakut: 0.008 | glomerulopathy: 0.007); OMIM:613029 (cancer: 0.12 | complement: 0.036 | cakut: 0.008 | glomerulopathy: 0.007),OMIM:612555 (adult: 0.372),OMIM:155255 (syndromic: 0 | neurologic: 0.001); OMIM:605724 (syndromic: 0.043 | growth: 0.523 | skeletal: 0.052 | neurologic: 0.029); OMIM:613029 (syndromic: 0.001 | neurologic: 0.001),hm (false); ht (false),1,9463,0.8888888888888888,"9606.ENSP00000347942:163, 9606.ENSP00000330875:349, 9606.ENSP00000310842:955, 9606.ENSP00000421491:540, 9606.ENSP00000358866:972, 9606.ENSP00000385021:353, 9606.ENSP00000269305:870, 9606.ENSP00000360540:325, 9606.ENSP00000336701:867, 9606.ENSP00000287647:995, 9606.ENSP00000373952:637, 9606.ENSP00000227507:511, 9606.ENSP00000289081:349, 9606.ENSP00000371294:286, 9606.ENSP00000229769:292, 9606.ENSP00000261584:999",0.5,0.18749000000000002,0.06772180000000001,35.8275315031941,cur_585
CDC42,1736,2,1.301987123692195,NULL,NULL,NULL,NULL,Takenouchi-Kosaki syndrome[OMIM:616737]-Autosomal dominant inheritance,"Definitive, Strong, Strong (macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome[MONDO:0014757]-Autosomal dominant)",Definitive (macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome[MONDO:0014757]-AD),P:9; LP:11; VUS:12,OMIM:616737 (cakut: 0.121 | cancer: 0.02 | cyst_cilio: 0.018 | nephrocalcinosis: 0.007 | tubulopathy: 0.007 | glomerulopathy: 0.002),NULL,OMIM:616737 (syndromic: 0.173 | skeletal: 0.066 | neurologic: 0.214),hm (false); ht (false),0,NULL,NULL,NULL,0.5,71.4268,52.6484,147.769272025061,cur_586
CTLA4,2505,2,1.3223763729971068,NULL,NULL,NULL,NULL,"Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation[OMIM:616100]-Autosomal dominant inheritance | {Diabetes mellitus, insulin-dependent, 12}[OMIM:601388]-NA | {Celiac disease, susceptibility to, 3}[OMIM:609755]-NA | {Hashimoto thyroiditis}[OMIM:140300]-Autosomal dominant inheritance | {Systemic lupus erythematosus, susceptibility to}[OMIM:152700]-Autosomal dominant inheritance","Definitive, Strong, Strong, Supportive (autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency[MONDO:0014493]-Autosomal dominant)",Definitive (autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency[MONDO:0014493]-AD),P:26; LP:9; VUS:103,OMIM:152700 (glomerulopathy: 0.02 | cyst_cilio: 0.003),NULL,OMIM:152700 (syndromic: 0.021 | skeletal: 0.003 | neurologic: 0.043); OMIM:616100 (syndromic: 0.002 | skeletal: 0.003),hm (false); ht (false),0,NULL,NULL,NULL,0,0.734245,0.31596,0.134342136256328,cur_587
CTNNB1,2514,2,1.3902633053418705,0.99999,0.02724,5.4616,3.846,"Exudative vitreoretinopathy 7[OMIM:617572]-Autosomal dominant inheritance | Pilomatricoma, somatic[OMIM:132600]-NA | Colorectal cancer, somatic[OMIM:114500]-NA | Neurodevelopmental disorder with spastic diplegia and visual defects[OMIM:615075]-Autosomal dominant inheritance | Medulloblastoma, somatic[OMIM:155255]-NA | Ovarian cancer, somatic[OMIM:167000]-NA | Hepatocellular carcinoma, somatic[OMIM:114550]-NA","Definitive, Definitive, Strong, Strong (severe intellectual disability-progressive spastic diplegia syndrome[MONDO:0014035]-Autosomal dominant) | Supportive (severe intellectual disability-progressive spastic diplegia syndrome[MONDO:0014035]-Unknown) | Supportive (exudative vitreoretinopathy[MONDO:0019516]-Autosomal dominant) | Moderate (exudative vitreoretinopathy 7[MONDO:0033123]-Autosomal dominant)",Definitive (severe intellectual disability-progressive spastic diplegia syndrome[MONDO:0014035]-AD),P:148; LP:69; VUS:174,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),OMIM:615075 (neonatal_or_pediatric: 0.537); OMIM:617572 (neonatal_or_pediatric: 0.2),OMIM:155255 (syndromic: 0 | neurologic: 0.001); OMIM:615075 (syndromic: 0.11 | growth: 0.137 | skeletal: 0.04 | neurologic: 0.157),hm (false); ht (false),0,NULL,NULL,NULL,0.5,76.8584,43.2705,317.073977132894,cur_588
HMOX1,5013,2,1.301987123692195,0.009682,0.4407,1.7457,-0.52002,"Heme oxygenase-1 deficiency[OMIM:614034]-Autosomal recessive inheritance | {Pulmonary disease, chronic obstructive, susceptibility to}[OMIM:606963]-NA","Strong, Limited, Supportive (heme oxygenase 1 deficiency[MONDO:0013536]-Autosomal recessive)",NULL,P:5; LP:4; VUS:76,OMIM:614034 (complement: 0.143 | glomerulopathy: 0.06 | tubulopathy: 0.035 | nephrocalcinosis: 0.028 | cakut: 0.016 | cyst_cilio: 0.013),NULL,OMIM:614034 (syndromic: 0.03 | growth: 0.091 | neurologic: 0.051),hm (true); ht (false),0.5,1306,0.3081761006289308,"9606.ENSP00000365380:241, 9606.ENSP00000339191:487, 9606.ENSP00000293288:338, 9606.ENSP00000287820:240",0,55.2107,59.73,8.54869809263557,cur_589
IFIH1,18873,2,1.1882243804113792,NULL,NULL,NULL,NULL,Immunodeficiency 95[OMIM:619773]-Autosomal recessive inheritance | Aicardi-Goutieres syndrome 7[OMIM:615846]-Autosomal dominant inheritance | Singleton-Merten syndrome 1[OMIM:182250]-Autosomal dominant inheritance,"Supportive (Singleton-Merten dysplasia[MONDO:0008429]-Autosomal dominant) | Definitive, Definitive, Strong (Aicardi-Goutieres syndrome 7[MONDO:0014367]-Autosomal dominant) | Supportive (Aicardi-Goutieres syndrome[MONDO:0018866]-Autosomal dominant) | Strong (Singleton-Merten syndrome 1[MONDO:0024535]-Autosomal dominant)",NULL,P:30; LP:13; VUS:603,OMIM:615846 (glomerulopathy: 0.109 | complement: 0.036 | cancer: 0.03 | cakut: 0.008),OMIM:182250 (neonatal_or_pediatric: 0.865 | adult: 0.372); OMIM:615846 (antenatal_or_congenital: 0.899 | neonatal_or_pediatric: 0.537); OMIM:619773 (neonatal_or_pediatric: 0.402),OMIM:182250 (syndromic: 0.047 | growth: 0.276 | skeletal: 0.075 | neurologic: 0.003); OMIM:615846 (syndromic: 0.115 | growth: 0.113 | skeletal: 0.057 | neurologic: 0.225); OMIM:619773 (syndromic: 0),hm (false); ht (true),0,NULL,NULL,NULL,0,7.97238,4.16213,3.38543481965312,cur_590
IL6,6018,2,1.399762841949841,NULL,NULL,NULL,NULL,"{Type 2 diabetes mellitus}[OMIM:125853]-Autosomal dominant inheritance | {Rheumatoid arthritis, systemic juvenile}[OMIM:604302]-NA | {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}[OMIM:108010]-Somatic mutation | {Type 1 diabetes mellitus}[OMIM:222100]-Autosomal recessive inheritance | {Crohn disease-associated growth failure}[OMIM:266600]-Multifactorial inheritance | {Kaposi sarcoma, susceptibility to}[OMIM:148000]-Autosomal dominant inheritance",NULL,NULL,P:0; LP:0; VUS:5,OMIM:222100 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:125853 (adult: 0.108),OMIM:108010 (syndromic: 0 | neurologic: 0); OMIM:125853 (syndromic: 0.001 | growth: 0.011); OMIM:222100 (syndromic: 0.001 | neurologic: 0.002); OMIM:266600 (syndromic: 0.006 | growth: 0.102),hm (true); ht (false),0.5,5440,0.7651991614255765,"9606.ENSP00000215832:657, 9606.ENSP00000317272:669, 9606.ENSP00000265171:501, 9606.ENSP00000262418:349, 9606.ENSP00000256078:579, 9606.ENSP00000322323:630, 9606.ENSP00000339191:267, 9606.ENSP00000420194:392, 9606.ENSP00000484824:306, 9606.ENSP00000245451:275, 9606.ENSP00000363773:250, 9606.ENSP00000346839:565",0,5.34635,1.0078200000000002,0.493579362494435,cur_591
ITPR3,6182,2,1.285536706639368,NULL,NULL,NULL,NULL,"Charcot-Marie-Tooth disease, demyelinating, type 1J[OMIM:620111]-Autosomal dominant inheritance | {Diabetes, type 1, susceptibility to}[OMIM:222100]-Autosomal recessive inheritance",Limited (NA[NA]-Autosomal dominant),NULL,P:1; LP:1; VUS:121,OMIM:222100 (tubulopathy: 0.112 | nephrocalcinosis: 0.076 | cyst_cilio: 0.024 | cakut: 0.008 | glomerulopathy: 0.004),OMIM:620111 (adult: 0.575 | neonatal_or_pediatric: 0.262),OMIM:222100 (syndromic: 0.001 | neurologic: 0.002); OMIM:620111 (syndromic: 0.008 | skeletal: 0.003 | neurologic: 0.014),hm (false); ht (false),0.5,7072,0.8218029350104822,"9606.ENSP00000377789:165, 9606.ENSP00000297185:986, 9606.ENSP00000361021:292, 9606.ENSP00000340913:457, 9606.ENSP00000216181:194, 9606.ENSP00000288139:254, 9606.ENSP00000226760:367, 9606.ENSP00000315602:231, 9606.ENSP00000339191:699, 9606.ENSP00000451828:934, 9606.ENSP00000356319:292, 9606.ENSP00000358866:159, 9606.ENSP00000301067:206, 9606.ENSP00000231509:165, 9606.ENSP00000264896:163, 9606.ENSP00000265748:382, 9606.ENSP00000417132:563, 9606.ENSP00000237596:398, 9606.ENSP00000357998:165",0.5,27.9632,12.9917,11.4522789660532,cur_592
MAPK1,6871,2,1.394897225638441,0.99698,0,3.8272,3.6111,Noonan syndrome 13[OMIM:619087]-Autosomal dominant inheritance,NULL,NULL,P:8; LP:4; VUS:12,OMIM:619087 (cancer: 0.04 | cakut: 0.008 | cyst_cilio: 0.003),NULL,OMIM:619087 (syndromic: 0.162 | growth: 0.002 | skeletal: 0.165 | neurologic: 0.162),hm (false); ht (false),1,11224,0.9350104821802935,"9606.ENSP00000348849:154, 9606.ENSP00000451828:798, 9606.ENSP00000269305:893, 9606.ENSP00000262367:653, 9606.ENSP00000256078:837, 9606.ENSP00000227507:320, 9606.ENSP00000312987:292, 9606.ENSP00000358866:476, 9606.ENSP00000362680:891, 9606.ENSP00000385675:657, 9606.ENSP00000359345:190, 9606.ENSP00000228606:294, 9606.ENSP00000470972:154, 9606.ENSP00000349458:457, 9606.ENSP00000287820:457, 9606.ENSP00000246957:292, 9606.ENSP00000365891:262, 9606.ENSP00000219476:292, 9606.ENSP00000339191:292, 9606.ENSP00000290866:379, 9606.ENSP00000380321:359, 9606.ENSP00000445306:292, 9606.ENSP00000437256:354, 9606.ENSP00000347942:386, 9606.ENSP00000262613:286, 9606.ENSP00000346839:507",0.5,16.3765,11.0486,156.908818952671,cur_593
PRKAG2,9386,2,1.3223763729971068,0.99692,0.099222,4.5898,1.6544,"Glycogen storage disease of heart, lethal congenital[OMIM:261740]-Autosomal dominant inheritance | Wolff-Parkinson-White syndrome[OMIM:194200]-Autosomal dominant inheritance | Cardiomyopathy, hypertrophic 6[OMIM:600858]-Autosomal dominant inheritance","Definitive (hypertrophic cardiomyopathy[MONDO:0005045]-Autosomal dominant) | Strong (Wolff-Parkinson-White syndrome[MONDO:0008685]-Autosomal dominant) | Strong, Strong (lethal congenital glycogen storage disease of heart[MONDO:0009867]-Autosomal dominant) | Definitive, Strong (hypertrophic cardiomyopathy 6[MONDO:0010946]-Autosomal dominant)",Definitive (hypertrophic cardiomyopathy[MONDO:0005045]-AD),P:13; LP:9; VUS:412,OMIM:261740 (cancer: 0.03 | cyst_cilio: 0.024 | cakut: 0.016 | glomerulopathy: 0.007),OMIM:194200 (neonatal_or_pediatric: 0.463 | adult: 0.372); OMIM:261740 (antenatal_or_congenital: 0.849),OMIM:261740 (syndromic: 0.024 | neurologic: 0.048),hm (false); ht (false),0.5,632,0.16352201257861634,"9606.ENSP00000252486:382, 9606.ENSP00000324856:250",0.5,12.7334,9.27567,62.778791225729,cur_594
SRC,11283,2,1.261672017112028,0.99691,0.077465,4.3438,3.8709,"?Thrombocytopenia 6[OMIM:616937]-Autosomal dominant inheritance | Colon cancer, advanced, somatic[OMIM:114500]-NA","No Known Disease Relationship (colorectal cancer[MONDO:0005575]-Unknown) | Moderate, Supportive (thrombocytopenia 6[MONDO:0014837]-Autosomal dominant)",Moderate (thrombocytopenia 6[MONDO:0014837]-AD),P:1; LP:2; VUS:12,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),NULL,OMIM:616937 (syndromic: 0.002 | skeletal: 0.007),hm (false); ht (false),1,22549,0.9979035639412998,"9606.ENSP00000324856:297, 9606.ENSP00000356319:292, 9606.ENSP00000358866:590, 9606.ENSP00000360141:700, 9606.ENSP00000260010:258, 9606.ENSP00000409007:499, 9606.ENSP00000228872:351, 9606.ENSP00000297316:265, 9606.ENSP00000228606:457, 9606.ENSP00000269305:556, 9606.ENSP00000451828:981, 9606.ENSP00000362924:729, 9606.ENSP00000256078:687, 9606.ENSP00000265748:292, 9606.ENSP00000262367:888, 9606.ENSP00000312987:497, 9606.ENSP00000227507:286, 9606.ENSP00000294304:432, 9606.ENSP00000319756:376, 9606.ENSP00000484824:983, 9606.ENSP00000445306:371, 9606.ENSP00000317272:909, 9606.ENSP00000352264:408, 9606.ENSP00000264896:454, 9606.ENSP00000347942:820, 9606.ENSP00000262304:292, 9606.ENSP00000340913:543, 9606.ENSP00000366563:313, 9606.ENSP00000346839:677, 9606.ENSP00000478927:906, 9606.ENSP00000347591:499, 9606.ENSP00000337383:292, 9606.ENSP00000393312:575, 9606.ENSP00000315011:292, 9606.ENSP00000215832:891, 9606.ENSP00000287820:434, 9606.ENSP00000361021:226, 9606.ENSP00000313875:292, 9606.ENSP00000285379:347, 9606.ENSP00000410294:308, 9606.ENSP00000339191:988, 9606.ENSP00000219476:351, 9606.ENSP00000365891:945",0.5,27.2379,16.8538,27.8165710652021,cur_595
TFE3,11752,2,1.2329417112732886,0.97985,0.061175,3.5174,2.1546,"Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies[OMIM:301066]-X-linked inheritance | Renal cell carcinoma, papillary, 1[OMIM:300854]-NA",Moderate (complex neurodevelopmental disorder[MONDO:0100038]-Autosomal dominant),NULL,P:9; LP:8; VUS:30,OMIM:300854 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),NULL,OMIM:301066 (syndromic: 0.145 | growth: 0.043 | skeletal: 0.054 | neurologic: 0.197),hm (false); ht (false),0,165,0.018867924528301886,9606.ENSP00000231509:165,0.5,42.4603,34.4282,22.5383678948864,cur_596
TLR2,11848,2,1.7804408626022077,NULL,NULL,NULL,NULL,"{Colorectal cancer, susceptibility to}[OMIM:114500]-Autosomal dominant inheritance | {Colorectal cancer, susceptibility to}[OMIM:114500]-Somatic mutation | {Leprosy, susceptibility to}[OMIM:246300]-Autosomal dominant inheritance | {Mycobacterium tuberculosis, susceptibility to}[OMIM:607948]-NA",NULL,NULL,P:0; LP:0; VUS:29,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002),NULL,NULL,hm (true); ht (false),0.5,3135,0.5828092243186582,"9606.ENSP00000346839:814, 9606.ENSP00000484824:171, 9606.ENSP00000362680:258, 9606.ENSP00000264896:982, 9606.ENSP00000262367:292, 9606.ENSP00000256646:216, 9606.ENSP00000451828:165, 9606.ENSP00000337383:237",0,3.84259,3.93851,1.9755719513869,cur_597
TP53,11998,2,1.9063149350840036,0.53235,0.20476,3.2571,0.98255,"{Basal cell carcinoma 7}[OMIM:614740]-Autosomal dominant inheritance | {Adrenocortical carcinoma, pediatric}[OMIM:202300]-Autosomal dominant inheritance | Hepatocellular carcinoma, somatic[OMIM:114550]-NA | Breast cancer, somatic[OMIM:114480]-NA | Li-Fraumeni syndrome[OMIM:151623]-Autosomal dominant inheritance | Pancreatic cancer, somatic[OMIM:260350]-NA | Nasopharyngeal carcinoma, somatic[OMIM:607107]-NA | {Osteosarcoma}[OMIM:259500]-Somatic mutation | {Choroid plexus papilloma}[OMIM:260500]-Autosomal dominant inheritance | {Colorectal cancer}[OMIM:114500]-Autosomal dominant inheritance | {Colorectal cancer}[OMIM:114500]-Somatic mutation | {Glioma susceptibility 1}[OMIM:137800]-Autosomal dominant inheritance | {Glioma susceptibility 1}[OMIM:137800]-Somatic mutation | Bone marrow failure syndrome 5[OMIM:618165]-Autosomal dominant inheritance","Strong (sarcoma[MONDO:0005089]-Autosomal dominant) | Definitive (breast cancer[MONDO:0007254]-Autosomal dominant) | Definitive, Definitive, Strong, Strong (Li-Fraumeni syndrome 1[MONDO:0007903]-Autosomal dominant) | Strong (adrenocortical carcinoma, hereditary[MONDO:0008734]-Autosomal dominant) | Limited (familial ovarian cancer[MONDO:0016248]-Autosomal dominant) | Supportive (choroid plexus carcinoma[MONDO:0016718]-Autosomal dominant) | Definitive, Supportive (Li-Fraumeni syndrome[MONDO:0018875]-Autosomal dominant) | Limited (bone marrow failure syndrome 5[MONDO:0032573]-Autosomal dominant)",Definitive (Li-Fraumeni syndrome 1[MONDO:0007903]-AD) | Limited (familial ovarian cancer[MONDO:0016248]-AD),P:648; LP:238; VUS:860,OMIM:114500 (cancer: 0.13 | cyst_cilio: 0.013 | tubulopathy: 0.007 | cakut: 0.004 | glomerulopathy: 0.002); OMIM:151623 (cancer: 0.12 | complement: 0.036 | cakut: 0.008 | glomerulopathy: 0.007),OMIM:260350 (adult: 0.218); OMIM:260500 (adult: 0.016); OMIM:618165 (neonatal_or_pediatric: 0.537),OMIM:137800 (syndromic: 0.001 | neurologic: 0.001); OMIM:151623 (syndromic: 0 | skeletal: 0.001); OMIM:202300 (syndromic: 0 | neurologic: 0); OMIM:259500 (syndromic: 0 | skeletal: 0.001); OMIM:260500 (syndromic: 0.024 | skeletal: 0.001 | neurologic: 0.049); OMIM:607107 (syndromic: 0); OMIM:618165 (syndromic: 0.082 | growth: 0.341 | skeletal: 0.058 | neurologic: 0.128),hm (NA); ht (NA),1,30756,1,"9606.ENSP00000287820:497, 9606.ENSP00000361021:615, 9606.ENSP00000262518:236, 9606.ENSP00000368632:252, 9606.ENSP00000260570:163, 9606.ENSP00000337439:163, 9606.ENSP00000337383:345, 9606.ENSP00000360431:292, 9606.ENSP00000301067:181, 9606.ENSP00000231509:782, 9606.ENSP00000216911:963, 9606.ENSP00000349458:237, 9606.ENSP00000417132:292, 9606.ENSP00000408292:387, 9606.ENSP00000401678:163, 9606.ENSP00000264731:839, 9606.ENSP00000216862:292, 9606.ENSP00000246868:292, 9606.ENSP00000349823:305, 9606.ENSP00000344314:292, 9606.ENSP00000227507:292, 9606.ENSP00000226760:163, 9606.ENSP00000261267:224, 9606.ENSP00000484824:901, 9606.ENSP00000293288:562, 9606.ENSP00000367721:163, 9606.ENSP00000315569:163, 9606.ENSP00000370047:163, 9606.ENSP00000348849:366, 9606.ENSP00000362924:307, 9606.ENSP00000252699:163, 9606.ENSP00000466134:163, 9606.ENSP00000360540:163, 9606.ENSP00000262367:999, 9606.ENSP00000261396:163, 9606.ENSP00000297316:205, 9606.ENSP00000355627:229, 9606.ENSP00000384092:225, 9606.ENSP00000482245:515, 9606.ENSP00000414321:256, 9606.ENSP00000340466:163, 9606.ENSP00000463784:775, 9606.ENSP00000287538:292, 9606.ENSP00000470972:163, 9606.ENSP00000361186:827, 9606.ENSP00000360154:163, 9606.ENSP00000324856:716, 9606.ENSP00000362680:556, 9606.ENSP00000377862:157, 9606.ENSP00000369497:870, 9606.ENSP00000264664:163, 9606.ENSP00000479904:190, 9606.ENSP00000365891:194, 9606.ENSP00000481646:361, 9606.ENSP00000215832:893, 9606.ENSP00000380432:173, 9606.ENSP00000337088:292, 9606.ENSP00000349658:165, 9606.ENSP00000317272:194, 9606.ENSP00000352264:313, 9606.ENSP00000480291:327, 9606.ENSP00000413720:292, 9606.ENSP00000297185:989, 9606.ENSP00000216181:392, 9606.ENSP00000312987:457, 9606.ENSP00000278935:225, 9606.ENSP00000361845:163, 9606.ENSP00000256474:560, 9606.ENSP00000243253:163, 9606.ENSP00000451828:205, 9606.ENSP00000390436:311, 9606.ENSP00000377836:307, 9606.ENSP00000264499:163, 9606.ENSP00000252486:202, 9606.ENSP00000357283:374, 9606.ENSP00000251810:888, 9606.ENSP00000484803:292, 9606.ENSP00000359345:667, 9606.ENSP00000228872:309, 9606.ENSP00000228606:292, 9606.ENSP00000358866:165, 9606.ENSP00000326424:163, 9606.ENSP00000360141:301, 9606.ENSP00000367203:292, 9606.ENSP00000274813:359, 9606.ENSP00000472847:305",0.5,13.012,5.9639999999999995,84.4407739031863,cur_598
